{"f0ea0ae0629b45679f011a4f89d953f5": {"prediction": {"id": "f0ea0ae0629b45679f011a4f89d953f5", "prediction_text": "Neutrophil elastase"}, "reference": {"id": "f0ea0ae0629b45679f011a4f89d953f5", "answers": {"answer_start": [0], "text": ["The neutrophil elastase gene (ELANE)"]}}}, "e146e3b3b00e4b30b48f11c3f9398d29": {"prediction": {"id": "e146e3b3b00e4b30b48f11c3f9398d29", "prediction_text": "chronic therapy with classical antipsychotic medications"}, "reference": {"id": "e146e3b3b00e4b30b48f11c3f9398d29", "answers": {"answer_start": [0], "text": ["Tardive dyskinesia (TD) is a movement disorder characterized by abnormal involuntary facial movements induced by chronic therapy with classical antipsychotic medications."]}}}, "483fc3a1201849db9be4c198a58f0f49": {"prediction": {"id": "483fc3a1201849db9be4c198a58f0f49", "prediction_text": "antioxidant"}, "reference": {"id": "483fc3a1201849db9be4c198a58f0f49", "answers": {"answer_start": [274], "text": ["antioxidant"]}}}, "65951bb5dcbf4643b859a321f7c00afb": {"prediction": {"id": "65951bb5dcbf4643b859a321f7c00afb", "prediction_text": "antioxidant"}, "reference": {"id": "65951bb5dcbf4643b859a321f7c00afb", "answers": {"answer_start": [195], "text": ["antioxidant"]}}}, "fb46260848db4f69994eed7d99b696dc": {"prediction": {"id": "fb46260848db4f69994eed7d99b696dc", "prediction_text": "antioxidant"}, "reference": {"id": "fb46260848db4f69994eed7d99b696dc", "answers": {"answer_start": [52], "text": ["antioxidant"]}}}, "c494d379d14b4eeea34a7fdc7b83e326": {"prediction": {"id": "c494d379d14b4eeea34a7fdc7b83e326", "prediction_text": "antioxidant"}, "reference": {"id": "c494d379d14b4eeea34a7fdc7b83e326", "answers": {"answer_start": [1311], "text": ["antioxidant"]}}}, "f412aab992df4921b541f99ed88ca485": {"prediction": {"id": "f412aab992df4921b541f99ed88ca485", "prediction_text": "antioxidant"}, "reference": {"id": "f412aab992df4921b541f99ed88ca485", "answers": {"answer_start": [657], "text": ["antioxidant"]}}}, "ddf614c2778a435c8f034ba96c0a75eb": {"prediction": {"id": "ddf614c2778a435c8f034ba96c0a75eb", "prediction_text": "antioxidant"}, "reference": {"id": "ddf614c2778a435c8f034ba96c0a75eb", "answers": {"answer_start": [856], "text": ["antioxidant"]}}}, "efefa2a07046484782b51773134b2258": {"prediction": {"id": "efefa2a07046484782b51773134b2258", "prediction_text": "mammalian"}, "reference": {"id": "efefa2a07046484782b51773134b2258", "answers": {"answer_start": [1094], "text": ["antioxidant"]}}}, "0b2237936f3840e2b725b6df5e439a60": {"prediction": {"id": "0b2237936f3840e2b725b6df5e439a60", "prediction_text": "antioxidant"}, "reference": {"id": "0b2237936f3840e2b725b6df5e439a60", "answers": {"answer_start": [888], "text": ["antioxidant"]}}}, "529ccea6fcb0445686efbbad2835e09a": {"prediction": {"id": "529ccea6fcb0445686efbbad2835e09a", "prediction_text": "antioxidant"}, "reference": {"id": "529ccea6fcb0445686efbbad2835e09a", "answers": {"answer_start": [233], "text": ["antioxidant"]}}}, "85b84d2fdf7b4c908eff3a983c8b2330": {"prediction": {"id": "85b84d2fdf7b4c908eff3a983c8b2330", "prediction_text": "classical antioxidant"}, "reference": {"id": "85b84d2fdf7b4c908eff3a983c8b2330", "answers": {"answer_start": [1133], "text": ["antioxidant"]}}}, "eb11c6402e4749238a66f56eaffdab34": {"prediction": {"id": "eb11c6402e4749238a66f56eaffdab34", "prediction_text": "lymphocyte"}, "reference": {"id": "eb11c6402e4749238a66f56eaffdab34", "answers": {"answer_start": [1127], "text": ["antioxidant"]}}}, "96c134ed47514d0c9dfa6b1ad3787b0f": {"prediction": {"id": "96c134ed47514d0c9dfa6b1ad3787b0f", "prediction_text": "an enzyme reducing hydrogen peroxide and lipid peroxides"}, "reference": {"id": "96c134ed47514d0c9dfa6b1ad3787b0f", "answers": {"answer_start": [371], "text": ["antioxidant"]}}}, "f3aca50883b741999477703a98495eb4": {"prediction": {"id": "f3aca50883b741999477703a98495eb4", "prediction_text": "dopamine"}, "reference": {"id": "f3aca50883b741999477703a98495eb4", "answers": {"answer_start": [485], "text": ["L-Dopa"]}}}, "2dcb760ceec3465dbbba16b243e4f4a8": {"prediction": {"id": "2dcb760ceec3465dbbba16b243e4f4a8", "prediction_text": "DOPA decarboxylase inhibitor"}, "reference": {"id": "2dcb760ceec3465dbbba16b243e4f4a8", "answers": {"answer_start": [26], "text": ["L-Dopa"]}}}, "74a344b982fc47c2b5f37f3c78bf94a1": {"prediction": {"id": "74a344b982fc47c2b5f37f3c78bf94a1", "prediction_text": "3,4-dihydroxyphenyl-l-alanine (l-DOPA) in Parkinson's disease. The biological mechanisms behind this side effect are not fully comprehended although involvement of dopaminergic, serotonergic, and glutamatergic systems has been suggested. The present study utilizes in vivo amperometry to investigate the impact from unilateral 6-hydroxydopamine lesions and l-DOPA (4 mg/kg, including benserazide 15 mg/kg) -induced dyskinetic behavior on striatal basal extracellular glutamate concentration and potassium-evoked glutamate release in urethane-anesthetized rats. Recordings were performed before and after local L-DOPA application in the striatum. In addition, effects from the 5-HT(1A) receptor agonist (2R)-(+)-8-hydroxy-2-(di-n-propylamino)tetralin hydrobromide (8-OHDPAT; 1 mg/kg) was assessed on glutamate release and on dyskinetic behavior. The results revealed a bilateral \u2248 30% reduction of basal extracellular glutamate concentration and attenuated potassium-evoked glutamate release after a unilateral dopamine-depletion in L-DOPA na\u00efve animals. In dyskinetic subjects, basal glutamate concentration was comparable to normal controls, although potassium-evoked glutamate release was reduced to similar levels as in drug na\u00efve dopamine-lesioned animals. Furthermore, acute striatal L-DOPA administration attenuated glutamate release in all groups, except in the dopamine-lesioned striatum of dyskinetic animals. Co-administration of 8-OHDPAT and L-DOPA"}, "reference": {"id": "74a344b982fc47c2b5f37f3c78bf94a1", "answers": {"answer_start": [1542], "text": ["L-Dopa"]}}}, "4a6b2ca2044b400db60f42d9a030df17": {"prediction": {"id": "4a6b2ca2044b400db60f42d9a030df17", "prediction_text": "ip)+the 5-HT(1A) antagonist, WAY100635 (0.5 mg/kg, ip) 5 min prior to l-DOPA (12 mg/kg+15 mg/kg benserazide, ip). Rats were tested for LID using the abnormal involuntary movements (AIMs) scale and motor performance using the forepaw adjusting steps test (FAS). In experiment 2, l-DOPA-na\u00efve rats received co-administration of l-DOPA+buspirone (1.0 or 2.5 mg/kg, ip) for 2 weeks. AIMs and FAS were measured throughout. In l-DOPA-primed rats, buspirone dose-dependently reduced LID and improved l-DOPA-related motor performance due to action at the 5-HT(1A) receptor. In l-DOPA-na\u00efve rats"}, "reference": {"id": "4a6b2ca2044b400db60f42d9a030df17", "answers": {"answer_start": [1086], "text": ["L-Dopa"]}}}, "eddd294d719d4e6f886256f99ebb1330": {"prediction": {"id": "eddd294d719d4e6f886256f99ebb1330", "prediction_text": "L-Dopa/benserazide"}, "reference": {"id": "eddd294d719d4e6f886256f99ebb1330", "answers": {"answer_start": [1279], "text": ["L-Dopa"]}}}, "0b4116543f66494abf23936914ec7acf": {"prediction": {"id": "0b4116543f66494abf23936914ec7acf", "prediction_text": "monkeys"}, "reference": {"id": "0b4116543f66494abf23936914ec7acf", "answers": {"answer_start": [642], "text": ["L-Dopa"]}}}, "ec7811803c6748eb99b3d82d3d096ba8": {"prediction": {"id": "ec7811803c6748eb99b3d82d3d096ba8", "prediction_text": "peripheral decarboxylase inhibitor"}, "reference": {"id": "ec7811803c6748eb99b3d82d3d096ba8", "answers": {"answer_start": [725], "text": ["L-Dopa"]}}}, "6f7e7481efc04075ac3a43f386039763": {"prediction": {"id": "6f7e7481efc04075ac3a43f386039763", "prediction_text": "peripheral DDC inhibitors"}, "reference": {"id": "6f7e7481efc04075ac3a43f386039763", "answers": {"answer_start": [298], "text": ["L-Dopa"]}}}, "bb77a8839cc94bcd9807dbc22148da42": {"prediction": {"id": "bb77a8839cc94bcd9807dbc22148da42", "prediction_text": "L-DOPA"}, "reference": {"id": "bb77a8839cc94bcd9807dbc22148da42", "answers": {"answer_start": [518], "text": ["L-Dopa"]}}}, "11e7f070d30e4e48b4ac39d6e0b2d0b2": {"prediction": {"id": "11e7f070d30e4e48b4ac39d6e0b2d0b2", "prediction_text": "dopamine, DOPAC, HVA and 3-methoxytyramine. The co-administration of tolcapone (30 mg/kg p.o.) further increased dopamine"}, "reference": {"id": "11e7f070d30e4e48b4ac39d6e0b2d0b2", "answers": {"answer_start": [189], "text": ["L-Dopa"]}}}, "24a17165f6e94588b13db930ddaea137": {"prediction": {"id": "24a17165f6e94588b13db930ddaea137", "prediction_text": "NOTCH3"}, "reference": {"id": "24a17165f6e94588b13db930ddaea137", "answers": {"answer_start": [131], "text": ["Notch3 gene"]}}}, "211c11f250734e4a878bc97d5fb58e09": {"prediction": {"id": "211c11f250734e4a878bc97d5fb58e09", "prediction_text": "NOTCH3"}, "reference": {"id": "211c11f250734e4a878bc97d5fb58e09", "answers": {"answer_start": [167], "text": ["Notch3 gene"]}}}, "9981373409684667b3295bbfba769ec6": {"prediction": {"id": "9981373409684667b3295bbfba769ec6", "prediction_text": "NOTCH3 gene (C19p13.2-p13.1), previously shown to be a gene involved in CADASIL and the TNFSF7"}, "reference": {"id": "9981373409684667b3295bbfba769ec6", "answers": {"answer_start": [83], "text": ["Notch3 gene"]}}}, "29314c4e388344d99dbb2dd1de80629e": {"prediction": {"id": "29314c4e388344d99dbb2dd1de80629e", "prediction_text": "NOTCH3"}, "reference": {"id": "29314c4e388344d99dbb2dd1de80629e", "answers": {"answer_start": [160], "text": ["Notch3 gene"]}}}, "d68108d6804048db9b6eeeef1c9c4684": {"prediction": {"id": "d68108d6804048db9b6eeeef1c9c4684", "prediction_text": "peripheral blood lymphocytes"}, "reference": {"id": "d68108d6804048db9b6eeeef1c9c4684", "answers": {"answer_start": [453], "text": ["Notch3 gene"]}}}, "e79f62c01c7542a6b58c57b9901120ab": {"prediction": {"id": "e79f62c01c7542a6b58c57b9901120ab", "prediction_text": "NOTCH3"}, "reference": {"id": "e79f62c01c7542a6b58c57b9901120ab", "answers": {"answer_start": [182], "text": ["Notch3 gene"]}}}, "721b02be3b3940339ad53cd53ee5b44a": {"prediction": {"id": "721b02be3b3940339ad53cd53ee5b44a", "prediction_text": "Notch intracellular domain (NICD) which then translocates to the nucleus and activates the transcription factor CBF1/JBP-Jkappa, regulating downstream gene expression. To date four Notch receptors have been found in mammals. Of these, Notch3 is predominantly expressed in adult arterial smooth muscle cells in human. NOTCH3 gene mutations cause the autosomal dominant condition, cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoecephelopathy (CADASIL), an inherited early stroke syndrome leading to dementia due to systemic vascular degeneration. This suggests that Notch3 plays a critical role in maintaining the phenotypic stability of vascular smooth muscle cells (VSMCs). Recent publications indicate that Notch3 is involved in vascular injury and is a determinant of VSMC survival, but its exact function is unknown. The molecular mechanisms underlying CADASIL pathology are therefore intriguing. Investigation of CADASIL mutant Notch3 shows that the majority of mutations do not change CBF1/JBP-Jkappa mediated classic Notch activation, so the pathological consequences of NOTCH3 mutations in CADASIL patients can not be simply explained by loss- or gain-of-function in the classic Notch signalling pathway. This suggests that a novel Notch3-mediated signalling pathway may be present in VSMCs, or cross-regulation of Notch3 to other signalling pathway(s) may play a critical role on VSMCs survival. Alternatively, the mutant Notch3"}, "reference": {"id": "721b02be3b3940339ad53cd53ee5b44a", "answers": {"answer_start": [680], "text": ["Notch3 gene"]}}}, "22a0d6de9840429fac7a0cc649ea4124": {"prediction": {"id": "22a0d6de9840429fac7a0cc649ea4124", "prediction_text": "Mutations in Notch3 gene are linked to cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), a disorder characterized by stroke and dementia in young adults. Studies evaluating Notch3 expression in human differentiated cells and adult tissues have shown high Notch3 levels only in vascular smooth muscle cells (VSMC). However, it has been hypothesized that Notch3 is ubiquitously expressed in adult human tissues. Our aim was to evaluate Notch3 expression in human peripheral blood lymphocytes"}, "reference": {"id": "22a0d6de9840429fac7a0cc649ea4124", "answers": {"answer_start": [276], "text": ["Notch3 gene"]}}}, "2a23dc0bbf674b1a917fd65c7412c564": {"prediction": {"id": "2a23dc0bbf674b1a917fd65c7412c564", "prediction_text": "NOTCH3"}, "reference": {"id": "2a23dc0bbf674b1a917fd65c7412c564", "answers": {"answer_start": [184], "text": ["Notch3 gene"]}}}, "06c18a1003e24c15899208edcba18bf2": {"prediction": {"id": "06c18a1003e24c15899208edcba18bf2", "prediction_text": "nick end-labeling"}, "reference": {"id": "06c18a1003e24c15899208edcba18bf2", "answers": {"answer_start": [275], "text": ["Notch3 gene"]}}}, "9e6cd2513ba14352a776367154c496ac": {"prediction": {"id": "9e6cd2513ba14352a776367154c496ac", "prediction_text": "IFN"}, "reference": {"id": "9e6cd2513ba14352a776367154c496ac", "answers": {"answer_start": [482], "text": ["IFN signature"]}}}, "b385b1611c2a40998ecc2c1c8effe248": {"prediction": {"id": "b385b1611c2a40998ecc2c1c8effe248", "prediction_text": "RA"}, "reference": {"id": "b385b1611c2a40998ecc2c1c8effe248", "answers": {"answer_start": [601], "text": ["IFN signature"]}}}, "f3c1ecefdfbf4c24b1be2fa0decb0a1a": {"prediction": {"id": "f3c1ecefdfbf4c24b1be2fa0decb0a1a", "prediction_text": "IFN"}, "reference": {"id": "f3c1ecefdfbf4c24b1be2fa0decb0a1a", "answers": {"answer_start": [1615], "text": ["IFN signature"]}}}, "6d7035dd00fe4dc091250ca269d872b6": {"prediction": {"id": "6d7035dd00fe4dc091250ca269d872b6", "prediction_text": "IFN"}, "reference": {"id": "6d7035dd00fe4dc091250ca269d872b6", "answers": {"answer_start": [1227], "text": ["IFN signature"]}}}, "8e301fd55f5249a39a5035b2e1efccb0": {"prediction": {"id": "8e301fd55f5249a39a5035b2e1efccb0", "prediction_text": "interferon signature"}, "reference": {"id": "8e301fd55f5249a39a5035b2e1efccb0", "answers": {"answer_start": [1169], "text": ["Interferon signature"]}}}, "79e89a6be8bf435c9cafa89504e6af2a": {"prediction": {"id": "79e89a6be8bf435c9cafa89504e6af2a", "prediction_text": "Gene expression analysis of peripheral blood cells"}, "reference": {"id": "79e89a6be8bf435c9cafa89504e6af2a", "answers": {"answer_start": [457], "text": ["Interferon signature"]}}}, "c0f9d65df45f4cdfa5d54a7f934b6b36": {"prediction": {"id": "c0f9d65df45f4cdfa5d54a7f934b6b36", "prediction_text": "IFN"}, "reference": {"id": "c0f9d65df45f4cdfa5d54a7f934b6b36", "answers": {"answer_start": [1644], "text": ["IFN signature"]}}}, "52e833a67acf45c08c40777015b033d3": {"prediction": {"id": "52e833a67acf45c08c40777015b033d3", "prediction_text": "SNP"}, "reference": {"id": "52e833a67acf45c08c40777015b033d3", "answers": {"answer_start": [936], "text": ["Interferon signature"]}}}, "5aa7e758e099484ab8a303c319029e04": {"prediction": {"id": "5aa7e758e099484ab8a303c319029e04", "prediction_text": "tyrosine kinase"}, "reference": {"id": "5aa7e758e099484ab8a303c319029e04", "answers": {"answer_start": [52], "text": ["epidermal growth factor receptor (EGFR) gene"]}}}, "4126870e3e3f45e79544aba11c221728": {"prediction": {"id": "4126870e3e3f45e79544aba11c221728", "prediction_text": "epidermal growth factor receptor (EGFR)"}, "reference": {"id": "4126870e3e3f45e79544aba11c221728", "answers": {"answer_start": [203], "text": ["epidermal growth factor receptor (EGFR) gene"]}}}, "a565d2b5bb4c42d7b825a8e352341437": {"prediction": {"id": "a565d2b5bb4c42d7b825a8e352341437", "prediction_text": "epidermal growth factor receptor"}, "reference": {"id": "a565d2b5bb4c42d7b825a8e352341437", "answers": {"answer_start": [17], "text": ["epidermal growth factor receptor (EGFR) gene"]}}}, "7d45188e40ba432db4c1dba2efcfb7df": {"prediction": {"id": "7d45188e40ba432db4c1dba2efcfb7df", "prediction_text": "EGFR"}, "reference": {"id": "7d45188e40ba432db4c1dba2efcfb7df", "answers": {"answer_start": [56], "text": ["epidermal growth factor receptor (EGFR) gene"]}}}, "b7a64892a50d45119e7688744ca9af96": {"prediction": {"id": "b7a64892a50d45119e7688744ca9af96", "prediction_text": "EGFR"}, "reference": {"id": "b7a64892a50d45119e7688744ca9af96", "answers": {"answer_start": [0], "text": ["epidermal growth factor receptor (EGFR) gene"]}}}, "ea90ffb555dd4eeba780d08039252d39": {"prediction": {"id": "ea90ffb555dd4eeba780d08039252d39", "prediction_text": "EGFR"}, "reference": {"id": "ea90ffb555dd4eeba780d08039252d39", "answers": {"answer_start": [44], "text": ["epidermal growth factor receptor (EGFR) gene"]}}}, "70be94aee14a44e899053a83f4c8d221": {"prediction": {"id": "70be94aee14a44e899053a83f4c8d221", "prediction_text": "tyrosine kinase domain of the epidermal growth factor receptor (EGFR)"}, "reference": {"id": "70be94aee14a44e899053a83f4c8d221", "answers": {"answer_start": [55], "text": ["epidermal growth factor receptor (EGFR) gene"]}}}, "f1332a3f21ef4eda92289a0d80e9cdd3": {"prediction": {"id": "f1332a3f21ef4eda92289a0d80e9cdd3", "prediction_text": "Somatic mutations in the epidermal growth factor receptor (EGFR) gene are associated with the responses to the tyrosine kinase inhibitors gefitinib and erlotinib in patients with non-small-cell lung cancer (NSCLC). Although various methods for detecting EGFR gene mutations have been developed, they have several disadvantages. We attempted to establish a new method for the detection of EGFR gene mutations with the use of paraffin-embedded samples. The detections of T790M mutations in exon 20 and L858R mutations in exon 21 are based on the principle of allele-specific oligonucleotide polymerase chain reaction (PCR). We also designed PCR primers that enable to detect all types of deletions in exon 19. We assessed the basic performance efficiency of this method, and to confirm its clinical applicability, we performed PCR using DNA extracted from 66 tissue sections that were obtained from patients with NSCLC and embedded in paraffin. The sensitivity of this method for the detection of deletions or mutations was as low as 0.5%. In the 66 subjects whose samples were analyzed, we detected the following deletions and mutations in the EGFR gene: 11 deletions in exon 19, 8 L858R mutations, and 1 double mutation of L858R and T790M. The present method is sensitive and specific for the detection of deletions and mutations in the EGFR"}, "reference": {"id": "f1332a3f21ef4eda92289a0d80e9cdd3", "answers": {"answer_start": [25], "text": ["epidermal growth factor receptor (EGFR) gene"]}}}, "51ad77bcd3614edcb0705cd9ea532e66": {"prediction": {"id": "51ad77bcd3614edcb0705cd9ea532e66", "prediction_text": "exons"}, "reference": {"id": "51ad77bcd3614edcb0705cd9ea532e66", "answers": {"answer_start": [70], "text": ["epidermal growth factor receptor (EGFR) gene"]}}}, "c86214fcb1d44331afaba07b10aa4ef0": {"prediction": {"id": "c86214fcb1d44331afaba07b10aa4ef0", "prediction_text": "tyrosine kinase (TK) domain of the epidermal growth factor receptor (EGFR) gene are reportedly associated with sensitivity of lung cancers to gefitinib (Iressa), kinase inhibitor"}, "reference": {"id": "c86214fcb1d44331afaba07b10aa4ef0", "answers": {"answer_start": [60], "text": ["epidermal growth factor receptor (EGFR) gene"]}}}, "8a7dc95bfab74cc28e9359a36600f86b": {"prediction": {"id": "8a7dc95bfab74cc28e9359a36600f86b", "prediction_text": "EGFR"}, "reference": {"id": "8a7dc95bfab74cc28e9359a36600f86b", "answers": {"answer_start": [121], "text": ["epidermal growth factor receptor (EGFR) gene"]}}}, "0504eb149f34474c87385baad08c3ea9": {"prediction": {"id": "0504eb149f34474c87385baad08c3ea9", "prediction_text": "Parkinson"}, "reference": {"id": "0504eb149f34474c87385baad08c3ea9", "answers": {"answer_start": [0], "text": ["Parkinson's disease (PD)"]}}}, "ed2230958fe04fe4be8b3e80e467810a": {"prediction": {"id": "ed2230958fe04fe4be8b3e80e467810a", "prediction_text": "Parkinson"}, "reference": {"id": "ed2230958fe04fe4be8b3e80e467810a", "answers": {"answer_start": [0], "text": ["Parkinson's disease (PD)"]}}}, "dd6e358d35a74f3bac89178ad2749264": {"prediction": {"id": "dd6e358d35a74f3bac89178ad2749264", "prediction_text": "Parkinson"}, "reference": {"id": "dd6e358d35a74f3bac89178ad2749264", "answers": {"answer_start": [0], "text": ["Parkinson's disease (PD)"]}}}, "58f01e0394364d9fbca3041943334a1d": {"prediction": {"id": "58f01e0394364d9fbca3041943334a1d", "prediction_text": "Parkinson"}, "reference": {"id": "58f01e0394364d9fbca3041943334a1d", "answers": {"answer_start": [128], "text": ["Parkinson's disease (PD)"]}}}, "791ed759e26042e1b534e3c223ff86cf": {"prediction": {"id": "791ed759e26042e1b534e3c223ff86cf", "prediction_text": "Parkinson"}, "reference": {"id": "791ed759e26042e1b534e3c223ff86cf", "answers": {"answer_start": [0], "text": ["Parkinson's disease (PD)"]}}}, "5e2fdae91b66432a8d5519ebb091035e": {"prediction": {"id": "5e2fdae91b66432a8d5519ebb091035e", "prediction_text": "degeneration of dopaminergic neurons"}, "reference": {"id": "5e2fdae91b66432a8d5519ebb091035e", "answers": {"answer_start": [0], "text": ["Parkinson's disease (PD)"]}}}, "c93d9584794b4550ab910ad8e2e95211": {"prediction": {"id": "c93d9584794b4550ab910ad8e2e95211", "prediction_text": "Parkinson"}, "reference": {"id": "c93d9584794b4550ab910ad8e2e95211", "answers": {"answer_start": [0], "text": ["Parkinson's disease (PD)"]}}}, "b7c538286eae427682f780a052f54211": {"prediction": {"id": "b7c538286eae427682f780a052f54211", "prediction_text": "Parkinson's Disease"}, "reference": {"id": "b7c538286eae427682f780a052f54211", "answers": {"answer_start": [170], "text": ["Parkinson's disease (PD)"]}}}, "afa9e2e4f2e14bbeadd631846a23a617": {"prediction": {"id": "afa9e2e4f2e14bbeadd631846a23a617", "prediction_text": "AF-LB"}, "reference": {"id": "afa9e2e4f2e14bbeadd631846a23a617", "answers": {"answer_start": [153], "text": ["Parkinson's disease (PD)"]}}}, "7088bfdeded3426093b2fb8299fe290b": {"prediction": {"id": "7088bfdeded3426093b2fb8299fe290b", "prediction_text": "Intron F"}, "reference": {"id": "7088bfdeded3426093b2fb8299fe290b", "answers": {"answer_start": [391], "text": ["UUCCUUAAC"]}}}, "bc2d7f2be93a4f6b91adde9df8f91d4a": {"prediction": {"id": "bc2d7f2be93a4f6b91adde9df8f91d4a", "prediction_text": "beta-spectrin"}, "reference": {"id": "bc2d7f2be93a4f6b91adde9df8f91d4a", "answers": {"answer_start": [865], "text": ["antiparallel"]}}}, "fb97007caaa44b798483d0b8dad14ccf": {"prediction": {"id": "fb97007caaa44b798483d0b8dad14ccf", "prediction_text": "The alpha-spectrin and beta-spectrin"}, "reference": {"id": "fb97007caaa44b798483d0b8dad14ccf", "answers": {"answer_start": [126], "text": ["antiparallel"]}}}, "58c8e0a14b694c9da65c9987e265c8b0": {"prediction": {"id": "58c8e0a14b694c9da65c9987e265c8b0", "prediction_text": "antiparallel lateral association of an alpha and a beta subunit"}, "reference": {"id": "58c8e0a14b694c9da65c9987e265c8b0", "answers": {"answer_start": [42], "text": ["antiparallel"]}}}, "3767b44dadb8467788390f6114bbd1a1": {"prediction": {"id": "3767b44dadb8467788390f6114bbd1a1", "prediction_text": "parallel"}, "reference": {"id": "3767b44dadb8467788390f6114bbd1a1", "answers": {"answer_start": [746], "text": ["antiparallel"]}}}, "69edfd11cbd343cb8c6ef25a5b4e8de0": {"prediction": {"id": "69edfd11cbd343cb8c6ef25a5b4e8de0", "prediction_text": "\u03b2-spectrin"}, "reference": {"id": "69edfd11cbd343cb8c6ef25a5b4e8de0", "answers": {"answer_start": [1239], "text": ["antiparallel"]}}}, "7df6edf13a6d4768946776fb4aed5d24": {"prediction": {"id": "7df6edf13a6d4768946776fb4aed5d24", "prediction_text": "antiparallel side-to-side association of spectrin"}, "reference": {"id": "7df6edf13a6d4768946776fb4aed5d24", "answers": {"answer_start": [4], "text": ["antiparallel"]}}}, "ea1c447226954242b0ff5424c96ad444": {"prediction": {"id": "ea1c447226954242b0ff5424c96ad444", "prediction_text": "The alpha and beta subunits are homologous"}, "reference": {"id": "ea1c447226954242b0ff5424c96ad444", "answers": {"answer_start": [546], "text": ["antiparallel"]}}}, "8cfa068cda2642558db734a393d2721f": {"prediction": {"id": "8cfa068cda2642558db734a393d2721f", "prediction_text": "antiparallel"}, "reference": {"id": "8cfa068cda2642558db734a393d2721f", "answers": {"answer_start": [1285], "text": ["antiparallel"]}}}, "f83c18541eeb4846b74b104e6d7f5e47": {"prediction": {"id": "f83c18541eeb4846b74b104e6d7f5e47", "prediction_text": "antiparallel heterodimer comprised of a 280 kDa alpha subunit and a 246 kDa beta subunit"}, "reference": {"id": "f83c18541eeb4846b74b104e6d7f5e47", "answers": {"answer_start": [33], "text": ["antiparallel"]}}}, "26863e3384f14f1bad371db47c711155": {"prediction": {"id": "26863e3384f14f1bad371db47c711155", "prediction_text": "antiparallel"}, "reference": {"id": "26863e3384f14f1bad371db47c711155", "answers": {"answer_start": [717], "text": ["antiparallel"]}}}, "b8d02ae4035b4d3ca7e3ce0020544fbc": {"prediction": {"id": "b8d02ae4035b4d3ca7e3ce0020544fbc", "prediction_text": "CAFE"}, "reference": {"id": "b8d02ae4035b4d3ca7e3ce0020544fbc", "answers": {"answer_start": [520], "text": ["CAFE"]}}}, "2c0b79d09d4743c7907f0eedddc17ee9": {"prediction": {"id": "2c0b79d09d4743c7907f0eedddc17ee9", "prediction_text": "ESR"}, "reference": {"id": "2c0b79d09d4743c7907f0eedddc17ee9", "answers": {"answer_start": [262], "text": ["diabetic foot osteomyelitis"]}}}, "d4d9536ac2894360add36572f26637d5": {"prediction": {"id": "d4d9536ac2894360add36572f26637d5", "prediction_text": "diabetic foot osteomyelitis"}, "reference": {"id": "d4d9536ac2894360add36572f26637d5", "answers": {"answer_start": [312], "text": ["diabetic foot osteomyelitis"]}}}, "afa2e448b0af4b70bfe10d7369587f7d": {"prediction": {"id": "afa2e448b0af4b70bfe10d7369587f7d", "prediction_text": "PTB"}, "reference": {"id": "afa2e448b0af4b70bfe10d7369587f7d", "answers": {"answer_start": [140], "text": ["diabetic foot osteomyelitis"]}}}, "2c26d35513244634b39ba041cc491b8e": {"prediction": {"id": "2c26d35513244634b39ba041cc491b8e", "prediction_text": "osteomyelitis"}, "reference": {"id": "2c26d35513244634b39ba041cc491b8e", "answers": {"answer_start": [1460], "text": ["diabetic foot osteomyelitis"]}}}, "08cf9825b2b34cab8db67e040c9e1c17": {"prediction": {"id": "08cf9825b2b34cab8db67e040c9e1c17", "prediction_text": "diabetes"}, "reference": {"id": "08cf9825b2b34cab8db67e040c9e1c17", "answers": {"answer_start": [1597], "text": ["diabetic foot osteomyelitis"]}}}, "9a24ace7698c4990a5b07f4cdc59e8de": {"prediction": {"id": "9a24ace7698c4990a5b07f4cdc59e8de", "prediction_text": "X"}, "reference": {"id": "9a24ace7698c4990a5b07f4cdc59e8de", "answers": {"answer_start": [501], "text": ["X-linked intellectual disability"]}}}, "a044ee39533a4ab281123aad1fec97e4": {"prediction": {"id": "a044ee39533a4ab281123aad1fec97e4", "prediction_text": "violaceous"}, "reference": {"id": "a044ee39533a4ab281123aad1fec97e4", "answers": {"answer_start": [581], "text": ["Bazex syndrome"]}}}, "c1d2b33ddd684a0990467360dfffccb2": {"prediction": {"id": "c1d2b33ddd684a0990467360dfffccb2", "prediction_text": "Bazex' syndrome) is a rare but clinically distinctive dermatosis that has been associated in all reported cases, to our knowledge, with either a primary malignant neoplasm of the upper aerodigestive tract or metastatic cancer to the lymph nodes of the neck. Acrokeratosis paraneoplastica was found in a 53-year-old black man with squamous"}, "reference": {"id": "c1d2b33ddd684a0990467360dfffccb2", "answers": {"answer_start": [31], "text": ["Bazex syndrome"]}}}, "a3bcfa353de84b55a08f4bb4fb30c281": {"prediction": {"id": "a3bcfa353de84b55a08f4bb4fb30c281", "prediction_text": "squamous cell carcinoma of the upper aerodigestive tract. In this review of 113 cases of acrokeratosis paraneoplastica (mean age, 61 years; 105 males, 8 females"}, "reference": {"id": "a3bcfa353de84b55a08f4bb4fb30c281", "answers": {"answer_start": [751], "text": ["Bazex syndrome"]}}}, "89febecbf06642fc9cca9795f20a8deb": {"prediction": {"id": "89febecbf06642fc9cca9795f20a8deb", "prediction_text": "Bazex syndrome"}, "reference": {"id": "89febecbf06642fc9cca9795f20a8deb", "answers": {"answer_start": [0], "text": ["Bazex syndrome"]}}}, "80947bb95ca04d34a93ef4b0e94fb55c": {"prediction": {"id": "80947bb95ca04d34a93ef4b0e94fb55c", "prediction_text": "cervical"}, "reference": {"id": "80947bb95ca04d34a93ef4b0e94fb55c", "answers": {"answer_start": [257], "text": ["Bazex syndrome"]}}}, "559aa40b3c054f9b86dc9e5c5c642df1": {"prediction": {"id": "559aa40b3c054f9b86dc9e5c5c642df1", "prediction_text": "Bazex syndrome"}, "reference": {"id": "559aa40b3c054f9b86dc9e5c5c642df1", "answers": {"answer_start": [497], "text": ["Bazex syndrome"]}}}, "1432d06a5b30431c852fc928466f5b17": {"prediction": {"id": "1432d06a5b30431c852fc928466f5b17", "prediction_text": "syndrome"}, "reference": {"id": "1432d06a5b30431c852fc928466f5b17", "answers": {"answer_start": [0], "text": ["Bazex syndrome"]}}}, "9433a7f7929148df8b1d8e88ff727a2d": {"prediction": {"id": "9433a7f7929148df8b1d8e88ff727a2d", "prediction_text": "ventral intermediate thalamic nucleus (VIM"}, "reference": {"id": "9433a7f7929148df8b1d8e88ff727a2d", "answers": {"answer_start": [236], "text": ["globus pallidus internus"]}}}, "ab0dc513c6944f17b4b2eb5bc06562c0": {"prediction": {"id": "ab0dc513c6944f17b4b2eb5bc06562c0", "prediction_text": "pallidus"}, "reference": {"id": "ab0dc513c6944f17b4b2eb5bc06562c0", "answers": {"answer_start": [49], "text": ["globus pallidus internus"]}}}, "5cf221b85c5a473aa6f22b1120646f2b": {"prediction": {"id": "5cf221b85c5a473aa6f22b1120646f2b", "prediction_text": "thalamus"}, "reference": {"id": "5cf221b85c5a473aa6f22b1120646f2b", "answers": {"answer_start": [839], "text": ["globus pallidus internus"]}}}, "a3b63f77b0674688a28b3d5fc5b326ec": {"prediction": {"id": "a3b63f77b0674688a28b3d5fc5b326ec", "prediction_text": "deep brain structures for the treatment of conditions such as essential tremor, dystonia, Parkinson's disease and chronic pain syndromes. The procedure uses implanted deep brain stimulation electrodes connected to extension leads and an implantable pulse generator (IPG). Hardware failure related to the DBS procedure is not infrequent, and includes electrode migration and disconnection. We describe a patient who received bilateral globus pallidus"}, "reference": {"id": "a3b63f77b0674688a28b3d5fc5b326ec", "answers": {"answer_start": [503], "text": ["globus pallidus internus"]}}}, "0904fe7febbe45c3855fde207a6da37a": {"prediction": {"id": "0904fe7febbe45c3855fde207a6da37a", "prediction_text": "pallidus"}, "reference": {"id": "0904fe7febbe45c3855fde207a6da37a", "answers": {"answer_start": [209], "text": ["globus pallidus internus"]}}}, "5228f5d8f787455db095aab4d16ec722": {"prediction": {"id": "5228f5d8f787455db095aab4d16ec722", "prediction_text": "radial artery"}, "reference": {"id": "5228f5d8f787455db095aab4d16ec722", "answers": {"answer_start": [195], "text": ["median"]}}}, "efc974a8e36248968775d538b4688724": {"prediction": {"id": "efc974a8e36248968775d538b4688724", "prediction_text": "Entrapment"}, "reference": {"id": "efc974a8e36248968775d538b4688724", "answers": {"answer_start": [1283], "text": ["median"]}}}, "70e2872792814a918a36fdfb377a7fca": {"prediction": {"id": "70e2872792814a918a36fdfb377a7fca", "prediction_text": "pathophysiology"}, "reference": {"id": "70e2872792814a918a36fdfb377a7fca", "answers": {"answer_start": [14], "text": ["median"]}}}, "99958a58c1854cbe848b3df57637a382": {"prediction": {"id": "99958a58c1854cbe848b3df57637a382", "prediction_text": "median nerve"}, "reference": {"id": "99958a58c1854cbe848b3df57637a382", "answers": {"answer_start": [138], "text": ["median"]}}}, "c6930ddbc30a45e2b0a14e33140b9713": {"prediction": {"id": "c6930ddbc30a45e2b0a14e33140b9713", "prediction_text": "median nerve neuropathy"}, "reference": {"id": "c6930ddbc30a45e2b0a14e33140b9713", "answers": {"answer_start": [366], "text": ["median"]}}}, "e6177a892e174eb7925a29ad9734b732": {"prediction": {"id": "e6177a892e174eb7925a29ad9734b732", "prediction_text": "Ultrasound"}, "reference": {"id": "e6177a892e174eb7925a29ad9734b732", "answers": {"answer_start": [175], "text": ["median"]}}}, "f817e48fafa64fd1b053a428b062bf46": {"prediction": {"id": "f817e48fafa64fd1b053a428b062bf46", "prediction_text": "median"}, "reference": {"id": "f817e48fafa64fd1b053a428b062bf46", "answers": {"answer_start": [272], "text": ["median"]}}}, "f984c9e4535047b48f09c05838d50a66": {"prediction": {"id": "f984c9e4535047b48f09c05838d50a66", "prediction_text": "median"}, "reference": {"id": "f984c9e4535047b48f09c05838d50a66", "answers": {"answer_start": [70], "text": ["median"]}}}, "5499509e32674df08e92c5c397cd5695": {"prediction": {"id": "5499509e32674df08e92c5c397cd5695", "prediction_text": "CTS"}, "reference": {"id": "5499509e32674df08e92c5c397cd5695", "answers": {"answer_start": [1130], "text": ["median"]}}}, "edbc4f97e09f4c57be612dde9c34f2c5": {"prediction": {"id": "edbc4f97e09f4c57be612dde9c34f2c5", "prediction_text": "median"}, "reference": {"id": "edbc4f97e09f4c57be612dde9c34f2c5", "answers": {"answer_start": [82], "text": ["median"]}}}, "8f98a25b9fb14ef6a997738f6361c8bb": {"prediction": {"id": "8f98a25b9fb14ef6a997738f6361c8bb", "prediction_text": "sonography"}, "reference": {"id": "8f98a25b9fb14ef6a997738f6361c8bb", "answers": {"answer_start": [1072], "text": ["median"]}}}, "3d28945c1ac74c2c98ca346a7e30a2b4": {"prediction": {"id": "3d28945c1ac74c2c98ca346a7e30a2b4", "prediction_text": "17q21"}, "reference": {"id": "3d28945c1ac74c2c98ca346a7e30a2b4", "answers": {"answer_start": [933], "text": ["The Plakoglobin gene"]}}}, "5003323cfe6b4999bf97e03e342d8b63": {"prediction": {"id": "5003323cfe6b4999bf97e03e342d8b63", "prediction_text": "plakoglobin"}, "reference": {"id": "5003323cfe6b4999bf97e03e342d8b63", "answers": {"answer_start": [1565], "text": ["The Plakoglobin gene"]}}}, "836b296a87e341f08ef5ea33ade11464": {"prediction": {"id": "836b296a87e341f08ef5ea33ade11464", "prediction_text": "change dramatically in morphology and composition"}, "reference": {"id": "836b296a87e341f08ef5ea33ade11464", "answers": {"answer_start": [470], "text": ["Mitotic arrest"]}}}, "19ad1729f8bf46fc91b874f532a8f466": {"prediction": {"id": "19ad1729f8bf46fc91b874f532a8f466", "prediction_text": "epilepsy"}, "reference": {"id": "19ad1729f8bf46fc91b874f532a8f466", "answers": {"answer_start": [652], "text": ["focal cortical dysplasia"]}}}, "08c733f10f42480ea9c83460a362ddd9": {"prediction": {"id": "08c733f10f42480ea9c83460a362ddd9", "prediction_text": "dysplasia"}, "reference": {"id": "08c733f10f42480ea9c83460a362ddd9", "answers": {"answer_start": [96], "text": ["focal cortical dysplasia"]}}}, "fe2dacc5fa4e42af95fa20a9615484aa": {"prediction": {"id": "fe2dacc5fa4e42af95fa20a9615484aa", "prediction_text": "FCD type II"}, "reference": {"id": "fe2dacc5fa4e42af95fa20a9615484aa", "answers": {"answer_start": [94], "text": ["focal cortical dysplasia"]}}}, "99b2f23df1604b188980c5fb1780aeb5": {"prediction": {"id": "99b2f23df1604b188980c5fb1780aeb5", "prediction_text": "Type IIb"}, "reference": {"id": "99b2f23df1604b188980c5fb1780aeb5", "answers": {"answer_start": [800], "text": ["focal cortical dysplasia"]}}}, "866e3e1f1df246f48b8c0df9ca9c9380": {"prediction": {"id": "866e3e1f1df246f48b8c0df9ca9c9380", "prediction_text": "epilepsy"}, "reference": {"id": "866e3e1f1df246f48b8c0df9ca9c9380", "answers": {"answer_start": [49], "text": ["focal cortical dysplasia"]}}}, "64b989bdfb2440789154074da0082f5a": {"prediction": {"id": "64b989bdfb2440789154074da0082f5a", "prediction_text": "parenchyma"}, "reference": {"id": "64b989bdfb2440789154074da0082f5a", "answers": {"answer_start": [1569], "text": ["focal cortical dysplasia"]}}}, "8123938bddcd4d9ab37e91bb58c00054": {"prediction": {"id": "8123938bddcd4d9ab37e91bb58c00054", "prediction_text": "pathological subtypes"}, "reference": {"id": "8123938bddcd4d9ab37e91bb58c00054", "answers": {"answer_start": [1295], "text": ["focal cortical dysplasia"]}}}, "82d59db5f80b4a648232414c2c95d79e": {"prediction": {"id": "82d59db5f80b4a648232414c2c95d79e", "prediction_text": "II"}, "reference": {"id": "82d59db5f80b4a648232414c2c95d79e", "answers": {"answer_start": [601], "text": ["focal cortical dysplasia"]}}}, "df839a97b7ca48ab955b797f89769218": {"prediction": {"id": "df839a97b7ca48ab955b797f89769218", "prediction_text": "hippocampal sclerosis (MTLE/HS). Eighteen patients with intractable MTLE/HS and 30 sex- and age-matched healthy controls were included in the study. All of the patients fulfilled the diagnostic criteria for MTLE/HS and underwent anteromedial temporal resection. VBM without a modulation step was applied to the magnetic resonance (MR) images of the brain. Statistical parametric maps were used to compare structural characteristics such as gray matter concentration (GMC) within the temporal pole among patients and controls separately. The acquired data were then statistically analyzed to determine the congruency between visually inspected MR imaging (MRI) scans and VBM results in the detection of morphologic abnormalities in the temporal pole compared to postoperative histopathologic findings of cortical dysplasia. Histopathologic examination revealed cortical dysplasia within the temporal pole in 11 patients. In detail, according to Palmini's classification, mild malformations of cortical development (mMCDs) were disclosed in three patients, focal cortical dysplasia (FCD) type Ia in three patients, and FCD type Ib in five patients. Some type of structural temporal pole abnormality was suggested by VBM in 14 patients and by visually inspected MRI scans in 11 patients. The results of VBM were in agreement with the presence/absence of cortical dysplasia in 13 patients (72.2%); this correspondence was significant (p = 0.047). In one case, VBM was false negative and in four cases it was false positive. There was congruence between the results of visual analysis and histologic proof in 55.6% of examined patients, which was not significant. We found that VBM made a superior contribution to the detection of temporopolar structural malformations (cortical dysplasia"}, "reference": {"id": "df839a97b7ca48ab955b797f89769218", "answers": {"answer_start": [1238], "text": ["focal cortical dysplasia"]}}}, "c1582abac73a4917a6a92a0f3bc82106": {"prediction": {"id": "c1582abac73a4917a6a92a0f3bc82106", "prediction_text": "Neurology"}, "reference": {"id": "c1582abac73a4917a6a92a0f3bc82106", "answers": {"answer_start": [326], "text": ["focal cortical dysplasia"]}}}, "97e3aaee0f58458dab2c28c7a0e8df13": {"prediction": {"id": "97e3aaee0f58458dab2c28c7a0e8df13", "prediction_text": "Palmini, which considered only histologic"}, "reference": {"id": "97e3aaee0f58458dab2c28c7a0e8df13", "answers": {"answer_start": [72], "text": ["focal cortical dysplasia"]}}}, "d2f8263ded654589aefe42b13b1723ea": {"prediction": {"id": "d2f8263ded654589aefe42b13b1723ea", "prediction_text": "Focal cortical dysplasia"}, "reference": {"id": "d2f8263ded654589aefe42b13b1723ea", "answers": {"answer_start": [621], "text": ["focal cortical dysplasia"]}}}, "102dae4c9c4d4675b85a55401781c605": {"prediction": {"id": "102dae4c9c4d4675b85a55401781c605", "prediction_text": "dynamin-related protein Opa1 is localized to the mitochondrial intermembrane space"}, "reference": {"id": "102dae4c9c4d4675b85a55401781c605", "answers": {"answer_start": [53], "text": ["mitochondrial intermembrane space"]}}}, "b492a3a4670147719373f2ff9a24b6d4": {"prediction": {"id": "b492a3a4670147719373f2ff9a24b6d4", "prediction_text": "Mgm1"}, "reference": {"id": "b492a3a4670147719373f2ff9a24b6d4", "answers": {"answer_start": [486], "text": ["mitochondrial intermembrane space"]}}}, "d7ace145c36b497d998cfc2c76df93eb": {"prediction": {"id": "d7ace145c36b497d998cfc2c76df93eb", "prediction_text": "Maximum S-COMT inhibition"}, "reference": {"id": "d7ace145c36b497d998cfc2c76df93eb", "answers": {"answer_start": [116], "text": ["catechol-O-methyltransferase"]}}}, "661d73cb9d424dbab02ad763875bd391": {"prediction": {"id": "661d73cb9d424dbab02ad763875bd391", "prediction_text": "nigra"}, "reference": {"id": "661d73cb9d424dbab02ad763875bd391", "answers": {"answer_start": [96], "text": ["catechol-O-methyltransferase"]}}}, "1ba0a214f799470ab4db72b3ec243089": {"prediction": {"id": "1ba0a214f799470ab4db72b3ec243089", "prediction_text": "COMT"}, "reference": {"id": "1ba0a214f799470ab4db72b3ec243089", "answers": {"answer_start": [38], "text": ["catechol-O-methyltransferase"]}}}, "4fd043464f9847be9d56eb34ab5a1d3f": {"prediction": {"id": "4fd043464f9847be9d56eb34ab5a1d3f", "prediction_text": "COMT"}, "reference": {"id": "4fd043464f9847be9d56eb34ab5a1d3f", "answers": {"answer_start": [21], "text": ["catechol-O-methyltransferase"]}}}, "5ad3bbb2ca374ffb966c1dcb46c068f9": {"prediction": {"id": "5ad3bbb2ca374ffb966c1dcb46c068f9", "prediction_text": "Maximum S-COMT"}, "reference": {"id": "5ad3bbb2ca374ffb966c1dcb46c068f9", "answers": {"answer_start": [27], "text": ["catechol-O-methyltransferase"]}}}, "922a394c66c245aa9c03db0ecb9083da": {"prediction": {"id": "922a394c66c245aa9c03db0ecb9083da", "prediction_text": "base-excision"}, "reference": {"id": "922a394c66c245aa9c03db0ecb9083da", "answers": {"answer_start": [109], "text": ["base excision repair (BER) pathway"]}}}, "884220e606f44d1986c6a90113e0bb5b": {"prediction": {"id": "884220e606f44d1986c6a90113e0bb5b", "prediction_text": "autosomal"}, "reference": {"id": "884220e606f44d1986c6a90113e0bb5b", "answers": {"answer_start": [1468], "text": ["autosomal dominant"]}}}, "f9c4cfb1be9947cf9fa9850c44068e5e": {"prediction": {"id": "f9c4cfb1be9947cf9fa9850c44068e5e", "prediction_text": "autosomal recessive"}, "reference": {"id": "f9c4cfb1be9947cf9fa9850c44068e5e", "answers": {"answer_start": [790], "text": ["autosomal dominant"]}}}, "3569554d13d24e23ae8641155fd72db2": {"prediction": {"id": "3569554d13d24e23ae8641155fd72db2", "prediction_text": "autosomal dominant or recessive"}, "reference": {"id": "3569554d13d24e23ae8641155fd72db2", "answers": {"answer_start": [706], "text": ["autosomal dominant"]}}}, "00325f0c11164f20b3d2ead453e568d8": {"prediction": {"id": "00325f0c11164f20b3d2ead453e568d8", "prediction_text": "NSD1"}, "reference": {"id": "00325f0c11164f20b3d2ead453e568d8", "answers": {"answer_start": [630], "text": ["NSD1 gene"]}}}, "4d6bc4f66c2e4d3f931faee7e78209d3": {"prediction": {"id": "4d6bc4f66c2e4d3f931faee7e78209d3", "prediction_text": "Mutations"}, "reference": {"id": "4d6bc4f66c2e4d3f931faee7e78209d3", "answers": {"answer_start": [31], "text": ["NSD1 gene"]}}}, "ce457bf17e3c40aba305138c901c7b06": {"prediction": {"id": "ce457bf17e3c40aba305138c901c7b06", "prediction_text": "NSD1 gene mutations"}, "reference": {"id": "ce457bf17e3c40aba305138c901c7b06", "answers": {"answer_start": [903], "text": ["NSD1 gene"]}}}, "56513680636e4f008df078067e49ba80": {"prediction": {"id": "56513680636e4f008df078067e49ba80", "prediction_text": "protein 1 (NSD1)"}, "reference": {"id": "56513680636e4f008df078067e49ba80", "answers": {"answer_start": [234], "text": ["NSD1 gene"]}}}, "9a2201c7cdec4e8ebe034286c6351d3d": {"prediction": {"id": "9a2201c7cdec4e8ebe034286c6351d3d", "prediction_text": "NSD1"}, "reference": {"id": "9a2201c7cdec4e8ebe034286c6351d3d", "answers": {"answer_start": [225], "text": ["NSD1 gene"]}}}, "851fe176edbc48e1845b63f104778af8": {"prediction": {"id": "851fe176edbc48e1845b63f104778af8", "prediction_text": "partial gene deletions"}, "reference": {"id": "851fe176edbc48e1845b63f104778af8", "answers": {"answer_start": [209], "text": ["NSD1 gene"]}}}, "b125d67102d44db49cc63b7d8495deb8": {"prediction": {"id": "b125d67102d44db49cc63b7d8495deb8", "prediction_text": "SET-Domain 1"}, "reference": {"id": "b125d67102d44db49cc63b7d8495deb8", "answers": {"answer_start": [438], "text": ["NSD1 gene"]}}}, "558446d628b946e9bced078039f88a4d": {"prediction": {"id": "558446d628b946e9bced078039f88a4d", "prediction_text": "NSD1"}, "reference": {"id": "558446d628b946e9bced078039f88a4d", "answers": {"answer_start": [192], "text": ["NSD1 gene"]}}}, "82a5df1fb4184a5db8fa0658daf5a79e": {"prediction": {"id": "82a5df1fb4184a5db8fa0658daf5a79e", "prediction_text": "NSD1 gene"}, "reference": {"id": "82a5df1fb4184a5db8fa0658daf5a79e", "answers": {"answer_start": [83], "text": ["NSD1 gene"]}}}, "45573c76dd7d49a59dde9759b29cfccf": {"prediction": {"id": "45573c76dd7d49a59dde9759b29cfccf", "prediction_text": "SIOD"}, "reference": {"id": "45573c76dd7d49a59dde9759b29cfccf", "answers": {"answer_start": [0, 121], "text": ["SMARCAL1 (SWI/SNF Related, Matrix Associated, Actin Dependent Regulator Of Chromatin, Subfamily A-Like 1)", "HARP"]}}}, "f034a8bfbc3c4cdf93ba5c8498e60692": {"prediction": {"id": "f034a8bfbc3c4cdf93ba5c8498e60692", "prediction_text": "SMARCAL1"}, "reference": {"id": "f034a8bfbc3c4cdf93ba5c8498e60692", "answers": {"answer_start": [125], "text": ["SMARCAL1 (SWI/SNF Related, Matrix Associated, Actin Dependent Regulator Of Chromatin, Subfamily A-Like 1)"]}}}, "160e70a55c2d4d79a48fbf66840ebdbe": {"prediction": {"id": "160e70a55c2d4d79a48fbf66840ebdbe", "prediction_text": "DNA annealing helicase SMARCAL1"}, "reference": {"id": "160e70a55c2d4d79a48fbf66840ebdbe", "answers": {"answer_start": [50], "text": ["SMARCAL1 (SWI/SNF Related, Matrix Associated, Actin Dependent Regulator Of Chromatin, Subfamily A-Like 1)"]}}}, "1e9325213cf54214995245e229b4eac2": {"prediction": {"id": "1e9325213cf54214995245e229b4eac2", "prediction_text": "lysosomal membrane"}, "reference": {"id": "1e9325213cf54214995245e229b4eac2", "answers": {"answer_start": [0], "text": ["LAMP2A"]}}}, "32f07b21035a43ed8530d91f3eb9cf20": {"prediction": {"id": "32f07b21035a43ed8530d91f3eb9cf20", "prediction_text": "selective degradation"}, "reference": {"id": "32f07b21035a43ed8530d91f3eb9cf20", "answers": {"answer_start": [282], "text": ["LAMP2A"]}}}, "a2bd5ea85ac846909655cf2ce2cc85dd": {"prediction": {"id": "a2bd5ea85ac846909655cf2ce2cc85dd", "prediction_text": "lamp2a"}, "reference": {"id": "a2bd5ea85ac846909655cf2ce2cc85dd", "answers": {"answer_start": [628], "text": ["LAMP2A"]}}}, "05a2a4f8a2bc47d7b2861f4d8b3db5f1": {"prediction": {"id": "05a2a4f8a2bc47d7b2861f4d8b3db5f1", "prediction_text": "substrate proteins are translocated directly from the cytosol across the lysosomal membrane for degradation inside lysosomes. CMA substrates are cytosolic proteins bearing a pentapeptide motif"}, "reference": {"id": "05a2a4f8a2bc47d7b2861f4d8b3db5f1", "answers": {"answer_start": [528], "text": ["LAMP2A"]}}}, "f1abc0376a3e4a74bd3c3a0af06d0b44": {"prediction": {"id": "f1abc0376a3e4a74bd3c3a0af06d0b44", "prediction_text": "degradation of cytosolic proteins"}, "reference": {"id": "f1abc0376a3e4a74bd3c3a0af06d0b44", "answers": {"answer_start": [1096], "text": ["LAMP2A"]}}}, "844b92d584a44e158b53260d22d2975b": {"prediction": {"id": "844b92d584a44e158b53260d22d2975b", "prediction_text": "lysosomal membrane"}, "reference": {"id": "844b92d584a44e158b53260d22d2975b", "answers": {"answer_start": [630], "text": ["LAMP2A"]}}}, "1f1781d7bb404b67afa77daac4816e78": {"prediction": {"id": "1f1781d7bb404b67afa77daac4816e78", "prediction_text": "\u03b1-synuclein"}, "reference": {"id": "1f1781d7bb404b67afa77daac4816e78", "answers": {"answer_start": [876], "text": ["LAMP2A"]}}}, "a4b880f964bb4bf58e5ac8ccdc522eb9": {"prediction": {"id": "a4b880f964bb4bf58e5ac8ccdc522eb9", "prediction_text": "N-CoR"}, "reference": {"id": "a4b880f964bb4bf58e5ac8ccdc522eb9", "answers": {"answer_start": [1227], "text": ["LAMP2A"]}}}, "edecd1e07020479e9392e21d8640a457": {"prediction": {"id": "edecd1e07020479e9392e21d8640a457", "prediction_text": "autophagy-lysosome"}, "reference": {"id": "edecd1e07020479e9392e21d8640a457", "answers": {"answer_start": [777], "text": ["LAMP2A"]}}}, "b5173f45fc2f41149bd3aec924b2164a": {"prediction": {"id": "b5173f45fc2f41149bd3aec924b2164a", "prediction_text": "TPY activation loop motif"}, "reference": {"id": "b5173f45fc2f41149bd3aec924b2164a", "answers": {"answer_start": [178], "text": ["JNK"]}}}, "1c14ab3cabda446aaca109583c5918c8": {"prediction": {"id": "1c14ab3cabda446aaca109583c5918c8", "prediction_text": "HSP70"}, "reference": {"id": "1c14ab3cabda446aaca109583c5918c8", "answers": {"answer_start": [314], "text": ["JNK"]}}}, "c24c90cbf68542b8b19024bb8d35e2cd": {"prediction": {"id": "c24c90cbf68542b8b19024bb8d35e2cd", "prediction_text": "M3/6"}, "reference": {"id": "c24c90cbf68542b8b19024bb8d35e2cd", "answers": {"answer_start": [474], "text": ["JNK"]}}}, "eee140ab0045484ab2980e7331936c95": {"prediction": {"id": "eee140ab0045484ab2980e7331936c95", "prediction_text": "ischemia"}, "reference": {"id": "eee140ab0045484ab2980e7331936c95", "answers": {"answer_start": [1025], "text": ["JNK"]}}}, "ab295f0ea7d64fa68ce5885262288d97": {"prediction": {"id": "ab295f0ea7d64fa68ce5885262288d97", "prediction_text": "M3/6 phosphatase"}, "reference": {"id": "ab295f0ea7d64fa68ce5885262288d97", "answers": {"answer_start": [260], "text": ["JNK"]}}}, "9c5930dc08214e559c056995683bf5fa": {"prediction": {"id": "9c5930dc08214e559c056995683bf5fa", "prediction_text": "copper ions"}, "reference": {"id": "9c5930dc08214e559c056995683bf5fa", "answers": {"answer_start": [233], "text": ["JNK"]}}}, "fe72e0d737c3455a964ba21440d5a63b": {"prediction": {"id": "fe72e0d737c3455a964ba21440d5a63b", "prediction_text": "JNK interacting protein (JIP) family"}, "reference": {"id": "fe72e0d737c3455a964ba21440d5a63b", "answers": {"answer_start": [1726], "text": ["JNK"]}}}, "0db51a16f91648f4860007c3bc969f42": {"prediction": {"id": "0db51a16f91648f4860007c3bc969f42", "prediction_text": "Phthiriasis palpebrarum"}, "reference": {"id": "0db51a16f91648f4860007c3bc969f42", "answers": {"answer_start": [80], "text": ["Pthirus pubis"]}}}, "a205b65c43f9427f835ac582079876a5": {"prediction": {"id": "a205b65c43f9427f835ac582079876a5", "prediction_text": "louse Pthirus pubis"}, "reference": {"id": "a205b65c43f9427f835ac582079876a5", "answers": {"answer_start": [79], "text": ["Pthirus pubis"]}}}, "d86b58b83c1e4450b57d19a3650244de": {"prediction": {"id": "d86b58b83c1e4450b57d19a3650244de", "prediction_text": "infestation of the eyelashes"}, "reference": {"id": "d86b58b83c1e4450b57d19a3650244de", "answers": {"answer_start": [71], "text": ["Pthirus pubis"]}}}, "7ac635c1f61e423d804b9750801d9773": {"prediction": {"id": "7ac635c1f61e423d804b9750801d9773", "prediction_text": "neuroendocrine cells"}, "reference": {"id": "7ac635c1f61e423d804b9750801d9773", "answers": {"answer_start": [744], "text": ["neuroendocrine cells"]}}}, "37a08fda2d3044439ccdb5c6229bf0c2": {"prediction": {"id": "37a08fda2d3044439ccdb5c6229bf0c2", "prediction_text": "Northeast Siberia"}, "reference": {"id": "37a08fda2d3044439ccdb5c6229bf0c2", "answers": {"answer_start": [70], "text": ["Northeast Siberia"]}}}, "8b7681b0c7f848b39b92743ec310dcad": {"prediction": {"id": "8b7681b0c7f848b39b92743ec310dcad", "prediction_text": "Gro"}, "reference": {"id": "8b7681b0c7f848b39b92743ec310dcad", "answers": {"answer_start": [0], "text": ["Groucho (Gro) is a Drosophila melanogaster transcriptional corepressor"]}}}, "156f4a4f8027430f947b69d678a41c01": {"prediction": {"id": "156f4a4f8027430f947b69d678a41c01", "prediction_text": "SET domain genes have been identified in numbers of bacterial genomes based on similarity to SET domains of eukaryotic histone methyltransferases. Herein, a Chlamydophila pneumoniae SET domain gene was clarified to be coincidently expressed with hctA and hctB genes encoding chlamydial histone H1-like proteins, Hc1 and Hc2, respectively. The SET domain protein (cpnSET) is localized in chlamydial cells and interacts with Hc1 and Hc2 through the C-terminal SET domain. As expected from conservation of catalytic sites in cpnSET, it functions as a protein methyltransferase to murine histone H3 and Hc1. However, little is known about protein methylation in the molecular pathogenesis of chlamydial infection. cpnSET may play an important role in chlamydial cell maturation due to modification of chlamydial"}, "reference": {"id": "156f4a4f8027430f947b69d678a41c01", "answers": {"answer_start": [0], "text": ["SET domain"]}}}, "9c55e43005154de9a135504fc5a5f49e": {"prediction": {"id": "9c55e43005154de9a135504fc5a5f49e", "prediction_text": "PR/SET"}, "reference": {"id": "9c55e43005154de9a135504fc5a5f49e", "answers": {"answer_start": [153], "text": ["SET domain"]}}}, "56fb87e856564ce8af5ac1585197bba6": {"prediction": {"id": "56fb87e856564ce8af5ac1585197bba6", "prediction_text": "histone H3"}, "reference": {"id": "56fb87e856564ce8af5ac1585197bba6", "answers": {"answer_start": [187], "text": ["SET domain"]}}}, "846adfc4bcf64961b93e943603c435be": {"prediction": {"id": "846adfc4bcf64961b93e943603c435be", "prediction_text": "SET-domain"}, "reference": {"id": "846adfc4bcf64961b93e943603c435be", "answers": {"answer_start": [298], "text": ["SET domain"]}}}, "f633b591789347248d421662c0bc2fe0": {"prediction": {"id": "f633b591789347248d421662c0bc2fe0", "prediction_text": "PRC2"}, "reference": {"id": "f633b591789347248d421662c0bc2fe0", "answers": {"answer_start": [742], "text": ["SET domain"]}}}, "9a3b4b9ce48c4542a0aa7009cecc8c70": {"prediction": {"id": "9a3b4b9ce48c4542a0aa7009cecc8c70", "prediction_text": "methylates Lys 20"}, "reference": {"id": "9a3b4b9ce48c4542a0aa7009cecc8c70", "answers": {"answer_start": [928], "text": ["SET domain"]}}}, "58cbd4baf8f348d8b5bed7b3c9a16eab": {"prediction": {"id": "58cbd4baf8f348d8b5bed7b3c9a16eab", "prediction_text": "SET"}, "reference": {"id": "58cbd4baf8f348d8b5bed7b3c9a16eab", "answers": {"answer_start": [0], "text": ["SET domain"]}}}, "75278375df78471f9023009022e3c741": {"prediction": {"id": "75278375df78471f9023009022e3c741", "prediction_text": "SET domain"}, "reference": {"id": "75278375df78471f9023009022e3c741", "answers": {"answer_start": [4], "text": ["SET domain"]}}}, "2a024ec1d3e84104bbd84e271ad13211": {"prediction": {"id": "2a024ec1d3e84104bbd84e271ad13211", "prediction_text": "conserved SET domain"}, "reference": {"id": "2a024ec1d3e84104bbd84e271ad13211", "answers": {"answer_start": [435], "text": ["SET domain"]}}}, "c0ac63c55557401ba281fae8d2512c7d": {"prediction": {"id": "c0ac63c55557401ba281fae8d2512c7d", "prediction_text": "SET"}, "reference": {"id": "c0ac63c55557401ba281fae8d2512c7d", "answers": {"answer_start": [4], "text": ["SET domain"]}}}, "16a96883ef31459e87c0cd7804286a39": {"prediction": {"id": "16a96883ef31459e87c0cd7804286a39", "prediction_text": "vitro"}, "reference": {"id": "16a96883ef31459e87c0cd7804286a39", "answers": {"answer_start": [516], "text": ["SET domain"]}}}, "1f43329b5c9d4b2cb87035a4109f6a93": {"prediction": {"id": "1f43329b5c9d4b2cb87035a4109f6a93", "prediction_text": "HMTase"}, "reference": {"id": "1f43329b5c9d4b2cb87035a4109f6a93", "answers": {"answer_start": [443], "text": ["SET domain"]}}}, "5642de3e41e14dfbb4281b2696376fc5": {"prediction": {"id": "5642de3e41e14dfbb4281b2696376fc5", "prediction_text": "SET"}, "reference": {"id": "5642de3e41e14dfbb4281b2696376fc5", "answers": {"answer_start": [150], "text": ["SET domain"]}}}, "0160a9512db24e4787edad9ebbda714e": {"prediction": {"id": "0160a9512db24e4787edad9ebbda714e", "prediction_text": "vivo"}, "reference": {"id": "0160a9512db24e4787edad9ebbda714e", "answers": {"answer_start": [100], "text": ["SET domain"]}}}, "8971d34a2679489482e88ebebda697bc": {"prediction": {"id": "8971d34a2679489482e88ebebda697bc", "prediction_text": "C-terminal SET"}, "reference": {"id": "8971d34a2679489482e88ebebda697bc", "answers": {"answer_start": [462], "text": ["SET domain"]}}}, "1d64366285494d36b010ae48f8d830c3": {"prediction": {"id": "1d64366285494d36b010ae48f8d830c3", "prediction_text": "NSD1"}, "reference": {"id": "1d64366285494d36b010ae48f8d830c3", "answers": {"answer_start": [44], "text": ["SET domain"]}}}, "c67ec54b7d734922b82367fb17cd179f": {"prediction": {"id": "c67ec54b7d734922b82367fb17cd179f", "prediction_text": "Drosophila Su(var)3-9 and of Schizosaccharomyces pombe clr4--encode histone H3-specific methyltransferases that selectively methylate lysine 9 of the amino terminus of histone H3 in vitro. We mapped the catalytic motif to the evolutionarily conserved SET domain, which requires adjacent cysteine-rich"}, "reference": {"id": "c67ec54b7d734922b82367fb17cd179f", "answers": {"answer_start": [644], "text": ["SET domain"]}}}, "b187bd49c5e442b48c8d6b8b8c46e1c3": {"prediction": {"id": "b187bd49c5e442b48c8d6b8b8c46e1c3", "prediction_text": "H3"}, "reference": {"id": "b187bd49c5e442b48c8d6b8b8c46e1c3", "answers": {"answer_start": [300], "text": ["SET domain"]}}}, "a58fda47b56b476faf6b337c5065a7a2": {"prediction": {"id": "a58fda47b56b476faf6b337c5065a7a2", "prediction_text": "ESET"}, "reference": {"id": "a58fda47b56b476faf6b337c5065a7a2", "answers": {"answer_start": [36], "text": ["SET domain"]}}}, "808fdbc18df44c3388d093a58f5a0920": {"prediction": {"id": "808fdbc18df44c3388d093a58f5a0920", "prediction_text": "methylation"}, "reference": {"id": "808fdbc18df44c3388d093a58f5a0920", "answers": {"answer_start": [1857], "text": ["SET domain"]}}}, "552b12fdd75f46c294d332ca801e3121": {"prediction": {"id": "552b12fdd75f46c294d332ca801e3121", "prediction_text": "Drosophila melanogaster Polycomb group"}, "reference": {"id": "552b12fdd75f46c294d332ca801e3121", "answers": {"answer_start": [310], "text": ["SET domain"]}}}, "5e2457211cc646a69e25f25232e1364c": {"prediction": {"id": "5e2457211cc646a69e25f25232e1364c", "prediction_text": "protein"}, "reference": {"id": "5e2457211cc646a69e25f25232e1364c", "answers": {"answer_start": [304], "text": ["SET domain"]}}}, "427a56ea484e436ea5907d337140ca62": {"prediction": {"id": "427a56ea484e436ea5907d337140ca62", "prediction_text": "SET"}, "reference": {"id": "427a56ea484e436ea5907d337140ca62", "answers": {"answer_start": [269], "text": ["SET domain"]}}}, "351b06f63792433fa7aada56ae719fde": {"prediction": {"id": "351b06f63792433fa7aada56ae719fde", "prediction_text": "SET domain"}, "reference": {"id": "351b06f63792433fa7aada56ae719fde", "answers": {"answer_start": [826], "text": ["SET domain"]}}}, "9777fdf47dc54a9a963b43a6507999c6": {"prediction": {"id": "9777fdf47dc54a9a963b43a6507999c6", "prediction_text": "SET domain protein"}, "reference": {"id": "9777fdf47dc54a9a963b43a6507999c6", "answers": {"answer_start": [117], "text": ["SET domain"]}}}, "593deb4d5a254b71a085087aad9fa3c8": {"prediction": {"id": "593deb4d5a254b71a085087aad9fa3c8", "prediction_text": "carboxyl-terminal SET"}, "reference": {"id": "593deb4d5a254b71a085087aad9fa3c8", "answers": {"answer_start": [517], "text": ["SET domain"]}}}, "d1fa9326019c43e0a4f97a1a19a364af": {"prediction": {"id": "d1fa9326019c43e0a4f97a1a19a364af", "prediction_text": "score >4 or \u22644 with elevated d-dimer level"}, "reference": {"id": "d1fa9326019c43e0a4f97a1a19a364af", "answers": {"answer_start": [462], "text": ["pulmonary embolism"]}}}, "180cc00a4107472ca20f9e7c61098f40": {"prediction": {"id": "180cc00a4107472ca20f9e7c61098f40", "prediction_text": "high probability of PE according"}, "reference": {"id": "180cc00a4107472ca20f9e7c61098f40", "answers": {"answer_start": [37], "text": ["pulmonary embolism"]}}}, "09748955a4fb45c88d40c7de49921d94": {"prediction": {"id": "09748955a4fb45c88d40c7de49921d94", "prediction_text": "pretest probability"}, "reference": {"id": "09748955a4fb45c88d40c7de49921d94", "answers": {"answer_start": [150], "text": ["pulmonary embolism"]}}}, "0cf61a0c30714d21b704d92e3afc2930": {"prediction": {"id": "0cf61a0c30714d21b704d92e3afc2930", "prediction_text": "high sensitivity but low specificity in PE diagnostics. The Wells score does not correlate well with the Quanadli index"}, "reference": {"id": "0cf61a0c30714d21b704d92e3afc2930", "answers": {"answer_start": [36], "text": ["pulmonary embolism"]}}}, "dd406e42b89545aab5cf976ed8b3e24c": {"prediction": {"id": "dd406e42b89545aab5cf976ed8b3e24c", "prediction_text": "provide a reliable and reproducible means of determining this pretest probability"}, "reference": {"id": "dd406e42b89545aab5cf976ed8b3e24c", "answers": {"answer_start": [628], "text": ["pulmonary embolism"]}}}, "3ab49f6907e84809a8f822931e6a3a36": {"prediction": {"id": "3ab49f6907e84809a8f822931e6a3a36", "prediction_text": "post-implementation of CDS intervention based"}, "reference": {"id": "3ab49f6907e84809a8f822931e6a3a36", "answers": {"answer_start": [149], "text": ["pulmonary embolism"]}}}, "3d71225a706f46b2a49542e6cb50cc22": {"prediction": {"id": "3d71225a706f46b2a49542e6cb50cc22", "prediction_text": "Limb-Enhancer Genie"}, "reference": {"id": "3d71225a706f46b2a49542e6cb50cc22", "answers": {"answer_start": [435], "text": ["Limb-Enhancer Genie (LEG)"]}}}, "581a50c086e3442490fff61d1106f9c6": {"prediction": {"id": "581a50c086e3442490fff61d1106f9c6", "prediction_text": "vertebral"}, "reference": {"id": "581a50c086e3442490fff61d1106f9c6", "answers": {"answer_start": [67], "text": ["receptor activator of nuclear factor-\u03baB ligand"]}}}, "58d85ededb3f49bc80a894e22489d856": {"prediction": {"id": "58d85ededb3f49bc80a894e22489d856", "prediction_text": "RANKL"}, "reference": {"id": "58d85ededb3f49bc80a894e22489d856", "answers": {"answer_start": [532, 625], "text": ["receptor activator of nuclear factor-\u03baB ligand", "RANKL"]}}}, "9844f44980ab42a3867083a163752d70": {"prediction": {"id": "9844f44980ab42a3867083a163752d70", "prediction_text": "RANKL"}, "reference": {"id": "9844f44980ab42a3867083a163752d70", "answers": {"answer_start": [432, 480], "text": ["receptor activator of nuclear factor-\u03baB ligand", "RANKL"]}}}, "1db59adfd7ed4d2bbfa9d2effdee9749": {"prediction": {"id": "1db59adfd7ed4d2bbfa9d2effdee9749", "prediction_text": "deleted"}, "reference": {"id": "1db59adfd7ed4d2bbfa9d2effdee9749", "answers": {"answer_start": [0], "text": ["Lack of the yeast Rrm3p DNA helicase causes replication defects at multiple sites within ribosomal DNA (rDNA), including at the replication fork barrier (RFB)."]}}}, "659525d284474dd7ad08b542ae800aaa": {"prediction": {"id": "659525d284474dd7ad08b542ae800aaa", "prediction_text": "splice-switching oligonucleotide AVI-4658"}, "reference": {"id": "659525d284474dd7ad08b542ae800aaa", "answers": {"answer_start": [203], "text": ["skipping of dystrophin exon 51"]}}}, "9410cc6fc269469ba621da7174ce0f48": {"prediction": {"id": "9410cc6fc269469ba621da7174ce0f48", "prediction_text": "WED"}, "reference": {"id": "9410cc6fc269469ba621da7174ce0f48", "answers": {"answer_start": [0], "text": ["Restless legs syndrome"]}}}, "61c7f920148f452eb1155ae4b8870f96": {"prediction": {"id": "61c7f920148f452eb1155ae4b8870f96", "prediction_text": "RLS/WED"}, "reference": {"id": "61c7f920148f452eb1155ae4b8870f96", "answers": {"answer_start": [166], "text": ["Restless legs syndrome"]}}}, "fe93cca7871d4d17b3286640ec120b19": {"prediction": {"id": "fe93cca7871d4d17b3286640ec120b19", "prediction_text": "WED"}, "reference": {"id": "fe93cca7871d4d17b3286640ec120b19", "answers": {"answer_start": [0], "text": ["Restless legs syndrome"]}}}, "978a7b247f9e47dd8a9419c38cf69501": {"prediction": {"id": "978a7b247f9e47dd8a9419c38cf69501", "prediction_text": "WED"}, "reference": {"id": "978a7b247f9e47dd8a9419c38cf69501", "answers": {"answer_start": [0], "text": ["Restless legs syndrome"]}}}, "f39c495eb2af4bed8699728adc5c5d71": {"prediction": {"id": "f39c495eb2af4bed8699728adc5c5d71", "prediction_text": "RLS"}, "reference": {"id": "f39c495eb2af4bed8699728adc5c5d71", "answers": {"answer_start": [0], "text": ["Restless legs syndrome"]}}}, "5daf60e4b4a04a79900f46897fea09c9": {"prediction": {"id": "5daf60e4b4a04a79900f46897fea09c9", "prediction_text": "RLS/WED"}, "reference": {"id": "5daf60e4b4a04a79900f46897fea09c9", "answers": {"answer_start": [0], "text": ["Restless legs syndrome"]}}}, "e662c7e20e7c4482b705b5d0f9228f01": {"prediction": {"id": "e662c7e20e7c4482b705b5d0f9228f01", "prediction_text": "WED"}, "reference": {"id": "e662c7e20e7c4482b705b5d0f9228f01", "answers": {"answer_start": [279], "text": ["Restless legs syndrome"]}}}, "5f8b8d82ecad42cc9d693b7fc02343ff": {"prediction": {"id": "5f8b8d82ecad42cc9d693b7fc02343ff", "prediction_text": "RLS/WED"}, "reference": {"id": "5f8b8d82ecad42cc9d693b7fc02343ff", "answers": {"answer_start": [60], "text": ["Restless legs syndrome"]}}}, "4e5e680f99cc4103957c95e44abbbced": {"prediction": {"id": "4e5e680f99cc4103957c95e44abbbced", "prediction_text": "RLS/WED"}, "reference": {"id": "4e5e680f99cc4103957c95e44abbbced", "answers": {"answer_start": [0], "text": ["Restless legs syndrome"]}}}, "0fa82ed92b8f4c479fa3fb9aaaef67ac": {"prediction": {"id": "0fa82ed92b8f4c479fa3fb9aaaef67ac", "prediction_text": "WED"}, "reference": {"id": "0fa82ed92b8f4c479fa3fb9aaaef67ac", "answers": {"answer_start": [5], "text": ["Restless legs syndrome"]}}}, "39444a11830a43d6b53b74d96183cef1": {"prediction": {"id": "39444a11830a43d6b53b74d96183cef1", "prediction_text": "RLS"}, "reference": {"id": "39444a11830a43d6b53b74d96183cef1", "answers": {"answer_start": [142], "text": ["Restless legs syndrome"]}}}, "35b6a8bd5c8e40189db61c32f136a2e6": {"prediction": {"id": "35b6a8bd5c8e40189db61c32f136a2e6", "prediction_text": "WED/RLS"}, "reference": {"id": "35b6a8bd5c8e40189db61c32f136a2e6", "answers": {"answer_start": [21], "text": ["Restless legs syndrome"]}}}, "b8ceb5ab98aa4c78a7863dd8a7f8e558": {"prediction": {"id": "b8ceb5ab98aa4c78a7863dd8a7f8e558", "prediction_text": "RLS/WED"}, "reference": {"id": "b8ceb5ab98aa4c78a7863dd8a7f8e558", "answers": {"answer_start": [201], "text": ["Restless legs syndrome"]}}}, "562184419f4f45a5bb51451f39ba6e25": {"prediction": {"id": "562184419f4f45a5bb51451f39ba6e25", "prediction_text": "RLS"}, "reference": {"id": "562184419f4f45a5bb51451f39ba6e25", "answers": {"answer_start": [780], "text": ["Restless legs syndrome"]}}}, "15e2e502e2a7450b91050966375f6a8c": {"prediction": {"id": "15e2e502e2a7450b91050966375f6a8c", "prediction_text": "RLS/WED"}, "reference": {"id": "15e2e502e2a7450b91050966375f6a8c", "answers": {"answer_start": [0], "text": ["Restless legs syndrome"]}}}, "2962129977264e90bb8f0850dd693077": {"prediction": {"id": "2962129977264e90bb8f0850dd693077", "prediction_text": "RLS"}, "reference": {"id": "2962129977264e90bb8f0850dd693077", "answers": {"answer_start": [168], "text": ["Restless legs syndrome"]}}}, "eced4e17fa784119830d068d3c069223": {"prediction": {"id": "eced4e17fa784119830d068d3c069223", "prediction_text": "RLS"}, "reference": {"id": "eced4e17fa784119830d068d3c069223", "answers": {"answer_start": [128], "text": ["Restless legs syndrome"]}}}, "383501bef07649f1972cbe2c88614cbd": {"prediction": {"id": "383501bef07649f1972cbe2c88614cbd", "prediction_text": "WED"}, "reference": {"id": "383501bef07649f1972cbe2c88614cbd", "answers": {"answer_start": [0], "text": ["Restless legs syndrome"]}}}, "32bc563590b14a45aa5072e240b131b5": {"prediction": {"id": "32bc563590b14a45aa5072e240b131b5", "prediction_text": "WED/RLS"}, "reference": {"id": "32bc563590b14a45aa5072e240b131b5", "answers": {"answer_start": [21], "text": ["Restless legs syndrome"]}}}, "ba139119553f40daa637d9f41241d4f3": {"prediction": {"id": "ba139119553f40daa637d9f41241d4f3", "prediction_text": "WED"}, "reference": {"id": "ba139119553f40daa637d9f41241d4f3", "answers": {"answer_start": [50], "text": ["Restless legs syndrome"]}}}, "faca176e17ff45ffa954cff6092c6585": {"prediction": {"id": "faca176e17ff45ffa954cff6092c6585", "prediction_text": "WED"}, "reference": {"id": "faca176e17ff45ffa954cff6092c6585", "answers": {"answer_start": [143], "text": ["Restless legs syndrome"]}}}, "b2d908cfcec04101993523f7cf4863b5": {"prediction": {"id": "b2d908cfcec04101993523f7cf4863b5", "prediction_text": "RLS"}, "reference": {"id": "b2d908cfcec04101993523f7cf4863b5", "answers": {"answer_start": [0], "text": ["Restless legs syndrome"]}}}, "f19a14bff6614fab89501eba43cecfaa": {"prediction": {"id": "f19a14bff6614fab89501eba43cecfaa", "prediction_text": "WED"}, "reference": {"id": "f19a14bff6614fab89501eba43cecfaa", "answers": {"answer_start": [0], "text": ["Restless legs syndrome"]}}}, "60d4b09e24dd48658a8439d3456b3578": {"prediction": {"id": "60d4b09e24dd48658a8439d3456b3578", "prediction_text": "RLS/WED"}, "reference": {"id": "60d4b09e24dd48658a8439d3456b3578", "answers": {"answer_start": [0], "text": ["Restless legs syndrome"]}}}, "955907f4bce1441a81f9d3fb7eefafbb": {"prediction": {"id": "955907f4bce1441a81f9d3fb7eefafbb", "prediction_text": "RLS"}, "reference": {"id": "955907f4bce1441a81f9d3fb7eefafbb", "answers": {"answer_start": [0], "text": ["Restless legs syndrome"]}}}, "b1559bfb65be4453bba5d7a2915c65e9": {"prediction": {"id": "b1559bfb65be4453bba5d7a2915c65e9", "prediction_text": "RLS"}, "reference": {"id": "b1559bfb65be4453bba5d7a2915c65e9", "answers": {"answer_start": [213], "text": ["Restless legs syndrome"]}}}, "dff4057643054cde9930da273032df3d": {"prediction": {"id": "dff4057643054cde9930da273032df3d", "prediction_text": "syndrome"}, "reference": {"id": "dff4057643054cde9930da273032df3d", "answers": {"answer_start": [19], "text": ["Restless legs syndrome"]}}}, "39c292ad328447feb051bbe3505596b2": {"prediction": {"id": "39c292ad328447feb051bbe3505596b2", "prediction_text": "RLS/WED"}, "reference": {"id": "39c292ad328447feb051bbe3505596b2", "answers": {"answer_start": [133], "text": ["Restless legs syndrome"]}}}, "1b34233a1c9f4f168867f0d2ec849d32": {"prediction": {"id": "1b34233a1c9f4f168867f0d2ec849d32", "prediction_text": "RLS"}, "reference": {"id": "1b34233a1c9f4f168867f0d2ec849d32", "answers": {"answer_start": [82], "text": ["Restless legs syndrome"]}}}, "626d19fc4d64471198d321963cb77d2a": {"prediction": {"id": "626d19fc4d64471198d321963cb77d2a", "prediction_text": "WED"}, "reference": {"id": "626d19fc4d64471198d321963cb77d2a", "answers": {"answer_start": [811], "text": ["Restless legs syndrome"]}}}, "d09b789c695d4d388a600bb2b0c4db44": {"prediction": {"id": "d09b789c695d4d388a600bb2b0c4db44", "prediction_text": "Restless Legs Syndrome"}, "reference": {"id": "d09b789c695d4d388a600bb2b0c4db44", "answers": {"answer_start": [738], "text": ["Restless legs syndrome"]}}}, "4400889d23e44496b4b2b1d267fcea32": {"prediction": {"id": "4400889d23e44496b4b2b1d267fcea32", "prediction_text": "chromDraw"}, "reference": {"id": "4400889d23e44496b4b2b1d267fcea32", "answers": {"answer_start": [916], "text": ["chromDraw"]}}}, "b1128cd823674455b1b467edbf29abeb": {"prediction": {"id": "b1128cd823674455b1b467edbf29abeb", "prediction_text": "lysosomal"}, "reference": {"id": "b1128cd823674455b1b467edbf29abeb", "answers": {"answer_start": [280], "text": ["Beta glucocerebrosidase"]}}}, "da89ed41e5c4436e8c5a1509a5368b5d": {"prediction": {"id": "da89ed41e5c4436e8c5a1509a5368b5d", "prediction_text": "beta glucocerebrosidase"}, "reference": {"id": "da89ed41e5c4436e8c5a1509a5368b5d", "answers": {"answer_start": [121], "text": ["Beta glucocerebrosidase"]}}}, "0af7d9b892b54864989d6b837d069142": {"prediction": {"id": "0af7d9b892b54864989d6b837d069142", "prediction_text": "beta glucocerebrosidase"}, "reference": {"id": "0af7d9b892b54864989d6b837d069142", "answers": {"answer_start": [109], "text": ["Beta glucocerebrosidase"]}}}, "6566f85066ca4d3cb170416aa34363c6": {"prediction": {"id": "6566f85066ca4d3cb170416aa34363c6", "prediction_text": "idarucizumab"}, "reference": {"id": "6566f85066ca4d3cb170416aa34363c6", "answers": {"answer_start": [856], "text": ["dabigatran"]}}}, "fca31ca7d7ec4edcb5808c142484a604": {"prediction": {"id": "fca31ca7d7ec4edcb5808c142484a604", "prediction_text": "preferential use of idarucizumab"}, "reference": {"id": "fca31ca7d7ec4edcb5808c142484a604", "answers": {"answer_start": [924], "text": ["dabigatran"]}}}, "91ee6df83a814e359d523db761dedec6": {"prediction": {"id": "91ee6df83a814e359d523db761dedec6", "prediction_text": "dabigatran therapy and using supportive measures, there are rare clinical situations that require urgent reversal of the anticoagulant effect of dabigatran. The effectiveness and safety of 5 g of intravenous idarucizumab is being investigated in a prospective, open-label, single-cohort study in patients with serious bleeding or in those requiring an urgent procedure. In an interim analysis of the first 90 participants, idarucizumab rapidly and completely reversed the anticoagulant activity of dabigatran in 88%-98% of participants, and there were no safety concerns, with no deaths or serious adverse events being attributable to idarucizumab. Supported by these interim results, idarucizumab has been approved in the United States and the European Union for use when reversal of the anticoagulant effects of dabigatran is needed for emergency surgery/urgent procedures or in patients with life-threatening or uncontrolled bleeding. Clinical use of idarucizumab should follow the same processes as patient enrollment in this study, which is projected to be completed in 2016. The outcomes achieved with this specific reversal agent are likely to be of continued interest to treating physicians"}, "reference": {"id": "91ee6df83a814e359d523db761dedec6", "answers": {"answer_start": [405], "text": ["dabigatran"]}}}, "71bd3b76233a43cea11f1ef523c93fcf": {"prediction": {"id": "71bd3b76233a43cea11f1ef523c93fcf", "prediction_text": "FDA approval of idarucizumab, there had been no reversal agent for dabigatran-induced anticoagulation in patients with life-threatening or uncontrollable bleeding, or those requiring emergent procedures. The primary purpose of this review is to summarize the safety and efficacy of idarucizumab, a monoclonal antibody fragment"}, "reference": {"id": "71bd3b76233a43cea11f1ef523c93fcf", "answers": {"answer_start": [214], "text": ["dabigatran"]}}}, "4d577bdf3b1e4135a562c5097f4c258a": {"prediction": {"id": "4d577bdf3b1e4135a562c5097f4c258a", "prediction_text": "antibody fragment"}, "reference": {"id": "4d577bdf3b1e4135a562c5097f4c258a", "answers": {"answer_start": [1252], "text": ["dabigatran"]}}}, "662a5743a140429385c0ba4eed68c749": {"prediction": {"id": "662a5743a140429385c0ba4eed68c749", "prediction_text": "bleeding associated"}, "reference": {"id": "662a5743a140429385c0ba4eed68c749", "answers": {"answer_start": [385], "text": ["dabigatran"]}}}, "0e5349a429af420ca4fdd05bdbf0bd32": {"prediction": {"id": "0e5349a429af420ca4fdd05bdbf0bd32", "prediction_text": "thrombin inhibitor"}, "reference": {"id": "0e5349a429af420ca4fdd05bdbf0bd32", "answers": {"answer_start": [432], "text": ["dabigatran"]}}}, "d3dc1551d2b14a198bc01b330bf3de17": {"prediction": {"id": "d3dc1551d2b14a198bc01b330bf3de17", "prediction_text": "antibody fragment"}, "reference": {"id": "d3dc1551d2b14a198bc01b330bf3de17", "answers": {"answer_start": [102], "text": ["dabigatran"]}}}, "f5bac7b7e392482fa18d4d1959d444e1": {"prediction": {"id": "f5bac7b7e392482fa18d4d1959d444e1", "prediction_text": "vitamin K"}, "reference": {"id": "f5bac7b7e392482fa18d4d1959d444e1", "answers": {"answer_start": [1138], "text": ["dabigatran"]}}}, "28fc774a70474ff3a463a81cb5fd4f7c": {"prediction": {"id": "28fc774a70474ff3a463a81cb5fd4f7c", "prediction_text": "overdose"}, "reference": {"id": "28fc774a70474ff3a463a81cb5fd4f7c", "answers": {"answer_start": [95], "text": ["dabigatran"]}}}, "fb7852fd04d64ec1be63ea6e77b30244": {"prediction": {"id": "fb7852fd04d64ec1be63ea6e77b30244", "prediction_text": "vitamin K is the first choice in vitamin K antagonist-related ICH"}, "reference": {"id": "fb7852fd04d64ec1be63ea6e77b30244", "answers": {"answer_start": [463], "text": ["dabigatran"]}}}, "bc704a0207764c2db1b9bce2a3964c7a": {"prediction": {"id": "bc704a0207764c2db1b9bce2a3964c7a", "prediction_text": "blood pressure"}, "reference": {"id": "bc704a0207764c2db1b9bce2a3964c7a", "answers": {"answer_start": [0], "text": ["dabigatran"]}}}, "d9e1fac219d243c187590f5e447143d6": {"prediction": {"id": "d9e1fac219d243c187590f5e447143d6", "prediction_text": "Food and Drug Administration"}, "reference": {"id": "d9e1fac219d243c187590f5e447143d6", "answers": {"answer_start": [938], "text": ["dabigatran"]}}}, "a8e8d7f4f8744887b9dfc196e999139e": {"prediction": {"id": "a8e8d7f4f8744887b9dfc196e999139e", "prediction_text": "vitamin K antagonists in patients without cancer or renal failure, more so after the development of reversal agents such as idarucizumab and andexanet alfa"}, "reference": {"id": "a8e8d7f4f8744887b9dfc196e999139e", "answers": {"answer_start": [1399], "text": ["dabigatran"]}}}, "b922a38896614102ba8e62c466e83e4e": {"prediction": {"id": "b922a38896614102ba8e62c466e83e4e", "prediction_text": "Idarucizumab"}, "reference": {"id": "b922a38896614102ba8e62c466e83e4e", "answers": {"answer_start": [1474], "text": ["dabigatran"]}}}, "9f3c7ad19a674156b1d21b0a0d535cf6": {"prediction": {"id": "9f3c7ad19a674156b1d21b0a0d535cf6", "prediction_text": "Idarucizumab"}, "reference": {"id": "9f3c7ad19a674156b1d21b0a0d535cf6", "answers": {"answer_start": [1870], "text": ["dabigatran"]}}}, "4ec63a883b884a74acec7b497d174b6c": {"prediction": {"id": "4ec63a883b884a74acec7b497d174b6c", "prediction_text": "coagulation variables"}, "reference": {"id": "4ec63a883b884a74acec7b497d174b6c", "answers": {"answer_start": [301], "text": ["dabigatran"]}}}, "d2c32fa6abfe4276863c3dea1efd0216": {"prediction": {"id": "d2c32fa6abfe4276863c3dea1efd0216", "prediction_text": "Dabigatran etexilate"}, "reference": {"id": "d2c32fa6abfe4276863c3dea1efd0216", "answers": {"answer_start": [746], "text": ["dabigatran"]}}}, "fee6f4f719d64e96b80d8bb994934b6a": {"prediction": {"id": "fee6f4f719d64e96b80d8bb994934b6a", "prediction_text": "coagulation parameters or endogenous thrombin potential. Overall adverse event (AE) frequency was similar for idarucizumab and placebo"}, "reference": {"id": "fee6f4f719d64e96b80d8bb994934b6a", "answers": {"answer_start": [1024], "text": ["dabigatran"]}}}, "7d7bf5b619c6477ca92bfba3beee3e55": {"prediction": {"id": "7d7bf5b619c6477ca92bfba3beee3e55", "prediction_text": "dabigatran therapy and using supportive measures, there are rare clinical situations that require urgent reversal of the anticoagulant effect of dabigatran. The effectiveness and safety of 5 g of intravenous idarucizumab is being investigated in a prospective, open-label, single-cohort study in patients with serious bleeding or in those requiring an urgent procedure. In an interim analysis of the first 90 participants, idarucizumab rapidly and completely reversed the anticoagulant activity of dabigatran in 88%-98% of participants, and there were no safety concerns, with no deaths or serious adverse events being attributable to idarucizumab. Supported by these interim results, idarucizumab has been approved in the United States and the European Union for use when reversal of the anticoagulant effects of dabigatran is needed for emergency surgery/urgent procedures or in patients with life-threatening or uncontrolled bleeding. Clinical use of idarucizumab should follow the same processes as patient enrollment in this study, which is projected to be completed in 2016. The outcomes achieved with this specific reversal agent are likely to be of continued interest to treating physicians"}, "reference": {"id": "7d7bf5b619c6477ca92bfba3beee3e55", "answers": {"answer_start": [405], "text": ["dabigatran"]}}}, "927ef43b20214534a89906d22e1ae82c": {"prediction": {"id": "927ef43b20214534a89906d22e1ae82c", "prediction_text": "placebo"}, "reference": {"id": "927ef43b20214534a89906d22e1ae82c", "answers": {"answer_start": [1357], "text": ["dabigatran"]}}}, "614441d8a3174cab95616d7197533acb": {"prediction": {"id": "614441d8a3174cab95616d7197533acb", "prediction_text": "Food and Drug Administration (FDA)"}, "reference": {"id": "614441d8a3174cab95616d7197533acb", "answers": {"answer_start": [906], "text": ["dabigatran"]}}}, "5a7ee4d0d0c8421b8da614bb9bcafde2": {"prediction": {"id": "5a7ee4d0d0c8421b8da614bb9bcafde2", "prediction_text": "de Quervain"}, "reference": {"id": "5a7ee4d0d0c8421b8da614bb9bcafde2", "answers": {"answer_start": [1461], "text": ["de Quervain's disease"]}}}, "f4407d540a3b421897f09055ba0da0ed": {"prediction": {"id": "f4407d540a3b421897f09055ba0da0ed", "prediction_text": "dQD"}, "reference": {"id": "f4407d540a3b421897f09055ba0da0ed", "answers": {"answer_start": [1061], "text": ["de Quervain's disease"]}}}, "1fbf12541b2948ac8f970d2cb00b5c1b": {"prediction": {"id": "1fbf12541b2948ac8f970d2cb00b5c1b", "prediction_text": "de Quervain"}, "reference": {"id": "1fbf12541b2948ac8f970d2cb00b5c1b", "answers": {"answer_start": [54], "text": ["de Quervain's disease"]}}}, "0969f2fc90154aeb90929c9b2520751e": {"prediction": {"id": "0969f2fc90154aeb90929c9b2520751e", "prediction_text": "de Quervain's disease (DD) is nonoperative in the first instance, but surgery should be considered if conservative measures fail. We present the long-term results of operative treatment of DD. From July 1988 to July 1998, 94 consecutive patients with DD were treated operatively by a single surgeon. There were 80 women and 14 men. Average age at the time of operation was 47.4 years (range 22-76). The right wrist was involved in 43 cases, the left in 51 cases. All operations were done under tourniquet control with local infiltration anaesthesia using a longitudinal incision and partial resection of the extensor ligament. There were six perioperative complications, including one superficial wound infection, one delayed wound healing, and four transient lesions of the radial nerve"}, "reference": {"id": "0969f2fc90154aeb90929c9b2520751e", "answers": {"answer_start": [18], "text": ["de Quervain's disease"]}}}, "940d665d0e2e421cbc05710c325debfb": {"prediction": {"id": "940d665d0e2e421cbc05710c325debfb", "prediction_text": "de Quervain"}, "reference": {"id": "940d665d0e2e421cbc05710c325debfb", "answers": {"answer_start": [0], "text": ["de Quervain's disease"]}}}, "3922538ac4d341e0b6d75a1151a11903": {"prediction": {"id": "3922538ac4d341e0b6d75a1151a11903", "prediction_text": "study CaSR expression, the mutation was introduced by site-directed mutagenesis into a wild-type (WT) CaSR-expressing pCR3.1 vector"}, "reference": {"id": "3922538ac4d341e0b6d75a1151a11903", "answers": {"answer_start": [4], "text": ["The calcium-sensing receptor (CaSR) is a G-protein-coupled receptor that plays an essential role in maintaining calcium homeostasis."]}}}, "5f84b67d55ff4522a156a717fe93839c": {"prediction": {"id": "5f84b67d55ff4522a156a717fe93839c", "prediction_text": "gas"}, "reference": {"id": "5f84b67d55ff4522a156a717fe93839c", "answers": {"answer_start": [1553], "text": ["pneumoperitoneum"]}}}, "79791101b46e47fdaf1da7961310d5c3": {"prediction": {"id": "79791101b46e47fdaf1da7961310d5c3", "prediction_text": "CT signs"}, "reference": {"id": "79791101b46e47fdaf1da7961310d5c3", "answers": {"answer_start": [923], "text": ["pneumoperitoneum"]}}}, "2b33020690d04d2da5b9d9d4f5646723": {"prediction": {"id": "2b33020690d04d2da5b9d9d4f5646723", "prediction_text": "high fever, dry cough and general malaise"}, "reference": {"id": "2b33020690d04d2da5b9d9d4f5646723", "answers": {"answer_start": [128], "text": ["Schistosoma spp"]}}}, "a7529579402b4ce290adfcac75becd12": {"prediction": {"id": "a7529579402b4ce290adfcac75becd12", "prediction_text": "gene regulatory blocks"}, "reference": {"id": "a7529579402b4ce290adfcac75becd12", "answers": {"answer_start": [362], "text": ["gene regulatory blocks (GRBs)"]}}}, "1de8a50bc1c84556b4aad12a2f151b43": {"prediction": {"id": "1de8a50bc1c84556b4aad12a2f151b43", "prediction_text": "chipmunk"}, "reference": {"id": "1de8a50bc1c84556b4aad12a2f151b43", "answers": {"answer_start": [799], "text": ["7SL RNA"]}}}, "89855926b57845cf84b53db8f4ca156f": {"prediction": {"id": "89855926b57845cf84b53db8f4ca156f", "prediction_text": "7SL RNA gene"}, "reference": {"id": "89855926b57845cf84b53db8f4ca156f", "answers": {"answer_start": [312], "text": ["7SL RNA"]}}}, "ae695836b1e34fd3b0882c1443f04f3b": {"prediction": {"id": "ae695836b1e34fd3b0882c1443f04f3b", "prediction_text": "OikoBase will provide a valuable resource"}, "reference": {"id": "ae695836b1e34fd3b0882c1443f04f3b", "answers": {"answer_start": [234], "text": ["OikoBase"]}}}, "4dd12ee3449c40c4a10ecd89144e695e": {"prediction": {"id": "4dd12ee3449c40c4a10ecd89144e695e", "prediction_text": "centriole"}, "reference": {"id": "4dd12ee3449c40c4a10ecd89144e695e", "answers": {"answer_start": [618], "text": ["centrosome"]}}}, "f97b9a32dd7047d6a32895b713d7abb2": {"prediction": {"id": "f97b9a32dd7047d6a32895b713d7abb2", "prediction_text": "high resolution imaging"}, "reference": {"id": "f97b9a32dd7047d6a32895b713d7abb2", "answers": {"answer_start": [1151], "text": ["centrosome"]}}}, "abc2353d25d646d9bb837337e1b7a598": {"prediction": {"id": "abc2353d25d646d9bb837337e1b7a598", "prediction_text": "different stages of procentriole formation and in association with different centriolar structures"}, "reference": {"id": "abc2353d25d646d9bb837337e1b7a598", "answers": {"answer_start": [80], "text": ["centrosome"]}}}, "8f7311de496b49d192a58637569ced3c": {"prediction": {"id": "8f7311de496b49d192a58637569ced3c", "prediction_text": "centrosome"}, "reference": {"id": "8f7311de496b49d192a58637569ced3c", "answers": {"answer_start": [770], "text": ["centrosome"]}}}, "6d06179e78e344489b53eca71f5cf85b": {"prediction": {"id": "6d06179e78e344489b53eca71f5cf85b", "prediction_text": "Cdks were knocked out by chemical genetics"}, "reference": {"id": "6d06179e78e344489b53eca71f5cf85b", "answers": {"answer_start": [26], "text": ["centrosome"]}}}, "73a10cb2958c445ab8dc787ae15d995b": {"prediction": {"id": "73a10cb2958c445ab8dc787ae15d995b", "prediction_text": "yeast two-hybrid libraries"}, "reference": {"id": "73a10cb2958c445ab8dc787ae15d995b", "answers": {"answer_start": [756], "text": ["centrosome"]}}}, "1b4023a8b6fd412cb4410399f7846b79": {"prediction": {"id": "1b4023a8b6fd412cb4410399f7846b79", "prediction_text": "daughter centriole assembly"}, "reference": {"id": "1b4023a8b6fd412cb4410399f7846b79", "answers": {"answer_start": [97], "text": ["centrosome"]}}}, "cda9f81dd6c14244acb063256473ce9c": {"prediction": {"id": "cda9f81dd6c14244acb063256473ce9c", "prediction_text": "cell cycle regulation. CEP family protein is the active component of centrosome and plays a vital role in centriole biogenesis and cell cycle progression control. A total of 31 proteins have been categorized into CEP family protein category and many more are under candidate evaluation. Furthermore, by the recent advancements in genomics and proteomics researches, several new CEP proteins have also been characterized. Here we have summarized the importance of CEP family proteins and their regulation mechanism involved in proper cell cycle progression. Further, we have reviewed the detailed molecular mechanism behind the associated pathological phenotypes and the possible therapeutic approaches. Proteins such as CEP57, CEP63, CEP152, CEP164, and CEP215 have been extensively studied with a detailed description of their molecular mechanisms"}, "reference": {"id": "cda9f81dd6c14244acb063256473ce9c", "answers": {"answer_start": [0], "text": ["centrosome"]}}}, "8681a6517179499e867f99e0c808b57a": {"prediction": {"id": "8681a6517179499e867f99e0c808b57a", "prediction_text": "downstream regulators"}, "reference": {"id": "8681a6517179499e867f99e0c808b57a", "answers": {"answer_start": [978], "text": ["centrosome"]}}}, "7343366062324bada970955e56f283da": {"prediction": {"id": "7343366062324bada970955e56f283da", "prediction_text": "intestine"}, "reference": {"id": "7343366062324bada970955e56f283da", "answers": {"answer_start": [1486], "text": ["centrosome"]}}}, "9520f4acb66c48a4b6ed2bfbd69dcb31": {"prediction": {"id": "9520f4acb66c48a4b6ed2bfbd69dcb31", "prediction_text": "CBB and flagella biogenesis"}, "reference": {"id": "9520f4acb66c48a4b6ed2bfbd69dcb31", "answers": {"answer_start": [112], "text": ["centrosome"]}}}, "9d9532bd73e34e9bb25269b1a319a664": {"prediction": {"id": "9d9532bd73e34e9bb25269b1a319a664", "prediction_text": "the centrosomal structure"}, "reference": {"id": "9d9532bd73e34e9bb25269b1a319a664", "answers": {"answer_start": [1086], "text": ["centrosome"]}}}, "c6af9df014fc4064b6f760f439cdf090": {"prediction": {"id": "c6af9df014fc4064b6f760f439cdf090", "prediction_text": "nick-end labeling)-positive cells and the expression of phosphorylated"}, "reference": {"id": "c6af9df014fc4064b6f760f439cdf090", "answers": {"answer_start": [34, 253], "text": ["Na(+)/Ca(2+) exchanger", "NCX"]}}}, "2b9027fd03054b048f6ecf0ea582637c": {"prediction": {"id": "2b9027fd03054b048f6ecf0ea582637c", "prediction_text": "Na(+)/Ca(2+"}, "reference": {"id": "2b9027fd03054b048f6ecf0ea582637c", "answers": {"answer_start": [53, 419], "text": ["Na(+)/Ca(2+) exchanger", "NCX"]}}}, "330833cb9d6f45aeb5b9c11a6a8a7988": {"prediction": {"id": "330833cb9d6f45aeb5b9c11a6a8a7988", "prediction_text": "MAP)/extracellular signal-regulated kinase (ERK) kinase inhibitor U0126 and the p38 MAP kinase (MAPK) inhibitor SB203580, but not by the c-Jun N-terminal kinase (JNK) inhibitor SP60012. SNP increased Ca(2+) influx and intracellular Ca(2+) levels. In addition, SNP increased ERK and p38 MAPK phosphorylation, and production of reactive oxygen species (ROS) in an extracellular Ca(2+)-dependent manner. These effects of SNP were prevented by SEA0400. SNP-induced cytotoxicity was not affected by inhibitors of the Ca(2+), Na(+) and store-operated/capacitative channels. Moreover, SNP-induced increase in intracellular Ca(2+) levels, ROS production and decrease in cell viability were blocked by a cGMP-dependent protein kinase (PKG) inhibitor. These results suggest that Ca(2+) influx via the reverse of NCX is involved in the cascade of NO-induced neuronal apoptosis and NO activates the NCX"}, "reference": {"id": "330833cb9d6f45aeb5b9c11a6a8a7988", "answers": {"answer_start": [4, 1572], "text": ["Na(+)/Ca(2+) exchanger", "NCX"]}}}, "5a049136b61c42efa9085f131ce3fc34": {"prediction": {"id": "5a049136b61c42efa9085f131ce3fc34", "prediction_text": "NCX"}, "reference": {"id": "5a049136b61c42efa9085f131ce3fc34", "answers": {"answer_start": [127, 1491], "text": ["Na(+)/Ca(2+) exchanger", "NCX"]}}}, "ab4827c974bd4fd8a14ebd0c7c84d823": {"prediction": {"id": "ab4827c974bd4fd8a14ebd0c7c84d823", "prediction_text": "MEMRI"}, "reference": {"id": "ab4827c974bd4fd8a14ebd0c7c84d823", "answers": {"answer_start": [356], "text": ["NCX"]}}}, "92a70dc4ae2745cb94c21dc49a2bc2bc": {"prediction": {"id": "92a70dc4ae2745cb94c21dc49a2bc2bc", "prediction_text": "Na(+)/Ca(2+"}, "reference": {"id": "92a70dc4ae2745cb94c21dc49a2bc2bc", "answers": {"answer_start": [35], "text": ["Na(+)/Ca(2+) exchanger"]}}}, "de5c0614cc014d1fb75ef0e64bce37c5": {"prediction": {"id": "de5c0614cc014d1fb75ef0e64bce37c5", "prediction_text": "NCX"}, "reference": {"id": "de5c0614cc014d1fb75ef0e64bce37c5", "answers": {"answer_start": [336], "text": ["NCX"]}}}, "13c54190ff1c4da4a9643c9a0d77c108": {"prediction": {"id": "13c54190ff1c4da4a9643c9a0d77c108", "prediction_text": "NCX"}, "reference": {"id": "13c54190ff1c4da4a9643c9a0d77c108", "answers": {"answer_start": [390], "text": ["NCX"]}}}, "e1de4e2ed9af493189230c2727516b6d": {"prediction": {"id": "e1de4e2ed9af493189230c2727516b6d", "prediction_text": "Na(+)/Ca(2+"}, "reference": {"id": "e1de4e2ed9af493189230c2727516b6d", "answers": {"answer_start": [250], "text": ["Na(+)/Ca(2+) exchanger"]}}}, "7903b39fed844153ac9ef3ddcb4a4fec": {"prediction": {"id": "7903b39fed844153ac9ef3ddcb4a4fec", "prediction_text": "NCX"}, "reference": {"id": "7903b39fed844153ac9ef3ddcb4a4fec", "answers": {"answer_start": [20, 489], "text": ["Na(+)/Ca(2+) exchanger", "NCX"]}}}, "12aabfd2db5548c383ce80ca91b2c81b": {"prediction": {"id": "12aabfd2db5548c383ce80ca91b2c81b", "prediction_text": "NCX"}, "reference": {"id": "12aabfd2db5548c383ce80ca91b2c81b", "answers": {"answer_start": [1422], "text": ["NCX"]}}}, "0000d452b7d849c6970bdc09e73009e5": {"prediction": {"id": "0000d452b7d849c6970bdc09e73009e5", "prediction_text": "PPADS"}, "reference": {"id": "0000d452b7d849c6970bdc09e73009e5", "answers": {"answer_start": [176], "text": ["NCX"]}}}, "6331c30bc6e14b69aa82ec77f91a05c7": {"prediction": {"id": "6331c30bc6e14b69aa82ec77f91a05c7", "prediction_text": "synthase"}, "reference": {"id": "6331c30bc6e14b69aa82ec77f91a05c7", "answers": {"answer_start": [32, 420], "text": ["Na(+)/Ca(2+) exchanger", "NCX"]}}}, "d950c8bdf03b46df8cce03cd69c4a6de": {"prediction": {"id": "d950c8bdf03b46df8cce03cd69c4a6de", "prediction_text": "NCX"}, "reference": {"id": "d950c8bdf03b46df8cce03cd69c4a6de", "answers": {"answer_start": [198], "text": ["NCX"]}}}, "c9c13e03a9bb4a8aa70c1f3a8a231787": {"prediction": {"id": "c9c13e03a9bb4a8aa70c1f3a8a231787", "prediction_text": "guanylate cyclase inhibitor LY83583"}, "reference": {"id": "c9c13e03a9bb4a8aa70c1f3a8a231787", "answers": {"answer_start": [471, 574], "text": ["Na(+)/Ca(2+) exchanger", "NCX"]}}}, "cf75dbb0346c4446a1b1a1a6c21b3ee1": {"prediction": {"id": "cf75dbb0346c4446a1b1a1a6c21b3ee1", "prediction_text": "Na+-Ca2+"}, "reference": {"id": "cf75dbb0346c4446a1b1a1a6c21b3ee1", "answers": {"answer_start": [1293], "text": ["NCX"]}}}, "d60e1fea0fa04c86af2559336fdecca3": {"prediction": {"id": "d60e1fea0fa04c86af2559336fdecca3", "prediction_text": "LARVA"}, "reference": {"id": "d60e1fea0fa04c86af2559336fdecca3", "answers": {"answer_start": [864], "text": ["LARVA"]}}}, "107a7a8da7864dbdbb421bc3e7caa572": {"prediction": {"id": "107a7a8da7864dbdbb421bc3e7caa572", "prediction_text": "Reintroduction"}, "reference": {"id": "107a7a8da7864dbdbb421bc3e7caa572", "answers": {"answer_start": [689], "text": ["PU.1"]}}}, "54b8e24810454c57b9ba9e48eec4170e": {"prediction": {"id": "54b8e24810454c57b9ba9e48eec4170e", "prediction_text": "MBP"}, "reference": {"id": "54b8e24810454c57b9ba9e48eec4170e", "answers": {"answer_start": [1325], "text": ["PU.1"]}}}, "d225b0f82696400ba5a4df0267a0d467": {"prediction": {"id": "d225b0f82696400ba5a4df0267a0d467", "prediction_text": "progesterone function"}, "reference": {"id": "d225b0f82696400ba5a4df0267a0d467", "answers": {"answer_start": [981], "text": ["RANKL"]}}}, "ce95bf6fe41947e5b9dafb70fcde67b3": {"prediction": {"id": "ce95bf6fe41947e5b9dafb70fcde67b3", "prediction_text": "RANK"}, "reference": {"id": "ce95bf6fe41947e5b9dafb70fcde67b3", "answers": {"answer_start": [954], "text": ["RANKL"]}}}, "a9a460cc7e1f4e17a9b9717652fbf72c": {"prediction": {"id": "a9a460cc7e1f4e17a9b9717652fbf72c", "prediction_text": "Wnt-inhibitor"}, "reference": {"id": "a9a460cc7e1f4e17a9b9717652fbf72c", "answers": {"answer_start": [449], "text": ["RANKL"]}}}, "d2523475ef2f4e7294cd014caf775d8e": {"prediction": {"id": "d2523475ef2f4e7294cd014caf775d8e", "prediction_text": "bone diseases"}, "reference": {"id": "d2523475ef2f4e7294cd014caf775d8e", "answers": {"answer_start": [847], "text": ["RANKL"]}}}, "f6312ef543c94624ab3f72c20007024e": {"prediction": {"id": "f6312ef543c94624ab3f72c20007024e", "prediction_text": "activator of nuclear factor"}, "reference": {"id": "f6312ef543c94624ab3f72c20007024e", "answers": {"answer_start": [670], "text": ["RANKL"]}}}, "2b6890cc949342149afd27d93d362b6a": {"prediction": {"id": "2b6890cc949342149afd27d93d362b6a", "prediction_text": "III clinical testing"}, "reference": {"id": "2b6890cc949342149afd27d93d362b6a", "answers": {"answer_start": [513], "text": ["RANKL"]}}}, "cf56853204d14a1c8314a22e38d4c477": {"prediction": {"id": "cf56853204d14a1c8314a22e38d4c477", "prediction_text": "prostate cancer"}, "reference": {"id": "cf56853204d14a1c8314a22e38d4c477", "answers": {"answer_start": [1736], "text": ["RANKL"]}}}, "8c88113485764639ae5959c470b81e52": {"prediction": {"id": "8c88113485764639ae5959c470b81e52", "prediction_text": "primary afferent nerve"}, "reference": {"id": "8c88113485764639ae5959c470b81e52", "answers": {"answer_start": [1065], "text": ["RANKL"]}}}, "4ed3d5bd679b43ab8a651ec05eed92e6": {"prediction": {"id": "4ed3d5bd679b43ab8a651ec05eed92e6", "prediction_text": "bone"}, "reference": {"id": "4ed3d5bd679b43ab8a651ec05eed92e6", "answers": {"answer_start": [1391], "text": ["RANKL"]}}}, "61bc63ebc41b4143b1a407afa8a9ae31": {"prediction": {"id": "61bc63ebc41b4143b1a407afa8a9ae31", "prediction_text": "1 and 5, interleukin-3, and Wnt signaling"}, "reference": {"id": "61bc63ebc41b4143b1a407afa8a9ae31", "answers": {"answer_start": [634], "text": ["RANKL"]}}}, "96ab9cd291e94fe5bf1f986a5de69c44": {"prediction": {"id": "96ab9cd291e94fe5bf1f986a5de69c44", "prediction_text": "nuclear factor-\u03ba\u0392 ligand/receptor activator of nuclear factor-\u03ba\u0392/osteoprotegerin"}, "reference": {"id": "96ab9cd291e94fe5bf1f986a5de69c44", "answers": {"answer_start": [1287], "text": ["RANKL"]}}}, "99d420d51d324f16b0a9dd35d3e44225": {"prediction": {"id": "99d420d51d324f16b0a9dd35d3e44225", "prediction_text": "RANKL"}, "reference": {"id": "99d420d51d324f16b0a9dd35d3e44225", "answers": {"answer_start": [397], "text": ["RANKL"]}}}, "4d3f5b83062b4517835850b751a8e380": {"prediction": {"id": "4d3f5b83062b4517835850b751a8e380", "prediction_text": "bone resorption"}, "reference": {"id": "4d3f5b83062b4517835850b751a8e380", "answers": {"answer_start": [1192], "text": ["RANKL"]}}}, "8b1ea455e2794029834393aeefc8a391": {"prediction": {"id": "8b1ea455e2794029834393aeefc8a391", "prediction_text": "RANKL"}, "reference": {"id": "8b1ea455e2794029834393aeefc8a391", "answers": {"answer_start": [766], "text": ["RANKL"]}}}, "0982d5433b7d4eed8fa06615c999909c": {"prediction": {"id": "0982d5433b7d4eed8fa06615c999909c", "prediction_text": "\u03b1-synuclein"}, "reference": {"id": "0982d5433b7d4eed8fa06615c999909c", "answers": {"answer_start": [809], "text": ["\u03b1-synuclein"]}}}, "08328dad0966431aa566f3bb61779f64": {"prediction": {"id": "08328dad0966431aa566f3bb61779f64", "prediction_text": "alpha-synuclein"}, "reference": {"id": "08328dad0966431aa566f3bb61779f64", "answers": {"answer_start": [344], "text": ["alpha-synuclein"]}}}, "2be5ef746b7841c58eb2962557e6f3c4": {"prediction": {"id": "2be5ef746b7841c58eb2962557e6f3c4", "prediction_text": "\u03b1-synuclein"}, "reference": {"id": "2be5ef746b7841c58eb2962557e6f3c4", "answers": {"answer_start": [167], "text": ["\u03b1-synuclein"]}}}, "d506417576734216887e0e5d8d16edfe": {"prediction": {"id": "d506417576734216887e0e5d8d16edfe", "prediction_text": "Alpha-synuclein"}, "reference": {"id": "d506417576734216887e0e5d8d16edfe", "answers": {"answer_start": [0], "text": ["alpha-synuclein"]}}}, "ad506c323a9240d3b7386b353f34e1c4": {"prediction": {"id": "ad506c323a9240d3b7386b353f34e1c4", "prediction_text": "\u03b1-Synuclein"}, "reference": {"id": "ad506c323a9240d3b7386b353f34e1c4", "answers": {"answer_start": [149], "text": ["\u03b1-synuclein"]}}}, "2a69a324ebc546dd8ef84e61d14a6f7b": {"prediction": {"id": "2a69a324ebc546dd8ef84e61d14a6f7b", "prediction_text": "alpha-synuclein"}, "reference": {"id": "2a69a324ebc546dd8ef84e61d14a6f7b", "answers": {"answer_start": [343], "text": ["alpha-synuclein"]}}}, "eb26b09b128247ee9315e5627c58ad06": {"prediction": {"id": "eb26b09b128247ee9315e5627c58ad06", "prediction_text": "Aggregation of \u03b1-synuclein"}, "reference": {"id": "eb26b09b128247ee9315e5627c58ad06", "answers": {"answer_start": [15, 967], "text": ["\u03b1-synuclein", "\u03b1Syn"]}}}, "97a55fdc221042afa93edec03f8b7a9b": {"prediction": {"id": "97a55fdc221042afa93edec03f8b7a9b", "prediction_text": "pathogenesis"}, "reference": {"id": "97a55fdc221042afa93edec03f8b7a9b", "answers": {"answer_start": [1055], "text": ["alpha-synuclein"]}}}, "77ec3ffe44794d379deda5432c274ace": {"prediction": {"id": "77ec3ffe44794d379deda5432c274ace", "prediction_text": "alpha-synuclein"}, "reference": {"id": "77ec3ffe44794d379deda5432c274ace", "answers": {"answer_start": [776], "text": ["alpha-synuclein"]}}}, "44d700672fcf4fcda3229fe822867e75": {"prediction": {"id": "44d700672fcf4fcda3229fe822867e75", "prediction_text": "\u03b1-Synuclein"}, "reference": {"id": "44d700672fcf4fcda3229fe822867e75", "answers": {"answer_start": [252], "text": ["\u03b1-synuclein"]}}}, "fdd9e75a3f044fb4ac66e89dc3fc1a7c": {"prediction": {"id": "fdd9e75a3f044fb4ac66e89dc3fc1a7c", "prediction_text": "Fibrillar \u03b1-synuclein"}, "reference": {"id": "fdd9e75a3f044fb4ac66e89dc3fc1a7c", "answers": {"answer_start": [10], "text": ["\u03b1-synuclein"]}}}, "5c44576097224947821c7a77029e01a8": {"prediction": {"id": "5c44576097224947821c7a77029e01a8", "prediction_text": "Fibrillar \u03b1-synuclein"}, "reference": {"id": "5c44576097224947821c7a77029e01a8", "answers": {"answer_start": [10], "text": ["\u03b1-synuclein"]}}}, "1e3445b91e1946fba210dc02e8a566a6": {"prediction": {"id": "1e3445b91e1946fba210dc02e8a566a6", "prediction_text": "\u03b1-synuclein and \u03b2-amyloid"}, "reference": {"id": "1e3445b91e1946fba210dc02e8a566a6", "answers": {"answer_start": [853], "text": ["\u03b1-synuclein"]}}}, "ab6a1a1535224e8cad2787c637fda655": {"prediction": {"id": "ab6a1a1535224e8cad2787c637fda655", "prediction_text": "alpha-synuclein"}, "reference": {"id": "ab6a1a1535224e8cad2787c637fda655", "answers": {"answer_start": [1031], "text": ["alpha-synuclein"]}}}, "090b551d0ae14996b0d05e5bf20b7bf7": {"prediction": {"id": "090b551d0ae14996b0d05e5bf20b7bf7", "prediction_text": "alpha-synuclein"}, "reference": {"id": "090b551d0ae14996b0d05e5bf20b7bf7", "answers": {"answer_start": [767], "text": ["alpha-synuclein"]}}}, "2d46dd807a694ac0b5353bb1938fa377": {"prediction": {"id": "2d46dd807a694ac0b5353bb1938fa377", "prediction_text": "alpha-synuclein"}, "reference": {"id": "2d46dd807a694ac0b5353bb1938fa377", "answers": {"answer_start": [697], "text": ["alpha-synuclein"]}}}, "bb07e6dab17e457bbf9b4163b4661f14": {"prediction": {"id": "bb07e6dab17e457bbf9b4163b4661f14", "prediction_text": "Alpha-synuclein"}, "reference": {"id": "bb07e6dab17e457bbf9b4163b4661f14", "answers": {"answer_start": [0], "text": ["alpha-synuclein"]}}}, "d211165f5e764ab6b0be00e744693408": {"prediction": {"id": "d211165f5e764ab6b0be00e744693408", "prediction_text": "alpha-synuclein to label Parkinson disease-specific Lewy bodies and Lewy neurites as well as synaptic boutons containing the unaltered protein, an initial attempt is made to map the overall distribution pattern and describe the staining behavior of the immunoreactive punctae in select regions of the prosencephalon. Neocortical immunolabeling is most prominent in the prodigious, but incompletely myelinated, association fields and faintest in the heavily myelinated"}, "reference": {"id": "d211165f5e764ab6b0be00e744693408", "answers": {"answer_start": [508], "text": ["alpha-synuclein"]}}}, "a4ffedcfdbaa47a9872cce9c96ab80c0": {"prediction": {"id": "a4ffedcfdbaa47a9872cce9c96ab80c0", "prediction_text": "TDP-43"}, "reference": {"id": "a4ffedcfdbaa47a9872cce9c96ab80c0", "answers": {"answer_start": [1014], "text": ["alpha-synuclein"]}}}, "483fd02d0a9a4bdb8efe5c2743a53597": {"prediction": {"id": "483fd02d0a9a4bdb8efe5c2743a53597", "prediction_text": "Alpha-synuclein"}, "reference": {"id": "483fd02d0a9a4bdb8efe5c2743a53597", "answers": {"answer_start": [1031], "text": ["alpha-synuclein"]}}}, "3a7abe2fecc148e08b95f931e49d84d1": {"prediction": {"id": "3a7abe2fecc148e08b95f931e49d84d1", "prediction_text": "Human \u03b1-synuclein"}, "reference": {"id": "3a7abe2fecc148e08b95f931e49d84d1", "answers": {"answer_start": [6], "text": ["\u03b1-synuclein"]}}}, "07135a44f9484f29a59521271a7e2770": {"prediction": {"id": "07135a44f9484f29a59521271a7e2770", "prediction_text": "Alpha-synuclein"}, "reference": {"id": "07135a44f9484f29a59521271a7e2770", "answers": {"answer_start": [698], "text": ["alpha-synuclein"]}}}, "83c6a9660a8d4972978ff5b512659d0b": {"prediction": {"id": "83c6a9660a8d4972978ff5b512659d0b", "prediction_text": "Lipids"}, "reference": {"id": "83c6a9660a8d4972978ff5b512659d0b", "answers": {"answer_start": [370], "text": ["alpha-synuclein"]}}}, "5cbc90fd3bcf496682b16855c4edbd8d": {"prediction": {"id": "5cbc90fd3bcf496682b16855c4edbd8d", "prediction_text": "TDP-43"}, "reference": {"id": "5cbc90fd3bcf496682b16855c4edbd8d", "answers": {"answer_start": [986], "text": ["alpha-synuclein"]}}}, "a9c3095167f74abda231b653371a0d26": {"prediction": {"id": "a9c3095167f74abda231b653371a0d26", "prediction_text": "alpha-synuclein"}, "reference": {"id": "a9c3095167f74abda231b653371a0d26", "answers": {"answer_start": [1111], "text": ["alpha-synuclein"]}}}, "1af96a67b0054520bf85a7dabfdd83f2": {"prediction": {"id": "1af96a67b0054520bf85a7dabfdd83f2", "prediction_text": "Alpha-synuclein"}, "reference": {"id": "1af96a67b0054520bf85a7dabfdd83f2", "answers": {"answer_start": [0], "text": ["alpha-synuclein"]}}}, "fe5bfd82393e44618f04baaeef343015": {"prediction": {"id": "fe5bfd82393e44618f04baaeef343015", "prediction_text": "Alpha-synuclein"}, "reference": {"id": "fe5bfd82393e44618f04baaeef343015", "answers": {"answer_start": [282], "text": ["alpha-synuclein"]}}}, "4bffe2d0a1a845328c081d54fcfa0bb8": {"prediction": {"id": "4bffe2d0a1a845328c081d54fcfa0bb8", "prediction_text": "\u03b1-syn"}, "reference": {"id": "4bffe2d0a1a845328c081d54fcfa0bb8", "answers": {"answer_start": [225], "text": ["\u03b1-synuclein"]}}}, "5be0de167fef4efd8d420d8bb9950106": {"prediction": {"id": "5be0de167fef4efd8d420d8bb9950106", "prediction_text": "alpha-synuclein"}, "reference": {"id": "5be0de167fef4efd8d420d8bb9950106", "answers": {"answer_start": [910], "text": ["alpha-synuclein"]}}}, "3a33c3496ecc498189cce1d38f1ce1c7": {"prediction": {"id": "3a33c3496ecc498189cce1d38f1ce1c7", "prediction_text": "\u03b1-Synuclein"}, "reference": {"id": "3a33c3496ecc498189cce1d38f1ce1c7", "answers": {"answer_start": [450], "text": ["\u03b1-synuclein"]}}}, "2ed87ce087274b25bda4ace115ff19e9": {"prediction": {"id": "2ed87ce087274b25bda4ace115ff19e9", "prediction_text": "filamentous"}, "reference": {"id": "2ed87ce087274b25bda4ace115ff19e9", "answers": {"answer_start": [413], "text": ["alpha-synuclein"]}}}, "c815eac2dfb84a8fb62b2dbd4fb3bf34": {"prediction": {"id": "c815eac2dfb84a8fb62b2dbd4fb3bf34", "prediction_text": "\u03b1-synuclein"}, "reference": {"id": "c815eac2dfb84a8fb62b2dbd4fb3bf34", "answers": {"answer_start": [1593], "text": ["\u03b1-synuclein"]}}}, "0aa82da7270f4aee8fbee824f4f33e57": {"prediction": {"id": "0aa82da7270f4aee8fbee824f4f33e57", "prediction_text": "alpha-Syn"}, "reference": {"id": "0aa82da7270f4aee8fbee824f4f33e57", "answers": {"answer_start": [199], "text": ["alpha-synuclein"]}}}, "fea590069a824c329c01cf87ef573aac": {"prediction": {"id": "fea590069a824c329c01cf87ef573aac", "prediction_text": "dopamine neurons"}, "reference": {"id": "fea590069a824c329c01cf87ef573aac", "answers": {"answer_start": [450], "text": ["alpha-synuclein"]}}}, "4bb0cacce3da45ea947f7b54ead3666d": {"prediction": {"id": "4bb0cacce3da45ea947f7b54ead3666d", "prediction_text": "alpha-synuclein"}, "reference": {"id": "4bb0cacce3da45ea947f7b54ead3666d", "answers": {"answer_start": [12], "text": ["alpha-synuclein"]}}}, "8b7291b8cb264606b31c08a247ef0b2b": {"prediction": {"id": "8b7291b8cb264606b31c08a247ef0b2b", "prediction_text": "alpha-synuclein"}, "reference": {"id": "8b7291b8cb264606b31c08a247ef0b2b", "answers": {"answer_start": [12], "text": ["alpha-synuclein"]}}}, "6286ac5e6a514f318184fef50ce9468e": {"prediction": {"id": "6286ac5e6a514f318184fef50ce9468e", "prediction_text": "alpha-synuclein protein"}, "reference": {"id": "6286ac5e6a514f318184fef50ce9468e", "answers": {"answer_start": [17], "text": ["alpha-synuclein"]}}}, "ce5c2d442aaa4d1a9b0bac2089cc625e": {"prediction": {"id": "ce5c2d442aaa4d1a9b0bac2089cc625e", "prediction_text": "Alpha-synuclein"}, "reference": {"id": "ce5c2d442aaa4d1a9b0bac2089cc625e", "answers": {"answer_start": [0], "text": ["alpha-synuclein"]}}}, "c27139b73951400889f3b0f0a490d7fb": {"prediction": {"id": "c27139b73951400889f3b0f0a490d7fb", "prediction_text": "\u03b1-Synuclein"}, "reference": {"id": "c27139b73951400889f3b0f0a490d7fb", "answers": {"answer_start": [481], "text": ["\u03b1-synuclein"]}}}, "10516c8451b5419aa2312005fd851c64": {"prediction": {"id": "10516c8451b5419aa2312005fd851c64", "prediction_text": "\u03b1-Synuclein"}, "reference": {"id": "10516c8451b5419aa2312005fd851c64", "answers": {"answer_start": [0, 1046], "text": ["\u03b1-synuclein", "\u03b1Syn"]}}}, "8bbde4beff344963ae461c4ec3c25bdf": {"prediction": {"id": "8bbde4beff344963ae461c4ec3c25bdf", "prediction_text": "\u03b1-synuclein"}, "reference": {"id": "8bbde4beff344963ae461c4ec3c25bdf", "answers": {"answer_start": [1683], "text": ["\u03b1-synuclein"]}}}, "a54da0e0d262495badf80b27c5773007": {"prediction": {"id": "a54da0e0d262495badf80b27c5773007", "prediction_text": "Tau"}, "reference": {"id": "a54da0e0d262495badf80b27c5773007", "answers": {"answer_start": [1661], "text": ["alpha-synuclein"]}}}, "8915a70f4da34782bedc090e454614ee": {"prediction": {"id": "8915a70f4da34782bedc090e454614ee", "prediction_text": "alpha-synuclein"}, "reference": {"id": "8915a70f4da34782bedc090e454614ee", "answers": {"answer_start": [1431], "text": ["alpha-synuclein"]}}}, "cde99760dbbd4bd7b2f82ae368ef15e0": {"prediction": {"id": "cde99760dbbd4bd7b2f82ae368ef15e0", "prediction_text": "Abnormal filamentous"}, "reference": {"id": "cde99760dbbd4bd7b2f82ae368ef15e0", "answers": {"answer_start": [305], "text": ["alpha-synuclein"]}}}, "ac854596b356456db305c1401d7cc148": {"prediction": {"id": "ac854596b356456db305c1401d7cc148", "prediction_text": "\u03b1-Synuclein"}, "reference": {"id": "ac854596b356456db305c1401d7cc148", "answers": {"answer_start": [1208], "text": ["\u03b1-synuclein"]}}}, "a9a9d3c20c3c4b93b3c406daa74f43b6": {"prediction": {"id": "a9a9d3c20c3c4b93b3c406daa74f43b6", "prediction_text": "deletions"}, "reference": {"id": "a9a9d3c20c3c4b93b3c406daa74f43b6", "answers": {"answer_start": [171], "text": ["Prader-Willi syndrome"]}}}, "bf421f707f154b5dae9d7146d41d07cb": {"prediction": {"id": "bf421f707f154b5dae9d7146d41d07cb", "prediction_text": "15q11q13. While AS and PWS share a similar cytogenetic anomaly, they have very different clinical phenotypes. DNAs from 4 AS patients were examined using 5 chromosome 15q11q13-specific cloned DNA segments. With the present level of resolution, the molecular deletions between AS and those previously reported for PWS did not appear to differ. However, in contrast to the paternal inheritance of the deleted chromosome 15 observed in the majority of PWS patients, maternal inheritance of the deleted chromosome 15 was demonstrated in the AS patients by restriction fragment length polymorphisms"}, "reference": {"id": "bf421f707f154b5dae9d7146d41d07cb", "answers": {"answer_start": [5], "text": ["Prader-Willi syndrome"]}}}, "e32026c9ab0d4aa99e64d65dea9963f6": {"prediction": {"id": "e32026c9ab0d4aa99e64d65dea9963f6", "prediction_text": "observed"}, "reference": {"id": "e32026c9ab0d4aa99e64d65dea9963f6", "answers": {"answer_start": [518], "text": ["Prader-Willi syndrome"]}}}, "e86591784d714f138a5d9777c450ef2b": {"prediction": {"id": "e86591784d714f138a5d9777c450ef2b", "prediction_text": "PWS the deletion is found in the paternally inherited chromosome 15"}, "reference": {"id": "e86591784d714f138a5d9777c450ef2b", "answers": {"answer_start": [158], "text": ["Prader-Willi syndrome"]}}}, "0fc67d69cef74d629f3f389fd49604c9": {"prediction": {"id": "0fc67d69cef74d629f3f389fd49604c9", "prediction_text": "paternal genes"}, "reference": {"id": "0fc67d69cef74d629f3f389fd49604c9", "answers": {"answer_start": [0], "text": ["Prader-Willi syndrome"]}}}, "3dd3c76660dc4fd08ab12dafc317eb55": {"prediction": {"id": "3dd3c76660dc4fd08ab12dafc317eb55", "prediction_text": "lipid metabolism"}, "reference": {"id": "3dd3c76660dc4fd08ab12dafc317eb55", "answers": {"answer_start": [1756], "text": ["Recessive hypolipidemia"]}}}, "75b212a11b3f47cb9789ac7e59bb5f29": {"prediction": {"id": "75b212a11b3f47cb9789ac7e59bb5f29", "prediction_text": "the gene"}, "reference": {"id": "75b212a11b3f47cb9789ac7e59bb5f29", "answers": {"answer_start": [287], "text": ["SLC9A6"]}}}, "f6289c69e7024f4cb787919c263717b5": {"prediction": {"id": "f6289c69e7024f4cb787919c263717b5", "prediction_text": "SLC9A6"}, "reference": {"id": "f6289c69e7024f4cb787919c263717b5", "answers": {"answer_start": [466], "text": ["SLC9A6"]}}}, "6d565de22c894050acea9e950c7a2fa1": {"prediction": {"id": "6d565de22c894050acea9e950c7a2fa1", "prediction_text": "SLC9A6"}, "reference": {"id": "6d565de22c894050acea9e950c7a2fa1", "answers": {"answer_start": [17], "text": ["SLC9A6"]}}}, "17f68100153444e7817a9333711ed9df": {"prediction": {"id": "17f68100153444e7817a9333711ed9df", "prediction_text": "Na(+)/H(+"}, "reference": {"id": "17f68100153444e7817a9333711ed9df", "answers": {"answer_start": [557], "text": ["SLC9A6"]}}}, "b53aeeb19265425db977825f104b11a0": {"prediction": {"id": "b53aeeb19265425db977825f104b11a0", "prediction_text": "deleterious mutations"}, "reference": {"id": "b53aeeb19265425db977825f104b11a0", "answers": {"answer_start": [105], "text": ["SLC9A6"]}}}, "2dce6256c8f64e87bd098c6e6bb527f1": {"prediction": {"id": "2dce6256c8f64e87bd098c6e6bb527f1", "prediction_text": "SLC9A6"}, "reference": {"id": "2dce6256c8f64e87bd098c6e6bb527f1", "answers": {"answer_start": [303], "text": ["SLC9A6"]}}}, "09bf14ab3f2c41aaa2941bab0d3e4c03": {"prediction": {"id": "09bf14ab3f2c41aaa2941bab0d3e4c03", "prediction_text": "Pitt-Hopkins"}, "reference": {"id": "09bf14ab3f2c41aaa2941bab0d3e4c03", "answers": {"answer_start": [413], "text": ["SLC9A6"]}}}, "788e89d2212c45798408fb5052c26939": {"prediction": {"id": "788e89d2212c45798408fb5052c26939", "prediction_text": "Differentiation between CS"}, "reference": {"id": "788e89d2212c45798408fb5052c26939", "answers": {"answer_start": [1010], "text": ["SLC9A6"]}}}, "325e47ec64d64eca85b3cb77c2ff4082": {"prediction": {"id": "325e47ec64d64eca85b3cb77c2ff4082", "prediction_text": "A member 6 (SLC9A6)"}, "reference": {"id": "325e47ec64d64eca85b3cb77c2ff4082", "answers": {"answer_start": [576], "text": ["SLC9A6"]}}}, "860ef3172db04173b019f01c7afcad74": {"prediction": {"id": "860ef3172db04173b019f01c7afcad74", "prediction_text": "Zebrin II"}, "reference": {"id": "860ef3172db04173b019f01c7afcad74", "answers": {"answer_start": [2091], "text": ["SLC9A6"]}}}, "b132dd0dda494b8ca73d23bbf52e5861": {"prediction": {"id": "b132dd0dda494b8ca73d23bbf52e5861", "prediction_text": "UBE3A gene in the brain. However, about 10% of individuals with a clinical diagnosis of AS do not have an identifiable molecular defect. It is likely that most of those individuals have an AS-like syndrome that is clinically and molecularly distinct from AS. These AS-like syndromes can be broadly classified into chromosomal microdeletion and microduplication syndromes, and single-gene disorders. The microdeletion/microduplication syndromes are now easily identified by chromosomal microarray analysis and include Phelan\u2013McDermid syndrome (chromosome 22q13.3 deletion), MBD5 haploinsufficiency syndrome (chromosome 2q23.1 deletion), and KANSL1 haploinsufficiency syndrome (chromosome 17q21.31 deletion). The single-gene disorders include Pitt\u2013Hopkins syndrome (TCF4), Christianson syndrome (SLC9A6), Mowat\u2013Wilson syndrome (ZEB2), Kleefstra syndrome (EHMT1), and Rett (MECP2) syndrome. They also include disorders due to mutations in HERC2, adenylosuccinase lyase (ADSL), CDKL5, FOXG1, MECP2 (duplications), MEF2C, and ATRX. Although many of these single-gene disorders can be caused by chromosomal microdeletions resulting in haploinsufficiency of the critical"}, "reference": {"id": "b132dd0dda494b8ca73d23bbf52e5861", "answers": {"answer_start": [879], "text": ["SLC9A6"]}}}, "bc2f31037c494f069f05865753fc3597": {"prediction": {"id": "bc2f31037c494f069f05865753fc3597", "prediction_text": "SLC9A6"}, "reference": {"id": "bc2f31037c494f069f05865753fc3597", "answers": {"answer_start": [124], "text": ["SLC9A6"]}}}, "b9bdd62243e14799944dfa3c7415226a": {"prediction": {"id": "b9bdd62243e14799944dfa3c7415226a", "prediction_text": "SLC9A6"}, "reference": {"id": "b9bdd62243e14799944dfa3c7415226a", "answers": {"answer_start": [1702], "text": ["SLC9A6"]}}}, "17745e4aaf9e445b8802aada1319b707": {"prediction": {"id": "17745e4aaf9e445b8802aada1319b707", "prediction_text": "FHL1"}, "reference": {"id": "17745e4aaf9e445b8802aada1319b707", "answers": {"answer_start": [1346], "text": ["SLC9A6"]}}}, "6702e0bcaae543f9beb7b84e2cd18bb4": {"prediction": {"id": "6702e0bcaae543f9beb7b84e2cd18bb4", "prediction_text": "SLC9A6"}, "reference": {"id": "6702e0bcaae543f9beb7b84e2cd18bb4", "answers": {"answer_start": [837], "text": ["SLC9A6"]}}}, "55d39878f3b74ac9a9b299c223b7eeda": {"prediction": {"id": "55d39878f3b74ac9a9b299c223b7eeda", "prediction_text": "human Chediak-Higashi Syndrome"}, "reference": {"id": "55d39878f3b74ac9a9b299c223b7eeda", "answers": {"answer_start": [337], "text": ["Chediak-Higashi syndrome"]}}}, "bc256fb28de341f88d1bc6ec46191402": {"prediction": {"id": "bc256fb28de341f88d1bc6ec46191402", "prediction_text": "Chediak Higashi syndrome (CHS) is an autosomal-recessive disorder characterized by oculocutaneous albinism, recurrent infections and a progressive primary neurological disease. Here, we describe two siblings with CHS due to a novel homozygous R1836X mutation in the LYST gene associated with loss of NK cell degranulation"}, "reference": {"id": "bc256fb28de341f88d1bc6ec46191402", "answers": {"answer_start": [0], "text": ["Chediak-Higashi syndrome"]}}}, "41b906314bc04eccb624fc62d86cd798": {"prediction": {"id": "41b906314bc04eccb624fc62d86cd798", "prediction_text": "Chediak-Higashi syndrome"}, "reference": {"id": "41b906314bc04eccb624fc62d86cd798", "answers": {"answer_start": [0], "text": ["Chediak-Higashi syndrome"]}}}, "e03d6274e8cc484598b792470760dc3c": {"prediction": {"id": "e03d6274e8cc484598b792470760dc3c", "prediction_text": "homologous disorders"}, "reference": {"id": "e03d6274e8cc484598b792470760dc3c", "answers": {"answer_start": [93], "text": ["Chediak-Higashi syndrome"]}}}, "1c3ec85ab63f466ebf2d958e8cb88244": {"prediction": {"id": "1c3ec85ab63f466ebf2d958e8cb88244", "prediction_text": "Chediak-Higashi syndrome"}, "reference": {"id": "1c3ec85ab63f466ebf2d958e8cb88244", "answers": {"answer_start": [147], "text": ["Chediak-Higashi syndrome"]}}}, "a7ed1d36024348cf842eee9defa28554": {"prediction": {"id": "a7ed1d36024348cf842eee9defa28554", "prediction_text": "Chediak-Higashi syndrome"}, "reference": {"id": "a7ed1d36024348cf842eee9defa28554", "answers": {"answer_start": [0], "text": ["Chediak-Higashi syndrome"]}}}, "146d26f31e9b43c89ccbc3549adea6c1": {"prediction": {"id": "146d26f31e9b43c89ccbc3549adea6c1", "prediction_text": "Chediak-Higashi"}, "reference": {"id": "146d26f31e9b43c89ccbc3549adea6c1", "answers": {"answer_start": [926], "text": ["Chediak-Higashi syndrome"]}}}, "7a7bbdde4d3a47089ceae790593518a4": {"prediction": {"id": "7a7bbdde4d3a47089ceae790593518a4", "prediction_text": "beige"}, "reference": {"id": "7a7bbdde4d3a47089ceae790593518a4", "answers": {"answer_start": [68], "text": ["Chediak-Higashi syndrome"]}}}, "9db11e89fe474933a6b65b7eab8d6366": {"prediction": {"id": "9db11e89fe474933a6b65b7eab8d6366", "prediction_text": "Chediak-Higashi syndrome (CHS) is a rare, autosomal, recessive lysosomal disorder with hematological and immunologic abnormalities; however, stem-cell transplantation from a matched or related donor may be curative. Many mutations of the CHS1/LYST gene have been reported to date. We report a novel nonsense mutation of the CHS1/LYST gene in 3 Omani patients. Three patients from 2 different families presented with clinical and laboratory features of CHS and a history of death of a previous sibling because of a severe illness, suggestive of the accelerated phase of CHS. Giant granules were present in the myeloid cell lines. Before the stem-cell transplant"}, "reference": {"id": "9db11e89fe474933a6b65b7eab8d6366", "answers": {"answer_start": [0], "text": ["Chediak-Higashi syndrome"]}}}, "021a2581ad5148eca8cf18b347a38a2a": {"prediction": {"id": "021a2581ad5148eca8cf18b347a38a2a", "prediction_text": "Chediak-Higashi syndrome"}, "reference": {"id": "021a2581ad5148eca8cf18b347a38a2a", "answers": {"answer_start": [148], "text": ["Chediak-Higashi syndrome"]}}}, "61dedac41cdd4c5d9a93be1758b047ae": {"prediction": {"id": "61dedac41cdd4c5d9a93be1758b047ae", "prediction_text": "Chediak-Higashi"}, "reference": {"id": "61dedac41cdd4c5d9a93be1758b047ae", "answers": {"answer_start": [676], "text": ["Chediak-Higashi syndrome"]}}}, "6fae2e9b38d147019f37bf13eeb18646": {"prediction": {"id": "6fae2e9b38d147019f37bf13eeb18646", "prediction_text": "Chediak-Higashi Syndrome"}, "reference": {"id": "6fae2e9b38d147019f37bf13eeb18646", "answers": {"answer_start": [187], "text": ["Chediak-Higashi syndrome"]}}}, "046e649006be4a778d6524e9f8e9831d": {"prediction": {"id": "046e649006be4a778d6524e9f8e9831d", "prediction_text": "Kufor-Rakeb syndrome"}, "reference": {"id": "046e649006be4a778d6524e9f8e9831d", "answers": {"answer_start": [1253], "text": ["Chediak-Higashi syndrome"]}}}, "fa669fe24d094fba80e06121cb69b6a9": {"prediction": {"id": "fa669fe24d094fba80e06121cb69b6a9", "prediction_text": "Chediak-Higashi syndrome"}, "reference": {"id": "fa669fe24d094fba80e06121cb69b6a9", "answers": {"answer_start": [0], "text": ["Chediak-Higashi syndrome"]}}}, "e959e5c1b3a048edbea7a84159468234": {"prediction": {"id": "e959e5c1b3a048edbea7a84159468234", "prediction_text": "CHS"}, "reference": {"id": "e959e5c1b3a048edbea7a84159468234", "answers": {"answer_start": [0], "text": ["Chediak-Higashi syndrome"]}}}, "cf33fb10d58c4ddfb999d01ba3f2a118": {"prediction": {"id": "cf33fb10d58c4ddfb999d01ba3f2a118", "prediction_text": "Chediak-Higashi Syndrome"}, "reference": {"id": "cf33fb10d58c4ddfb999d01ba3f2a118", "answers": {"answer_start": [12], "text": ["Chediak-Higashi syndrome"]}}}, "c50a16e5e2a340b3ad4e50b947938245": {"prediction": {"id": "c50a16e5e2a340b3ad4e50b947938245", "prediction_text": "infant"}, "reference": {"id": "c50a16e5e2a340b3ad4e50b947938245", "answers": {"answer_start": [0], "text": ["Chediak-Higashi syndrome"]}}}, "db032a6767c64bf1b1831937c5b3e60a": {"prediction": {"id": "db032a6767c64bf1b1831937c5b3e60a", "prediction_text": "human Chediak-Higashi"}, "reference": {"id": "db032a6767c64bf1b1831937c5b3e60a", "answers": {"answer_start": [48], "text": ["Chediak-Higashi syndrome"]}}}, "95be2cf9e62549188835966eb4903ff6": {"prediction": {"id": "95be2cf9e62549188835966eb4903ff6", "prediction_text": "Chediak-Higashi syndrome (CHS) is an inherited disorder caused by mutations in the lysosomal trafficking regulator gene, LYST. It results in defective membrane targeting of the proteins present in secretory lysosomes, and it is associated with a variety of features, including a lymphoproliferative syndrome"}, "reference": {"id": "95be2cf9e62549188835966eb4903ff6", "answers": {"answer_start": [265], "text": ["Chediak-Higashi syndrome"]}}}, "3972711070804acab043ad34f334d710": {"prediction": {"id": "3972711070804acab043ad34f334d710", "prediction_text": "bone marrow transplantation die"}, "reference": {"id": "3972711070804acab043ad34f334d710", "answers": {"answer_start": [0], "text": ["Chediak-Higashi syndrome"]}}}, "963dbefad00f491195248c36f0e07e7f": {"prediction": {"id": "963dbefad00f491195248c36f0e07e7f", "prediction_text": "Chediak-Higashi syndrome"}, "reference": {"id": "963dbefad00f491195248c36f0e07e7f", "answers": {"answer_start": [0], "text": ["Chediak-Higashi syndrome"]}}}, "7c5d48e8cd5c4bfbb0ca3febc926ac96": {"prediction": {"id": "7c5d48e8cd5c4bfbb0ca3febc926ac96", "prediction_text": "uptake by mOCT3 and human OCT3"}, "reference": {"id": "7c5d48e8cd5c4bfbb0ca3febc926ac96", "answers": {"answer_start": [214], "text": ["serotonin clearance"]}}}, "d5df46660c0c4388be0f331a74522403": {"prediction": {"id": "d5df46660c0c4388be0f331a74522403", "prediction_text": "men and women, despite the elevating effect of age on ESR. In elderly men"}, "reference": {"id": "d5df46660c0c4388be0f331a74522403", "answers": {"answer_start": [1337], "text": ["Women"]}}}, "42cd8040169b4bf586d8e5a74cd8fd5b": {"prediction": {"id": "42cd8040169b4bf586d8e5a74cd8fd5b", "prediction_text": "women"}, "reference": {"id": "42cd8040169b4bf586d8e5a74cd8fd5b", "answers": {"answer_start": [1320], "text": ["Women"]}}}, "3eccdb90c7de4fc185a40862ad23e3fc": {"prediction": {"id": "3eccdb90c7de4fc185a40862ad23e3fc", "prediction_text": "women the DAS28 was significantly higher than in men due to higher scores for general health and tender joints. Likewise, HAQ and VAS pain were rated significantly higher in women. The SOFI score was worse in men during the first 2 years, depending on higher upper limb scores. Total Sharp score (TotSharp), erosion score and joint space narrowing score did not differ between the sexes at any time point. The DAS28 area under the curve (AUC) correlated significantly with TotSharp at 5 years in both genders (r = 0.316, r = 0.313) mainly owing to swollen joints and erythrocyte sedimentation rate (ESR). The SOFI AUC correlated significantly with TotSharp in women (r = 0.135 to 0.220) but not in men"}, "reference": {"id": "3eccdb90c7de4fc185a40862ad23e3fc", "answers": {"answer_start": [1297], "text": ["Women"]}}}, "ac48f3127da1411f8953428d2d2b60f6": {"prediction": {"id": "ac48f3127da1411f8953428d2d2b60f6", "prediction_text": "women"}, "reference": {"id": "ac48f3127da1411f8953428d2d2b60f6", "answers": {"answer_start": [900], "text": ["Women"]}}}, "36ffa184593e4be1a875fa3350f9b4f2": {"prediction": {"id": "36ffa184593e4be1a875fa3350f9b4f2", "prediction_text": "Women"}, "reference": {"id": "36ffa184593e4be1a875fa3350f9b4f2", "answers": {"answer_start": [786], "text": ["Women"]}}}, "acfc5c93cf6c447f9d29569092eab6db": {"prediction": {"id": "acfc5c93cf6c447f9d29569092eab6db", "prediction_text": "women"}, "reference": {"id": "acfc5c93cf6c447f9d29569092eab6db", "answers": {"answer_start": [1255], "text": ["Women"]}}}, "cf803b66552a45288698f62e4929cabe": {"prediction": {"id": "cf803b66552a45288698f62e4929cabe", "prediction_text": "women"}, "reference": {"id": "cf803b66552a45288698f62e4929cabe", "answers": {"answer_start": [1012], "text": ["Women"]}}}, "17e1673d076b44c093cbb5831737dc21": {"prediction": {"id": "17e1673d076b44c093cbb5831737dc21", "prediction_text": "women but not among men"}, "reference": {"id": "17e1673d076b44c093cbb5831737dc21", "answers": {"answer_start": [1176], "text": ["Women"]}}}, "34466f46341e4912aa8a41b2749ca17c": {"prediction": {"id": "34466f46341e4912aa8a41b2749ca17c", "prediction_text": "women"}, "reference": {"id": "34466f46341e4912aa8a41b2749ca17c", "answers": {"answer_start": [86], "text": ["Women"]}}}, "6fdb263c98474c87b9f0243c39b6d66a": {"prediction": {"id": "6fdb263c98474c87b9f0243c39b6d66a", "prediction_text": "women"}, "reference": {"id": "6fdb263c98474c87b9f0243c39b6d66a", "answers": {"answer_start": [1522], "text": ["Women"]}}}, "bfb73ad4bf564dbe8ce4529cb058db33": {"prediction": {"id": "bfb73ad4bf564dbe8ce4529cb058db33", "prediction_text": "FAM105B"}, "reference": {"id": "bfb73ad4bf564dbe8ce4529cb058db33", "answers": {"answer_start": [710], "text": ["deubiquitination"]}}}, "6b8d64c7f758402cb00042a1f8e23f65": {"prediction": {"id": "6b8d64c7f758402cb00042a1f8e23f65", "prediction_text": "variable expressivity and incomplete penetrance"}, "reference": {"id": "6b8d64c7f758402cb00042a1f8e23f65", "answers": {"answer_start": [92], "text": ["autosomal dominant"]}}}, "29f130d50cdf4bb8a88bc5bc1d807c38": {"prediction": {"id": "29f130d50cdf4bb8a88bc5bc1d807c38", "prediction_text": "by the autosomal dominant type"}, "reference": {"id": "29f130d50cdf4bb8a88bc5bc1d807c38", "answers": {"answer_start": [75], "text": ["autosomal dominant"]}}}, "ae5de58b7898467da1c81c205daaaa60": {"prediction": {"id": "ae5de58b7898467da1c81c205daaaa60", "prediction_text": "by an expansion of a CTG triplet repeat in the DMPK gene"}, "reference": {"id": "ae5de58b7898467da1c81c205daaaa60", "answers": {"answer_start": [38], "text": ["autosomal dominant"]}}}, "da84e02ea7604447a937d12c6d97fdaa": {"prediction": {"id": "da84e02ea7604447a937d12c6d97fdaa", "prediction_text": "PROMM"}, "reference": {"id": "da84e02ea7604447a937d12c6d97fdaa", "answers": {"answer_start": [172], "text": ["autosomal dominant"]}}}, "8767d090bea547a08e2105f3e4ba0e20": {"prediction": {"id": "8767d090bea547a08e2105f3e4ba0e20", "prediction_text": "chromosome 3q 21.3"}, "reference": {"id": "8767d090bea547a08e2105f3e4ba0e20", "answers": {"answer_start": [38], "text": ["autosomal dominant"]}}}, "5183406d3a334dfca09a7c38a6d1f5f4": {"prediction": {"id": "5183406d3a334dfca09a7c38a6d1f5f4", "prediction_text": "INteractive Codon usage Analysis"}, "reference": {"id": "5183406d3a334dfca09a7c38a6d1f5f4", "answers": {"answer_start": [595], "text": ["INCA"]}}}, "5959c7f98db045aab8537ab30472776c": {"prediction": {"id": "5959c7f98db045aab8537ab30472776c", "prediction_text": "S129"}, "reference": {"id": "5959c7f98db045aab8537ab30472776c", "answers": {"answer_start": [34], "text": ["Serine 129"]}}}, "341fe086bf2b441babb45e61af54a1e1": {"prediction": {"id": "341fe086bf2b441babb45e61af54a1e1", "prediction_text": "serine 129"}, "reference": {"id": "341fe086bf2b441babb45e61af54a1e1", "answers": {"answer_start": [37], "text": ["Serine 129"]}}}, "7a0ec72961c74edca997386327adf629": {"prediction": {"id": "7a0ec72961c74edca997386327adf629", "prediction_text": "\u03b1-syn"}, "reference": {"id": "7a0ec72961c74edca997386327adf629", "answers": {"answer_start": [367], "text": ["Serine 129"]}}}, "f336d96d61c544afa9da641709c68931": {"prediction": {"id": "f336d96d61c544afa9da641709c68931", "prediction_text": "25.7%"}, "reference": {"id": "f336d96d61c544afa9da641709c68931", "answers": {"answer_start": [78], "text": ["tuberculosis"]}}}, "42af94265e584280b463f26912366138": {"prediction": {"id": "42af94265e584280b463f26912366138", "prediction_text": "low TB incidence"}, "reference": {"id": "42af94265e584280b463f26912366138", "answers": {"answer_start": [64], "text": ["tuberculosis"]}}}, "3bd6f46af07f424bbe966ac06021055b": {"prediction": {"id": "3bd6f46af07f424bbe966ac06021055b", "prediction_text": "prevalence of latent tuberculosis infection (LTBI"}, "reference": {"id": "3bd6f46af07f424bbe966ac06021055b", "answers": {"answer_start": [615], "text": ["tuberculosis"]}}}, "57ef9d80e2e045d88880aa8ebe141f2c": {"prediction": {"id": "57ef9d80e2e045d88880aa8ebe141f2c", "prediction_text": "active tuberculosis disease"}, "reference": {"id": "57ef9d80e2e045d88880aa8ebe141f2c", "answers": {"answer_start": [68], "text": ["tuberculosis"]}}}, "5377f626f00f477ebf0e6399b082e52d": {"prediction": {"id": "5377f626f00f477ebf0e6399b082e52d", "prediction_text": "Diagnosis of tuberculosis (TB) is difficult, since symptoms are often very unspecific or lacking"}, "reference": {"id": "5377f626f00f477ebf0e6399b082e52d", "answers": {"answer_start": [196], "text": ["tuberculosis"]}}}, "e641593a36f64e71aa987fb564a2ceb1": {"prediction": {"id": "e641593a36f64e71aa987fb564a2ceb1", "prediction_text": "tuberculosis"}, "reference": {"id": "e641593a36f64e71aa987fb564a2ceb1", "answers": {"answer_start": [658], "text": ["tuberculosis"]}}}, "34b5177efe53462b8fb97f58c0d86699": {"prediction": {"id": "34b5177efe53462b8fb97f58c0d86699", "prediction_text": "278"}, "reference": {"id": "34b5177efe53462b8fb97f58c0d86699", "answers": {"answer_start": [810], "text": ["tuberculosis"]}}}, "03356107699d4ce59967c3f3f2498c42": {"prediction": {"id": "03356107699d4ce59967c3f3f2498c42", "prediction_text": "tuberculosis"}, "reference": {"id": "03356107699d4ce59967c3f3f2498c42", "answers": {"answer_start": [86], "text": ["tuberculosis"]}}}, "8979999f5ab84796a082adb6d96ef555": {"prediction": {"id": "8979999f5ab84796a082adb6d96ef555", "prediction_text": "tuberculosis"}, "reference": {"id": "8979999f5ab84796a082adb6d96ef555", "answers": {"answer_start": [865], "text": ["tuberculosis"]}}}, "68aa9b2388d84a28bfc31a1dfccfa945": {"prediction": {"id": "68aa9b2388d84a28bfc31a1dfccfa945", "prediction_text": "tuberculosis"}, "reference": {"id": "68aa9b2388d84a28bfc31a1dfccfa945", "answers": {"answer_start": [0], "text": ["tuberculosis"]}}}, "8b3f642906fa4ed39afe32ffc957636f": {"prediction": {"id": "8b3f642906fa4ed39afe32ffc957636f", "prediction_text": "eight"}, "reference": {"id": "8b3f642906fa4ed39afe32ffc957636f", "answers": {"answer_start": [423], "text": ["eight"]}}}, "736d391e15c643579406a330bb54a190": {"prediction": {"id": "736d391e15c643579406a330bb54a190", "prediction_text": "c-Abl"}, "reference": {"id": "736d391e15c643579406a330bb54a190", "answers": {"answer_start": [58], "text": ["Protein-Tyrosine Kinase"]}}}, "a7ba4e7bba7b4cdeafb84aa770e671fe": {"prediction": {"id": "a7ba4e7bba7b4cdeafb84aa770e671fe", "prediction_text": "UV-induced DNA damage"}, "reference": {"id": "a7ba4e7bba7b4cdeafb84aa770e671fe", "answers": {"answer_start": [513], "text": ["the transcribed strand"]}}}, "848059b88cfb452e9d12a6cd86af0753": {"prediction": {"id": "848059b88cfb452e9d12a6cd86af0753", "prediction_text": "NER"}, "reference": {"id": "848059b88cfb452e9d12a6cd86af0753", "answers": {"answer_start": [524], "text": ["the transcribed strand"]}}}, "d306a80978ae479c94d4f28b8dbed78a": {"prediction": {"id": "d306a80978ae479c94d4f28b8dbed78a", "prediction_text": "hMSH2"}, "reference": {"id": "d306a80978ae479c94d4f28b8dbed78a", "answers": {"answer_start": [669], "text": ["the transcribed strand"]}}}, "201a430746ec43fbb7f12eb86f75c4e9": {"prediction": {"id": "201a430746ec43fbb7f12eb86f75c4e9", "prediction_text": "transcription elongation"}, "reference": {"id": "201a430746ec43fbb7f12eb86f75c4e9", "answers": {"answer_start": [99], "text": ["the transcribed strand"]}}}, "638a0b1b85f4495e8b3e9bc4c9957b59": {"prediction": {"id": "638a0b1b85f4495e8b3e9bc4c9957b59", "prediction_text": "active gene"}, "reference": {"id": "638a0b1b85f4495e8b3e9bc4c9957b59", "answers": {"answer_start": [843], "text": ["the transcribed strand"]}}}, "df7fc7422409417d9d7bd86e89adf84d": {"prediction": {"id": "df7fc7422409417d9d7bd86e89adf84d", "prediction_text": "active structural genes"}, "reference": {"id": "df7fc7422409417d9d7bd86e89adf84d", "answers": {"answer_start": [906], "text": ["the transcribed strand"]}}}, "250ff015448249fcadbad105e982dc6b": {"prediction": {"id": "250ff015448249fcadbad105e982dc6b", "prediction_text": "active genes"}, "reference": {"id": "250ff015448249fcadbad105e982dc6b", "answers": {"answer_start": [116], "text": ["the transcribed strand"]}}}, "cd0adc24067f4dd2a10450d7ddd877e5": {"prediction": {"id": "cd0adc24067f4dd2a10450d7ddd877e5", "prediction_text": "active genes"}, "reference": {"id": "cd0adc24067f4dd2a10450d7ddd877e5", "answers": {"answer_start": [538], "text": ["the transcribed strand"]}}}, "91352c2b74024dedab596321667b51f7": {"prediction": {"id": "91352c2b74024dedab596321667b51f7", "prediction_text": "dihydrofolate reductase"}, "reference": {"id": "91352c2b74024dedab596321667b51f7", "answers": {"answer_start": [992], "text": ["the transcribed strand"]}}}, "b51e895defdc4080a2ebe94ef51ade71": {"prediction": {"id": "b51e895defdc4080a2ebe94ef51ade71", "prediction_text": "CHO-UV61 cells"}, "reference": {"id": "b51e895defdc4080a2ebe94ef51ade71", "answers": {"answer_start": [605], "text": ["the transcribed strand"]}}}, "237e0c434a944567ae092ef4f2c73e81": {"prediction": {"id": "237e0c434a944567ae092ef4f2c73e81", "prediction_text": "Mfd"}, "reference": {"id": "237e0c434a944567ae092ef4f2c73e81", "answers": {"answer_start": [128], "text": ["the transcribed strand"]}}}, "935e3ee8f99245d6aa154a604d711841": {"prediction": {"id": "935e3ee8f99245d6aa154a604d711841", "prediction_text": "nontranscribed"}, "reference": {"id": "935e3ee8f99245d6aa154a604d711841", "answers": {"answer_start": [443], "text": ["the transcribed strand"]}}}, "9a72692bcf274145a4d875f1e7b975e0": {"prediction": {"id": "9a72692bcf274145a4d875f1e7b975e0", "prediction_text": "CS fibroblasts"}, "reference": {"id": "9a72692bcf274145a4d875f1e7b975e0", "answers": {"answer_start": [1531], "text": ["the transcribed strand"]}}}, "0b1cd75c419347b2a691954a889ff0cf": {"prediction": {"id": "0b1cd75c419347b2a691954a889ff0cf", "prediction_text": "Cockayne syndrome B"}, "reference": {"id": "0b1cd75c419347b2a691954a889ff0cf", "answers": {"answer_start": [883], "text": ["the transcribed strand"]}}}, "ef91bf98edce466e97c3af43697ae475": {"prediction": {"id": "ef91bf98edce466e97c3af43697ae475", "prediction_text": "NER"}, "reference": {"id": "ef91bf98edce466e97c3af43697ae475", "answers": {"answer_start": [606], "text": ["the transcribed strand"]}}}, "a50247c13b3443379e01ca3cadedad0e": {"prediction": {"id": "a50247c13b3443379e01ca3cadedad0e", "prediction_text": "non-transcribed"}, "reference": {"id": "a50247c13b3443379e01ca3cadedad0e", "answers": {"answer_start": [402], "text": ["the transcribed strand"]}}}, "a98f1a6fb0ee490290155aa84c011378": {"prediction": {"id": "a98f1a6fb0ee490290155aa84c011378", "prediction_text": "non-transcribed strand"}, "reference": {"id": "a98f1a6fb0ee490290155aa84c011378", "answers": {"answer_start": [186], "text": ["the transcribed strand"]}}}, "3fc63d61f658448da2070e2f61d1a9f4": {"prediction": {"id": "3fc63d61f658448da2070e2f61d1a9f4", "prediction_text": "RAD26"}, "reference": {"id": "3fc63d61f658448da2070e2f61d1a9f4", "answers": {"answer_start": [1350], "text": ["the transcribed strand"]}}}, "6e7ae892779c4e8fb35afc4b5f56e662": {"prediction": {"id": "6e7ae892779c4e8fb35afc4b5f56e662", "prediction_text": "Cockayne syndrome B (CSB)"}, "reference": {"id": "6e7ae892779c4e8fb35afc4b5f56e662", "answers": {"answer_start": [728], "text": ["the transcribed strand"]}}}, "9a26161d117e464f8e6c158d2c8e6d65": {"prediction": {"id": "9a26161d117e464f8e6c158d2c8e6d65", "prediction_text": "dG-C8-AF"}, "reference": {"id": "9a26161d117e464f8e6c158d2c8e6d65", "answers": {"answer_start": [1361], "text": ["the transcribed strand"]}}}, "dd03ef03cb5d406ea1c0130031b3a225": {"prediction": {"id": "dd03ef03cb5d406ea1c0130031b3a225", "prediction_text": "NER"}, "reference": {"id": "dd03ef03cb5d406ea1c0130031b3a225", "answers": {"answer_start": [582], "text": ["the transcribed strand"]}}}, "b856cb8add534a019b19d64894a254a1": {"prediction": {"id": "b856cb8add534a019b19d64894a254a1", "prediction_text": "DNA lesions"}, "reference": {"id": "b856cb8add534a019b19d64894a254a1", "answers": {"answer_start": [1360], "text": ["the transcribed strand"]}}}, "bee3012c04ae4f5582e7032cf5a71be8": {"prediction": {"id": "bee3012c04ae4f5582e7032cf5a71be8", "prediction_text": "RNA polymerase"}, "reference": {"id": "bee3012c04ae4f5582e7032cf5a71be8", "answers": {"answer_start": [288], "text": ["the transcribed strand"]}}}, "f84d2cdc67e54bbaa720f32ea9c3839e": {"prediction": {"id": "f84d2cdc67e54bbaa720f32ea9c3839e", "prediction_text": "active genes"}, "reference": {"id": "f84d2cdc67e54bbaa720f32ea9c3839e", "answers": {"answer_start": [125], "text": ["the transcribed strand"]}}}, "7c33cf4597e242c996edbbdaa9992e71": {"prediction": {"id": "7c33cf4597e242c996edbbdaa9992e71", "prediction_text": "DNA-PKcs"}, "reference": {"id": "7c33cf4597e242c996edbbdaa9992e71", "answers": {"answer_start": [223], "text": ["the transcribed strand"]}}}, "4192aa694ab54fdfa696860364c61578": {"prediction": {"id": "4192aa694ab54fdfa696860364c61578", "prediction_text": "lateral ventricles"}, "reference": {"id": "4192aa694ab54fdfa696860364c61578", "answers": {"answer_start": [65], "text": ["connective tissue"]}}}, "ae314b599735403893e888ac1f5dbaa1": {"prediction": {"id": "ae314b599735403893e888ac1f5dbaa1", "prediction_text": "skin and tissue fragility"}, "reference": {"id": "ae314b599735403893e888ac1f5dbaa1", "answers": {"answer_start": [73], "text": ["connective tissue"]}}}, "469b4c54e3bf4372ad89b4d971bcbeba": {"prediction": {"id": "469b4c54e3bf4372ad89b4d971bcbeba", "prediction_text": "connective tissue"}, "reference": {"id": "469b4c54e3bf4372ad89b4d971bcbeba", "answers": {"answer_start": [78], "text": ["connective tissue"]}}}, "95e4b9176e6d45dfba8bc407c4fbe99c": {"prediction": {"id": "95e4b9176e6d45dfba8bc407c4fbe99c", "prediction_text": "tissue diseases"}, "reference": {"id": "95e4b9176e6d45dfba8bc407c4fbe99c", "answers": {"answer_start": [52], "text": ["connective tissue"]}}}, "b9b24aefdf1444fd9e753d0738e32a68": {"prediction": {"id": "b9b24aefdf1444fd9e753d0738e32a68", "prediction_text": "thin, translucent skin"}, "reference": {"id": "b9b24aefdf1444fd9e753d0738e32a68", "answers": {"answer_start": [128], "text": ["connective tissue"]}}}, "8f083704cf6d487e8d5c68d029241412": {"prediction": {"id": "8f083704cf6d487e8d5c68d029241412", "prediction_text": "fragility"}, "reference": {"id": "8f083704cf6d487e8d5c68d029241412", "answers": {"answer_start": [49], "text": ["connective tissue"]}}}, "8124279d68c14e4e9bf8b171f615aef1": {"prediction": {"id": "8124279d68c14e4e9bf8b171f615aef1", "prediction_text": "connective tissue"}, "reference": {"id": "8124279d68c14e4e9bf8b171f615aef1", "answers": {"answer_start": [104], "text": ["connective tissue"]}}}, "48a42f1f73564955a71e68c092190ef4": {"prediction": {"id": "48a42f1f73564955a71e68c092190ef4", "prediction_text": "tendon"}, "reference": {"id": "48a42f1f73564955a71e68c092190ef4", "answers": {"answer_start": [1522], "text": ["connective tissue"]}}}, "198866c5e0d64bfaa7de04930837ae0e": {"prediction": {"id": "198866c5e0d64bfaa7de04930837ae0e", "prediction_text": "skin and joints and visceral and neurological manifestations"}, "reference": {"id": "198866c5e0d64bfaa7de04930837ae0e", "answers": {"answer_start": [47], "text": ["connective tissue"]}}}, "6240890dffd849ddb185e2d0aa5805d1": {"prediction": {"id": "6240890dffd849ddb185e2d0aa5805d1", "prediction_text": "connective tissue"}, "reference": {"id": "6240890dffd849ddb185e2d0aa5805d1", "answers": {"answer_start": [56], "text": ["connective tissue"]}}}, "dc0bbfb3cc7b4895acb88b2a7c1b0771": {"prediction": {"id": "dc0bbfb3cc7b4895acb88b2a7c1b0771", "prediction_text": "connective"}, "reference": {"id": "dc0bbfb3cc7b4895acb88b2a7c1b0771", "answers": {"answer_start": [90], "text": ["connective tissue"]}}}, "1a507cbd8b2346dfb6e95c5bb7860bfd": {"prediction": {"id": "1a507cbd8b2346dfb6e95c5bb7860bfd", "prediction_text": "connective tissue genes"}, "reference": {"id": "1a507cbd8b2346dfb6e95c5bb7860bfd", "answers": {"answer_start": [67], "text": ["connective tissue"]}}}, "9ed7916e7f2e49479b0064b32cbb0e3c": {"prediction": {"id": "9ed7916e7f2e49479b0064b32cbb0e3c", "prediction_text": "fragility"}, "reference": {"id": "9ed7916e7f2e49479b0064b32cbb0e3c", "answers": {"answer_start": [73], "text": ["connective tissue"]}}}, "ad2e098361d542fc96d2da91f4bac364": {"prediction": {"id": "ad2e098361d542fc96d2da91f4bac364", "prediction_text": "heritable connective"}, "reference": {"id": "ad2e098361d542fc96d2da91f4bac364", "answers": {"answer_start": [59], "text": ["connective tissue"]}}}, "03638f43a2a24d149c407a5c11ccc579": {"prediction": {"id": "03638f43a2a24d149c407a5c11ccc579", "prediction_text": "musculoskeletal pain and tissue fragility"}, "reference": {"id": "03638f43a2a24d149c407a5c11ccc579", "answers": {"answer_start": [70], "text": ["connective tissue"]}}}, "57790c94e0a6410785633e0316fb629d": {"prediction": {"id": "57790c94e0a6410785633e0316fb629d", "prediction_text": "fracture"}, "reference": {"id": "57790c94e0a6410785633e0316fb629d", "answers": {"answer_start": [61], "text": ["connective tissue"]}}}, "828e933b20f84d2e9b5bf22151c45578": {"prediction": {"id": "828e933b20f84d2e9b5bf22151c45578", "prediction_text": "fragility"}, "reference": {"id": "828e933b20f84d2e9b5bf22151c45578", "answers": {"answer_start": [99], "text": ["connective tissue"]}}}, "5e1b4b23297a43798cc260f7da2ac02b": {"prediction": {"id": "5e1b4b23297a43798cc260f7da2ac02b", "prediction_text": "connective tissue"}, "reference": {"id": "5e1b4b23297a43798cc260f7da2ac02b", "answers": {"answer_start": [127], "text": ["connective tissue"]}}}, "2dcf918ea2ed44eaadfeff5a299c03eb": {"prediction": {"id": "2dcf918ea2ed44eaadfeff5a299c03eb", "prediction_text": "tissue diseases"}, "reference": {"id": "2dcf918ea2ed44eaadfeff5a299c03eb", "answers": {"answer_start": [68], "text": ["connective tissue"]}}}, "39096b81dce44da08d9fc953197ca20d": {"prediction": {"id": "39096b81dce44da08d9fc953197ca20d", "prediction_text": "type V collagen"}, "reference": {"id": "39096b81dce44da08d9fc953197ca20d", "answers": {"answer_start": [46], "text": ["connective tissue"]}}}, "141c9b1c758b4659bf058f7d6e09f85d": {"prediction": {"id": "141c9b1c758b4659bf058f7d6e09f85d", "prediction_text": "soft connective tissues"}, "reference": {"id": "141c9b1c758b4659bf058f7d6e09f85d", "answers": {"answer_start": [43], "text": ["connective tissue"]}}}, "fa0192a4457f44ceae8feaa966a4951f": {"prediction": {"id": "fa0192a4457f44ceae8feaa966a4951f", "prediction_text": "connective"}, "reference": {"id": "fa0192a4457f44ceae8feaa966a4951f", "answers": {"answer_start": [56], "text": ["connective tissue"]}}}, "cb5935f2aa284d65a8507c3883b04952": {"prediction": {"id": "cb5935f2aa284d65a8507c3883b04952", "prediction_text": "heritable connective"}, "reference": {"id": "cb5935f2aa284d65a8507c3883b04952", "answers": {"answer_start": [69], "text": ["connective tissue"]}}}, "d7d7f9f1444f4d338402f2dca485ad78": {"prediction": {"id": "d7d7f9f1444f4d338402f2dca485ad78", "prediction_text": "fibrillar-collagen"}, "reference": {"id": "d7d7f9f1444f4d338402f2dca485ad78", "answers": {"answer_start": [42], "text": ["connective tissue"]}}}, "2e07114b08d54508a53bdce4fd5077be": {"prediction": {"id": "2e07114b08d54508a53bdce4fd5077be", "prediction_text": "soft connective tissues"}, "reference": {"id": "2e07114b08d54508a53bdce4fd5077be", "answers": {"answer_start": [1707], "text": ["connective tissue"]}}}, "e805e8256cb249febac8edc49da06717": {"prediction": {"id": "e805e8256cb249febac8edc49da06717", "prediction_text": "evolved enhancers"}, "reference": {"id": "e805e8256cb249febac8edc49da06717", "answers": {"answer_start": [742], "text": ["enhancers"]}}}, "ec464d2066474d96870a741a6c406211": {"prediction": {"id": "ec464d2066474d96870a741a6c406211", "prediction_text": "evolution of enhancers"}, "reference": {"id": "ec464d2066474d96870a741a6c406211", "answers": {"answer_start": [150], "text": ["enhancers"]}}}, "f98d49f013d84e95b9105edfb3cb741d": {"prediction": {"id": "f98d49f013d84e95b9105edfb3cb741d", "prediction_text": "illuminating the way that developmental biologists"}, "reference": {"id": "f98d49f013d84e95b9105edfb3cb741d", "answers": {"answer_start": [152], "text": ["enhancers"]}}}, "27cc58dcd4ef48ffa5eec1ea44b28ae9": {"prediction": {"id": "27cc58dcd4ef48ffa5eec1ea44b28ae9", "prediction_text": "enhancers"}, "reference": {"id": "27cc58dcd4ef48ffa5eec1ea44b28ae9", "answers": {"answer_start": [445], "text": ["enhancers"]}}}, "043a9dbab34e4558a2058353f638af30": {"prediction": {"id": "043a9dbab34e4558a2058353f638af30", "prediction_text": "neuromuscular disease"}, "reference": {"id": "043a9dbab34e4558a2058353f638af30", "answers": {"answer_start": [94], "text": ["autosomal dominant"]}}}, "74d964719b1541bc9a27278165139476": {"prediction": {"id": "74d964719b1541bc9a27278165139476", "prediction_text": "autosomal recessive"}, "reference": {"id": "74d964719b1541bc9a27278165139476", "answers": {"answer_start": [657], "text": ["autosomal dominant or autosomal recessive"]}}}, "dc55e0213ead4535a413843dc2fa114f": {"prediction": {"id": "dc55e0213ead4535a413843dc2fa114f", "prediction_text": "ruptured"}, "reference": {"id": "dc55e0213ead4535a413843dc2fa114f", "answers": {"answer_start": [348], "text": ["Situs inversus totalis is a rare congenital anomaly with a complete mirror image of the thoracic and abdominal organs."]}}}, "9bcbb63ad9454cdbac1b2368116a555c": {"prediction": {"id": "9bcbb63ad9454cdbac1b2368116a555c", "prediction_text": "ciRS-7"}, "reference": {"id": "9bcbb63ad9454cdbac1b2368116a555c", "answers": {"answer_start": [939], "text": ["miR-7"]}}}, "1b570d5695934853aafe8ded728fd941": {"prediction": {"id": "1b570d5695934853aafe8ded728fd941", "prediction_text": "pancreatic cancer"}, "reference": {"id": "1b570d5695934853aafe8ded728fd941", "answers": {"answer_start": [11], "text": ["Point mutations"]}}}, "1d9813b61d69400caafe1bc9f7460a64": {"prediction": {"id": "1d9813b61d69400caafe1bc9f7460a64", "prediction_text": "chromosomal deletion/amplification) and single point mutations are well described for carcinogenesis inducers. Mutations classically occur within key regions of the genome. Consequences are various and include activation of mitogenic pathways or silencing of apoptotic processes. Alterations of K-RAS, P16 and DPC4 genes are frequently observed in PDAC samples and have been described to arise gradually during carcinogenesis. DNA methylation"}, "reference": {"id": "1d9813b61d69400caafe1bc9f7460a64", "answers": {"answer_start": [1111], "text": ["Point mutations"]}}}, "aca5812d06824bd8aa5050c17524c71c": {"prediction": {"id": "aca5812d06824bd8aa5050c17524c71c", "prediction_text": "Mutations"}, "reference": {"id": "aca5812d06824bd8aa5050c17524c71c", "answers": {"answer_start": [1107], "text": ["Point mutations"]}}}, "9ebc8b4435d149f9acc819a5558e6ced": {"prediction": {"id": "9ebc8b4435d149f9acc819a5558e6ced", "prediction_text": "PCR"}, "reference": {"id": "9ebc8b4435d149f9acc819a5558e6ced", "answers": {"answer_start": [494], "text": ["Ribotype 027"]}}}, "feaa00d2bd8d4c1286b96a34102ec114": {"prediction": {"id": "feaa00d2bd8d4c1286b96a34102ec114", "prediction_text": "027"}, "reference": {"id": "feaa00d2bd8d4c1286b96a34102ec114", "answers": {"answer_start": [235], "text": ["Ribotype 027"]}}}, "371cd0c331454c85baf1bd6bc87266d7": {"prediction": {"id": "371cd0c331454c85baf1bd6bc87266d7", "prediction_text": "027"}, "reference": {"id": "371cd0c331454c85baf1bd6bc87266d7", "answers": {"answer_start": [157], "text": ["Ribotype 027"]}}}, "ee299ae417b7403f98ee5f9564d0ecc2": {"prediction": {"id": "ee299ae417b7403f98ee5f9564d0ecc2", "prediction_text": "CDI"}, "reference": {"id": "ee299ae417b7403f98ee5f9564d0ecc2", "answers": {"answer_start": [877], "text": ["Ribotype 027"]}}}, "b0362dd8d8d747c789a9dcab62637a4a": {"prediction": {"id": "b0362dd8d8d747c789a9dcab62637a4a", "prediction_text": "CDI"}, "reference": {"id": "b0362dd8d8d747c789a9dcab62637a4a", "answers": {"answer_start": [930], "text": ["Ribotype 027"]}}}, "5ad89850b4d54a71bd288a5d76a3a4e6": {"prediction": {"id": "5ad89850b4d54a71bd288a5d76a3a4e6", "prediction_text": "027"}, "reference": {"id": "5ad89850b4d54a71bd288a5d76a3a4e6", "answers": {"answer_start": [455], "text": ["Ribotype 027"]}}}, "ec1afbac15ae47cbb7415b11dfa4fcd6": {"prediction": {"id": "ec1afbac15ae47cbb7415b11dfa4fcd6", "prediction_text": "027"}, "reference": {"id": "ec1afbac15ae47cbb7415b11dfa4fcd6", "answers": {"answer_start": [37], "text": ["Ribotype 027"]}}}, "e479fb0922104787be0f46889abf9921": {"prediction": {"id": "e479fb0922104787be0f46889abf9921", "prediction_text": "027"}, "reference": {"id": "e479fb0922104787be0f46889abf9921", "answers": {"answer_start": [63], "text": ["Ribotype 027"]}}}, "f8fd1c12498d4eb79589d6a10167083d": {"prediction": {"id": "f8fd1c12498d4eb79589d6a10167083d", "prediction_text": "telomerase-mediated enzymatic addition of telomeric DNA repeats and subsequent PCR amplification of the extension products"}, "reference": {"id": "f8fd1c12498d4eb79589d6a10167083d", "answers": {"answer_start": [189], "text": ["Telomerase enzyme activity can be detected in whole cell lysates by a polymerase chain reaction (PCR)-based method referred to as the telomeric repeat amplification protocol (TRAP)."]}}}, "8a49977588f142a4aa4016c711b92b67": {"prediction": {"id": "8a49977588f142a4aa4016c711b92b67", "prediction_text": "ADAR"}, "reference": {"id": "8a49977588f142a4aa4016c711b92b67", "answers": {"answer_start": [896], "text": ["ADAR"]}}}, "d33a22340d1d434e9c34a8d8e814059d": {"prediction": {"id": "d33a22340d1d434e9c34a8d8e814059d", "prediction_text": "ADARs"}, "reference": {"id": "d33a22340d1d434e9c34a8d8e814059d", "answers": {"answer_start": [665], "text": ["ADAR"]}}}, "51db59f4846745c88ed3e41c2d4cdc7e": {"prediction": {"id": "51db59f4846745c88ed3e41c2d4cdc7e", "prediction_text": "cis-RNA editing quantitative trait loci or cis-edQTLs, P\u00a0<\u00a010(-8"}, "reference": {"id": "51db59f4846745c88ed3e41c2d4cdc7e", "answers": {"answer_start": [130, 136], "text": ["ADAR", "adenosine deaminase, RNA-specific"]}}}, "12b316ea19b441f894b55a240569f770": {"prediction": {"id": "12b316ea19b441f894b55a240569f770", "prediction_text": "ADAR"}, "reference": {"id": "12b316ea19b441f894b55a240569f770", "answers": {"answer_start": [606, 38], "text": ["ADAR", "adenosine deaminase, RNA-specific"]}}}, "bcabad378423473186f17fabfcdfb561": {"prediction": {"id": "bcabad378423473186f17fabfcdfb561", "prediction_text": "Transcripts with convergent overlapping 3' ends are also edited and the first discovered instance of RNA editing in Drosophila, in the Rnp4F transcript"}, "reference": {"id": "bcabad378423473186f17fabfcdfb561", "answers": {"answer_start": [1685], "text": ["ADAR"]}}}, "d29d1afb2bbc48fbac07ace8664506d4": {"prediction": {"id": "d29d1afb2bbc48fbac07ace8664506d4", "prediction_text": "P transposable"}, "reference": {"id": "d29d1afb2bbc48fbac07ace8664506d4", "answers": {"answer_start": [721], "text": ["ADAR"]}}}, "624442d33c94403eb884cb0a54d5f598": {"prediction": {"id": "624442d33c94403eb884cb0a54d5f598", "prediction_text": "ADAR"}, "reference": {"id": "624442d33c94403eb884cb0a54d5f598", "answers": {"answer_start": [994], "text": ["ADAR"]}}}, "2ce57f8a3f154ca49913705db9dfe28c": {"prediction": {"id": "2ce57f8a3f154ca49913705db9dfe28c", "prediction_text": "fruitfly"}, "reference": {"id": "2ce57f8a3f154ca49913705db9dfe28c", "answers": {"answer_start": [625], "text": ["ADAR"]}}}, "38004b268a9548f3938c7319b178e8b3": {"prediction": {"id": "38004b268a9548f3938c7319b178e8b3", "prediction_text": "Recoding"}, "reference": {"id": "38004b268a9548f3938c7319b178e8b3", "answers": {"answer_start": [645], "text": ["ADAR"]}}}, "009ea58e93964e2c9e518213a5d07c58": {"prediction": {"id": "009ea58e93964e2c9e518213a5d07c58", "prediction_text": "Polaris"}, "reference": {"id": "009ea58e93964e2c9e518213a5d07c58", "answers": {"answer_start": [0], "text": ["Polycystic kidney disease (PKD)"]}}}, "b9068eb6b23b4e27ab77ade9d7d6fa1d": {"prediction": {"id": "b9068eb6b23b4e27ab77ade9d7d6fa1d", "prediction_text": "diabetes"}, "reference": {"id": "b9068eb6b23b4e27ab77ade9d7d6fa1d", "answers": {"answer_start": [1176], "text": ["Polycystic kidney disease (PKD)"]}}}, "246fe92e5ce7478f96a4315332622775": {"prediction": {"id": "246fe92e5ce7478f96a4315332622775", "prediction_text": "Erythrasma"}, "reference": {"id": "246fe92e5ce7478f96a4315332622775", "answers": {"answer_start": [533], "text": ["Corynebacterium minutissimum"]}}}, "a40ff22c22bf48b48315ab006c2728e5": {"prediction": {"id": "a40ff22c22bf48b48315ab006c2728e5", "prediction_text": "yeasts"}, "reference": {"id": "a40ff22c22bf48b48315ab006c2728e5", "answers": {"answer_start": [136], "text": ["Corynebacterium minutissimum"]}}}, "90e511330fe14b7cbf00b3423a1761be": {"prediction": {"id": "90e511330fe14b7cbf00b3423a1761be", "prediction_text": "Erythrasma"}, "reference": {"id": "90e511330fe14b7cbf00b3423a1761be", "answers": {"answer_start": [53], "text": ["Corynebacterium minutissimum"]}}}, "3116ec8c3c894ce39cca894ae59c4f8a": {"prediction": {"id": "3116ec8c3c894ce39cca894ae59c4f8a", "prediction_text": "infective organism, Corynebacterium minutissimum, has not been previously found to cause ocular or multisystem diseases. It is a common mucocutaneous"}, "reference": {"id": "3116ec8c3c894ce39cca894ae59c4f8a", "answers": {"answer_start": [157], "text": ["Corynebacterium minutissimum"]}}}, "92b23433deb747f38517a2f813b2aaf8": {"prediction": {"id": "92b23433deb747f38517a2f813b2aaf8", "prediction_text": "Erythrasma"}, "reference": {"id": "92b23433deb747f38517a2f813b2aaf8", "answers": {"answer_start": [50], "text": ["Corynebacterium minutissimum"]}}}, "9e6f6aabfdf24c9bbcc5dd477f122b0b": {"prediction": {"id": "9e6f6aabfdf24c9bbcc5dd477f122b0b", "prediction_text": "Corynebacterium"}, "reference": {"id": "9e6f6aabfdf24c9bbcc5dd477f122b0b", "answers": {"answer_start": [0], "text": ["Corynebacterium minutissimum"]}}}, "094435ef98844a1c9632f22aa8bf105b": {"prediction": {"id": "094435ef98844a1c9632f22aa8bf105b", "prediction_text": "Erythrasma"}, "reference": {"id": "094435ef98844a1c9632f22aa8bf105b", "answers": {"answer_start": [48], "text": ["Corynebacterium minutissimum"]}}}, "a452b18490a540959668e0e6fac2f686": {"prediction": {"id": "a452b18490a540959668e0e6fac2f686", "prediction_text": "Erythrasma is a superficial cutaneous infection"}, "reference": {"id": "a452b18490a540959668e0e6fac2f686", "answers": {"answer_start": [58], "text": ["Corynebacterium minutissimum"]}}}, "1f99e1024ece4df6a55e904ef3eeb2bf": {"prediction": {"id": "1f99e1024ece4df6a55e904ef3eeb2bf", "prediction_text": "Adempas"}, "reference": {"id": "1f99e1024ece4df6a55e904ef3eeb2bf", "answers": {"answer_start": [0], "text": ["riociguat"]}}}, "9a2ec983f0a0495a9e6f5040807b87bd": {"prediction": {"id": "9a2ec983f0a0495a9e6f5040807b87bd", "prediction_text": "macitentan"}, "reference": {"id": "9a2ec983f0a0495a9e6f5040807b87bd", "answers": {"answer_start": [31], "text": ["riociguat"]}}}, "c50a8285f6ae4a2ba25ed1caa85fd3da": {"prediction": {"id": "c50a8285f6ae4a2ba25ed1caa85fd3da", "prediction_text": "Adempas(\u00ae)), a soluble guanylate cyclase stimulator, is a new, first-in-class drug approved for the treatment of patients with chronic thromboembolic pulmonary hypertension (CTEPH) [inoperable or persistent/recurrent following surgery] or pulmonary arterial hypertension (PAH). It has been designated an orphan medicine by the European Medicines Agency and the US FDA. This article reviews the available pharmacological properties of oral riociguat and its clinical efficacy and tolerability in adults with CTEPH or PAH. Riociguat is effective and well tolerated in patients with inoperable CTEPH or persistent/recurrent CTEPH following pulmonary endarterectomy, and in patients with PAH. It has a positive result on exercise capacity and pulmonary haemodynamics, and improves WHO functional class. Most adverse events can be attributed to the vasodilatory mechanism of riociguat; however, there is a potential for serious bleeding and fetal harm, and riociguat use is contraindicated in pregnant patients. Pulmonary endarterectomy"}, "reference": {"id": "c50a8285f6ae4a2ba25ed1caa85fd3da", "answers": {"answer_start": [0], "text": ["riociguat"]}}}, "43ffcc246c174165a1f3953948f43027": {"prediction": {"id": "43ffcc246c174165a1f3953948f43027", "prediction_text": "Adempas(\u00ae)), an oral first-in-class soluble guanylate cyclase"}, "reference": {"id": "43ffcc246c174165a1f3953948f43027", "answers": {"answer_start": [0], "text": ["riociguat"]}}}, "13bef698c1ee4c3a9da9acd901ee4c2c": {"prediction": {"id": "13bef698c1ee4c3a9da9acd901ee4c2c", "prediction_text": "riociguat"}, "reference": {"id": "13bef698c1ee4c3a9da9acd901ee4c2c", "answers": {"answer_start": [743], "text": ["riociguat"]}}}, "8b7c9648c5df4c54ab0129cf5320cf94": {"prediction": {"id": "8b7c9648c5df4c54ab0129cf5320cf94", "prediction_text": "liver, kidney and heart"}, "reference": {"id": "8b7c9648c5df4c54ab0129cf5320cf94", "answers": {"answer_start": [654], "text": ["alpha-galactosidase A"]}}}, "cca6905ae5e74b8a93346264591bd7ae": {"prediction": {"id": "cca6905ae5e74b8a93346264591bd7ae", "prediction_text": "enzyme replacement therapy (ERT), in which a recombinant version of the defective enzyme is expressed in vitro and administered by infusion. However, in many cases the biodistribution of the administered protein does not match that of the accumulated substrate due to the glycosylation-mediated clearance of the enzymes from circulation, resulting in poor or absent substrate clearance from some tissues"}, "reference": {"id": "cca6905ae5e74b8a93346264591bd7ae", "answers": {"answer_start": [755], "text": ["alpha-galactosidase A"]}}}, "6973725682cd4162b24f24325dcf0d0e": {"prediction": {"id": "6973725682cd4162b24f24325dcf0d0e", "prediction_text": "alpha-galactosidase"}, "reference": {"id": "6973725682cd4162b24f24325dcf0d0e", "answers": {"answer_start": [132], "text": ["alpha-galactosidase A"]}}}, "a6d95a557bf94a1282be8b70a25c7218": {"prediction": {"id": "a6d95a557bf94a1282be8b70a25c7218", "prediction_text": "heart and kidney"}, "reference": {"id": "a6d95a557bf94a1282be8b70a25c7218", "answers": {"answer_start": [182], "text": ["alpha-galactosidase A"]}}}, "e98fa87c88ac4a15ad0786ea9dbb82d0": {"prediction": {"id": "e98fa87c88ac4a15ad0786ea9dbb82d0", "prediction_text": "Human alpha-galactosidase"}, "reference": {"id": "e98fa87c88ac4a15ad0786ea9dbb82d0", "answers": {"answer_start": [6], "text": ["alpha-galactosidase A"]}}}, "2c293ea109da4c5398514370e4b9c585": {"prediction": {"id": "2c293ea109da4c5398514370e4b9c585", "prediction_text": "ADAM"}, "reference": {"id": "2c293ea109da4c5398514370e4b9c585", "answers": {"answer_start": [315], "text": ["Nardilysin (N-arginine dibasic convertase; Nrdc) is a metalloendopeptidase of the M16 family that promotes ectodomain shedding of the precursor forms of various growth factors and cytokines by enhancing the protease activities of a disintegrin and metalloproteinase (ADAM) proteins."]}}}, "9df4be93e4154c82a0e5ff0731755d0c": {"prediction": {"id": "9df4be93e4154c82a0e5ff0731755d0c", "prediction_text": "murine Fgfr3"}, "reference": {"id": "9df4be93e4154c82a0e5ff0731755d0c", "answers": {"answer_start": [75], "text": ["Fibroblast Growth Factor Receptor 3 (FGFR3)"]}}}, "26c9018557b4459196b7ae49d5d5064f": {"prediction": {"id": "26c9018557b4459196b7ae49d5d5064f", "prediction_text": "receptor 3"}, "reference": {"id": "26c9018557b4459196b7ae49d5d5064f", "answers": {"answer_start": [202], "text": ["Fibroblast Growth Factor Receptor 3 (FGFR3)"]}}}, "7368a11272de436895b8526c242a129b": {"prediction": {"id": "7368a11272de436895b8526c242a129b", "prediction_text": "Fibroblast Growth Factor Receptor 3"}, "reference": {"id": "7368a11272de436895b8526c242a129b", "answers": {"answer_start": [35], "text": ["Fibroblast Growth Factor Receptor 3 (FGFR3)"]}}}, "b0a27d62171a432fa5a79f60a74fc1a6": {"prediction": {"id": "b0a27d62171a432fa5a79f60a74fc1a6", "prediction_text": "receptor 3"}, "reference": {"id": "b0a27d62171a432fa5a79f60a74fc1a6", "answers": {"answer_start": [479], "text": ["Fibroblast Growth Factor Receptor 3 (FGFR3)"]}}}, "528ac6f8764a45738485423e5c332ee0": {"prediction": {"id": "528ac6f8764a45738485423e5c332ee0", "prediction_text": "signal transduction pathway"}, "reference": {"id": "528ac6f8764a45738485423e5c332ee0", "answers": {"answer_start": [282], "text": ["Calcineurin"]}}}, "a9f00f7a22404823b249e4f4254afba3": {"prediction": {"id": "a9f00f7a22404823b249e4f4254afba3", "prediction_text": "Calcineurin"}, "reference": {"id": "a9f00f7a22404823b249e4f4254afba3", "answers": {"answer_start": [0], "text": ["Calcineurin"]}}}, "e6fe4683ad4647aeb53d4b0e8636358f": {"prediction": {"id": "e6fe4683ad4647aeb53d4b0e8636358f", "prediction_text": "NFAT"}, "reference": {"id": "e6fe4683ad4647aeb53d4b0e8636358f", "answers": {"answer_start": [1168], "text": ["Calcineurin"]}}}, "71371223f24c41c08f286e9a3e1ab3e3": {"prediction": {"id": "71371223f24c41c08f286e9a3e1ab3e3", "prediction_text": "gene transcription through Nuclear Factor of Activated T-cells, (NFAT) proteins, is emerging as a ubiquitous mechanism for the control of important physiological processes. Of the five mammalian NFAT isoforms, transcriptional activities of NFATs 1-4 are stimulated by a calcium driven association between the ubiquitous phosphatase calcineurin"}, "reference": {"id": "71371223f24c41c08f286e9a3e1ab3e3", "answers": {"answer_start": [580, 557], "text": ["Calcineurin", "CaN"]}}}, "4a1b7b8f40f94dc29b3b262290efd00d": {"prediction": {"id": "4a1b7b8f40f94dc29b3b262290efd00d", "prediction_text": "NFAT"}, "reference": {"id": "4a1b7b8f40f94dc29b3b262290efd00d", "answers": {"answer_start": [1427], "text": ["Calcineurin"]}}}, "088e65b076074d1e9eca743270a6c641": {"prediction": {"id": "088e65b076074d1e9eca743270a6c641", "prediction_text": "catalytic and regulatory subunits"}, "reference": {"id": "088e65b076074d1e9eca743270a6c641", "answers": {"answer_start": [0], "text": ["Calcineurin"]}}}, "3f472d5638fa410499bf49bc257f91ce": {"prediction": {"id": "3f472d5638fa410499bf49bc257f91ce", "prediction_text": "calmodulin"}, "reference": {"id": "3f472d5638fa410499bf49bc257f91ce", "answers": {"answer_start": [1106], "text": ["Calcineurin"]}}}, "5a9ff24507454de6a10ec9e2d89f02eb": {"prediction": {"id": "5a9ff24507454de6a10ec9e2d89f02eb", "prediction_text": "regulation of its nuclear import"}, "reference": {"id": "5a9ff24507454de6a10ec9e2d89f02eb", "answers": {"answer_start": [490, 586], "text": ["Calcineurin", "CaN"]}}}, "6f7d67786d7d41d68e8729b67dd42ff0": {"prediction": {"id": "6f7d67786d7d41d68e8729b67dd42ff0", "prediction_text": "CaM, CaMKII"}, "reference": {"id": "6f7d67786d7d41d68e8729b67dd42ff0", "answers": {"answer_start": [1079], "text": ["Calcineurin"]}}}, "df5d8d2a5ebd4b13ad71070edea16ea7": {"prediction": {"id": "df5d8d2a5ebd4b13ad71070edea16ea7", "prediction_text": "Transcription downstream of Ca(2+) influx is in large part funneled through the transcription factor nuclear factor of activated T cells (NFAT), a heavily phosphorylated protein that is cytoplasmic in resting cells, but that enters the nucleus"}, "reference": {"id": "df5d8d2a5ebd4b13ad71070edea16ea7", "answers": {"answer_start": [1015], "text": ["Calcineurin"]}}}, "60fa179da0934ea69b7d403efdd36c0d": {"prediction": {"id": "60fa179da0934ea69b7d403efdd36c0d", "prediction_text": "2B"}, "reference": {"id": "60fa179da0934ea69b7d403efdd36c0d", "answers": {"answer_start": [285, 571, 270], "text": ["Calcineurin", "CaN", "phosphatase 2b"]}}}, "d1ef267d4d104e39923df7b68fe51898": {"prediction": {"id": "d1ef267d4d104e39923df7b68fe51898", "prediction_text": "filter-aided sample preparation"}, "reference": {"id": "d1ef267d4d104e39923df7b68fe51898", "answers": {"answer_start": [23], "text": ["proteomic sample preparation"]}}}, "07cf1d6c74b84c9d9e73b7461fae58dd": {"prediction": {"id": "07cf1d6c74b84c9d9e73b7461fae58dd", "prediction_text": "macromolecular assemblies of the respiratory chain complexes I, III and IV in the inner mitochondrial membrane"}, "reference": {"id": "07cf1d6c74b84c9d9e73b7461fae58dd", "answers": {"answer_start": [92], "text": ["In the inner mitochondrial membrane"]}}}, "300cdac08a00426185360a15f053fb85": {"prediction": {"id": "300cdac08a00426185360a15f053fb85", "prediction_text": "Protein methylation"}, "reference": {"id": "300cdac08a00426185360a15f053fb85", "answers": {"answer_start": [629], "text": ["Immunoaffinity purification"]}}}, "f8821cb66f5f47f3b48f40761b2431c7": {"prediction": {"id": "f8821cb66f5f47f3b48f40761b2431c7", "prediction_text": "Genomiser"}, "reference": {"id": "f8821cb66f5f47f3b48f40761b2431c7", "answers": {"answer_start": [232], "text": ["Genomiser"]}}}, "f67b8b58a2f54eea88201c6d9ea3ec13": {"prediction": {"id": "f67b8b58a2f54eea88201c6d9ea3ec13", "prediction_text": "Machado-Joseph"}, "reference": {"id": "f67b8b58a2f54eea88201c6d9ea3ec13", "answers": {"answer_start": [1285], "text": ["LYST gene"]}}}, "4bb5ad8c3e2843de865dfb4eb8e7917b": {"prediction": {"id": "4bb5ad8c3e2843de865dfb4eb8e7917b", "prediction_text": "the mink CHS"}, "reference": {"id": "4bb5ad8c3e2843de865dfb4eb8e7917b", "answers": {"answer_start": [481], "text": ["LYST gene"]}}}, "204e93e09fce4e889b2fa189f0ef89eb": {"prediction": {"id": "204e93e09fce4e889b2fa189f0ef89eb", "prediction_text": "AR-HSP with cerebellar ataxia and neuropathy"}, "reference": {"id": "204e93e09fce4e889b2fa189f0ef89eb", "answers": {"answer_start": [804], "text": ["LYST gene"]}}}, "fdb53d90e42646a7ba44a7f0a0d142e0": {"prediction": {"id": "fdb53d90e42646a7ba44a7f0a0d142e0", "prediction_text": "CHS"}, "reference": {"id": "fdb53d90e42646a7ba44a7f0a0d142e0", "answers": {"answer_start": [699], "text": ["LYST gene"]}}}, "65514377d6274419ade34475d2e15a7a": {"prediction": {"id": "65514377d6274419ade34475d2e15a7a", "prediction_text": "Peripheral blood neutropenia"}, "reference": {"id": "65514377d6274419ade34475d2e15a7a", "answers": {"answer_start": [585], "text": ["LYST gene"]}}}, "2375327383994b96ad758c6658d69bda": {"prediction": {"id": "2375327383994b96ad758c6658d69bda", "prediction_text": "LYST"}, "reference": {"id": "2375327383994b96ad758c6658d69bda", "answers": {"answer_start": [13], "text": ["LYST gene"]}}}, "8aeee62d54c1445984d0ba0fb5f85129": {"prediction": {"id": "8aeee62d54c1445984d0ba0fb5f85129", "prediction_text": "Lyst"}, "reference": {"id": "8aeee62d54c1445984d0ba0fb5f85129", "answers": {"answer_start": [131], "text": ["LYST gene"]}}}, "082f2467e43f4489b1110e770811ae3e": {"prediction": {"id": "082f2467e43f4489b1110e770811ae3e", "prediction_text": "immunodeficiency, neurological dysfunction, and oculocutaneous albinism. Recently, several clinical CHS phenotypes have been reported. Here, we report results of a nationwide survey performed to clarify clinical characteristics and outcomes of CHS patients in Japan. Questionnaires were sent to 287 institutions to collect data regarding CHS patients diagnosed between 2000 and 2010, including results of lysosomal trafficking regulator (LYST) gene analysis. Cytotoxicity and degranulation activity of cytotoxic T lymphocytes"}, "reference": {"id": "082f2467e43f4489b1110e770811ae3e", "answers": {"answer_start": [525], "text": ["LYST gene"]}}}, "aa87be5cbe864d4697e3c3a1380a6012": {"prediction": {"id": "aa87be5cbe864d4697e3c3a1380a6012", "prediction_text": "Intravenous immunoglobulin (IVIG) has shown limited promise so far in human clinical studies on Alzheimer's disease (AD), yet overwhelmingly positive preclinical work in animals and human brain cultures support the notion that the therapy remains potentially efficacious. Here, we elaborate on IVIG neuropreservation by demonstrating that IVIG protects human primary neurons against oxidative stress in vitro and that IVIG preserves antioxidant defense mechanisms in vivo. Based on these results, we propose the following translational impact: If the dosage and treatment conditions are adequately optimized"}, "reference": {"id": "aa87be5cbe864d4697e3c3a1380a6012", "answers": {"answer_start": [0], "text": ["Intravenous"]}}}, "d4ef6ca14ce7405dbdce5cefccfe7a71": {"prediction": {"id": "d4ef6ca14ce7405dbdce5cefccfe7a71", "prediction_text": "phospholipase A2"}, "reference": {"id": "d4ef6ca14ce7405dbdce5cefccfe7a71", "answers": {"answer_start": [37], "text": ["secretory phospholipase A2"]}}}, "9b47acc224a84534b792b0cc630df6b0": {"prediction": {"id": "9b47acc224a84534b792b0cc630df6b0", "prediction_text": "Alveolar macrophages"}, "reference": {"id": "9b47acc224a84534b792b0cc630df6b0", "answers": {"answer_start": [101], "text": ["secretory phospholipase A2"]}}}, "649b6ad2edf64f009e6e1f8ec666ac81": {"prediction": {"id": "649b6ad2edf64f009e6e1f8ec666ac81", "prediction_text": "Varespladib methyl"}, "reference": {"id": "649b6ad2edf64f009e6e1f8ec666ac81", "answers": {"answer_start": [30], "text": ["secretory phospholipase A2"]}}}, "f446a604ace8468c8e9274b82979870e": {"prediction": {"id": "f446a604ace8468c8e9274b82979870e", "prediction_text": "plasma sPLA2-IIA"}, "reference": {"id": "f446a604ace8468c8e9274b82979870e", "answers": {"answer_start": [37], "text": ["secretory phospholipase A2"]}}}, "2122dc4347ac4c0d804b0b4a12356cff": {"prediction": {"id": "2122dc4347ac4c0d804b0b4a12356cff", "prediction_text": "sPLA2"}, "reference": {"id": "2122dc4347ac4c0d804b0b4a12356cff", "answers": {"answer_start": [0], "text": ["secretory phospholipase A2"]}}}, "2e9b768ab32c4768bfd7bc2e4a04ffdb": {"prediction": {"id": "2e9b768ab32c4768bfd7bc2e4a04ffdb", "prediction_text": "sPLA2"}, "reference": {"id": "2e9b768ab32c4768bfd7bc2e4a04ffdb", "answers": {"answer_start": [0], "text": ["secretory phospholipase A2"]}}}, "7c523ea8cfd24929a2d08a17ddf14a22": {"prediction": {"id": "7c523ea8cfd24929a2d08a17ddf14a22", "prediction_text": "secretory phospholipase A2"}, "reference": {"id": "7c523ea8cfd24929a2d08a17ddf14a22", "answers": {"answer_start": [254], "text": ["secretory phospholipase A2"]}}}, "7d5126ac7cdd441eb39e3962111f1bbb": {"prediction": {"id": "7d5126ac7cdd441eb39e3962111f1bbb", "prediction_text": "BTK"}, "reference": {"id": "7d5126ac7cdd441eb39e3962111f1bbb", "answers": {"answer_start": [1510], "text": ["Ibrutinib"]}}}, "cfd7c9f52d8a496cb510c8efeb85c392": {"prediction": {"id": "cfd7c9f52d8a496cb510c8efeb85c392", "prediction_text": "CLL"}, "reference": {"id": "cfd7c9f52d8a496cb510c8efeb85c392", "answers": {"answer_start": [52], "text": ["Ibrutinib"]}}}, "f0c04a34e5594da6879de18276c4bd70": {"prediction": {"id": "f0c04a34e5594da6879de18276c4bd70", "prediction_text": "Ibrutinib"}, "reference": {"id": "f0c04a34e5594da6879de18276c4bd70", "answers": {"answer_start": [629], "text": ["Ibrutinib"]}}}, "1bd09e20a68a4933b34a7c7a98b09af1": {"prediction": {"id": "1bd09e20a68a4933b34a7c7a98b09af1", "prediction_text": "study ibrutinib"}, "reference": {"id": "1bd09e20a68a4933b34a7c7a98b09af1", "answers": {"answer_start": [997], "text": ["Ibrutinib"]}}}, "a7e22400363f467fab93132008af4623": {"prediction": {"id": "a7e22400363f467fab93132008af4623", "prediction_text": "Btk"}, "reference": {"id": "a7e22400363f467fab93132008af4623", "answers": {"answer_start": [1103], "text": ["Ibrutinib"]}}}, "9a909f8fabba4aea95e2e4247dbc2090": {"prediction": {"id": "9a909f8fabba4aea95e2e4247dbc2090", "prediction_text": "Ibrutinib"}, "reference": {"id": "9a909f8fabba4aea95e2e4247dbc2090", "answers": {"answer_start": [292], "text": ["Ibrutinib"]}}}, "6c45ad97ef5f4c5289aa42186ac5af57": {"prediction": {"id": "6c45ad97ef5f4c5289aa42186ac5af57", "prediction_text": "BTK"}, "reference": {"id": "6c45ad97ef5f4c5289aa42186ac5af57", "answers": {"answer_start": [1141], "text": ["Ibrutinib"]}}}, "6bf0ea772b2c4445acc527f0db3eaf4d": {"prediction": {"id": "6bf0ea772b2c4445acc527f0db3eaf4d", "prediction_text": "ibrutinib or the PI3K"}, "reference": {"id": "6bf0ea772b2c4445acc527f0db3eaf4d", "answers": {"answer_start": [1168], "text": ["Ibrutinib"]}}}, "f63df3c74a5f4f32b41f5e8e6d53211e": {"prediction": {"id": "f63df3c74a5f4f32b41f5e8e6d53211e", "prediction_text": "Btk"}, "reference": {"id": "f63df3c74a5f4f32b41f5e8e6d53211e", "answers": {"answer_start": [354], "text": ["Ibrutinib"]}}}, "e2b310d575d4428c80cae9ccfbd95998": {"prediction": {"id": "e2b310d575d4428c80cae9ccfbd95998", "prediction_text": "BTK"}, "reference": {"id": "e2b310d575d4428c80cae9ccfbd95998", "answers": {"answer_start": [931], "text": ["Ibrutinib"]}}}, "e1d89f8bc7f54a4d97179ab2193a6dac": {"prediction": {"id": "e1d89f8bc7f54a4d97179ab2193a6dac", "prediction_text": "CLL"}, "reference": {"id": "e1d89f8bc7f54a4d97179ab2193a6dac", "answers": {"answer_start": [1135], "text": ["Ibrutinib"]}}}, "5fcc59e491a649639fbc70aec4a25b67": {"prediction": {"id": "5fcc59e491a649639fbc70aec4a25b67", "prediction_text": "Ibrutinib, AVL-263"}, "reference": {"id": "5fcc59e491a649639fbc70aec4a25b67", "answers": {"answer_start": [917], "text": ["Ibrutinib"]}}}, "66717a66d8d84cc9a9b889012557c78d": {"prediction": {"id": "66717a66d8d84cc9a9b889012557c78d", "prediction_text": "ALS"}, "reference": {"id": "66717a66d8d84cc9a9b889012557c78d", "answers": {"answer_start": [376], "text": ["ALS"]}}}, "010b2186c35943e08fb5216f15fd7355": {"prediction": {"id": "010b2186c35943e08fb5216f15fd7355", "prediction_text": "Amyotrophic lateral sclerosis (ALS"}, "reference": {"id": "010b2186c35943e08fb5216f15fd7355", "answers": {"answer_start": [1041, 0], "text": ["ALS", "amyotrophic lateral sclerosis"]}}}, "df407b3aafb149efb2afc73e05b13f9e": {"prediction": {"id": "df407b3aafb149efb2afc73e05b13f9e", "prediction_text": "ALS/FTD, we examined the biochemical and cellular characteristics of mutant UBQLN2 in vitro. UBQLN2 localized in Rab11-positive endosomal vesicles formed by the ALS-linked molecule optineurin (OPTN). These vesicles were ubiquitin- and p62-immunopositive and also co-localized with an initiator of the autophagic process, ULK1, after amino acid starvation. An ALS-linked mutation (E478G) in OPTN abolished vesicle formation. ALS"}, "reference": {"id": "df407b3aafb149efb2afc73e05b13f9e", "answers": {"answer_start": [246, 91], "text": ["ALS", "amyotrophic lateral sclerosis"]}}}, "f1002cfd265a4fb586f1174ee01cc1c2": {"prediction": {"id": "f1002cfd265a4fb586f1174ee01cc1c2", "prediction_text": "ALS"}, "reference": {"id": "f1002cfd265a4fb586f1174ee01cc1c2", "answers": {"answer_start": [1748, 0], "text": ["ALS", "amyotrophic lateral sclerosis"]}}}, "12096a4692c44d1e81e34f5b134d260e": {"prediction": {"id": "12096a4692c44d1e81e34f5b134d260e", "prediction_text": "ALS mutations slow degradation of Myc, a prototypic proteasome substrate. Examination of coprecipitating proteins indicated that the mutant proteins are generally capable of binding polyubiquitinated proteins, but defective in binding the proteasome. GST-pulldown studies revealed that many of the mutants bind weaker to the S5a subunit of the proteasome, compared with wild type (WT) ubiquilin-2 protein. The results suggest the mutant proteins are unable to deliver their captured cargo to the proteasome for degradation, which presumably leads to toxicity. Quantification of cell death is consistent with this idea. Measurement of protein turnover further indicated the mutant proteins have longer half-lives than WT ubiquilin-2. Our studies provide novel insight into the mechanism by which ALS"}, "reference": {"id": "12096a4692c44d1e81e34f5b134d260e", "answers": {"answer_start": [312, 222], "text": ["ALS", "amyotrophic lateral sclerosis"]}}}, "6bd029aad9634308a4b333edb9a4f564": {"prediction": {"id": "6bd029aad9634308a4b333edb9a4f564", "prediction_text": "40%"}, "reference": {"id": "6bd029aad9634308a4b333edb9a4f564", "answers": {"answer_start": [14], "text": ["2-4%"]}}}, "57d69beee5924f70a79f7e3dbe4d726f": {"prediction": {"id": "57d69beee5924f70a79f7e3dbe4d726f", "prediction_text": "Among three"}, "reference": {"id": "57d69beee5924f70a79f7e3dbe4d726f", "answers": {"answer_start": [232], "text": ["ApoE4 isoform"]}}}, "be3b73491b8948eca721943249173ce7": {"prediction": {"id": "be3b73491b8948eca721943249173ce7", "prediction_text": "ApoE4"}, "reference": {"id": "be3b73491b8948eca721943249173ce7", "answers": {"answer_start": [1647], "text": ["ApoE4 isoform"]}}}, "893a42fe1846410e8cb7cd1794a90188": {"prediction": {"id": "893a42fe1846410e8cb7cd1794a90188", "prediction_text": "E type 4 allele"}, "reference": {"id": "893a42fe1846410e8cb7cd1794a90188", "answers": {"answer_start": [300], "text": ["ApoE4 isoform"]}}}, "bda5becaad5a4bec81821f6b74598397": {"prediction": {"id": "bda5becaad5a4bec81821f6b74598397", "prediction_text": "gene"}, "reference": {"id": "bda5becaad5a4bec81821f6b74598397", "answers": {"answer_start": [1598], "text": ["ApoE4 isoform"]}}}, "699300d147534d00a1f43cf4cb318486": {"prediction": {"id": "699300d147534d00a1f43cf4cb318486", "prediction_text": "E"}, "reference": {"id": "699300d147534d00a1f43cf4cb318486", "answers": {"answer_start": [1133], "text": ["ApoE4 isoform"]}}}, "c767e28b3b8f46c2ae6f4cb3e38e12de": {"prediction": {"id": "c767e28b3b8f46c2ae6f4cb3e38e12de", "prediction_text": "APOE-epsilon4"}, "reference": {"id": "c767e28b3b8f46c2ae6f4cb3e38e12de", "answers": {"answer_start": [1415], "text": ["ApoE4 isoform"]}}}, "2ece9255d3bb410488adaac738bde118": {"prediction": {"id": "2ece9255d3bb410488adaac738bde118", "prediction_text": "http://www.ebi.ac.uk/huber-srv/hilbert/."}, "reference": {"id": "2ece9255d3bb410488adaac738bde118", "answers": {"answer_start": [488], "text": ["HilbertVis"]}}}, "082545fd9076412397473820ba4929c5": {"prediction": {"id": "082545fd9076412397473820ba4929c5", "prediction_text": "transgenic oncogenes"}, "reference": {"id": "082545fd9076412397473820ba4929c5", "answers": {"answer_start": [623], "text": ["NF1"]}}}, "4ff1cd1d34d2426e84bcd490aa5d9113": {"prediction": {"id": "4ff1cd1d34d2426e84bcd490aa5d9113", "prediction_text": "NF2"}, "reference": {"id": "4ff1cd1d34d2426e84bcd490aa5d9113", "answers": {"answer_start": [40], "text": ["NF1"]}}}, "ca12b401788e4a96be29e9e423a1bcff": {"prediction": {"id": "ca12b401788e4a96be29e9e423a1bcff", "prediction_text": "neurofibromin (NF1)"}, "reference": {"id": "ca12b401788e4a96be29e9e423a1bcff", "answers": {"answer_start": [411], "text": ["NF1"]}}}, "f767544e9e9443a2947061aacbbc3e2f": {"prediction": {"id": "f767544e9e9443a2947061aacbbc3e2f", "prediction_text": "NF1"}, "reference": {"id": "f767544e9e9443a2947061aacbbc3e2f", "answers": {"answer_start": [93], "text": ["NF1"]}}}, "502aef137f0f4197bbb7713342a44b6f": {"prediction": {"id": "502aef137f0f4197bbb7713342a44b6f", "prediction_text": "Cajal"}, "reference": {"id": "502aef137f0f4197bbb7713342a44b6f", "answers": {"answer_start": [1499], "text": ["NF1"]}}}, "13ca5e0ef1eb4098bf9889bdf776461b": {"prediction": {"id": "13ca5e0ef1eb4098bf9889bdf776461b", "prediction_text": "GTPase"}, "reference": {"id": "13ca5e0ef1eb4098bf9889bdf776461b", "answers": {"answer_start": [877], "text": ["NF1"]}}}, "2826bf382c7445eba80c10146bce42f8": {"prediction": {"id": "2826bf382c7445eba80c10146bce42f8", "prediction_text": "NF1"}, "reference": {"id": "2826bf382c7445eba80c10146bce42f8", "answers": {"answer_start": [522], "text": ["NF1"]}}}, "f4688b70ceb34f4f901288400765c0fc": {"prediction": {"id": "f4688b70ceb34f4f901288400765c0fc", "prediction_text": "protein truncation test (PTT)"}, "reference": {"id": "f4688b70ceb34f4f901288400765c0fc", "answers": {"answer_start": [484], "text": ["NF1"]}}}, "bbc4300962ab4255b69bbc52feb0d9bc": {"prediction": {"id": "bbc4300962ab4255b69bbc52feb0d9bc", "prediction_text": "Rho"}, "reference": {"id": "bbc4300962ab4255b69bbc52feb0d9bc", "answers": {"answer_start": [1228], "text": ["NF1"]}}}, "305a878458d540dbbffbde8a73fe4962": {"prediction": {"id": "305a878458d540dbbffbde8a73fe4962", "prediction_text": "NF1"}, "reference": {"id": "305a878458d540dbbffbde8a73fe4962", "answers": {"answer_start": [95], "text": ["NF1"]}}}, "d68fd96e03884cf9b405b876e7672ff8": {"prediction": {"id": "d68fd96e03884cf9b405b876e7672ff8", "prediction_text": "heterozygously"}, "reference": {"id": "d68fd96e03884cf9b405b876e7672ff8", "answers": {"answer_start": [354], "text": ["NF1"]}}}, "35a4f247ac214f09bb1ff3ea1f3a57a1": {"prediction": {"id": "35a4f247ac214f09bb1ff3ea1f3a57a1", "prediction_text": "deletions"}, "reference": {"id": "35a4f247ac214f09bb1ff3ea1f3a57a1", "answers": {"answer_start": [414], "text": ["NF1"]}}}, "36165e6bf9b848fd812d6aab35523ac8": {"prediction": {"id": "36165e6bf9b848fd812d6aab35523ac8", "prediction_text": "NF1"}, "reference": {"id": "36165e6bf9b848fd812d6aab35523ac8", "answers": {"answer_start": [709], "text": ["NF1"]}}}, "d99ad294949c43228b443eb85cb1bc3e": {"prediction": {"id": "d99ad294949c43228b443eb85cb1bc3e", "prediction_text": "N-ras gene"}, "reference": {"id": "d99ad294949c43228b443eb85cb1bc3e", "answers": {"answer_start": [447], "text": ["NF1"]}}}, "efcd4fa5bcc04e4991db55de61aca1a5": {"prediction": {"id": "efcd4fa5bcc04e4991db55de61aca1a5", "prediction_text": "NF1"}, "reference": {"id": "efcd4fa5bcc04e4991db55de61aca1a5", "answers": {"answer_start": [708], "text": ["NF1"]}}}, "e5e179d9eb30411d93a5c64fd7efecdc": {"prediction": {"id": "e5e179d9eb30411d93a5c64fd7efecdc", "prediction_text": "NF1"}, "reference": {"id": "e5e179d9eb30411d93a5c64fd7efecdc", "answers": {"answer_start": [1370], "text": ["NF1"]}}}, "303c6353120a48fe9e919f2a94a07742": {"prediction": {"id": "303c6353120a48fe9e919f2a94a07742", "prediction_text": "NF1"}, "reference": {"id": "303c6353120a48fe9e919f2a94a07742", "answers": {"answer_start": [464], "text": ["NF1"]}}}, "c8867a8edfd14e75ac2aa05f5aa4e09d": {"prediction": {"id": "c8867a8edfd14e75ac2aa05f5aa4e09d", "prediction_text": "NF1"}, "reference": {"id": "c8867a8edfd14e75ac2aa05f5aa4e09d", "answers": {"answer_start": [115], "text": ["NF1"]}}}, "48867e375e3b446f9b52945545063eb4": {"prediction": {"id": "48867e375e3b446f9b52945545063eb4", "prediction_text": "NF1 allele"}, "reference": {"id": "48867e375e3b446f9b52945545063eb4", "answers": {"answer_start": [291], "text": ["NF1"]}}}, "f68afb8d890346808b1aba2100d630fb": {"prediction": {"id": "f68afb8d890346808b1aba2100d630fb", "prediction_text": "NF1DeltaE7"}, "reference": {"id": "f68afb8d890346808b1aba2100d630fb", "answers": {"answer_start": [524], "text": ["NF1"]}}}, "8887d123cd2544d7a29f486e1b272d88": {"prediction": {"id": "8887d123cd2544d7a29f486e1b272d88", "prediction_text": "transcriptase-PCR of peripheral blood showed bi-allelic expression of both the wild-type NF1 and the mutated form, reverse transcriptase-PCR"}, "reference": {"id": "8887d123cd2544d7a29f486e1b272d88", "answers": {"answer_start": [721], "text": ["NF1"]}}}, "ae7daed7036740818cc7120eb3bf5ba1": {"prediction": {"id": "ae7daed7036740818cc7120eb3bf5ba1", "prediction_text": "NF1"}, "reference": {"id": "ae7daed7036740818cc7120eb3bf5ba1", "answers": {"answer_start": [1703], "text": ["NF1"]}}}, "903258f0679743cbacb937183a0c5269": {"prediction": {"id": "903258f0679743cbacb937183a0c5269", "prediction_text": "mice (GEM)"}, "reference": {"id": "903258f0679743cbacb937183a0c5269", "answers": {"answer_start": [602], "text": ["NF1"]}}}, "48035f593c78429abd4f68a11db8cddc": {"prediction": {"id": "48035f593c78429abd4f68a11db8cddc", "prediction_text": "exon 1"}, "reference": {"id": "48035f593c78429abd4f68a11db8cddc", "answers": {"answer_start": [1174], "text": ["NF1"]}}}, "363dc68e98f94e3892775405c6723bed": {"prediction": {"id": "363dc68e98f94e3892775405c6723bed", "prediction_text": "Mitochondrial DNA (mtDNA) is inherited extrachromosomally through the cytoplasm of the oocyte and often harbours heteroplasmic sequence variations. At the time of blastomere separation, these variants may be skewedly distributed and effect phenotypic differences. Because of their co-localization with the tumor suppressor protein neurofibromin"}, "reference": {"id": "363dc68e98f94e3892775405c6723bed", "answers": {"answer_start": [396], "text": ["NF1"]}}}, "1e1878b9c1c54db6841157f8f7b03eb9": {"prediction": {"id": "1e1878b9c1c54db6841157f8f7b03eb9", "prediction_text": "vascular smooth muscle cells"}, "reference": {"id": "1e1878b9c1c54db6841157f8f7b03eb9", "answers": {"answer_start": [440], "text": ["mammalian target of rapamycin"]}}}, "c00008c974714452b60d1c4e0036a670": {"prediction": {"id": "c00008c974714452b60d1c4e0036a670", "prediction_text": "glioblastoma"}, "reference": {"id": "c00008c974714452b60d1c4e0036a670", "answers": {"answer_start": [4], "text": ["mammalian target of rapamycin"]}}}, "509bdda8b7c341d482a1d37155a621d3": {"prediction": {"id": "509bdda8b7c341d482a1d37155a621d3", "prediction_text": "pulmonary arterial vascular smooth muscle cells"}, "reference": {"id": "509bdda8b7c341d482a1d37155a621d3", "answers": {"answer_start": [293], "text": ["mammalian target of rapamycin"]}}}, "231564e7c5384ce187738cd0819d6bdc": {"prediction": {"id": "231564e7c5384ce187738cd0819d6bdc", "prediction_text": "umbilical vein endothelial cells"}, "reference": {"id": "231564e7c5384ce187738cd0819d6bdc", "answers": {"answer_start": [603], "text": ["mammalian target of rapamycin"]}}}, "deb14370ea8b4434b563324477ab4ce1": {"prediction": {"id": "deb14370ea8b4434b563324477ab4ce1", "prediction_text": "inhibitor-associated stomatitis"}, "reference": {"id": "deb14370ea8b4434b563324477ab4ce1", "answers": {"answer_start": [46], "text": ["mammalian target of rapamycin"]}}}, "eb9ccb7fe6fc4bd8a778512f2e3b02d8": {"prediction": {"id": "eb9ccb7fe6fc4bd8a778512f2e3b02d8", "prediction_text": "cancer stem cells"}, "reference": {"id": "eb9ccb7fe6fc4bd8a778512f2e3b02d8", "answers": {"answer_start": [142], "text": ["mammalian target of rapamycin"]}}}, "320f052eb9874d048b7bac1f2e3e2d1f": {"prediction": {"id": "320f052eb9874d048b7bac1f2e3e2d1f", "prediction_text": "rapamycin"}, "reference": {"id": "320f052eb9874d048b7bac1f2e3e2d1f", "answers": {"answer_start": [95], "text": ["mammalian target of rapamycin"]}}}, "efb9b9589c0e4afdae21df6bdecd5eeb": {"prediction": {"id": "efb9b9589c0e4afdae21df6bdecd5eeb", "prediction_text": "Vascular endothelial growth factor"}, "reference": {"id": "efb9b9589c0e4afdae21df6bdecd5eeb", "answers": {"answer_start": [282], "text": ["mammalian target of rapamycin"]}}}, "2cd901fd9d7142268d0e9b8951d0cd76": {"prediction": {"id": "2cd901fd9d7142268d0e9b8951d0cd76", "prediction_text": "E-box protein 2 (ZEB2)"}, "reference": {"id": "2cd901fd9d7142268d0e9b8951d0cd76", "answers": {"answer_start": [322], "text": ["ZEB2"]}}}, "a47a5cf75f6e4258b696cf7ad9aaf1b3": {"prediction": {"id": "a47a5cf75f6e4258b696cf7ad9aaf1b3", "prediction_text": "zinc finger homeo box 1B gene"}, "reference": {"id": "a47a5cf75f6e4258b696cf7ad9aaf1b3", "answers": {"answer_start": [486], "text": ["ZFHX1B"]}}}, "900e1682ea9146db9af0ff3225d00188": {"prediction": {"id": "900e1682ea9146db9af0ff3225d00188", "prediction_text": "ZEB2"}, "reference": {"id": "900e1682ea9146db9af0ff3225d00188", "answers": {"answer_start": [564], "text": ["ZEB2"]}}}, "80992a716a2745adacff4bd25917876d": {"prediction": {"id": "80992a716a2745adacff4bd25917876d", "prediction_text": "Mutations"}, "reference": {"id": "80992a716a2745adacff4bd25917876d", "answers": {"answer_start": [379], "text": ["ZFHX1B"]}}}, "c95188ac78d34f5caf9ed7d152251748": {"prediction": {"id": "c95188ac78d34f5caf9ed7d152251748", "prediction_text": "variable MCAs"}, "reference": {"id": "c95188ac78d34f5caf9ed7d152251748", "answers": {"answer_start": [31], "text": ["ZFHX1B"]}}}, "4387270d3e5b4cd9b8795bcb81c76bfb": {"prediction": {"id": "4387270d3e5b4cd9b8795bcb81c76bfb", "prediction_text": "ZFHX1B or SIP-1"}, "reference": {"id": "4387270d3e5b4cd9b8795bcb81c76bfb", "answers": {"answer_start": [532, 1307, 542], "text": ["ZFHX1B", "ZEB2", "SIP-1"]}}}, "518b861f4e49412eb4a0f9930a524bae": {"prediction": {"id": "518b861f4e49412eb4a0f9930a524bae", "prediction_text": "MWS) is a genetic disease caused by heterozygous mutations or deletions of the ZEB2"}, "reference": {"id": "518b861f4e49412eb4a0f9930a524bae", "answers": {"answer_start": [102], "text": ["ZEB2"]}}}, "d0e992d676e844858b97f1e8a36fc350": {"prediction": {"id": "d0e992d676e844858b97f1e8a36fc350", "prediction_text": "Zinc Finger Homeobox 1 B gene"}, "reference": {"id": "d0e992d676e844858b97f1e8a36fc350", "answers": {"answer_start": [146], "text": ["ZFHX1B"]}}}, "adb3fe61e38043a9a5f5bfe94a7451d1": {"prediction": {"id": "adb3fe61e38043a9a5f5bfe94a7451d1", "prediction_text": "zfhz1b"}, "reference": {"id": "adb3fe61e38043a9a5f5bfe94a7451d1", "answers": {"answer_start": [718], "text": ["ZFHX1B"]}}}, "d25b8d714d6546a38f4b432e8acec09e": {"prediction": {"id": "d25b8d714d6546a38f4b432e8acec09e", "prediction_text": "de novo"}, "reference": {"id": "d25b8d714d6546a38f4b432e8acec09e", "answers": {"answer_start": [576], "text": ["ZEB2"]}}}, "932383a929bc49eb87307ed2bdcb77ba": {"prediction": {"id": "932383a929bc49eb87307ed2bdcb77ba", "prediction_text": "TWIST1"}, "reference": {"id": "932383a929bc49eb87307ed2bdcb77ba", "answers": {"answer_start": [1028], "text": ["ZEB2"]}}}, "433cf4b4b2d749dfb8d4eeaaed8c3ddc": {"prediction": {"id": "433cf4b4b2d749dfb8d4eeaaed8c3ddc", "prediction_text": "de novo"}, "reference": {"id": "433cf4b4b2d749dfb8d4eeaaed8c3ddc", "answers": {"answer_start": [411], "text": ["ZEB2"]}}}, "bd7b44a0fc4a4750873bcafebb9f2159": {"prediction": {"id": "bd7b44a0fc4a4750873bcafebb9f2159", "prediction_text": "protein 1"}, "reference": {"id": "bd7b44a0fc4a4750873bcafebb9f2159", "answers": {"answer_start": [0], "text": ["ZFHX1B"]}}}, "b131ec605f6c452580082d4237dc9da8": {"prediction": {"id": "b131ec605f6c452580082d4237dc9da8", "prediction_text": "Zfhx1b"}, "reference": {"id": "b131ec605f6c452580082d4237dc9da8", "answers": {"answer_start": [1052], "text": ["ZFHX1B"]}}}, "8f3723fbcd6e471890dcfa28a3c4dbb8": {"prediction": {"id": "8f3723fbcd6e471890dcfa28a3c4dbb8", "prediction_text": "ZEB2"}, "reference": {"id": "8f3723fbcd6e471890dcfa28a3c4dbb8", "answers": {"answer_start": [134], "text": ["ZEB2"]}}}, "e8a1cc08872d44ecb1833874aa5f9886": {"prediction": {"id": "e8a1cc08872d44ecb1833874aa5f9886", "prediction_text": "ZFHX1B"}, "reference": {"id": "e8a1cc08872d44ecb1833874aa5f9886", "answers": {"answer_start": [153], "text": ["ZFHX1B"]}}}, "d3e54b7de2664f45a67e6026c276b864": {"prediction": {"id": "d3e54b7de2664f45a67e6026c276b864", "prediction_text": "de novo"}, "reference": {"id": "d3e54b7de2664f45a67e6026c276b864", "answers": {"answer_start": [864], "text": ["ZFHX1B"]}}}, "5a77818b30784216af93626f5c4df846": {"prediction": {"id": "5a77818b30784216af93626f5c4df846", "prediction_text": "DUX4 downstream genes"}, "reference": {"id": "5a77818b30784216af93626f5c4df846", "answers": {"answer_start": [619], "text": ["FSHD"]}}}, "6e6a4c960945450f927840a00f116f7d": {"prediction": {"id": "6e6a4c960945450f927840a00f116f7d", "prediction_text": "Autosomal"}, "reference": {"id": "6e6a4c960945450f927840a00f116f7d", "answers": {"answer_start": [59], "text": ["FSHD"]}}}, "ca68dd1244484cf581a2f8b396fe6174": {"prediction": {"id": "ca68dd1244484cf581a2f8b396fe6174", "prediction_text": "decreased epigenetic repression"}, "reference": {"id": "ca68dd1244484cf581a2f8b396fe6174", "answers": {"answer_start": [0, 920], "text": ["Facioscapulohumeral dystrophy", "FSHD"]}}}, "de8ecaa98bd04495823e545e7204c2fd": {"prediction": {"id": "de8ecaa98bd04495823e545e7204c2fd", "prediction_text": "DUX4"}, "reference": {"id": "de8ecaa98bd04495823e545e7204c2fd", "answers": {"answer_start": [785], "text": ["FSHD"]}}}, "9c245290be6d4de881e39d1c19ef66fa": {"prediction": {"id": "9c245290be6d4de881e39d1c19ef66fa", "prediction_text": "DUX4"}, "reference": {"id": "9c245290be6d4de881e39d1c19ef66fa", "answers": {"answer_start": [403], "text": ["FSHD"]}}}, "b016f184150d4a859565d03ecfec3eb1": {"prediction": {"id": "b016f184150d4a859565d03ecfec3eb1", "prediction_text": "paired-like homeodomain transcription factor 1"}, "reference": {"id": "b016f184150d4a859565d03ecfec3eb1", "answers": {"answer_start": [40], "text": ["FSHD"]}}}, "c407f644b4584dc9a0b9452e21abc37d": {"prediction": {"id": "c407f644b4584dc9a0b9452e21abc37d", "prediction_text": "SMCHD1 mutation"}, "reference": {"id": "c407f644b4584dc9a0b9452e21abc37d", "answers": {"answer_start": [0, 31], "text": ["Facioscapulohumeral dystrophy", "FSHD"]}}}, "702663e5f28448e29429938a6555f3ac": {"prediction": {"id": "702663e5f28448e29429938a6555f3ac", "prediction_text": "mouse muscle"}, "reference": {"id": "702663e5f28448e29429938a6555f3ac", "answers": {"answer_start": [384], "text": ["FSHD"]}}}, "037e09d173064bd3b22c2a2b223a168e": {"prediction": {"id": "037e09d173064bd3b22c2a2b223a168e", "prediction_text": "green"}, "reference": {"id": "037e09d173064bd3b22c2a2b223a168e", "answers": {"answer_start": [555], "text": ["FSHD"]}}}, "271275fa9b374d0588d2a8d9f1ee4024": {"prediction": {"id": "271275fa9b374d0588d2a8d9f1ee4024", "prediction_text": "contraction of an array of tandem 3.3-kb repeats (D4Z4) at 4q35. Within each repeat unit is a gene, DUX4, that can encode a protein containing two homeodomains. A DUX4 transcript derived from the last repeat unit in a contracted array is associated with pathogenesis but it is unclear how. Using exon-based microarrays, the expression profiles of myogenic precursor cells were determined. Both undifferentiated myoblasts and myoblasts differentiated to myotubes derived from FSHD patients"}, "reference": {"id": "271275fa9b374d0588d2a8d9f1ee4024", "answers": {"answer_start": [1517], "text": ["FSHD"]}}}, "e784764a7f0d4c3e828f99fd60f45032": {"prediction": {"id": "e784764a7f0d4c3e828f99fd60f45032", "prediction_text": "Paired"}, "reference": {"id": "e784764a7f0d4c3e828f99fd60f45032", "answers": {"answer_start": [148], "text": ["FSHD"]}}}, "bb2d1999218e491888fc809f94f6ef8c": {"prediction": {"id": "bb2d1999218e491888fc809f94f6ef8c", "prediction_text": "Mutations"}, "reference": {"id": "bb2d1999218e491888fc809f94f6ef8c", "answers": {"answer_start": [802], "text": ["FSHD"]}}}, "feb5c8c4a58b4544a2a7a9936a46baca": {"prediction": {"id": "feb5c8c4a58b4544a2a7a9936a46baca", "prediction_text": "cell death"}, "reference": {"id": "feb5c8c4a58b4544a2a7a9936a46baca", "answers": {"answer_start": [57, 1063], "text": ["Facioscapulohumeral dystrophy", "FSHD"]}}}, "ef2a710d9bbe410c9824c278b0253f2b": {"prediction": {"id": "ef2a710d9bbe410c9824c278b0253f2b", "prediction_text": "Majority Rules')"}, "reference": {"id": "ef2a710d9bbe410c9824c278b0253f2b", "answers": {"answer_start": [387], "text": ["FSHD"]}}}, "0876998ee74b47feb08f1743746a5457": {"prediction": {"id": "0876998ee74b47feb08f1743746a5457", "prediction_text": "FSHD pathology is caused by the misexpression of the DUX4 (double homeobox 4) gene resulting in production of a pathogenic protein, DUX4-FL, which has been detected in FSHD, but not in unaffected control myogenic cells and muscle tissue. Here, we report the analysis of DUX4 mRNA and protein expression in a much larger collection of myogenic cells and muscle biopsies derived from biceps and deltoid muscles of FSHD affected subjects and their unaffected first-degree relatives. We confirmed that stable DUX4-fl mRNA and protein were expressed in myogenic cells and muscle tissues derived from FSHD affected subjects, including several genetically diagnosed adult FSHD subjects yet to show clinical manifestations of the disease in the assayed muscles. In addition, we report DUX4-fl mRNA and protein expression in muscle biopsies and myogenic cells from genetically unaffected relatives of the FSHD subjects, although at a significantly lower frequency. These results establish that DUX4-fl expression per se is not sufficient for FSHD muscle pathology and indicate that quantitative modifiers of DUX4-fl expression and/or function and family genetic background are determinants of FSHD muscle"}, "reference": {"id": "0876998ee74b47feb08f1743746a5457", "answers": {"answer_start": [1432], "text": ["FSHD"]}}}, "bda98550089b4cc983906b73335c0b4a": {"prediction": {"id": "bda98550089b4cc983906b73335c0b4a", "prediction_text": "Facioscapulohumeral Disease"}, "reference": {"id": "bda98550089b4cc983906b73335c0b4a", "answers": {"answer_start": [1470], "text": ["FSHD"]}}}, "49815b9acb8249c687ef1df242299917": {"prediction": {"id": "49815b9acb8249c687ef1df242299917", "prediction_text": "onset"}, "reference": {"id": "49815b9acb8249c687ef1df242299917", "answers": {"answer_start": [1222], "text": ["FSHD"]}}}, "1017e1fb28bb46899b1fa47e4440fa32": {"prediction": {"id": "1017e1fb28bb46899b1fa47e4440fa32", "prediction_text": "fine-tuning the RNA life cycle"}, "reference": {"id": "1017e1fb28bb46899b1fa47e4440fa32", "answers": {"answer_start": [683], "text": ["mRNA stability"]}}}, "11cfbb8bf66941a7aeb7fd14fea7c59b": {"prediction": {"id": "11cfbb8bf66941a7aeb7fd14fea7c59b", "prediction_text": "mRNA stability"}, "reference": {"id": "11cfbb8bf66941a7aeb7fd14fea7c59b", "answers": {"answer_start": [642], "text": ["mRNA stability"]}}}, "4053ac23b2f14de59c72e874c4d3042b": {"prediction": {"id": "4053ac23b2f14de59c72e874c4d3042b", "prediction_text": "\u03b2-galactosidase and \u03b2-hexosaminidase"}, "reference": {"id": "4053ac23b2f14de59c72e874c4d3042b", "answers": {"answer_start": [333], "text": ["\u03b2-galactosidase"]}}}, "dfa0d400498f4b50987484c7d8f7aedd": {"prediction": {"id": "dfa0d400498f4b50987484c7d8f7aedd", "prediction_text": "Insulin"}, "reference": {"id": "dfa0d400498f4b50987484c7d8f7aedd", "answers": {"answer_start": [336], "text": ["IL-1\u03b2"]}}}, "ca5ca288f4ef4bae977f9c51d7fb73c2": {"prediction": {"id": "ca5ca288f4ef4bae977f9c51d7fb73c2", "prediction_text": "lymphoid cells"}, "reference": {"id": "ca5ca288f4ef4bae977f9c51d7fb73c2", "answers": {"answer_start": [828], "text": ["IL-1\u03b2"]}}}, "ab03e38aae9a419abbeb0412881335f4": {"prediction": {"id": "ab03e38aae9a419abbeb0412881335f4", "prediction_text": "IL-1\u03b2 modulator gevokizumab"}, "reference": {"id": "ab03e38aae9a419abbeb0412881335f4", "answers": {"answer_start": [1330], "text": ["IL-1\u03b2"]}}}, "59033fb84de74ab78efae105c6ca0ac4": {"prediction": {"id": "59033fb84de74ab78efae105c6ca0ac4", "prediction_text": "IL-1\u03b2"}, "reference": {"id": "59033fb84de74ab78efae105c6ca0ac4", "answers": {"answer_start": [100], "text": ["IL-1\u03b2"]}}}, "d7bfdd0edd9c4be38b046d76c45d3a6a": {"prediction": {"id": "d7bfdd0edd9c4be38b046d76c45d3a6a", "prediction_text": "anti-IL-1\u03b2 antibody"}, "reference": {"id": "d7bfdd0edd9c4be38b046d76c45d3a6a", "answers": {"answer_start": [1400], "text": ["IL-1\u03b2"]}}}, "02dfba2a925b4668ad3038022e1e8cbd": {"prediction": {"id": "02dfba2a925b4668ad3038022e1e8cbd", "prediction_text": "IL-1"}, "reference": {"id": "02dfba2a925b4668ad3038022e1e8cbd", "answers": {"answer_start": [794], "text": ["IL-1\u03b2"]}}}, "35501c9f732c498f97eced3daa99b947": {"prediction": {"id": "35501c9f732c498f97eced3daa99b947", "prediction_text": "antibody complex"}, "reference": {"id": "35501c9f732c498f97eced3daa99b947", "answers": {"answer_start": [920], "text": ["IL-1\u03b2"]}}}, "662c913467244a56b6119baf1ae5f0b8": {"prediction": {"id": "662c913467244a56b6119baf1ae5f0b8", "prediction_text": "prostacyclin receptor agonist"}, "reference": {"id": "662c913467244a56b6119baf1ae5f0b8", "answers": {"answer_start": [201], "text": ["pulmonary arterial hypertension"]}}}, "818d5d749702453bb68863d247e554c1": {"prediction": {"id": "818d5d749702453bb68863d247e554c1", "prediction_text": "MCT)-PAH rats"}, "reference": {"id": "818d5d749702453bb68863d247e554c1", "answers": {"answer_start": [395], "text": ["pulmonary arterial hypertension"]}}}, "26307f3d7d9f43b3893f6b3f0f331fcc": {"prediction": {"id": "26307f3d7d9f43b3893f6b3f0f331fcc", "prediction_text": "pulmonary arterial hypertension (PAH). 43 adult patients with symptomatic PAH (receiving stable endothelin receptor antagonist and/or a phosphodiesterase type-5 inhibitor therapy) were randomised three to one to receive either selexipag or placebo. Dosage was up-titrated in 200-\u03bcg increments from 200 \u03bcg twice daily on day 1 to the maximum tolerated dose by day 35 (maximum allowed dose of 800 \u03bcg twice daily). Change in pulmonary vascular resistance at week 17 expressed as a percentage of the baseline value was the primary efficacy end-point, and was analysed in the per protocol set first and then in the all-treated set to assess robustness of results. A statistically significant 30.3% reduction in geometric mean pulmonary vascular resistance was observed after 17 weeks' treatment with selexipag compared with placebo (95% confidence limits -44.7- -12.2; p=0.0045, Wilcoxon rank sum test). This was supported by a similar result from the all-treated set. Selexipag was well tolerated with a safety profile in line with the expected pharmacological effect. Our results encourage the further investigation of selexipag for the treatment of PAH"}, "reference": {"id": "26307f3d7d9f43b3893f6b3f0f331fcc", "answers": {"answer_start": [184], "text": ["pulmonary arterial hypertension"]}}}, "ae29a7ab556c48329e142cf55871d308": {"prediction": {"id": "ae29a7ab556c48329e142cf55871d308", "prediction_text": "pulmonary arterial hypertension"}, "reference": {"id": "ae29a7ab556c48329e142cf55871d308", "answers": {"answer_start": [201], "text": ["pulmonary arterial hypertension"]}}}, "a7f6b41aff3a400182f9364517815974": {"prediction": {"id": "a7f6b41aff3a400182f9364517815974", "prediction_text": "pulmonary arterial hypertension"}, "reference": {"id": "a7f6b41aff3a400182f9364517815974", "answers": {"answer_start": [120], "text": ["pulmonary arterial hypertension"]}}}, "7dc25d3fbfe14b459ef6c5d3f3b05703": {"prediction": {"id": "7dc25d3fbfe14b459ef6c5d3f3b05703", "prediction_text": "CAGE toolbox"}, "reference": {"id": "7dc25d3fbfe14b459ef6c5d3f3b05703", "answers": {"answer_start": [997], "text": ["CAGEr"]}}}, "2c83c65cdb65457083ce5efd6533f01b": {"prediction": {"id": "2c83c65cdb65457083ce5efd6533f01b", "prediction_text": "protein hetero- and homodimerization in live cells using light. Using the FKF1 and GIGANTEA (GI) proteins of Arabidopsis thaliana, we have generated protein tags whose interaction is controlled by blue light. We demonstrated the utility of this system with LAD constructs that can recruit the small G-protein Rac1 to the plasma membrane and induce the local formation of lamellipodia in response to focal illumination. We also generated a light-activated transcription factor by fusing domains of GI and FKF1 to the DNA"}, "reference": {"id": "2c83c65cdb65457083ce5efd6533f01b", "answers": {"answer_start": [477], "text": ["Rac1"]}}}, "261f78db3f744227aaf46b115db6d581": {"prediction": {"id": "261f78db3f744227aaf46b115db6d581", "prediction_text": "DUb"}, "reference": {"id": "261f78db3f744227aaf46b115db6d581", "answers": {"answer_start": [1013], "text": ["Ataxin-3"]}}}, "ba32d443657b4c12a23e20d66b4ab7f3": {"prediction": {"id": "ba32d443657b4c12a23e20d66b4ab7f3", "prediction_text": "neurodegenerative disorder caused by the expansion of the polyglutamine repeat region within the ataxin-3 protein. The mutant protein forms intracellular aggregates in the brain. However, the cellular mechanisms causing toxicity are still poorly understood and there are currently no effective treatments. In this study we show that administration of a rapamycin ester"}, "reference": {"id": "ba32d443657b4c12a23e20d66b4ab7f3", "answers": {"answer_start": [1547], "text": ["Ataxin-3"]}}}, "9faaace23e6044a4855afb42fd565fb2": {"prediction": {"id": "9faaace23e6044a4855afb42fd565fb2", "prediction_text": "SCA3"}, "reference": {"id": "9faaace23e6044a4855afb42fd565fb2", "answers": {"answer_start": [0], "text": ["Ataxin-3"]}}}, "4a8cdb67ad984dc2bfd4f01b4858ce6f": {"prediction": {"id": "4a8cdb67ad984dc2bfd4f01b4858ce6f", "prediction_text": "polyglutamine expansion"}, "reference": {"id": "4a8cdb67ad984dc2bfd4f01b4858ce6f", "answers": {"answer_start": [695], "text": ["Ataxin-3"]}}}, "d27aa130133c4151bc5113664326e5cf": {"prediction": {"id": "d27aa130133c4151bc5113664326e5cf", "prediction_text": "SCA3/MJD), we show that the disease"}, "reference": {"id": "d27aa130133c4151bc5113664326e5cf", "answers": {"answer_start": [272], "text": ["Ataxin-3"]}}}, "d865eff213044d9ca9aed4dd3fc71ad1": {"prediction": {"id": "d865eff213044d9ca9aed4dd3fc71ad1", "prediction_text": "Machado-Joseph disease"}, "reference": {"id": "d865eff213044d9ca9aed4dd3fc71ad1", "answers": {"answer_start": [713], "text": ["Ataxin-3"]}}}, "f727460e76d1421eb5cdea03b0e694e0": {"prediction": {"id": "f727460e76d1421eb5cdea03b0e694e0", "prediction_text": "SCA3"}, "reference": {"id": "f727460e76d1421eb5cdea03b0e694e0", "answers": {"answer_start": [715], "text": ["Ataxin-3"]}}}, "18bbb6eacae549188b74fa3a4fcdab4b": {"prediction": {"id": "18bbb6eacae549188b74fa3a4fcdab4b", "prediction_text": "Ataxin-3"}, "reference": {"id": "18bbb6eacae549188b74fa3a4fcdab4b", "answers": {"answer_start": [0], "text": ["Ataxin-3"]}}}, "d5ec6e9f7b9b4d4f9808609878982b77": {"prediction": {"id": "d5ec6e9f7b9b4d4f9808609878982b77", "prediction_text": "SCA3"}, "reference": {"id": "d5ec6e9f7b9b4d4f9808609878982b77", "answers": {"answer_start": [150], "text": ["Ataxin-3"]}}}, "9f5d8b418c764476a15ab00b023786f7": {"prediction": {"id": "9f5d8b418c764476a15ab00b023786f7", "prediction_text": "C-terminal region"}, "reference": {"id": "9f5d8b418c764476a15ab00b023786f7", "answers": {"answer_start": [622], "text": ["Ataxin-3"]}}}, "6ffd979c642d4679b6699a1d97730c77": {"prediction": {"id": "6ffd979c642d4679b6699a1d97730c77", "prediction_text": "Ataxin-3 (AT3)"}, "reference": {"id": "6ffd979c642d4679b6699a1d97730c77", "answers": {"answer_start": [0], "text": ["Ataxin-3"]}}}, "092780baa490492882f5d2cda729a2b7": {"prediction": {"id": "092780baa490492882f5d2cda729a2b7", "prediction_text": "SCA3"}, "reference": {"id": "092780baa490492882f5d2cda729a2b7", "answers": {"answer_start": [206], "text": ["Ataxin-3"]}}}, "a5d1cf8cad02450e996e89deadc93081": {"prediction": {"id": "a5d1cf8cad02450e996e89deadc93081", "prediction_text": "formin"}, "reference": {"id": "a5d1cf8cad02450e996e89deadc93081", "answers": {"answer_start": [0], "text": ["mDia proteins are members of the formin family"]}}}, "97e83f4b6704494aad9ce514b034a026": {"prediction": {"id": "97e83f4b6704494aad9ce514b034a026", "prediction_text": "P cDNA"}, "reference": {"id": "97e83f4b6704494aad9ce514b034a026", "answers": {"answer_start": [92], "text": ["Selenoprotein P"]}}}, "07821d2e7b4f47a39f2349cd0ea90d2a": {"prediction": {"id": "07821d2e7b4f47a39f2349cd0ea90d2a", "prediction_text": "tubule cells of the kidney"}, "reference": {"id": "07821d2e7b4f47a39f2349cd0ea90d2a", "answers": {"answer_start": [0], "text": ["Selenoprotein P"]}}}, "32534fa2f5a946b9a50865c93b8cafa0": {"prediction": {"id": "32534fa2f5a946b9a50865c93b8cafa0", "prediction_text": "P (HSelP)"}, "reference": {"id": "32534fa2f5a946b9a50865c93b8cafa0", "answers": {"answer_start": [6], "text": ["Selenoprotein P"]}}}, "5f474b52236947b2a86a2de3b34491ac": {"prediction": {"id": "5f474b52236947b2a86a2de3b34491ac", "prediction_text": "bovine and rodent selenoprotein"}, "reference": {"id": "5f474b52236947b2a86a2de3b34491ac", "answers": {"answer_start": [0], "text": ["Selenoprotein P"]}}}, "77ca0e6746f64f05b74836e667b99c16": {"prediction": {"id": "77ca0e6746f64f05b74836e667b99c16", "prediction_text": "SeP"}, "reference": {"id": "77ca0e6746f64f05b74836e667b99c16", "answers": {"answer_start": [0], "text": ["Selenoprotein P"]}}}, "b3996b278786486a8ab7f1834c1cf479": {"prediction": {"id": "b3996b278786486a8ab7f1834c1cf479", "prediction_text": "epithelial kidney cell line"}, "reference": {"id": "b3996b278786486a8ab7f1834c1cf479", "answers": {"answer_start": [939], "text": ["Selenoprotein P"]}}}, "39a0108fffc148c5bc4d22d10b6f58a0": {"prediction": {"id": "39a0108fffc148c5bc4d22d10b6f58a0", "prediction_text": "P genes"}, "reference": {"id": "39a0108fffc148c5bc4d22d10b6f58a0", "answers": {"answer_start": [1148], "text": ["Selenoprotein P"]}}}, "7eff907fa08f4c3caf6ece9fd338bd42": {"prediction": {"id": "7eff907fa08f4c3caf6ece9fd338bd42", "prediction_text": "P cDNA"}, "reference": {"id": "7eff907fa08f4c3caf6ece9fd338bd42", "answers": {"answer_start": [117], "text": ["Selenoprotein P"]}}}, "5465bfa3f2e540a6a4f92311dfd47c6c": {"prediction": {"id": "5465bfa3f2e540a6a4f92311dfd47c6c", "prediction_text": "P"}, "reference": {"id": "5465bfa3f2e540a6a4f92311dfd47c6c", "answers": {"answer_start": [453], "text": ["Selenoprotein P"]}}}, "a53befc1912e4fffba180c1c017e2edc": {"prediction": {"id": "a53befc1912e4fffba180c1c017e2edc", "prediction_text": "TOB1"}, "reference": {"id": "a53befc1912e4fffba180c1c017e2edc", "answers": {"answer_start": [41], "text": ["Epidermal growth factor receptor (EGFR)"]}}}, "8d8288a074c9455ca71c4aa58f46d24f": {"prediction": {"id": "8d8288a074c9455ca71c4aa58f46d24f", "prediction_text": "downstream"}, "reference": {"id": "8d8288a074c9455ca71c4aa58f46d24f", "answers": {"answer_start": [41], "text": ["Epidermal growth factor receptor (EGFR)"]}}}, "63800ed4ca47414d9eba94c36bd26ead": {"prediction": {"id": "63800ed4ca47414d9eba94c36bd26ead", "prediction_text": "aging studies"}, "reference": {"id": "63800ed4ca47414d9eba94c36bd26ead", "answers": {"answer_start": [0], "text": ["aging research"]}}}, "e59fbdcbfc2542c2b501db620016483b": {"prediction": {"id": "e59fbdcbfc2542c2b501db620016483b", "prediction_text": "aging research community"}, "reference": {"id": "e59fbdcbfc2542c2b501db620016483b", "answers": {"answer_start": [1219], "text": ["aging research"]}}}, "b2742ad02f8b4e6c97d2251ec5ba3c68": {"prediction": {"id": "b2742ad02f8b4e6c97d2251ec5ba3c68", "prediction_text": "Syk"}, "reference": {"id": "b2742ad02f8b4e6c97d2251ec5ba3c68", "answers": {"answer_start": [0], "text": ["spleen tyrosine kinase"]}}}, "7601cc722833468b8cb638eba62a55da": {"prediction": {"id": "7601cc722833468b8cb638eba62a55da", "prediction_text": "spleen tyrosine kinase"}, "reference": {"id": "7601cc722833468b8cb638eba62a55da", "answers": {"answer_start": [846], "text": ["spleen tyrosine kinase"]}}}, "067847583693422c84cbc0e04fb6ab29": {"prediction": {"id": "067847583693422c84cbc0e04fb6ab29", "prediction_text": "malignant lymphocytes"}, "reference": {"id": "067847583693422c84cbc0e04fb6ab29", "answers": {"answer_start": [389], "text": ["spleen tyrosine kinase"]}}}, "5f32abb7595f4c35a55ecde2a19080c7": {"prediction": {"id": "5f32abb7595f4c35a55ecde2a19080c7", "prediction_text": "APCs Syk"}, "reference": {"id": "5f32abb7595f4c35a55ecde2a19080c7", "answers": {"answer_start": [257], "text": ["spleen tyrosine kinase"]}}}, "2d01aa203dbf4b92b77e2a0712895176": {"prediction": {"id": "2d01aa203dbf4b92b77e2a0712895176", "prediction_text": "spleen tyrosine kinase"}, "reference": {"id": "2d01aa203dbf4b92b77e2a0712895176", "answers": {"answer_start": [146], "text": ["spleen tyrosine kinase"]}}}, "4961499aad8a4f3ab78449d9444290ab": {"prediction": {"id": "4961499aad8a4f3ab78449d9444290ab", "prediction_text": "platelet activation through inhibition of spleen tyrosine kinase prevents tissue damage after mesenteric I/R injury. Platelets isolated from C57BL/6J mice fed with R788 for 10 days were transfused into C57BL/6J mice depleted of platelets 2 days before mesenteric I/R injury. Platelet-depleted mice transfused with platelets from R788-treated mice before mesenteric I/R displayed a significant reduction in the degree of remote lung damage, but with little change in the degree of local intestinal damage compared with control I/R mice. Transfusion of R788-treated platelets also decreased platelet sequestration, C3 deposition, and immunoglobulin deposition in lung, but not in the intestine, compared with control groups. These findings demonstrate that platelet activation"}, "reference": {"id": "4961499aad8a4f3ab78449d9444290ab", "answers": {"answer_start": [223], "text": ["spleen tyrosine kinase"]}}}, "cb619449cb1d4ee59e5f81d4ef9becd0": {"prediction": {"id": "cb619449cb1d4ee59e5f81d4ef9becd0", "prediction_text": "spleen tyrosine kinase"}, "reference": {"id": "cb619449cb1d4ee59e5f81d4ef9becd0", "answers": {"answer_start": [83], "text": ["spleen tyrosine kinase"]}}}, "7c1cb8392bd84935a91fad0e505857a6": {"prediction": {"id": "7c1cb8392bd84935a91fad0e505857a6", "prediction_text": "Spleen"}, "reference": {"id": "7c1cb8392bd84935a91fad0e505857a6", "answers": {"answer_start": [0], "text": ["spleen tyrosine kinase"]}}}, "596a568be48e438a90a174d86a1fef61": {"prediction": {"id": "596a568be48e438a90a174d86a1fef61", "prediction_text": "spleen"}, "reference": {"id": "596a568be48e438a90a174d86a1fef61", "answers": {"answer_start": [91], "text": ["spleen tyrosine kinase"]}}}, "e6ab98a77aa1456c86c7b1ee8f7e794a": {"prediction": {"id": "e6ab98a77aa1456c86c7b1ee8f7e794a", "prediction_text": "bone degradation in models of RA. In a phase II clinical trial, fostamatinib treatment effectively improved American College of Rheumatology response rates in patients with RA. Preclinical studies and phase II trials also suggested the potential of using fostamatinib for the treatment of ITP and B-cell lymphomas, by increasing platelet counts"}, "reference": {"id": "e6ab98a77aa1456c86c7b1ee8f7e794a", "answers": {"answer_start": [71], "text": ["spleen tyrosine kinase"]}}}, "d440c8e1aba045308e2766d415c9e323": {"prediction": {"id": "d440c8e1aba045308e2766d415c9e323", "prediction_text": "SYK"}, "reference": {"id": "d440c8e1aba045308e2766d415c9e323", "answers": {"answer_start": [0], "text": ["spleen tyrosine kinase"]}}}, "5dd4a566245f48d58d8c31cb2d957fbb": {"prediction": {"id": "5dd4a566245f48d58d8c31cb2d957fbb", "prediction_text": "macrophages"}, "reference": {"id": "5dd4a566245f48d58d8c31cb2d957fbb", "answers": {"answer_start": [294], "text": ["spleen tyrosine kinase"]}}}, "477f39fb14ca4b4e890db9af5c496aa7": {"prediction": {"id": "477f39fb14ca4b4e890db9af5c496aa7", "prediction_text": "Syk"}, "reference": {"id": "477f39fb14ca4b4e890db9af5c496aa7", "answers": {"answer_start": [0], "text": ["spleen tyrosine kinase"]}}}, "c5f04df41ac34636aba1efe25bb59b4f": {"prediction": {"id": "c5f04df41ac34636aba1efe25bb59b4f", "prediction_text": "Normal B lymphocytes"}, "reference": {"id": "c5f04df41ac34636aba1efe25bb59b4f", "answers": {"answer_start": [440], "text": ["spleen tyrosine kinase"]}}}, "8d9cb6739c4840dfb8877712c115dc9c": {"prediction": {"id": "8d9cb6739c4840dfb8877712c115dc9c", "prediction_text": "spleen tyrosine kinase"}, "reference": {"id": "8d9cb6739c4840dfb8877712c115dc9c", "answers": {"answer_start": [473], "text": ["spleen tyrosine kinase"]}}}, "6088741911a8480fa1c613788fa75f93": {"prediction": {"id": "6088741911a8480fa1c613788fa75f93", "prediction_text": "BCR"}, "reference": {"id": "6088741911a8480fa1c613788fa75f93", "answers": {"answer_start": [83], "text": ["spleen tyrosine kinase"]}}}, "5de9eed531af477a96b3aefcbf85fa62": {"prediction": {"id": "5de9eed531af477a96b3aefcbf85fa62", "prediction_text": "macrophages"}, "reference": {"id": "5de9eed531af477a96b3aefcbf85fa62", "answers": {"answer_start": [302], "text": ["spleen tyrosine kinase"]}}}, "5a4e197427e44c3a8e41bd5a286d7f6c": {"prediction": {"id": "5a4e197427e44c3a8e41bd5a286d7f6c", "prediction_text": "bile duct"}, "reference": {"id": "5a4e197427e44c3a8e41bd5a286d7f6c", "answers": {"answer_start": [4], "text": ["spleen tyrosine kinase"]}}}, "76d6999da190444db2f2325601a7d273": {"prediction": {"id": "76d6999da190444db2f2325601a7d273", "prediction_text": "Fcgamma-activating receptors"}, "reference": {"id": "76d6999da190444db2f2325601a7d273", "answers": {"answer_start": [0], "text": ["spleen tyrosine kinase"]}}}, "20d4792c7de5469f89c2e7947ac75a67": {"prediction": {"id": "20d4792c7de5469f89c2e7947ac75a67", "prediction_text": "spleen tyrosine kinase (SYK) inhibitor, for the treatment of rheumatoid arthritis"}, "reference": {"id": "20d4792c7de5469f89c2e7947ac75a67", "answers": {"answer_start": [107], "text": ["spleen tyrosine kinase"]}}}, "daca953294ca4eb0bf28d710ea64b617": {"prediction": {"id": "daca953294ca4eb0bf28d710ea64b617", "prediction_text": "enzymes whose biological activity can be turned off by drugs that block their catalytic site. In the last few years small molecular kinase inhibitors (KIs) have been synthesized and become available for preclinical studies and clinical trials. The first KI, introduced into clinical practice in 1998, was imatinib mesylate, which became the first choice drug in chronic myeloid leukemia. More recently, several KIs have been developed to target the proximal B-cell receptor (BCR) signaling pathway including spleen tyrosine kinase inhibitor (Fostamatinib) and Bruton's tyrosine kinase inhibitors (Ibrutinib, AVL-263). These agents are currently evaluated in early clinical trials in chronic lymphocytic leukemia (CLL) and other diseases. Cyclin-dependent kinase (Cdk) inhibitors"}, "reference": {"id": "daca953294ca4eb0bf28d710ea64b617", "answers": {"answer_start": [828], "text": ["spleen tyrosine kinase"]}}}, "144f608791ee4d138704252014292b3e": {"prediction": {"id": "144f608791ee4d138704252014292b3e", "prediction_text": "macrophages, and T cells. We investigated the ability of a small drug Syk inhibitor, R788, to protect mice against mesenteric ischemia-reperfusion (I/R)-induced local (intestine) and remote lung injury. Mice were fed with chow containing a Syk inhibitor for 6 days before the performance of intestinal I/R, which resulted in silencing of the expression of the active phosphorylated Syk. Syk"}, "reference": {"id": "144f608791ee4d138704252014292b3e", "answers": {"answer_start": [353], "text": ["spleen tyrosine kinase"]}}}, "b474b743a67b464b9710fc1ac77da3b2": {"prediction": {"id": "b474b743a67b464b9710fc1ac77da3b2", "prediction_text": "spleen"}, "reference": {"id": "b474b743a67b464b9710fc1ac77da3b2", "answers": {"answer_start": [667], "text": ["spleen tyrosine kinase"]}}}, "24ef2dea93e34634ac81dfc4ff7f6cb5": {"prediction": {"id": "24ef2dea93e34634ac81dfc4ff7f6cb5", "prediction_text": "lipoprotein uptake"}, "reference": {"id": "24ef2dea93e34634ac81dfc4ff7f6cb5", "answers": {"answer_start": [0], "text": ["spleen tyrosine kinase"]}}}, "e26abea7a1bb490d97e6c2338b7b3a7d": {"prediction": {"id": "e26abea7a1bb490d97e6c2338b7b3a7d", "prediction_text": "bone erosions"}, "reference": {"id": "e26abea7a1bb490d97e6c2338b7b3a7d", "answers": {"answer_start": [0], "text": ["spleen tyrosine kinase"]}}}, "3624c8c6677c4843b3ddc5039f818a15": {"prediction": {"id": "3624c8c6677c4843b3ddc5039f818a15", "prediction_text": "mantle cell lymphoma"}, "reference": {"id": "3624c8c6677c4843b3ddc5039f818a15", "answers": {"answer_start": [650], "text": ["The ubiquitin/proteasome pathway"]}}}, "2c6c67befa2c45b996f69fbb26cead82": {"prediction": {"id": "2c6c67befa2c45b996f69fbb26cead82", "prediction_text": "FDA) for the treatment of patients with multiple myeloma, therefore validating inhibition of the proteasome"}, "reference": {"id": "2c6c67befa2c45b996f69fbb26cead82", "answers": {"answer_start": [4], "text": ["The ubiquitin/proteasome pathway"]}}}, "baf3f3e544d04e13830509a8568d57be": {"prediction": {"id": "baf3f3e544d04e13830509a8568d57be", "prediction_text": "molecular"}, "reference": {"id": "baf3f3e544d04e13830509a8568d57be", "answers": {"answer_start": [4], "text": ["The ubiquitin/proteasome pathway"]}}}, "e813704f0a24417ea6112ff3c43254e2": {"prediction": {"id": "e813704f0a24417ea6112ff3c43254e2", "prediction_text": "ubiquitin-proteasome"}, "reference": {"id": "e813704f0a24417ea6112ff3c43254e2", "answers": {"answer_start": [4], "text": ["The ubiquitin/proteasome pathway"]}}}, "352f016d8f864523a824a98b85778f11": {"prediction": {"id": "352f016d8f864523a824a98b85778f11", "prediction_text": "novel anticancer drugs"}, "reference": {"id": "352f016d8f864523a824a98b85778f11", "answers": {"answer_start": [41], "text": ["The ubiquitin/proteasome pathway"]}}}, "6e472397247c4d26bab6ac571afb974b": {"prediction": {"id": "6e472397247c4d26bab6ac571afb974b", "prediction_text": "Diamond-Blackfan anemia"}, "reference": {"id": "6e472397247c4d26bab6ac571afb974b", "answers": {"answer_start": [55, 1005], "text": ["Diamond-Blackfan Anemia", "DBA"]}}}, "835b5d8a857c439a90ded2fac3dcc7cb": {"prediction": {"id": "835b5d8a857c439a90ded2fac3dcc7cb", "prediction_text": "mild anemia"}, "reference": {"id": "835b5d8a857c439a90ded2fac3dcc7cb", "answers": {"answer_start": [0, 25], "text": ["Diamond-Blackfan Anemia", "DBA"]}}}, "fee8cda49f964ae19c7eae76fae94be2": {"prediction": {"id": "fee8cda49f964ae19c7eae76fae94be2", "prediction_text": "Diamond Blackfan anemia"}, "reference": {"id": "fee8cda49f964ae19c7eae76fae94be2", "answers": {"answer_start": [95, 393], "text": ["Diamond-Blackfan Anemia", "DBA"]}}}, "00eeb75b29464a70bcf87f4e3aaaf501": {"prediction": {"id": "00eeb75b29464a70bcf87f4e3aaaf501", "prediction_text": "Diamond-Blackfan anemia"}, "reference": {"id": "00eeb75b29464a70bcf87f4e3aaaf501", "answers": {"answer_start": [0, 759], "text": ["Diamond-Blackfan Anemia", "DBA"]}}}, "da939bd409ae494db84643002c044ef5": {"prediction": {"id": "da939bd409ae494db84643002c044ef5", "prediction_text": "Diamond-Blackfan anemia"}, "reference": {"id": "da939bd409ae494db84643002c044ef5", "answers": {"answer_start": [0, 229], "text": ["Diamond-Blackfan Anemia", "DBA"]}}}, "7a7dcd34b9554b2bac858cc2a23891ee": {"prediction": {"id": "7a7dcd34b9554b2bac858cc2a23891ee", "prediction_text": "DBA"}, "reference": {"id": "7a7dcd34b9554b2bac858cc2a23891ee", "answers": {"answer_start": [0, 479], "text": ["Diamond-Blackfan Anemia", "DBA"]}}}, "db27968845f24a71aee8208d991e57ef": {"prediction": {"id": "db27968845f24a71aee8208d991e57ef", "prediction_text": "Diamond-Blackfan anemia"}, "reference": {"id": "db27968845f24a71aee8208d991e57ef", "answers": {"answer_start": [313], "text": ["Diamond-Blackfan Anemia"]}}}, "0cea5920bf764ac7a49c2478d08fa20a": {"prediction": {"id": "0cea5920bf764ac7a49c2478d08fa20a", "prediction_text": "Diamond-Blackfan anemia"}, "reference": {"id": "0cea5920bf764ac7a49c2478d08fa20a", "answers": {"answer_start": [0, 493], "text": ["Diamond-Blackfan Anemia", "DBA"]}}}, "7e69dafa14a442d79823c31e4fd189a7": {"prediction": {"id": "7e69dafa14a442d79823c31e4fd189a7", "prediction_text": "Diamond-Blackfan anemia"}, "reference": {"id": "7e69dafa14a442d79823c31e4fd189a7", "answers": {"answer_start": [77, 1038], "text": ["Diamond-Blackfan Anemia", "DBA"]}}}, "dc9c8d0ab94b4dcd93b1f4c9d60ea768": {"prediction": {"id": "dc9c8d0ab94b4dcd93b1f4c9d60ea768", "prediction_text": "Diamond-Blackfan Anemia"}, "reference": {"id": "dc9c8d0ab94b4dcd93b1f4c9d60ea768", "answers": {"answer_start": [501], "text": ["Diamond-Blackfan Anemia"]}}}, "68e50e81902c429ca47f70ef567fc873": {"prediction": {"id": "68e50e81902c429ca47f70ef567fc873", "prediction_text": "Diamond-Blackfan anemia"}, "reference": {"id": "68e50e81902c429ca47f70ef567fc873", "answers": {"answer_start": [93, 1271], "text": ["Diamond-Blackfan Anemia", "DBA"]}}}, "66c3dce2d1e349d88cb760c31724f268": {"prediction": {"id": "66c3dce2d1e349d88cb760c31724f268", "prediction_text": "Diamond-Blackfan anemia"}, "reference": {"id": "66c3dce2d1e349d88cb760c31724f268", "answers": {"answer_start": [116, 726], "text": ["Diamond-Blackfan Anemia", "DBA"]}}}, "eba9a3fc2ba34f358e8294cd419d5246": {"prediction": {"id": "eba9a3fc2ba34f358e8294cd419d5246", "prediction_text": "Diamond-Blackfan anemia"}, "reference": {"id": "eba9a3fc2ba34f358e8294cd419d5246", "answers": {"answer_start": [0, 25], "text": ["Diamond-Blackfan Anemia", "DBA"]}}}, "80b692e4d9604928b53c7e8040393788": {"prediction": {"id": "80b692e4d9604928b53c7e8040393788", "prediction_text": "Diamond-Blackfan anemia"}, "reference": {"id": "80b692e4d9604928b53c7e8040393788", "answers": {"answer_start": [0, 295], "text": ["Diamond-Blackfan Anemia", "DBA"]}}}, "0a347f3be03045deb300bc38cea4a90e": {"prediction": {"id": "0a347f3be03045deb300bc38cea4a90e", "prediction_text": "Diamond-Blackfan anemia"}, "reference": {"id": "0a347f3be03045deb300bc38cea4a90e", "answers": {"answer_start": [0, 25], "text": ["Diamond-Blackfan Anemia", "DBA"]}}}, "d00ac7714284454f96bd9899f828dd8e": {"prediction": {"id": "d00ac7714284454f96bd9899f828dd8e", "prediction_text": "Diamond Blackfan Anemia"}, "reference": {"id": "d00ac7714284454f96bd9899f828dd8e", "answers": {"answer_start": [1670, 1292], "text": ["Diamond-Blackfan Anemia", "DBA"]}}}, "f395aff2e2b84fac9094d9345b4aae80": {"prediction": {"id": "f395aff2e2b84fac9094d9345b4aae80", "prediction_text": "RNA interference"}, "reference": {"id": "f395aff2e2b84fac9094d9345b4aae80", "answers": {"answer_start": [0], "text": ["Patisiran"]}}}, "df61c923a07944b5b44246bd98282b93": {"prediction": {"id": "df61c923a07944b5b44246bd98282b93", "prediction_text": "phagocyte"}, "reference": {"id": "df61c923a07944b5b44246bd98282b93", "answers": {"answer_start": [613], "text": ["NOX1"]}}}, "7b6ea85f55c948498b0b8dedff0d4665": {"prediction": {"id": "7b6ea85f55c948498b0b8dedff0d4665", "prediction_text": "Organizer 1"}, "reference": {"id": "7b6ea85f55c948498b0b8dedff0d4665", "answers": {"answer_start": [227, 826], "text": ["NADPH oxidase 1", "NOX1"]}}}, "5e9b70a93ddb485782f1abd731918603": {"prediction": {"id": "5e9b70a93ddb485782f1abd731918603", "prediction_text": "SH3"}, "reference": {"id": "5e9b70a93ddb485782f1abd731918603", "answers": {"answer_start": [1187], "text": ["NOX1"]}}}, "ce5d333207b342e6a0c87eb62c6afc55": {"prediction": {"id": "ce5d333207b342e6a0c87eb62c6afc55", "prediction_text": "RNAs"}, "reference": {"id": "ce5d333207b342e6a0c87eb62c6afc55", "answers": {"answer_start": [0, 17], "text": ["NADPH oxidase 1", "NOX1"]}}}, "38670f3499844ab2a318b9e30b3258ed": {"prediction": {"id": "38670f3499844ab2a318b9e30b3258ed", "prediction_text": "Nox"}, "reference": {"id": "38670f3499844ab2a318b9e30b3258ed", "answers": {"answer_start": [25], "text": ["NOX1"]}}}, "bd337475bf1c44e7b85077692e0528ab": {"prediction": {"id": "bd337475bf1c44e7b85077692e0528ab", "prediction_text": "NOX"}, "reference": {"id": "bd337475bf1c44e7b85077692e0528ab", "answers": {"answer_start": [1888], "text": ["NOX1"]}}}, "f483756f271b464d854df54f8de51d51": {"prediction": {"id": "f483756f271b464d854df54f8de51d51", "prediction_text": "Nox"}, "reference": {"id": "f483756f271b464d854df54f8de51d51", "answers": {"answer_start": [510], "text": ["NOX1"]}}}, "63d98aee31bb4cc998ce50e55de90ea4": {"prediction": {"id": "63d98aee31bb4cc998ce50e55de90ea4", "prediction_text": "Nox3"}, "reference": {"id": "63d98aee31bb4cc998ce50e55de90ea4", "answers": {"answer_start": [246], "text": ["NOX1"]}}}, "3c8587d7c2054d4fafae5e60ba3ed25d": {"prediction": {"id": "3c8587d7c2054d4fafae5e60ba3ed25d", "prediction_text": "Nox"}, "reference": {"id": "3c8587d7c2054d4fafae5e60ba3ed25d", "answers": {"answer_start": [1353], "text": ["NOX1"]}}}, "e07fdab62cdb43c9ab803452312af5a6": {"prediction": {"id": "e07fdab62cdb43c9ab803452312af5a6", "prediction_text": "NOX1)"}, "reference": {"id": "e07fdab62cdb43c9ab803452312af5a6", "answers": {"answer_start": [44, 1543], "text": ["NADPH oxidase 1", "NOX1"]}}}, "d6c5f7f92212497e9155816670cedf5a": {"prediction": {"id": "d6c5f7f92212497e9155816670cedf5a", "prediction_text": "Nox1"}, "reference": {"id": "d6c5f7f92212497e9155816670cedf5a", "answers": {"answer_start": [830], "text": ["NOX1"]}}}, "b6ebde7c8dd64410992ea99188cd64f8": {"prediction": {"id": "b6ebde7c8dd64410992ea99188cd64f8", "prediction_text": "Nox"}, "reference": {"id": "b6ebde7c8dd64410992ea99188cd64f8", "answers": {"answer_start": [753], "text": ["NOX1"]}}}, "1fd0b4a0172e49c98f92559e05830bb8": {"prediction": {"id": "1fd0b4a0172e49c98f92559e05830bb8", "prediction_text": "Nox"}, "reference": {"id": "1fd0b4a0172e49c98f92559e05830bb8", "answers": {"answer_start": [1472], "text": ["NOX1"]}}}, "6ac7a18bcf314b2b909d8ffc39208218": {"prediction": {"id": "6ac7a18bcf314b2b909d8ffc39208218", "prediction_text": "superoxide"}, "reference": {"id": "6ac7a18bcf314b2b909d8ffc39208218", "answers": {"answer_start": [498], "text": ["NOX1"]}}}, "c1c919cb4af74e7e944657ce6483bc11": {"prediction": {"id": "c1c919cb4af74e7e944657ce6483bc11", "prediction_text": "Nox1"}, "reference": {"id": "c1c919cb4af74e7e944657ce6483bc11", "answers": {"answer_start": [68], "text": ["NOX1"]}}}, "9d3fd8ef3ebf47b8bc19694fe952350e": {"prediction": {"id": "9d3fd8ef3ebf47b8bc19694fe952350e", "prediction_text": "Nox"}, "reference": {"id": "9d3fd8ef3ebf47b8bc19694fe952350e", "answers": {"answer_start": [971], "text": ["NOX1"]}}}, "e23f9efa967d4f1fafbd3267e9c6ee6e": {"prediction": {"id": "e23f9efa967d4f1fafbd3267e9c6ee6e", "prediction_text": "Overexpression of Dhfr"}, "reference": {"id": "e23f9efa967d4f1fafbd3267e9c6ee6e", "answers": {"answer_start": [1362], "text": ["NOX1"]}}}, "ceb4231f4877481a86b4e1d7f5389d10": {"prediction": {"id": "ceb4231f4877481a86b4e1d7f5389d10", "prediction_text": "gp91(phox)/Nox2"}, "reference": {"id": "ceb4231f4877481a86b4e1d7f5389d10", "answers": {"answer_start": [273], "text": ["NOX1"]}}}, "af4f0bfa2ae14839b77c63852db12ec6": {"prediction": {"id": "af4f0bfa2ae14839b77c63852db12ec6", "prediction_text": "calcium"}, "reference": {"id": "af4f0bfa2ae14839b77c63852db12ec6", "answers": {"answer_start": [700], "text": ["NOX1"]}}}, "08d12088b25d4f169d90cf6548bf753f": {"prediction": {"id": "08d12088b25d4f169d90cf6548bf753f", "prediction_text": "100%"}, "reference": {"id": "08d12088b25d4f169d90cf6548bf753f", "answers": {"answer_start": [802], "text": ["100%"]}}}, "7fa0f1ae6db34092a0825a82de743b9b": {"prediction": {"id": "7fa0f1ae6db34092a0825a82de743b9b", "prediction_text": "abnormal iron metabolism"}, "reference": {"id": "7fa0f1ae6db34092a0825a82de743b9b", "answers": {"answer_start": [368], "text": ["iron"]}}}, "bfa156bd62254ed0b8b25743ba4a9b52": {"prediction": {"id": "bfa156bd62254ed0b8b25743ba4a9b52", "prediction_text": "inflammatory"}, "reference": {"id": "bfa156bd62254ed0b8b25743ba4a9b52", "answers": {"answer_start": [369], "text": ["iron"]}}}, "f24363b7993246858f5fe3afa96ce1c3": {"prediction": {"id": "f24363b7993246858f5fe3afa96ce1c3", "prediction_text": "iron deficiency"}, "reference": {"id": "f24363b7993246858f5fe3afa96ce1c3", "answers": {"answer_start": [332], "text": ["iron"]}}}, "81ceb4f087fc47ec929b558002e91b2d": {"prediction": {"id": "81ceb4f087fc47ec929b558002e91b2d", "prediction_text": "hemoglobin"}, "reference": {"id": "81ceb4f087fc47ec929b558002e91b2d", "answers": {"answer_start": [0], "text": ["iron"]}}}, "9a0cad2a84cd4d2d84bd50faf84f2267": {"prediction": {"id": "9a0cad2a84cd4d2d84bd50faf84f2267", "prediction_text": "iron deficiency"}, "reference": {"id": "9a0cad2a84cd4d2d84bd50faf84f2267", "answers": {"answer_start": [533], "text": ["iron"]}}}, "ed0c367f4e4945dda1ab2e234dc16fc8": {"prediction": {"id": "ed0c367f4e4945dda1ab2e234dc16fc8", "prediction_text": "RLS"}, "reference": {"id": "ed0c367f4e4945dda1ab2e234dc16fc8", "answers": {"answer_start": [885], "text": ["iron"]}}}, "fe269e038cde45098f09aa6ecb4f21df": {"prediction": {"id": "fe269e038cde45098f09aa6ecb4f21df", "prediction_text": "iron deficiency with febrile seizures, pica, breath holding spells"}, "reference": {"id": "fe269e038cde45098f09aa6ecb4f21df", "answers": {"answer_start": [0], "text": ["iron"]}}}, "dc42f056fc2f447689110bbcbdb6a104": {"prediction": {"id": "dc42f056fc2f447689110bbcbdb6a104", "prediction_text": "Iron improves hemoglobin"}, "reference": {"id": "dc42f056fc2f447689110bbcbdb6a104", "answers": {"answer_start": [283], "text": ["iron"]}}}, "ddbcadd3616447a5a64b4ab25d727e95": {"prediction": {"id": "ddbcadd3616447a5a64b4ab25d727e95", "prediction_text": "Iron deficiency in the central nervous system is known to cause motor impairment and cognitive deficits; more recently, it has been suggested that it may play a role in the pathophysiology"}, "reference": {"id": "ddbcadd3616447a5a64b4ab25d727e95", "answers": {"answer_start": [0], "text": ["iron"]}}}, "7221192e21734ca084a6b44610c41963": {"prediction": {"id": "7221192e21734ca084a6b44610c41963", "prediction_text": "iron deficiency"}, "reference": {"id": "7221192e21734ca084a6b44610c41963", "answers": {"answer_start": [161], "text": ["iron"]}}}, "d0dfff22c3d843ee9fab43e741ada990": {"prediction": {"id": "d0dfff22c3d843ee9fab43e741ada990", "prediction_text": "dopamine transporter"}, "reference": {"id": "d0dfff22c3d843ee9fab43e741ada990", "answers": {"answer_start": [1392], "text": ["iron"]}}}, "066b2ca36ac34da59a55c5d743294414": {"prediction": {"id": "066b2ca36ac34da59a55c5d743294414", "prediction_text": "iron deficiency in the brain has been observed on imaging and cerebrospinal fluid analyses of patients with RLS. In contrast, the results of neuroimaging studies evaluating brain dopaminergic functions in patients with RLS have yielded inconclusive results, although involvement of the hypothalamus"}, "reference": {"id": "066b2ca36ac34da59a55c5d743294414", "answers": {"answer_start": [617], "text": ["iron"]}}}, "537b761d0efe40498d9910cc5191186d": {"prediction": {"id": "537b761d0efe40498d9910cc5191186d", "prediction_text": "RLS) is a sensorimotor disorder. Clinical studies have implicated the dopaminergic system in RLS, while others have suggested that it is associated with insufficient levels of brain iron"}, "reference": {"id": "537b761d0efe40498d9910cc5191186d", "answers": {"answer_start": [241], "text": ["iron"]}}}, "e5870145f93e48998d0316bcfeb93a63": {"prediction": {"id": "e5870145f93e48998d0316bcfeb93a63", "prediction_text": "iron deficiency"}, "reference": {"id": "e5870145f93e48998d0316bcfeb93a63", "answers": {"answer_start": [1358], "text": ["iron"]}}}, "b1964cb9a212401e88c3046837eac667": {"prediction": {"id": "b1964cb9a212401e88c3046837eac667", "prediction_text": "unrecognized"}, "reference": {"id": "b1964cb9a212401e88c3046837eac667", "answers": {"answer_start": [769], "text": ["iron"]}}}, "eefb88dfb18e47869efc8f0784af40e9": {"prediction": {"id": "eefb88dfb18e47869efc8f0784af40e9", "prediction_text": "iron deficiency"}, "reference": {"id": "eefb88dfb18e47869efc8f0784af40e9", "answers": {"answer_start": [335], "text": ["iron"]}}}, "b07295486ddb42b7bb30f35345176324": {"prediction": {"id": "b07295486ddb42b7bb30f35345176324", "prediction_text": "iron status and/or restless leg syndrome (RLS"}, "reference": {"id": "b07295486ddb42b7bb30f35345176324", "answers": {"answer_start": [0], "text": ["iron"]}}}, "41a4929cf3534abc8e40c22afdc93fec": {"prediction": {"id": "41a4929cf3534abc8e40c22afdc93fec", "prediction_text": "brain iron deficiency"}, "reference": {"id": "41a4929cf3534abc8e40c22afdc93fec", "answers": {"answer_start": [139], "text": ["iron"]}}}, "799ed6b4f06143a4bb8ae27576651f6e": {"prediction": {"id": "799ed6b4f06143a4bb8ae27576651f6e", "prediction_text": "RLS"}, "reference": {"id": "799ed6b4f06143a4bb8ae27576651f6e", "answers": {"answer_start": [102], "text": ["iron"]}}}, "49fb62e8d0ac45e58ccaf9561c51b817": {"prediction": {"id": "49fb62e8d0ac45e58ccaf9561c51b817", "prediction_text": "pain"}, "reference": {"id": "49fb62e8d0ac45e58ccaf9561c51b817", "answers": {"answer_start": [1296], "text": ["iron"]}}}, "b0ff62889b7c4392928abcf7ed965b50": {"prediction": {"id": "b0ff62889b7c4392928abcf7ed965b50", "prediction_text": "iron deficiency anemia"}, "reference": {"id": "b0ff62889b7c4392928abcf7ed965b50", "answers": {"answer_start": [70], "text": ["iron"]}}}, "cd897cd2b5f74b3c9ad2c26303090fe0": {"prediction": {"id": "cd897cd2b5f74b3c9ad2c26303090fe0", "prediction_text": "disease"}, "reference": {"id": "cd897cd2b5f74b3c9ad2c26303090fe0", "answers": {"answer_start": [1504], "text": ["iron"]}}}, "da247af110c04119906a133652e67c1b": {"prediction": {"id": "da247af110c04119906a133652e67c1b", "prediction_text": "insomnia"}, "reference": {"id": "da247af110c04119906a133652e67c1b", "answers": {"answer_start": [1006], "text": ["iron"]}}}, "27c25eb9b6f04825a80b52a70c02df33": {"prediction": {"id": "27c25eb9b6f04825a80b52a70c02df33", "prediction_text": "RLS"}, "reference": {"id": "27c25eb9b6f04825a80b52a70c02df33", "answers": {"answer_start": [864], "text": ["iron"]}}}, "5cea607cbb2e45c6a15aa5c0e5696ec7": {"prediction": {"id": "5cea607cbb2e45c6a15aa5c0e5696ec7", "prediction_text": "iron deficiency"}, "reference": {"id": "5cea607cbb2e45c6a15aa5c0e5696ec7", "answers": {"answer_start": [974], "text": ["iron"]}}}, "f18e076f797d408f86e9ee1ef88baf54": {"prediction": {"id": "f18e076f797d408f86e9ee1ef88baf54", "prediction_text": "unpaired cysteine"}, "reference": {"id": "f18e076f797d408f86e9ee1ef88baf54", "answers": {"answer_start": [340], "text": ["Cysteine"]}}}, "a974f4eea91b4629966cf443ba225977": {"prediction": {"id": "a974f4eea91b4629966cf443ba225977", "prediction_text": "Mutations"}, "reference": {"id": "a974f4eea91b4629966cf443ba225977", "answers": {"answer_start": [400], "text": ["Cysteine"]}}}, "79609223e609458d9bac1eaa1ca589c0": {"prediction": {"id": "79609223e609458d9bac1eaa1ca589c0", "prediction_text": "cysteine residues"}, "reference": {"id": "79609223e609458d9bac1eaa1ca589c0", "answers": {"answer_start": [78], "text": ["Cysteine"]}}}, "6f0fc9460f1f4938adc8217d8224fea3": {"prediction": {"id": "6f0fc9460f1f4938adc8217d8224fea3", "prediction_text": "cysteine residues"}, "reference": {"id": "6f0fc9460f1f4938adc8217d8224fea3", "answers": {"answer_start": [269], "text": ["Cysteine"]}}}, "bb26c9dddb7e4cf5bf332e9f9da4ed31": {"prediction": {"id": "bb26c9dddb7e4cf5bf332e9f9da4ed31", "prediction_text": "cysteine"}, "reference": {"id": "bb26c9dddb7e4cf5bf332e9f9da4ed31", "answers": {"answer_start": [1277], "text": ["Cysteine"]}}}, "e1b9efc2c97e43e9b038ae6b0844550b": {"prediction": {"id": "e1b9efc2c97e43e9b038ae6b0844550b", "prediction_text": "1 cysteine"}, "reference": {"id": "e1b9efc2c97e43e9b038ae6b0844550b", "answers": {"answer_start": [357], "text": ["Cysteine"]}}}, "446a04cf749b4ee48483b215400a971b": {"prediction": {"id": "446a04cf749b4ee48483b215400a971b", "prediction_text": "CADASIL"}, "reference": {"id": "446a04cf749b4ee48483b215400a971b", "answers": {"answer_start": [166], "text": ["Cysteine"]}}}, "2e3746e5b133493d8b850a707ab77c61": {"prediction": {"id": "2e3746e5b133493d8b850a707ab77c61", "prediction_text": "Mutations within the NOTCH3 gene cause cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). CADASIL mutations appear to be restricted to the first twenty-four exons, resulting in the gain or loss of a cysteine"}, "reference": {"id": "2e3746e5b133493d8b850a707ab77c61", "answers": {"answer_start": [1821], "text": ["Cysteine"]}}}, "08c941bd60074d119a1c3870a3eb8647": {"prediction": {"id": "08c941bd60074d119a1c3870a3eb8647", "prediction_text": "CADASIL"}, "reference": {"id": "08c941bd60074d119a1c3870a3eb8647", "answers": {"answer_start": [1818], "text": ["Cysteine"]}}}, "df14550168db4646a6b4fca2d53e3cab": {"prediction": {"id": "df14550168db4646a6b4fca2d53e3cab", "prediction_text": "phase 2"}, "reference": {"id": "df14550168db4646a6b4fca2d53e3cab", "answers": {"answer_start": [718], "text": ["Phase 3"]}}}, "c6c26013020648cca82cd0ccadf5108f": {"prediction": {"id": "c6c26013020648cca82cd0ccadf5108f", "prediction_text": "array contraction-independent FSHD2"}, "reference": {"id": "c6c26013020648cca82cd0ccadf5108f", "answers": {"answer_start": [214], "text": ["autosomal dominant"]}}}, "d5588b3057ea4eb692b57af6578db157": {"prediction": {"id": "d5588b3057ea4eb692b57af6578db157", "prediction_text": "pattern"}, "reference": {"id": "d5588b3057ea4eb692b57af6578db157", "answers": {"answer_start": [610], "text": ["autosomal dominant"]}}}, "5f76f2bbfc0a46578a9ac0685707c1ad": {"prediction": {"id": "5f76f2bbfc0a46578a9ac0685707c1ad", "prediction_text": "pattern"}, "reference": {"id": "5f76f2bbfc0a46578a9ac0685707c1ad", "answers": {"answer_start": [610], "text": ["autosomal dominant"]}}}, "a66113c493d849b99241b1d11baf6c2f": {"prediction": {"id": "a66113c493d849b99241b1d11baf6c2f", "prediction_text": "a slowly progressive myopathy"}, "reference": {"id": "a66113c493d849b99241b1d11baf6c2f", "answers": {"answer_start": [84], "text": ["autosomal dominant"]}}}, "d4e582f280264a6f82081be922c1dc9a": {"prediction": {"id": "d4e582f280264a6f82081be922c1dc9a", "prediction_text": "autosomal-dominant disorder"}, "reference": {"id": "d4e582f280264a6f82081be922c1dc9a", "answers": {"answer_start": [43], "text": ["autosomal dominant"]}}}, "3a38df3a5e4f425da8c6c844164196d2": {"prediction": {"id": "3a38df3a5e4f425da8c6c844164196d2", "prediction_text": "autosomal-dominant muscular disorder"}, "reference": {"id": "3a38df3a5e4f425da8c6c844164196d2", "answers": {"answer_start": [43], "text": ["autosomal dominant"]}}}, "e05b1b3e234f4d35b1e34919de5586d8": {"prediction": {"id": "e05b1b3e234f4d35b1e34919de5586d8", "prediction_text": "DNA testing"}, "reference": {"id": "e05b1b3e234f4d35b1e34919de5586d8", "answers": {"answer_start": [594], "text": ["autosomal dominant"]}}}, "33baad80260e4eb0b9b2cd7c3a416a48": {"prediction": {"id": "33baad80260e4eb0b9b2cd7c3a416a48", "prediction_text": "Consensual diagnostic criteria"}, "reference": {"id": "33baad80260e4eb0b9b2cd7c3a416a48", "answers": {"answer_start": [200], "text": ["autosomal dominant"]}}}, "f1f031dd88cb47d29514df2e9f3d6fb4": {"prediction": {"id": "f1f031dd88cb47d29514df2e9f3d6fb4", "prediction_text": "primary muscle"}, "reference": {"id": "f1f031dd88cb47d29514df2e9f3d6fb4", "answers": {"answer_start": [80], "text": ["autosomal dominant"]}}}, "6cd5a9de422d4f4eb715e2572b872c31": {"prediction": {"id": "6cd5a9de422d4f4eb715e2572b872c31", "prediction_text": "neuromuscular disease"}, "reference": {"id": "6cd5a9de422d4f4eb715e2572b872c31", "answers": {"answer_start": [94], "text": ["autosomal dominant"]}}}, "c8e3b26ab85e4e2cb26344081204f153": {"prediction": {"id": "c8e3b26ab85e4e2cb26344081204f153", "prediction_text": "spinal"}, "reference": {"id": "c8e3b26ab85e4e2cb26344081204f153", "answers": {"answer_start": [1317], "text": ["autosomal dominant"]}}}, "12de7561688b47f7b848e7de0de23f89": {"prediction": {"id": "12de7561688b47f7b848e7de0de23f89", "prediction_text": "Staphylococcus aureus"}, "reference": {"id": "12de7561688b47f7b848e7de0de23f89", "answers": {"answer_start": [0], "text": ["Borderline oxacillin-resistant Staphylococcus aureus"]}}}, "a1ef3ce21e59438ab58a1a04c97968bf": {"prediction": {"id": "a1ef3ce21e59438ab58a1a04c97968bf", "prediction_text": "Staphylococcus aureus"}, "reference": {"id": "a1ef3ce21e59438ab58a1a04c97968bf", "answers": {"answer_start": [90], "text": ["Borderline oxacillin-resistant Staphylococcus aureus"]}}}, "68311c5acecd41ea8546003df5977ac9": {"prediction": {"id": "68311c5acecd41ea8546003df5977ac9", "prediction_text": "Staphylococcus aureus"}, "reference": {"id": "68311c5acecd41ea8546003df5977ac9", "answers": {"answer_start": [0], "text": ["Borderline oxacillin-resistant Staphylococcus aureus"]}}}, "d00ccd7c09874559a3afe8da8635920e": {"prediction": {"id": "d00ccd7c09874559a3afe8da8635920e", "prediction_text": "Staphylococcus aureus"}, "reference": {"id": "d00ccd7c09874559a3afe8da8635920e", "answers": {"answer_start": [0], "text": ["Borderline oxacillin-resistant Staphylococcus aureus"]}}}, "b946bfde38584046aa5945c8ba68a63c": {"prediction": {"id": "b946bfde38584046aa5945c8ba68a63c", "prediction_text": "Staphylococcus aureus"}, "reference": {"id": "b946bfde38584046aa5945c8ba68a63c", "answers": {"answer_start": [90], "text": ["Borderline oxacillin-resistant Staphylococcus aureus"]}}}, "06185f4cb314478db654d2f3a2acf373": {"prediction": {"id": "06185f4cb314478db654d2f3a2acf373", "prediction_text": "Staphylococcus aureus"}, "reference": {"id": "06185f4cb314478db654d2f3a2acf373", "answers": {"answer_start": [326], "text": ["Borderline oxacillin-resistant Staphylococcus aureus"]}}}, "bdaf26aab6fb4d018e2d9df87edf8476": {"prediction": {"id": "bdaf26aab6fb4d018e2d9df87edf8476", "prediction_text": "Staphylococcus aureus"}, "reference": {"id": "bdaf26aab6fb4d018e2d9df87edf8476", "answers": {"answer_start": [687], "text": ["Borderline oxacillin-resistant Staphylococcus aureus"]}}}, "ec3fc0dc489046c8aee3f33ee43a3240": {"prediction": {"id": "ec3fc0dc489046c8aee3f33ee43a3240", "prediction_text": "plasma protein profiles"}, "reference": {"id": "ec3fc0dc489046c8aee3f33ee43a3240", "answers": {"answer_start": [87], "text": ["personally normalized plasma protein profiles"]}}}, "31ffd2c5cbfa404199be65bf3db063ed": {"prediction": {"id": "31ffd2c5cbfa404199be65bf3db063ed", "prediction_text": "surgical treatment"}, "reference": {"id": "31ffd2c5cbfa404199be65bf3db063ed", "answers": {"answer_start": [313], "text": ["vestibular schwannoma"]}}}, "4771228cf3954e779a5e935a53c646d5": {"prediction": {"id": "4771228cf3954e779a5e935a53c646d5", "prediction_text": "STR"}, "reference": {"id": "4771228cf3954e779a5e935a53c646d5", "answers": {"answer_start": [96], "text": ["vestibular schwannoma"]}}}, "e4833d1c51934224b4bbdadbee838980": {"prediction": {"id": "e4833d1c51934224b4bbdadbee838980", "prediction_text": "cystic"}, "reference": {"id": "e4833d1c51934224b4bbdadbee838980", "answers": {"answer_start": [57], "text": ["vestibular schwannoma"]}}}, "c2228b48e52e41f5aa3944c34bf2f4ae": {"prediction": {"id": "c2228b48e52e41f5aa3944c34bf2f4ae", "prediction_text": "FN"}, "reference": {"id": "c2228b48e52e41f5aa3944c34bf2f4ae", "answers": {"answer_start": [199], "text": ["vestibular schwannoma"]}}}, "2c1ff6c50fa64d3cabb7d4e6af403554": {"prediction": {"id": "2c1ff6c50fa64d3cabb7d4e6af403554", "prediction_text": "facial nerve neuropathy"}, "reference": {"id": "2c1ff6c50fa64d3cabb7d4e6af403554", "answers": {"answer_start": [51], "text": ["vestibular schwannoma"]}}}, "bf16384c97a24feea6110f2073eaa3ad": {"prediction": {"id": "bf16384c97a24feea6110f2073eaa3ad", "prediction_text": "adhesion of the tumor"}, "reference": {"id": "bf16384c97a24feea6110f2073eaa3ad", "answers": {"answer_start": [1640], "text": ["vestibular schwannoma"]}}}, "19264e49bc2f46d19197578e7a5428ef": {"prediction": {"id": "19264e49bc2f46d19197578e7a5428ef", "prediction_text": "meningitis"}, "reference": {"id": "19264e49bc2f46d19197578e7a5428ef", "answers": {"answer_start": [402], "text": ["vestibular schwannoma"]}}}, "31eb7dc9e6a544269c48bab143385a8c": {"prediction": {"id": "31eb7dc9e6a544269c48bab143385a8c", "prediction_text": "atrial fibrillation and flutter"}, "reference": {"id": "31eb7dc9e6a544269c48bab143385a8c", "answers": {"answer_start": [367], "text": ["atrial fibrillation and flutter"]}}}, "13cf458bf2de48bbaecdaec5c638b8fe": {"prediction": {"id": "13cf458bf2de48bbaecdaec5c638b8fe", "prediction_text": "deltaF508"}, "reference": {"id": "13cf458bf2de48bbaecdaec5c638b8fe", "answers": {"answer_start": [860], "text": ["deltaF508"]}}}, "08b4206fa8e94e7a875a292b818cfb03": {"prediction": {"id": "08b4206fa8e94e7a875a292b818cfb03", "prediction_text": "p.F508del"}, "reference": {"id": "08b4206fa8e94e7a875a292b818cfb03", "answers": {"answer_start": [1282], "text": ["deltaF508"]}}}, "d98e56240f274e918342f66c29ea0f90": {"prediction": {"id": "d98e56240f274e918342f66c29ea0f90", "prediction_text": "DeltaF508"}, "reference": {"id": "d98e56240f274e918342f66c29ea0f90", "answers": {"answer_start": [1396], "text": ["deltaF508"]}}}, "119f74595ef24322a1d87add27c884cd": {"prediction": {"id": "119f74595ef24322a1d87add27c884cd", "prediction_text": "ill health"}, "reference": {"id": "119f74595ef24322a1d87add27c884cd", "answers": {"answer_start": [1279], "text": ["memory loss"]}}}, "3acf01d07bd54b11a7f9e7e78ba5ed95": {"prediction": {"id": "3acf01d07bd54b11a7f9e7e78ba5ed95", "prediction_text": "spinal muscular atrophy"}, "reference": {"id": "3acf01d07bd54b11a7f9e7e78ba5ed95", "answers": {"answer_start": [112], "text": ["Spinal Muscular Atrophy"]}}}, "9ffeb40b659e432291bdc52ec11c0e50": {"prediction": {"id": "9ffeb40b659e432291bdc52ec11c0e50", "prediction_text": "atrophy"}, "reference": {"id": "9ffeb40b659e432291bdc52ec11c0e50", "answers": {"answer_start": [233, 1481], "text": ["Spinal Muscular Atrophy", "SMA"]}}}, "be0c1d4f0f2b4144a863d8273b8478f2": {"prediction": {"id": "be0c1d4f0f2b4144a863d8273b8478f2", "prediction_text": "spinal muscular atrophy"}, "reference": {"id": "be0c1d4f0f2b4144a863d8273b8478f2", "answers": {"answer_start": [702], "text": ["Spinal Muscular Atrophy"]}}}, "e4de1bcc67d640799706c74b9e890034": {"prediction": {"id": "e4de1bcc67d640799706c74b9e890034", "prediction_text": "Spt-Ada-Gcn5-acetyltransferase"}, "reference": {"id": "e4de1bcc67d640799706c74b9e890034", "answers": {"answer_start": [429], "text": ["Spt-Ada-Gcn5-acetyltransferase"]}}}, "c773bff81df74ca1aaff708c99410c5c": {"prediction": {"id": "c773bff81df74ca1aaff708c99410c5c", "prediction_text": "Spt-Ada-Gcn5-acetyltransferase"}, "reference": {"id": "c773bff81df74ca1aaff708c99410c5c", "answers": {"answer_start": [814], "text": ["Spt-Ada-Gcn5-acetyltransferase"]}}}, "8b9a4adb9811424c856c62666f437d05": {"prediction": {"id": "8b9a4adb9811424c856c62666f437d05", "prediction_text": "yeast Spt-Ada-Gcn5-acetyltransferase"}, "reference": {"id": "8b9a4adb9811424c856c62666f437d05", "answers": {"answer_start": [10], "text": ["Spt-Ada-Gcn5-acetyltransferase"]}}}, "a30b1ea2292a430ea1bb31fc38f7e28f": {"prediction": {"id": "a30b1ea2292a430ea1bb31fc38f7e28f", "prediction_text": "LHCII"}, "reference": {"id": "a30b1ea2292a430ea1bb31fc38f7e28f", "answers": {"answer_start": [0], "text": ["LHCII"]}}}, "b1d481a242bd4d9e9c75951400257a01": {"prediction": {"id": "b1d481a242bd4d9e9c75951400257a01", "prediction_text": "The light-harvesting chlorophyll a/b-protein complex of photosystem II"}, "reference": {"id": "b1d481a242bd4d9e9c75951400257a01", "answers": {"answer_start": [327], "text": ["LHCII"]}}}, "87b143ad054443098aec5b491dac747f": {"prediction": {"id": "87b143ad054443098aec5b491dac747f", "prediction_text": "LHCII"}, "reference": {"id": "87b143ad054443098aec5b491dac747f", "answers": {"answer_start": [889], "text": ["LHCII"]}}}, "aa65c1b4a63c4f1ba15e71557d4d3e80": {"prediction": {"id": "aa65c1b4a63c4f1ba15e71557d4d3e80", "prediction_text": "LHCII"}, "reference": {"id": "aa65c1b4a63c4f1ba15e71557d4d3e80", "answers": {"answer_start": [0], "text": ["LHCII"]}}}, "b229ede07077426bbb9563999bf24509": {"prediction": {"id": "b229ede07077426bbb9563999bf24509", "prediction_text": "Light-harvesting pigment-protein complex of Photosystem II"}, "reference": {"id": "b229ede07077426bbb9563999bf24509", "answers": {"answer_start": [0, 1477], "text": ["Light-harvesting pigment-protein complex of Photosystem II", "LHCII"]}}}, "625ffa0254b54594ac9eaba0c3bb9728": {"prediction": {"id": "625ffa0254b54594ac9eaba0c3bb9728", "prediction_text": "late"}, "reference": {"id": "625ffa0254b54594ac9eaba0c3bb9728", "answers": {"answer_start": [1071], "text": ["Early"]}}}, "4754418f700b4aaea87c446c37c033d1": {"prediction": {"id": "4754418f700b4aaea87c446c37c033d1", "prediction_text": "late"}, "reference": {"id": "4754418f700b4aaea87c446c37c033d1", "answers": {"answer_start": [81], "text": ["Early"]}}}, "e0d42fec123841deb8cf9b94454c69f7": {"prediction": {"id": "e0d42fec123841deb8cf9b94454c69f7", "prediction_text": "early"}, "reference": {"id": "e0d42fec123841deb8cf9b94454c69f7", "answers": {"answer_start": [1688], "text": ["Early"]}}}, "5d5d574431d24e46a091f7d19f711d8f": {"prediction": {"id": "5d5d574431d24e46a091f7d19f711d8f", "prediction_text": "http://bioconductor.org/packages/release/bioc/html/psygenet2r.html"}, "reference": {"id": "5d5d574431d24e46a091f7d19f711d8f", "answers": {"answer_start": [745], "text": ["Psygenet2r"]}}}, "e09efb427d0c4721b5036c0046d35d3c": {"prediction": {"id": "e09efb427d0c4721b5036c0046d35d3c", "prediction_text": "hepatitis C virus"}, "reference": {"id": "e09efb427d0c4721b5036c0046d35d3c", "answers": {"answer_start": [414], "text": ["LOXL2"]}}}, "2809be4b78d74775b4c9280e15b19625": {"prediction": {"id": "2809be4b78d74775b4c9280e15b19625", "prediction_text": "LOX"}, "reference": {"id": "2809be4b78d74775b4c9280e15b19625", "answers": {"answer_start": [421], "text": ["LOXL2"]}}}, "10ce930be7574315a4069f870206fd30": {"prediction": {"id": "10ce930be7574315a4069f870206fd30", "prediction_text": "idiopathic pulmonary fibrosis"}, "reference": {"id": "10ce930be7574315a4069f870206fd30", "answers": {"answer_start": [562], "text": ["LOXL2"]}}}, "1e78971d0ff94636b9c4f08cdec06702": {"prediction": {"id": "1e78971d0ff94636b9c4f08cdec06702", "prediction_text": "the Bacteroidetes and Firmicutes"}, "reference": {"id": "1e78971d0ff94636b9c4f08cdec06702", "answers": {"answer_start": [275], "text": ["Bacteroidetes and Firmicutes"]}}}, "f5eca2174e7f4cfbb53297e360de08dc": {"prediction": {"id": "f5eca2174e7f4cfbb53297e360de08dc", "prediction_text": "Mutations"}, "reference": {"id": "f5eca2174e7f4cfbb53297e360de08dc", "answers": {"answer_start": [176], "text": ["RFX6"]}}}, "05b7de3c2d634ebd8dcd685653f344a9": {"prediction": {"id": "05b7de3c2d634ebd8dcd685653f344a9", "prediction_text": "bi-allelic mutations"}, "reference": {"id": "05b7de3c2d634ebd8dcd685653f344a9", "answers": {"answer_start": [750], "text": ["RFX6"]}}}, "ca374d8d5fbb4c2fb7a3016f5e3f9fa6": {"prediction": {"id": "ca374d8d5fbb4c2fb7a3016f5e3f9fa6", "prediction_text": "Yap and Taz"}, "reference": {"id": "ca374d8d5fbb4c2fb7a3016f5e3f9fa6", "answers": {"answer_start": [335], "text": ["Tead (TEA domain) transcription factors."]}}}, "40f31b2a572048d6bf651bbccc6cf3ed": {"prediction": {"id": "40f31b2a572048d6bf651bbccc6cf3ed", "prediction_text": "antibiotics"}, "reference": {"id": "40f31b2a572048d6bf651bbccc6cf3ed", "answers": {"answer_start": [738], "text": ["streptococcal pharyngitis"]}}}, "6e62986742fa4fbd9392ddcbb346c110": {"prediction": {"id": "6e62986742fa4fbd9392ddcbb346c110", "prediction_text": "sore throat"}, "reference": {"id": "6e62986742fa4fbd9392ddcbb346c110", "answers": {"answer_start": [252], "text": ["streptococcal pharyngitis"]}}}, "009a8c10a0c64ad4a16c398ff4e932ea": {"prediction": {"id": "009a8c10a0c64ad4a16c398ff4e932ea", "prediction_text": "Hypothesis"}, "reference": {"id": "009a8c10a0c64ad4a16c398ff4e932ea", "answers": {"answer_start": [1984], "text": ["streptococcal pharyngitis"]}}}, "59ae27ecabb143c7b45696d5529f2e0e": {"prediction": {"id": "59ae27ecabb143c7b45696d5529f2e0e", "prediction_text": "acute pharyngitis"}, "reference": {"id": "59ae27ecabb143c7b45696d5529f2e0e", "answers": {"answer_start": [1277], "text": ["streptococcal pharyngitis"]}}}, "7978d22430a944008473389ead22ed79": {"prediction": {"id": "7978d22430a944008473389ead22ed79", "prediction_text": "suppression of T-cell function"}, "reference": {"id": "7978d22430a944008473389ead22ed79", "answers": {"answer_start": [300], "text": ["inhibits"]}}}, "95b512d70bda4e749e02c0937fc07bd1": {"prediction": {"id": "95b512d70bda4e749e02c0937fc07bd1", "prediction_text": "dasatinib combined with cyclosporine A or rapamycin"}, "reference": {"id": "95b512d70bda4e749e02c0937fc07bd1", "answers": {"answer_start": [448], "text": ["inhibits"]}}}, "fd092f0c34f44d5a90514edab8570702": {"prediction": {"id": "fd092f0c34f44d5a90514edab8570702", "prediction_text": "X"}, "reference": {"id": "fd092f0c34f44d5a90514edab8570702", "answers": {"answer_start": [173], "text": ["X"]}}}, "855256eee2364dd29d7fb3c57ef8c3e4": {"prediction": {"id": "855256eee2364dd29d7fb3c57ef8c3e4", "prediction_text": "X chromosome is completely deleted, portions of an X"}, "reference": {"id": "855256eee2364dd29d7fb3c57ef8c3e4", "answers": {"answer_start": [735], "text": ["X"]}}}, "5b47e053d4474ac0ab15f4883f7f5d75": {"prediction": {"id": "5b47e053d4474ac0ab15f4883f7f5d75", "prediction_text": "14"}, "reference": {"id": "5b47e053d4474ac0ab15f4883f7f5d75", "answers": {"answer_start": [490], "text": ["X"]}}}, "ed318cf1a6084a4c81684b047d6b48cc": {"prediction": {"id": "ed318cf1a6084a4c81684b047d6b48cc", "prediction_text": "X"}, "reference": {"id": "ed318cf1a6084a4c81684b047d6b48cc", "answers": {"answer_start": [84], "text": ["X"]}}}, "ecff3fe6494c41c09412fc839fa75005": {"prediction": {"id": "ecff3fe6494c41c09412fc839fa75005", "prediction_text": "45,X/46,XX/47,XXX karyotype, who was also a fragile X obligate carrier as the mother of an affected boy, was identified by molecular diagnosis. Complete haplotyping and direct DNA analysis showed that the X"}, "reference": {"id": "ecff3fe6494c41c09412fc839fa75005", "answers": {"answer_start": [293], "text": ["X"]}}}, "4406244b815e4d559cda729fd74c0722": {"prediction": {"id": "4406244b815e4d559cda729fd74c0722", "prediction_text": "sSMC"}, "reference": {"id": "4406244b815e4d559cda729fd74c0722", "answers": {"answer_start": [734], "text": ["X"]}}}, "3aaf134334fe4909a58eeee8fa453a5d": {"prediction": {"id": "3aaf134334fe4909a58eeee8fa453a5d", "prediction_text": "X"}, "reference": {"id": "3aaf134334fe4909a58eeee8fa453a5d", "answers": {"answer_start": [98], "text": ["X"]}}}, "733cbe6c67864093b4fbeb1a24ea86f7": {"prediction": {"id": "733cbe6c67864093b4fbeb1a24ea86f7", "prediction_text": "45,X"}, "reference": {"id": "733cbe6c67864093b4fbeb1a24ea86f7", "answers": {"answer_start": [225], "text": ["X"]}}}, "8d1d8323486d4680a820bd0b0940d35a": {"prediction": {"id": "8d1d8323486d4680a820bd0b0940d35a", "prediction_text": "X"}, "reference": {"id": "8d1d8323486d4680a820bd0b0940d35a", "answers": {"answer_start": [0], "text": ["X"]}}}, "3934e48f34bd42ae999f5be6d8dae154": {"prediction": {"id": "3934e48f34bd42ae999f5be6d8dae154", "prediction_text": "FXS"}, "reference": {"id": "3934e48f34bd42ae999f5be6d8dae154", "answers": {"answer_start": [72], "text": ["X"]}}}, "0b11a44dfdb24f959f16cddf21505b6f": {"prediction": {"id": "0b11a44dfdb24f959f16cddf21505b6f", "prediction_text": "mouse X"}, "reference": {"id": "0b11a44dfdb24f959f16cddf21505b6f", "answers": {"answer_start": [0], "text": ["X"]}}}, "1bc01bf8b09b460a8fab91dc7df959fa": {"prediction": {"id": "1bc01bf8b09b460a8fab91dc7df959fa", "prediction_text": "X"}, "reference": {"id": "1bc01bf8b09b460a8fab91dc7df959fa", "answers": {"answer_start": [595], "text": ["X"]}}}, "cbd0854fca34454eb9cbb28369125bf6": {"prediction": {"id": "cbd0854fca34454eb9cbb28369125bf6", "prediction_text": "X"}, "reference": {"id": "cbd0854fca34454eb9cbb28369125bf6", "answers": {"answer_start": [1191], "text": ["X"]}}}, "55d1c43dc45b4c50855233dd70e5cb35": {"prediction": {"id": "55d1c43dc45b4c50855233dd70e5cb35", "prediction_text": "X"}, "reference": {"id": "55d1c43dc45b4c50855233dd70e5cb35", "answers": {"answer_start": [1288], "text": ["X"]}}}, "37ba36c23ca048eeb56dfef41f47a92a": {"prediction": {"id": "37ba36c23ca048eeb56dfef41f47a92a", "prediction_text": "ring chromosome (46, X,r(X)), marker chromosome"}, "reference": {"id": "37ba36c23ca048eeb56dfef41f47a92a", "answers": {"answer_start": [705], "text": ["X"]}}}, "808955bb69c5417d8e88e9f90cc3e56d": {"prediction": {"id": "808955bb69c5417d8e88e9f90cc3e56d", "prediction_text": "X"}, "reference": {"id": "808955bb69c5417d8e88e9f90cc3e56d", "answers": {"answer_start": [86], "text": ["X"]}}}, "0741defb84104530a9f9c1b3419d5360": {"prediction": {"id": "0741defb84104530a9f9c1b3419d5360", "prediction_text": "X"}, "reference": {"id": "0741defb84104530a9f9c1b3419d5360", "answers": {"answer_start": [70], "text": ["X"]}}}, "3e90e85024834a1e8c28a64a206b9743": {"prediction": {"id": "3e90e85024834a1e8c28a64a206b9743", "prediction_text": "X"}, "reference": {"id": "3e90e85024834a1e8c28a64a206b9743", "answers": {"answer_start": [17], "text": ["X"]}}}, "1c23e7979d5f4c71880d1a9b2d7d90a1": {"prediction": {"id": "1c23e7979d5f4c71880d1a9b2d7d90a1", "prediction_text": "X"}, "reference": {"id": "1c23e7979d5f4c71880d1a9b2d7d90a1", "answers": {"answer_start": [77], "text": ["X"]}}}, "12db034737904f91bf7b8f8c79e6b50e": {"prediction": {"id": "12db034737904f91bf7b8f8c79e6b50e", "prediction_text": "complex samples"}, "reference": {"id": "12db034737904f91bf7b8f8c79e6b50e", "answers": {"answer_start": [660], "text": ["nucleus"]}}}, "64d64566cc344644808754627d26c7b8": {"prediction": {"id": "64d64566cc344644808754627d26c7b8", "prediction_text": "Gilead Sciences' PI3K-\u03b4 inhibitor idelalisib produced rapid tumor shrinkage"}, "reference": {"id": "64d64566cc344644808754627d26c7b8", "answers": {"answer_start": [37], "text": ["PI3K-\u03b4"]}}}, "964db80e3f224cd1a419640668579be4": {"prediction": {"id": "964db80e3f224cd1a419640668579be4", "prediction_text": "Cseq-Simulator"}, "reference": {"id": "964db80e3f224cd1a419640668579be4", "answers": {"answer_start": [648], "text": ["Cseq-Simulator"]}}}, "dc13d0a741114a5ebee59c49888f1ee5": {"prediction": {"id": "dc13d0a741114a5ebee59c49888f1ee5", "prediction_text": "malaria"}, "reference": {"id": "dc13d0a741114a5ebee59c49888f1ee5", "answers": {"answer_start": [878], "text": ["malaria"]}}}, "b45e642fb41f43a4b581a34f50d40614": {"prediction": {"id": "b45e642fb41f43a4b581a34f50d40614", "prediction_text": "malaria"}, "reference": {"id": "b45e642fb41f43a4b581a34f50d40614", "answers": {"answer_start": [0], "text": ["malaria"]}}}, "6aac2d65a4514d83be79e16462a2c384": {"prediction": {"id": "6aac2d65a4514d83be79e16462a2c384", "prediction_text": "malaria"}, "reference": {"id": "6aac2d65a4514d83be79e16462a2c384", "answers": {"answer_start": [148], "text": ["malaria"]}}}, "63350dad9a4d4a978229007c27973e81": {"prediction": {"id": "63350dad9a4d4a978229007c27973e81", "prediction_text": "phase III testing. The rationale for selection of the circumsporozoite protein (CSP) as the target antigen and the preclinical development history of the vaccine are described. The RTS,S/AS candidate vaccine has been evaluated in multiple phase I/II studies and was shown to have a favorable safety profile and to be well tolerated in both adults and children. Consistent and significant efficacy has been observed in the target population of infants and children against Plasmodium falciparum infection and disease in different transmission settings, in different age groups, with or without Expanded Program of Immunization (EPI) vaccine co-administration. The RTS,S/AS01(E) malaria vaccine candidate has recently entered phase III testing. Reaching this important milestone is the culmination of more than 20 years of research and development by GlaxoSmithKline, their partners and collaborators. If the phase III results confirm the observations made during phase II testing, the RTS,S/AS01(E) vaccine, when broadly implemented and judiciously integrated with other malaria-prevention measures, would have a major public-health impact in sub-Saharan Africa"}, "reference": {"id": "63350dad9a4d4a978229007c27973e81", "answers": {"answer_start": [1155], "text": ["malaria"]}}}, "91d4a227f12a45df8cb978b2263fb560": {"prediction": {"id": "91d4a227f12a45df8cb978b2263fb560", "prediction_text": "Malaria"}, "reference": {"id": "91d4a227f12a45df8cb978b2263fb560", "answers": {"answer_start": [114], "text": ["malaria"]}}}, "27b5e59283a94ab18229830821e22ca9": {"prediction": {"id": "27b5e59283a94ab18229830821e22ca9", "prediction_text": "Malaria"}, "reference": {"id": "27b5e59283a94ab18229830821e22ca9", "answers": {"answer_start": [586], "text": ["malaria"]}}}, "d15e8f81f56548b8857dd926cc6ab472": {"prediction": {"id": "d15e8f81f56548b8857dd926cc6ab472", "prediction_text": "S malaria"}, "reference": {"id": "d15e8f81f56548b8857dd926cc6ab472", "answers": {"answer_start": [232], "text": ["malaria"]}}}, "eeb1ef0e258749a49a8b77ce2076a817": {"prediction": {"id": "eeb1ef0e258749a49a8b77ce2076a817", "prediction_text": "malaria incidence"}, "reference": {"id": "eeb1ef0e258749a49a8b77ce2076a817", "answers": {"answer_start": [663], "text": ["malaria"]}}}, "f752cbe230bb46878088f29ff9ae2652": {"prediction": {"id": "f752cbe230bb46878088f29ff9ae2652", "prediction_text": "malaria"}, "reference": {"id": "f752cbe230bb46878088f29ff9ae2652", "answers": {"answer_start": [0], "text": ["malaria"]}}}, "622f05dd6c9a4209921ec5ba34eb5f12": {"prediction": {"id": "622f05dd6c9a4209921ec5ba34eb5f12", "prediction_text": "malaria"}, "reference": {"id": "622f05dd6c9a4209921ec5ba34eb5f12", "answers": {"answer_start": [192], "text": ["malaria"]}}}, "45f7a23bb4654955b4335aee7764cee0": {"prediction": {"id": "45f7a23bb4654955b4335aee7764cee0", "prediction_text": "malaria"}, "reference": {"id": "45f7a23bb4654955b4335aee7764cee0", "answers": {"answer_start": [719], "text": ["malaria"]}}}, "9159188641524a3b9bc77e1a95930ae5": {"prediction": {"id": "9159188641524a3b9bc77e1a95930ae5", "prediction_text": "malaria"}, "reference": {"id": "9159188641524a3b9bc77e1a95930ae5", "answers": {"answer_start": [4], "text": ["malaria"]}}}, "6a2ed32b55a34d44afb7a88b08f48826": {"prediction": {"id": "6a2ed32b55a34d44afb7a88b08f48826", "prediction_text": "purified antigen"}, "reference": {"id": "6a2ed32b55a34d44afb7a88b08f48826", "answers": {"answer_start": [267], "text": ["malaria"]}}}, "86e78bb985ad4faa96c039c0a85f1bc7": {"prediction": {"id": "86e78bb985ad4faa96c039c0a85f1bc7", "prediction_text": "malaria"}, "reference": {"id": "86e78bb985ad4faa96c039c0a85f1bc7", "answers": {"answer_start": [44], "text": ["malaria"]}}}, "02971306959c417b9357f7490a3e7465": {"prediction": {"id": "02971306959c417b9357f7490a3e7465", "prediction_text": "malaria"}, "reference": {"id": "02971306959c417b9357f7490a3e7465", "answers": {"answer_start": [2311], "text": ["malaria"]}}}, "f648934db4f642a5a59a765d504773f3": {"prediction": {"id": "f648934db4f642a5a59a765d504773f3", "prediction_text": "Plasmodium falciparum"}, "reference": {"id": "f648934db4f642a5a59a765d504773f3", "answers": {"answer_start": [1017], "text": ["malaria"]}}}, "8e709421602944db9a2c8cd8d6264425": {"prediction": {"id": "8e709421602944db9a2c8cd8d6264425", "prediction_text": "immunisation"}, "reference": {"id": "8e709421602944db9a2c8cd8d6264425", "answers": {"answer_start": [1279], "text": ["malaria"]}}}, "e68ca474c9c74ac8a39fb372964e90c2": {"prediction": {"id": "e68ca474c9c74ac8a39fb372964e90c2", "prediction_text": "Expanded Program of Immunization"}, "reference": {"id": "e68ca474c9c74ac8a39fb372964e90c2", "answers": {"answer_start": [18], "text": ["malaria"]}}}, "df5bc55383d041349c1626b84b996822": {"prediction": {"id": "df5bc55383d041349c1626b84b996822", "prediction_text": "malaria"}, "reference": {"id": "df5bc55383d041349c1626b84b996822", "answers": {"answer_start": [1217], "text": ["malaria"]}}}, "4f0654defacd42839a4953d1a13ce737": {"prediction": {"id": "4f0654defacd42839a4953d1a13ce737", "prediction_text": "circularized"}, "reference": {"id": "4f0654defacd42839a4953d1a13ce737", "answers": {"answer_start": [260], "text": ["circularized oligodeoxynucleotides"]}}}, "6139453000cc49459f2c90f614e5654a": {"prediction": {"id": "6139453000cc49459f2c90f614e5654a", "prediction_text": "viroids"}, "reference": {"id": "6139453000cc49459f2c90f614e5654a", "answers": {"answer_start": [90], "text": ["Viroids"]}}}, "26c2f0f4c8e2402c97f52976315c687c": {"prediction": {"id": "26c2f0f4c8e2402c97f52976315c687c", "prediction_text": "viroids"}, "reference": {"id": "26c2f0f4c8e2402c97f52976315c687c", "answers": {"answer_start": [239], "text": ["Viroids"]}}}, "295087dc10a84be4934ac3664e4e4d55": {"prediction": {"id": "295087dc10a84be4934ac3664e4e4d55", "prediction_text": "Viroids"}, "reference": {"id": "295087dc10a84be4934ac3664e4e4d55", "answers": {"answer_start": [323], "text": ["Viroids"]}}}, "792c8bfaa3194a9ea0edc27456d46cce": {"prediction": {"id": "792c8bfaa3194a9ea0edc27456d46cce", "prediction_text": "Viroids"}, "reference": {"id": "792c8bfaa3194a9ea0edc27456d46cce", "answers": {"answer_start": [0], "text": ["Viroids"]}}}, "b4f0d4a6142b4533b4c404f86a138e63": {"prediction": {"id": "b4f0d4a6142b4533b4c404f86a138e63", "prediction_text": "Viroidlike satellite RNAs"}, "reference": {"id": "b4f0d4a6142b4533b4c404f86a138e63", "answers": {"answer_start": [465], "text": ["Viroids"]}}}, "b2fa868c89e24b10a07a02f7301ca4e2": {"prediction": {"id": "b2fa868c89e24b10a07a02f7301ca4e2", "prediction_text": "Viroids, satellite RNAs, satellites viruses and the human hepatitis delta virus form the 'brotherhood' of the smallest known infectious RNA agents, known as the subviral RNAs"}, "reference": {"id": "b2fa868c89e24b10a07a02f7301ca4e2", "answers": {"answer_start": [721], "text": ["Viroids"]}}}, "279c3028426f459aa0cef36e20aa184a": {"prediction": {"id": "279c3028426f459aa0cef36e20aa184a", "prediction_text": "viroids"}, "reference": {"id": "279c3028426f459aa0cef36e20aa184a", "answers": {"answer_start": [1033], "text": ["Viroids"]}}}, "d717cadc4e194232825236560d3e1f77": {"prediction": {"id": "d717cadc4e194232825236560d3e1f77", "prediction_text": "AHVd-like RNA"}, "reference": {"id": "d717cadc4e194232825236560d3e1f77", "answers": {"answer_start": [1520], "text": ["Viroids"]}}}, "9fde7e7fb1cc449f8f0b1aa362e89a33": {"prediction": {"id": "9fde7e7fb1cc449f8f0b1aa362e89a33", "prediction_text": "Viroids"}, "reference": {"id": "9fde7e7fb1cc449f8f0b1aa362e89a33", "answers": {"answer_start": [0], "text": ["Viroids"]}}}, "5c15330cf1bb4b2295968d84b4da5ab8": {"prediction": {"id": "5c15330cf1bb4b2295968d84b4da5ab8", "prediction_text": "viroid replication and pathogenicity"}, "reference": {"id": "5c15330cf1bb4b2295968d84b4da5ab8", "answers": {"answer_start": [419], "text": ["Viroids"]}}}, "1baf76d2c9a64ad2b4eb2c489d54a92b": {"prediction": {"id": "1baf76d2c9a64ad2b4eb2c489d54a92b", "prediction_text": "recessive cases"}, "reference": {"id": "1baf76d2c9a64ad2b4eb2c489d54a92b", "answers": {"answer_start": [504], "text": ["autosomal dominant"]}}}, "aa6a6d7cfc45420db6447ec65efd37d7": {"prediction": {"id": "aa6a6d7cfc45420db6447ec65efd37d7", "prediction_text": "autosomal"}, "reference": {"id": "aa6a6d7cfc45420db6447ec65efd37d7", "answers": {"answer_start": [12], "text": ["autosomal dominant"]}}}, "ca14285566834e18aeacdcccceba3789": {"prediction": {"id": "ca14285566834e18aeacdcccceba3789", "prediction_text": "malignant hyperthermia"}, "reference": {"id": "ca14285566834e18aeacdcccceba3789", "answers": {"answer_start": [1063], "text": ["autosomal dominant"]}}}, "ce35d3202601485ab6692e5218e0c657": {"prediction": {"id": "ce35d3202601485ab6692e5218e0c657", "prediction_text": "alpha-proteobacteria"}, "reference": {"id": "ce35d3202601485ab6692e5218e0c657", "answers": {"answer_start": [0], "text": ["Biologists agree that the ancestor of mitochondria was an alpha-proteobacterium."]}}}, "0c8f87a7af3c427c93efdf7a73b3d5f7": {"prediction": {"id": "0c8f87a7af3c427c93efdf7a73b3d5f7", "prediction_text": "luminal side of the endoplasmic reticulum"}, "reference": {"id": "0c8f87a7af3c427c93efdf7a73b3d5f7", "answers": {"answer_start": [286], "text": ["luminal side of the endoplasmic reticulum"]}}}, "0318da4903ab417ab4bac62dade24f87": {"prediction": {"id": "0318da4903ab417ab4bac62dade24f87", "prediction_text": "lower"}, "reference": {"id": "0318da4903ab417ab4bac62dade24f87", "answers": {"answer_start": [754], "text": ["longer than the general population"]}}}, "e82c1d7e3c0547aeb3a43d048b20539b": {"prediction": {"id": "e82c1d7e3c0547aeb3a43d048b20539b", "prediction_text": "autosomal"}, "reference": {"id": "e82c1d7e3c0547aeb3a43d048b20539b", "answers": {"answer_start": [64], "text": ["autosomal dominant"]}}}, "3c3d516d878e4ec68c2068587b46c239": {"prediction": {"id": "3c3d516d878e4ec68c2068587b46c239", "prediction_text": "autosomal recessive"}, "reference": {"id": "3c3d516d878e4ec68c2068587b46c239", "answers": {"answer_start": [157], "text": ["autosomal dominant"]}}}, "c225ecf19ac148729cec3aababebe08d": {"prediction": {"id": "c225ecf19ac148729cec3aababebe08d", "prediction_text": "autosomal recessive"}, "reference": {"id": "c225ecf19ac148729cec3aababebe08d", "answers": {"answer_start": [139], "text": ["autosomal dominant"]}}}, "2c5158d3af9747d6a5625a85a62cefbd": {"prediction": {"id": "2c5158d3af9747d6a5625a85a62cefbd", "prediction_text": "autosomal"}, "reference": {"id": "2c5158d3af9747d6a5625a85a62cefbd", "answers": {"answer_start": [193], "text": ["autosomal dominant"]}}}, "a168ee79fc724d97ac68c42489cb09d5": {"prediction": {"id": "a168ee79fc724d97ac68c42489cb09d5", "prediction_text": "autosomal"}, "reference": {"id": "a168ee79fc724d97ac68c42489cb09d5", "answers": {"answer_start": [771], "text": ["autosomal dominant"]}}}, "ea0cd40175d544cf842e8c4c8aafc292": {"prediction": {"id": "ea0cd40175d544cf842e8c4c8aafc292", "prediction_text": "autosomal"}, "reference": {"id": "ea0cd40175d544cf842e8c4c8aafc292", "answers": {"answer_start": [37], "text": ["autosomal dominant"]}}}, "374b3510a96f4dcbb57a700186d12e27": {"prediction": {"id": "374b3510a96f4dcbb57a700186d12e27", "prediction_text": "LQTS"}, "reference": {"id": "374b3510a96f4dcbb57a700186d12e27", "answers": {"answer_start": [46], "text": ["autosomal dominant"]}}}, "5e6160d10fdd41588e43acdfeb0ff474": {"prediction": {"id": "5e6160d10fdd41588e43acdfeb0ff474", "prediction_text": "autosomal"}, "reference": {"id": "5e6160d10fdd41588e43acdfeb0ff474", "answers": {"answer_start": [388], "text": ["autosomal dominant"]}}}, "173c788ee0fd439e96221909572aba0e": {"prediction": {"id": "173c788ee0fd439e96221909572aba0e", "prediction_text": "LQTS"}, "reference": {"id": "173c788ee0fd439e96221909572aba0e", "answers": {"answer_start": [47], "text": ["autosomal dominant"]}}}, "8132ea715d434e5da6cc6488bbc5fef6": {"prediction": {"id": "8132ea715d434e5da6cc6488bbc5fef6", "prediction_text": "LQTS"}, "reference": {"id": "8132ea715d434e5da6cc6488bbc5fef6", "answers": {"answer_start": [400], "text": ["autosomal dominant"]}}}, "8e20b6860e2943f6b2a57672df88e793": {"prediction": {"id": "8e20b6860e2943f6b2a57672df88e793", "prediction_text": "LQTS"}, "reference": {"id": "8e20b6860e2943f6b2a57672df88e793", "answers": {"answer_start": [27], "text": ["autosomal dominant"]}}}, "79f02dc834d341858b8f754ce4a4f96b": {"prediction": {"id": "79f02dc834d341858b8f754ce4a4f96b", "prediction_text": "truncated KCNQ1 splice variant"}, "reference": {"id": "79f02dc834d341858b8f754ce4a4f96b", "answers": {"answer_start": [1640], "text": ["autosomal dominant"]}}}, "8c37aaac935042a0a1e4073f782cf150": {"prediction": {"id": "8c37aaac935042a0a1e4073f782cf150", "prediction_text": "RADAR"}, "reference": {"id": "8c37aaac935042a0a1e4073f782cf150", "answers": {"answer_start": [493], "text": ["RADAR"]}}}, "9ae2de2752ad41e29c155f68dc9da23f": {"prediction": {"id": "9ae2de2752ad41e29c155f68dc9da23f", "prediction_text": "PTSD"}, "reference": {"id": "9ae2de2752ad41e29c155f68dc9da23f", "answers": {"answer_start": [141, 173], "text": ["post-traumatic stress disorder", "PTSD"]}}}, "f37bfd1f79f84127ac2bd455f069bbd5": {"prediction": {"id": "f37bfd1f79f84127ac2bd455f069bbd5", "prediction_text": "PTSD, as well as related aspects of somatic malaise, stress vulnerability and functional impairment. Validity"}, "reference": {"id": "f37bfd1f79f84127ac2bd455f069bbd5", "answers": {"answer_start": [130, 309], "text": ["post-traumatic stress disorder", "PTSD"]}}}, "facf5ba9e3bb48eb87e52c14ed938bb1": {"prediction": {"id": "facf5ba9e3bb48eb87e52c14ed938bb1", "prediction_text": "depressive"}, "reference": {"id": "facf5ba9e3bb48eb87e52c14ed938bb1", "answers": {"answer_start": [564], "text": ["PTSD"]}}}, "1f3f7087b60241d19d4ed9bb27a020b4": {"prediction": {"id": "1f3f7087b60241d19d4ed9bb27a020b4", "prediction_text": "PTSD"}, "reference": {"id": "1f3f7087b60241d19d4ed9bb27a020b4", "answers": {"answer_start": [118, 267], "text": ["post-traumatic stress disorder", "PTSD"]}}}, "86169a034b2745479f3c54fe8056cc62": {"prediction": {"id": "86169a034b2745479f3c54fe8056cc62", "prediction_text": "PTSD"}, "reference": {"id": "86169a034b2745479f3c54fe8056cc62", "answers": {"answer_start": [191], "text": ["PTSD"]}}}, "57c2838114f240c193046a4364f62e9b": {"prediction": {"id": "57c2838114f240c193046a4364f62e9b", "prediction_text": "PTSD"}, "reference": {"id": "57c2838114f240c193046a4364f62e9b", "answers": {"answer_start": [97, 129], "text": ["post-traumatic stress disorder", "PTSD"]}}}, "2549ca20c87443ddb4875ef30656a76d": {"prediction": {"id": "2549ca20c87443ddb4875ef30656a76d", "prediction_text": "PTSD"}, "reference": {"id": "2549ca20c87443ddb4875ef30656a76d", "answers": {"answer_start": [1095], "text": ["PTSD"]}}}, "94835f695a084e96a6bac76a7813a363": {"prediction": {"id": "94835f695a084e96a6bac76a7813a363", "prediction_text": "PTSD"}, "reference": {"id": "94835f695a084e96a6bac76a7813a363", "answers": {"answer_start": [104, 453], "text": ["post-traumatic stress disorder", "PTSD"]}}}, "89b20a3bffce44e4b20b3e3cf69159d7": {"prediction": {"id": "89b20a3bffce44e4b20b3e3cf69159d7", "prediction_text": "PTSD"}, "reference": {"id": "89b20a3bffce44e4b20b3e3cf69159d7", "answers": {"answer_start": [904], "text": ["PTSD"]}}}, "7ab6111c4507449ba954bca469660375": {"prediction": {"id": "7ab6111c4507449ba954bca469660375", "prediction_text": "Posttraumatic Stress Disorder"}, "reference": {"id": "7ab6111c4507449ba954bca469660375", "answers": {"answer_start": [102], "text": ["PTSD"]}}}, "454afb4b92414bcdafcc6a4ed8acff37": {"prediction": {"id": "454afb4b92414bcdafcc6a4ed8acff37", "prediction_text": "mild"}, "reference": {"id": "454afb4b92414bcdafcc6a4ed8acff37", "answers": {"answer_start": [1617], "text": ["PTSD"]}}}, "8ea3121c9e424ac1abaa32f9485c7b33": {"prediction": {"id": "8ea3121c9e424ac1abaa32f9485c7b33", "prediction_text": "PTSD"}, "reference": {"id": "8ea3121c9e424ac1abaa32f9485c7b33", "answers": {"answer_start": [768], "text": ["PTSD"]}}}, "fa46aca08a554e129e9f449db3afecc6": {"prediction": {"id": "fa46aca08a554e129e9f449db3afecc6", "prediction_text": "PTSD"}, "reference": {"id": "fa46aca08a554e129e9f449db3afecc6", "answers": {"answer_start": [165], "text": ["PTSD"]}}}, "3052bee772a744a991f43e1da8538383": {"prediction": {"id": "3052bee772a744a991f43e1da8538383", "prediction_text": "PTSD"}, "reference": {"id": "3052bee772a744a991f43e1da8538383", "answers": {"answer_start": [1745], "text": ["PTSD"]}}}, "dfa6043d182246b7a4f898edb0dbc043": {"prediction": {"id": "dfa6043d182246b7a4f898edb0dbc043", "prediction_text": "local context"}, "reference": {"id": "dfa6043d182246b7a4f898edb0dbc043", "answers": {"answer_start": [839], "text": ["PTSD"]}}}, "158efd85e02b43fbba5eabb432a12c1b": {"prediction": {"id": "158efd85e02b43fbba5eabb432a12c1b", "prediction_text": "PTSD and depression"}, "reference": {"id": "158efd85e02b43fbba5eabb432a12c1b", "answers": {"answer_start": [477], "text": ["PTSD"]}}}, "6e02db946f114bc99dda24afb7e02b2b": {"prediction": {"id": "6e02db946f114bc99dda24afb7e02b2b", "prediction_text": "post-traumatic stress disorder (PTSD"}, "reference": {"id": "6e02db946f114bc99dda24afb7e02b2b", "answers": {"answer_start": [178, 844], "text": ["post-traumatic stress disorder", "PTSD"]}}}, "3623a8b2ce0a4b99a86d040df9b13790": {"prediction": {"id": "3623a8b2ce0a4b99a86d040df9b13790", "prediction_text": "bipolar"}, "reference": {"id": "3623a8b2ce0a4b99a86d040df9b13790", "answers": {"answer_start": [785], "text": ["PTSD"]}}}, "069dbb2e450c49b58f41098a2b47ad05": {"prediction": {"id": "069dbb2e450c49b58f41098a2b47ad05", "prediction_text": "PTSD and other Axis I disorders"}, "reference": {"id": "069dbb2e450c49b58f41098a2b47ad05", "answers": {"answer_start": [627], "text": ["PTSD"]}}}, "9c48a00930864d5a88e0a6e05f66ef84": {"prediction": {"id": "9c48a00930864d5a88e0a6e05f66ef84", "prediction_text": "Combat exposure and PTSD"}, "reference": {"id": "9c48a00930864d5a88e0a6e05f66ef84", "answers": {"answer_start": [871], "text": ["PTSD"]}}}, "8340afcc9c17452ba271100395aed127": {"prediction": {"id": "8340afcc9c17452ba271100395aed127", "prediction_text": "PTSD"}, "reference": {"id": "8340afcc9c17452ba271100395aed127", "answers": {"answer_start": [83, 263], "text": ["post-traumatic stress disorder", "PTSD"]}}}, "ffdc8eb223f3435f8b2a1886e0821353": {"prediction": {"id": "ffdc8eb223f3435f8b2a1886e0821353", "prediction_text": "posttraumatic"}, "reference": {"id": "ffdc8eb223f3435f8b2a1886e0821353", "answers": {"answer_start": [691], "text": ["PTSD"]}}}, "e124c2072d2d4f2481ce73255d791b63": {"prediction": {"id": "e124c2072d2d4f2481ce73255d791b63", "prediction_text": "PTSD"}, "reference": {"id": "e124c2072d2d4f2481ce73255d791b63", "answers": {"answer_start": [224], "text": ["PTSD"]}}}, "357a03670f464b33be381e5801054f7b": {"prediction": {"id": "357a03670f464b33be381e5801054f7b", "prediction_text": "PTSD"}, "reference": {"id": "357a03670f464b33be381e5801054f7b", "answers": {"answer_start": [3, 1493], "text": ["post-traumatic stress disorder", "PTSD"]}}}, "30da7f51d17c49fa96094a1b7d39255c": {"prediction": {"id": "30da7f51d17c49fa96094a1b7d39255c", "prediction_text": "PTSD"}, "reference": {"id": "30da7f51d17c49fa96094a1b7d39255c", "answers": {"answer_start": [1349], "text": ["PTSD"]}}}, "fa4b939ebc4b413799bb74f59289cde0": {"prediction": {"id": "fa4b939ebc4b413799bb74f59289cde0", "prediction_text": "depression, anxiety, and post-traumatic stress disorder"}, "reference": {"id": "fa4b939ebc4b413799bb74f59289cde0", "answers": {"answer_start": [689, 1895], "text": ["post-traumatic stress disorder", "PTSD"]}}}, "77973de4be2940ebafd9c431508000ea": {"prediction": {"id": "77973de4be2940ebafd9c431508000ea", "prediction_text": "PTSD"}, "reference": {"id": "77973de4be2940ebafd9c431508000ea", "answers": {"answer_start": [371], "text": ["PTSD"]}}}, "50d58fa2b68346d08d30b0f346942db7": {"prediction": {"id": "50d58fa2b68346d08d30b0f346942db7", "prediction_text": "PTSD"}, "reference": {"id": "50d58fa2b68346d08d30b0f346942db7", "answers": {"answer_start": [71, 103], "text": ["post-traumatic stress disorder", "PTSD"]}}}, "6d80569f90c74f358d2d754cdc60bc1b": {"prediction": {"id": "6d80569f90c74f358d2d754cdc60bc1b", "prediction_text": "PLN signaling"}, "reference": {"id": "6d80569f90c74f358d2d754cdc60bc1b", "answers": {"answer_start": [1374], "text": ["PP1"]}}}, "fdfc2aa1c7c04271b070ac0f260bf592": {"prediction": {"id": "fdfc2aa1c7c04271b070ac0f260bf592", "prediction_text": "Epstein-Barr"}, "reference": {"id": "fdfc2aa1c7c04271b070ac0f260bf592", "answers": {"answer_start": [15], "text": ["Epstein-Barr virus"]}}}, "75e39d7193b147c0b507ff0d13344106": {"prediction": {"id": "75e39d7193b147c0b507ff0d13344106", "prediction_text": "Epstein-Barr"}, "reference": {"id": "75e39d7193b147c0b507ff0d13344106", "answers": {"answer_start": [373], "text": ["Epstein-Barr virus"]}}}, "92886fbd49aa4e2d8e457856f169fb2a": {"prediction": {"id": "92886fbd49aa4e2d8e457856f169fb2a", "prediction_text": "Epstein-Barr"}, "reference": {"id": "92886fbd49aa4e2d8e457856f169fb2a", "answers": {"answer_start": [675], "text": ["Epstein-Barr virus"]}}}, "36ea8fa661494aa9873fd2bbe2366bb6": {"prediction": {"id": "36ea8fa661494aa9873fd2bbe2366bb6", "prediction_text": "Epstein-Barr"}, "reference": {"id": "36ea8fa661494aa9873fd2bbe2366bb6", "answers": {"answer_start": [15], "text": ["Epstein-Barr virus"]}}}, "30f4b3fb7cde41fe9b784f1d5119d32c": {"prediction": {"id": "30f4b3fb7cde41fe9b784f1d5119d32c", "prediction_text": "Epstein-Barr virus (EBV) is a highly prevalent virus, transmitted via saliva, which often causes asymptomatic infection in children but frequently results in infectious mononucleosis in adolescents. Heterophile antibody tests, including the Monospot test, are red cell or latex agglutination assays, which detect antired cell antibodies"}, "reference": {"id": "30f4b3fb7cde41fe9b784f1d5119d32c", "answers": {"answer_start": [0], "text": ["Epstein-Barr virus"]}}}, "5954bbfc60094c3e96fadbf854b28f74": {"prediction": {"id": "5954bbfc60094c3e96fadbf854b28f74", "prediction_text": "Epstein-Barr"}, "reference": {"id": "5954bbfc60094c3e96fadbf854b28f74", "answers": {"answer_start": [336], "text": ["Epstein-Barr virus"]}}}, "3d57aa82c9b143a78fac6042ea350193": {"prediction": {"id": "3d57aa82c9b143a78fac6042ea350193", "prediction_text": "CMV infection. Herein"}, "reference": {"id": "3d57aa82c9b143a78fac6042ea350193", "answers": {"answer_start": [324], "text": ["Epstein-Barr virus"]}}}, "8f8ffcf7628942e48dfea934155671a4": {"prediction": {"id": "8f8ffcf7628942e48dfea934155671a4", "prediction_text": "Epstein-Barr"}, "reference": {"id": "8f8ffcf7628942e48dfea934155671a4", "answers": {"answer_start": [682], "text": ["Epstein-Barr virus"]}}}, "52268058980f4cd2ba2ad79e8603a8c4": {"prediction": {"id": "52268058980f4cd2ba2ad79e8603a8c4", "prediction_text": "Epstein-Barr Virus"}, "reference": {"id": "52268058980f4cd2ba2ad79e8603a8c4", "answers": {"answer_start": [115], "text": ["Epstein-Barr virus"]}}}, "cfbc2db7d2314e688b0af239addf4620": {"prediction": {"id": "cfbc2db7d2314e688b0af239addf4620", "prediction_text": "Epstein-Barr"}, "reference": {"id": "cfbc2db7d2314e688b0af239addf4620", "answers": {"answer_start": [239], "text": ["Epstein-Barr virus"]}}}, "352de99d78d64d77b966a04caa05f3e7": {"prediction": {"id": "352de99d78d64d77b966a04caa05f3e7", "prediction_text": "Epstein-Barr"}, "reference": {"id": "352de99d78d64d77b966a04caa05f3e7", "answers": {"answer_start": [945], "text": ["Epstein-Barr virus"]}}}, "5cbb361a862c4d7a9fbcd1ec933ebe1f": {"prediction": {"id": "5cbb361a862c4d7a9fbcd1ec933ebe1f", "prediction_text": "SLC49"}, "reference": {"id": "5cbb361a862c4d7a9fbcd1ec933ebe1f", "answers": {"answer_start": [843], "text": ["SLC49"]}}}, "04112b226587411386cd362ac05dbe26": {"prediction": {"id": "04112b226587411386cd362ac05dbe26", "prediction_text": "receptor"}, "reference": {"id": "04112b226587411386cd362ac05dbe26", "answers": {"answer_start": [115], "text": ["Apelin, a small regulatory peptide, is the endogenous ligand for the apelin receptor (APJ) receptor."]}}}, "82bc950287604a00a2f9050901fc3be6": {"prediction": {"id": "82bc950287604a00a2f9050901fc3be6", "prediction_text": "enzyme complex SWR1"}, "reference": {"id": "82bc950287604a00a2f9050901fc3be6", "answers": {"answer_start": [500], "text": ["SWR1"]}}}, "da63c0e6b8f641068aabad5e6e6101ce": {"prediction": {"id": "da63c0e6b8f641068aabad5e6e6101ce", "prediction_text": "fourteen-subunit SWR1 complex"}, "reference": {"id": "da63c0e6b8f641068aabad5e6e6101ce", "answers": {"answer_start": [636], "text": ["SWR1"]}}}, "02b1f92e8b7540f0939f895c8748c517": {"prediction": {"id": "02b1f92e8b7540f0939f895c8748c517", "prediction_text": "H2A.Z and Mcd1"}, "reference": {"id": "02b1f92e8b7540f0939f895c8748c517", "answers": {"answer_start": [854], "text": ["SWR1"]}}}, "781bc2dd683a4e4891f937b03cfe576b": {"prediction": {"id": "781bc2dd683a4e4891f937b03cfe576b", "prediction_text": "htz1Delta the nucleosome"}, "reference": {"id": "781bc2dd683a4e4891f937b03cfe576b", "answers": {"answer_start": [1007], "text": ["SWR1"]}}}, "af345616841a40ce95adc0d75a2f42e0": {"prediction": {"id": "af345616841a40ce95adc0d75a2f42e0", "prediction_text": "histone H2A"}, "reference": {"id": "af345616841a40ce95adc0d75a2f42e0", "answers": {"answer_start": [526], "text": ["SWR1"]}}}, "37442d3c06884c978222b4ae7bb0c73f": {"prediction": {"id": "37442d3c06884c978222b4ae7bb0c73f", "prediction_text": "SWR1"}, "reference": {"id": "37442d3c06884c978222b4ae7bb0c73f", "answers": {"answer_start": [824], "text": ["SWR1"]}}}, "cfd836fb5efe49bfacf92d293fbd050f": {"prediction": {"id": "cfd836fb5efe49bfacf92d293fbd050f", "prediction_text": "SWR1"}, "reference": {"id": "cfd836fb5efe49bfacf92d293fbd050f", "answers": {"answer_start": [239], "text": ["SWR1"]}}}, "d5f0f971b16f404785f3132ced7ac212": {"prediction": {"id": "d5f0f971b16f404785f3132ced7ac212", "prediction_text": "chromatin remodeler SWR1"}, "reference": {"id": "d5f0f971b16f404785f3132ced7ac212", "answers": {"answer_start": [646], "text": ["SWR1"]}}}, "e1c31e665f9f456db5ef79fa707988fc": {"prediction": {"id": "e1c31e665f9f456db5ef79fa707988fc", "prediction_text": "centromere"}, "reference": {"id": "e1c31e665f9f456db5ef79fa707988fc", "answers": {"answer_start": [368], "text": ["SWR1"]}}}, "d8337ebbd7fe4bc783f218e4d6ca481c": {"prediction": {"id": "d8337ebbd7fe4bc783f218e4d6ca481c", "prediction_text": "SWR1 complex"}, "reference": {"id": "d8337ebbd7fe4bc783f218e4d6ca481c", "answers": {"answer_start": [140], "text": ["SWR1"]}}}, "49eb5738364947c4af56726604cc94b7": {"prediction": {"id": "49eb5738364947c4af56726604cc94b7", "prediction_text": "histone"}, "reference": {"id": "49eb5738364947c4af56726604cc94b7", "answers": {"answer_start": [159], "text": ["SWR1"]}}}, "1413c2b895a84f20bdf59648e852bbbf": {"prediction": {"id": "1413c2b895a84f20bdf59648e852bbbf", "prediction_text": "Swc4p protein, encoded by an essential gene, is shared by two chromatin-remodeling complexes in Saccharomyces cerevisiae cells: NuA4 (nucleosome acetyltransferase of H4) and SWR1. The SWR1 complex catalyzes ATP-dependent exchange of the nucleosomal histone H2A for H2AZ (Htz1p). The activity of NuA4 is responsible mainly for the acetylation of the H4 histone but also for the acetylation of H2A and H2AZ. In this work we investigated the role of the Swc4p"}, "reference": {"id": "1413c2b895a84f20bdf59648e852bbbf", "answers": {"answer_start": [178], "text": ["SWR1"]}}}, "c82f0d88022143c6a4a158d72cd99c56": {"prediction": {"id": "c82f0d88022143c6a4a158d72cd99c56", "prediction_text": "histone H2A"}, "reference": {"id": "c82f0d88022143c6a4a158d72cd99c56", "answers": {"answer_start": [611], "text": ["SWR1"]}}}, "ed4e1b28892c4b99bf1e307b6c49464e": {"prediction": {"id": "ed4e1b28892c4b99bf1e307b6c49464e", "prediction_text": "SWR1"}, "reference": {"id": "ed4e1b28892c4b99bf1e307b6c49464e", "answers": {"answer_start": [403], "text": ["SWR1"]}}}, "16181fd9d4da4d13853ba8e3437d790b": {"prediction": {"id": "16181fd9d4da4d13853ba8e3437d790b", "prediction_text": "vs viral infections"}, "reference": {"id": "16181fd9d4da4d13853ba8e3437d790b", "answers": {"answer_start": [984], "text": ["pneumonia"]}}}, "fbe595656f144fa79c17d87efdd7ac68": {"prediction": {"id": "fbe595656f144fa79c17d87efdd7ac68", "prediction_text": "SEWS"}, "reference": {"id": "fbe595656f144fa79c17d87efdd7ac68", "answers": {"answer_start": [72], "text": ["pneumonia"]}}}, "a8e59bc29b37467ca216347e42d2e499": {"prediction": {"id": "a8e59bc29b37467ca216347e42d2e499", "prediction_text": "pneumonia"}, "reference": {"id": "a8e59bc29b37467ca216347e42d2e499", "answers": {"answer_start": [1588], "text": ["pneumonia"]}}}, "410f6f2462334ef0937e7581194fe7ed": {"prediction": {"id": "410f6f2462334ef0937e7581194fe7ed", "prediction_text": "pneumonia"}, "reference": {"id": "410f6f2462334ef0937e7581194fe7ed", "answers": {"answer_start": [105], "text": ["pneumonia"]}}}, "2210a77d69cf431c9b790ca927d030c1": {"prediction": {"id": "2210a77d69cf431c9b790ca927d030c1", "prediction_text": "pneumonia"}, "reference": {"id": "2210a77d69cf431c9b790ca927d030c1", "answers": {"answer_start": [274], "text": ["pneumonia"]}}}, "480dda4804f54d24b103172c2e88b982": {"prediction": {"id": "480dda4804f54d24b103172c2e88b982", "prediction_text": "Gram-negative pathogens"}, "reference": {"id": "480dda4804f54d24b103172c2e88b982", "answers": {"answer_start": [19], "text": ["pneumonia"]}}}, "74b45364218845f0ab613e596f08e73e": {"prediction": {"id": "74b45364218845f0ab613e596f08e73e", "prediction_text": "pneumonia"}, "reference": {"id": "74b45364218845f0ab613e596f08e73e", "answers": {"answer_start": [134], "text": ["pneumonia"]}}}, "5c8da681fdb54df5930f8fe2a072c066": {"prediction": {"id": "5c8da681fdb54df5930f8fe2a072c066", "prediction_text": "MR-pro-ADM"}, "reference": {"id": "5c8da681fdb54df5930f8fe2a072c066", "answers": {"answer_start": [320], "text": ["pneumonia"]}}}, "53eef6b66e624bccaa3c21f00d0cbb4f": {"prediction": {"id": "53eef6b66e624bccaa3c21f00d0cbb4f", "prediction_text": "ammonia"}, "reference": {"id": "53eef6b66e624bccaa3c21f00d0cbb4f", "answers": {"answer_start": [387], "text": ["Amanita phalloides"]}}}, "b67a2027f73a46bcb456bd1efd42170e": {"prediction": {"id": "b67a2027f73a46bcb456bd1efd42170e", "prediction_text": "Eco R1 enzyme"}, "reference": {"id": "b67a2027f73a46bcb456bd1efd42170e", "answers": {"answer_start": [267], "text": ["E coli"]}}}, "19baaff5235b468bbdb7d878c6e573e5": {"prediction": {"id": "19baaff5235b468bbdb7d878c6e573e5", "prediction_text": "filaggrin monomers"}, "reference": {"id": "19baaff5235b468bbdb7d878c6e573e5", "answers": {"answer_start": [582], "text": ["Intermediate filaments"]}}}, "4a882cf160494bb09059f668d33b4596": {"prediction": {"id": "4a882cf160494bb09059f668d33b4596", "prediction_text": "transport, mitosis, secretion, formation of cell extensions, intercellular communication and apoptosis"}, "reference": {"id": "4a882cf160494bb09059f668d33b4596", "answers": {"answer_start": [112], "text": ["Intermediate filaments"]}}}, "8fcac8bdad9a45cda86f814222948f4b": {"prediction": {"id": "8fcac8bdad9a45cda86f814222948f4b", "prediction_text": "scaffold"}, "reference": {"id": "8fcac8bdad9a45cda86f814222948f4b", "answers": {"answer_start": [519], "text": ["Intermediate filaments"]}}}, "956d82d55b12474db1436cb81f792d53": {"prediction": {"id": "956d82d55b12474db1436cb81f792d53", "prediction_text": "cytoskeletal networks"}, "reference": {"id": "956d82d55b12474db1436cb81f792d53", "answers": {"answer_start": [106], "text": ["Intermediate filaments"]}}}, "0a60650965cc4192beaaf2c18173dc56": {"prediction": {"id": "0a60650965cc4192beaaf2c18173dc56", "prediction_text": "Bacillus anthracis"}, "reference": {"id": "0a60650965cc4192beaaf2c18173dc56", "answers": {"answer_start": [495], "text": ["CO2"]}}}, "ca34d63282994b51a74e644631737d27": {"prediction": {"id": "ca34d63282994b51a74e644631737d27", "prediction_text": "Bacillus anthracis"}, "reference": {"id": "ca34d63282994b51a74e644631737d27", "answers": {"answer_start": [797], "text": ["CO2"]}}}, "11a1787d778244e480cac6599c3ffc02": {"prediction": {"id": "11a1787d778244e480cac6599c3ffc02", "prediction_text": "anthrax toxins"}, "reference": {"id": "11a1787d778244e480cac6599c3ffc02", "answers": {"answer_start": [142, 130], "text": ["CO2", "bicarbonate"]}}}, "41e0a3f14d73459d849cd12ea163a6aa": {"prediction": {"id": "41e0a3f14d73459d849cd12ea163a6aa", "prediction_text": "B. anthracis"}, "reference": {"id": "41e0a3f14d73459d849cd12ea163a6aa", "answers": {"answer_start": [872], "text": ["CO2"]}}}, "f868c08573204cafb9811d7c2a58f965": {"prediction": {"id": "f868c08573204cafb9811d7c2a58f965", "prediction_text": "Bacillus anthracis are the tripartite toxin and the polyglutamate capsule, which are encoded by genes on the large plasmids, pXO1 and pXO2, respectively. The genes atxA, located on pXO1, and acpA, located on pXO2, encode positive trans-acting proteins that are involved in bicarbonate-mediated regulation of toxin and capsule production, respectively. A derivative strain cured of pXO1 produced less capsular substance than the parent strain harbouring both pXO1 and pXO2, and electroporation of the strain cured of pXO1 with a plasmid containing the cloned atxA gene resulted in an increased level of capsule production. An acpA-null mutant was complemented by not only acpA but also the atxA gene. The cap region, which is essential for encapsulation, contains three genes capB, capC, and capA, arranged in that order. The atxA gene stimulated capsule synthesis from the cloned cap region. Transcriptional analysis of cap by RNA slot-blot hybridization and primer-extension analysis revealed that atxA activated expression of cap in trans at the transcriptional level. These results indicate that cross-talk occurs, in which the pXO1-located gene"}, "reference": {"id": "f868c08573204cafb9811d7c2a58f965", "answers": {"answer_start": [1568], "text": ["bicarbonate"]}}}, "b22874cbe4a344ef86b2c04d42031f9c": {"prediction": {"id": "b22874cbe4a344ef86b2c04d42031f9c", "prediction_text": "Bacillus anthracis"}, "reference": {"id": "b22874cbe4a344ef86b2c04d42031f9c", "answers": {"answer_start": [1428], "text": ["bicarbonate"]}}}, "b5c03864b4964326a75402037a3c1074": {"prediction": {"id": "b5c03864b4964326a75402037a3c1074", "prediction_text": "hepatic reuptake"}, "reference": {"id": "b5c03864b4964326a75402037a3c1074", "answers": {"answer_start": [323], "text": ["Rotor syndrome"]}}}, "a7fb1211bb0346769483241650790b81": {"prediction": {"id": "a7fb1211bb0346769483241650790b81", "prediction_text": "hepatic reuptake"}, "reference": {"id": "a7fb1211bb0346769483241650790b81", "answers": {"answer_start": [323], "text": ["Rotor syndrome"]}}}, "1204283b3a4c4ac4991e326bbbee76f0": {"prediction": {"id": "1204283b3a4c4ac4991e326bbbee76f0", "prediction_text": "H19 and miR-675"}, "reference": {"id": "1204283b3a4c4ac4991e326bbbee76f0", "answers": {"answer_start": [135], "text": ["lncRNA H19"]}}}, "01552858f12f48d8a4eaa433424ffdab": {"prediction": {"id": "01552858f12f48d8a4eaa433424ffdab", "prediction_text": "Flotillin-1 and TSG-101"}, "reference": {"id": "01552858f12f48d8a4eaa433424ffdab", "answers": {"answer_start": [0], "text": ["Exosomes are a subset of extracellular vesicles (EVs) that have important roles in intercellular communication. They contain and carry bioactive molecules within their membranes which are delivered to target cells."]}}}, "38145c2c946348baa409b60b733c8b1b": {"prediction": {"id": "38145c2c946348baa409b60b733c8b1b", "prediction_text": "anti-IL-17"}, "reference": {"id": "38145c2c946348baa409b60b733c8b1b", "answers": {"answer_start": [48], "text": ["interleukin-17A"]}}}, "5def199552ad4b10a644ced468fc4d4d": {"prediction": {"id": "5def199552ad4b10a644ced468fc4d4d", "prediction_text": "serum"}, "reference": {"id": "5def199552ad4b10a644ced468fc4d4d", "answers": {"answer_start": [127], "text": ["interleukin-17A"]}}}, "ab1790f6818b4b5999bc2b98f24ce818": {"prediction": {"id": "ab1790f6818b4b5999bc2b98f24ce818", "prediction_text": "Secukinumab"}, "reference": {"id": "ab1790f6818b4b5999bc2b98f24ce818", "answers": {"answer_start": [32], "text": ["interleukin-17A"]}}}, "fa6b42a21a8f4f508430b5cd54f2d493": {"prediction": {"id": "fa6b42a21a8f4f508430b5cd54f2d493", "prediction_text": "Secukinumab"}, "reference": {"id": "fa6b42a21a8f4f508430b5cd54f2d493", "answers": {"answer_start": [34], "text": ["interleukin-17A"]}}}, "502f8b50484d4d889f18fc8f5013d228": {"prediction": {"id": "502f8b50484d4d889f18fc8f5013d228", "prediction_text": "interleukin-17A blockade"}, "reference": {"id": "502f8b50484d4d889f18fc8f5013d228", "answers": {"answer_start": [119], "text": ["interleukin-17A"]}}}, "be5f0f1283754c5b9725aeb8f34eefc0": {"prediction": {"id": "be5f0f1283754c5b9725aeb8f34eefc0", "prediction_text": "secukinumab"}, "reference": {"id": "be5f0f1283754c5b9725aeb8f34eefc0", "answers": {"answer_start": [0], "text": ["interleukin-17A"]}}}, "ffeb0c0df3a14686b1a5de9b296c34d3": {"prediction": {"id": "ffeb0c0df3a14686b1a5de9b296c34d3", "prediction_text": "cellular adhesion function"}, "reference": {"id": "ffeb0c0df3a14686b1a5de9b296c34d3", "answers": {"answer_start": [734], "text": ["Cellular adhesion function"]}}}, "5d553d21a35545ae9d19d6b00dd0bd3b": {"prediction": {"id": "5d553d21a35545ae9d19d6b00dd0bd3b", "prediction_text": "CNTO 328) is a monoclonal anti-IL-6"}, "reference": {"id": "5d553d21a35545ae9d19d6b00dd0bd3b", "answers": {"answer_start": [0], "text": ["interleukin-6"]}}}, "514ba464acd8404fa9789dee6d690fd2": {"prediction": {"id": "514ba464acd8404fa9789dee6d690fd2", "prediction_text": "IL-6"}, "reference": {"id": "514ba464acd8404fa9789dee6d690fd2", "answers": {"answer_start": [0], "text": ["interleukin-6"]}}}, "b627ad6ea2cf4f729a9b72d7fbe4800b": {"prediction": {"id": "b627ad6ea2cf4f729a9b72d7fbe4800b", "prediction_text": "EGFR"}, "reference": {"id": "b627ad6ea2cf4f729a9b72d7fbe4800b", "answers": {"answer_start": [887], "text": ["interleukin-6"]}}}, "00a9440a3432483084d5cf9f0b0edb75": {"prediction": {"id": "00a9440a3432483084d5cf9f0b0edb75", "prediction_text": "Stat3"}, "reference": {"id": "00a9440a3432483084d5cf9f0b0edb75", "answers": {"answer_start": [65], "text": ["interleukin-6"]}}}, "b2e118bda38b49a18686f4851135fdd4": {"prediction": {"id": "b2e118bda38b49a18686f4851135fdd4", "prediction_text": "EGFR"}, "reference": {"id": "b2e118bda38b49a18686f4851135fdd4", "answers": {"answer_start": [0], "text": ["interleukin-6"]}}}, "674957912be64616a2739ee2cbb5502d": {"prediction": {"id": "674957912be64616a2739ee2cbb5502d", "prediction_text": "S + B."}, "reference": {"id": "674957912be64616a2739ee2cbb5502d", "answers": {"answer_start": [63], "text": ["interleukin-6"]}}}, "0846a53165da45979aeb580bbafb9365": {"prediction": {"id": "0846a53165da45979aeb580bbafb9365", "prediction_text": "IL6"}, "reference": {"id": "0846a53165da45979aeb580bbafb9365", "answers": {"answer_start": [0], "text": ["interleukin-6"]}}}, "a0d0019b0dbb4e9a90b05bc6a41678e2": {"prediction": {"id": "a0d0019b0dbb4e9a90b05bc6a41678e2", "prediction_text": "CNTO 328"}, "reference": {"id": "a0d0019b0dbb4e9a90b05bc6a41678e2", "answers": {"answer_start": [0], "text": ["interleukin-6"]}}}, "891157c428b44d07a6295cc78a3f4954": {"prediction": {"id": "891157c428b44d07a6295cc78a3f4954", "prediction_text": "prostate cancer (CRPC) patients. We assessed the safety and tolerability of siltuximab in combination with docetaxel"}, "reference": {"id": "891157c428b44d07a6295cc78a3f4954", "answers": {"answer_start": [31], "text": ["interleukin-6"]}}}, "ce8dd49fd0a140e18d4792285c81c146": {"prediction": {"id": "ce8dd49fd0a140e18d4792285c81c146", "prediction_text": "unicentric CD"}, "reference": {"id": "ce8dd49fd0a140e18d4792285c81c146", "answers": {"answer_start": [0], "text": ["interleukin-6"]}}}, "6e3eb4ab73ca4968baacc2ad8f759c3a": {"prediction": {"id": "6e3eb4ab73ca4968baacc2ad8f759c3a", "prediction_text": "bortezomib and dexamethasone in Japanese patients with relapsed or refractory multiple myeloma. This open-label, phase 1"}, "reference": {"id": "6e3eb4ab73ca4968baacc2ad8f759c3a", "answers": {"answer_start": [82], "text": ["interleukin-6"]}}}, "4cb24e8978564e5db94b236b2bf184ba": {"prediction": {"id": "4cb24e8978564e5db94b236b2bf184ba", "prediction_text": "Expression"}, "reference": {"id": "4cb24e8978564e5db94b236b2bf184ba", "answers": {"answer_start": [42], "text": ["interleukin-6"]}}}, "fc35f819679f4b24bc74b73159f9c49e": {"prediction": {"id": "fc35f819679f4b24bc74b73159f9c49e", "prediction_text": "BCR-ABL"}, "reference": {"id": "fc35f819679f4b24bc74b73159f9c49e", "answers": {"answer_start": [505], "text": ["BCR-ABL"]}}}, "811f20c005cc4765aca992fe7c45cee0": {"prediction": {"id": "811f20c005cc4765aca992fe7c45cee0", "prediction_text": "BCR-ABL"}, "reference": {"id": "811f20c005cc4765aca992fe7c45cee0", "answers": {"answer_start": [609], "text": ["BCR-ABL"]}}}, "df8bf177c09044aba25f1b40b62e0fbc": {"prediction": {"id": "df8bf177c09044aba25f1b40b62e0fbc", "prediction_text": "BCR-ABL"}, "reference": {"id": "df8bf177c09044aba25f1b40b62e0fbc", "answers": {"answer_start": [559], "text": ["BCR-ABL"]}}}, "07f7fd53c4e6499f8fb17dd14d11f628": {"prediction": {"id": "07f7fd53c4e6499f8fb17dd14d11f628", "prediction_text": "BCR-ABL"}, "reference": {"id": "07f7fd53c4e6499f8fb17dd14d11f628", "answers": {"answer_start": [291], "text": ["BCR-ABL"]}}}, "a46daa08292040bbb7b61cb4dab3aebc": {"prediction": {"id": "a46daa08292040bbb7b61cb4dab3aebc", "prediction_text": "BCR-ABL"}, "reference": {"id": "a46daa08292040bbb7b61cb4dab3aebc", "answers": {"answer_start": [1032], "text": ["BCR-ABL"]}}}, "e4ed80dbeb804b3c9202fa5198bbcd42": {"prediction": {"id": "e4ed80dbeb804b3c9202fa5198bbcd42", "prediction_text": "Bcr-Abl"}, "reference": {"id": "e4ed80dbeb804b3c9202fa5198bbcd42", "answers": {"answer_start": [44], "text": ["BCR-ABL"]}}}, "d2386b80ec67423eae8625bcf696dd26": {"prediction": {"id": "d2386b80ec67423eae8625bcf696dd26", "prediction_text": "BCR-ABL"}, "reference": {"id": "d2386b80ec67423eae8625bcf696dd26", "answers": {"answer_start": [995], "text": ["BCR-ABL"]}}}, "1653023a99114066b65ddb282681acbd": {"prediction": {"id": "1653023a99114066b65ddb282681acbd", "prediction_text": "ABL"}, "reference": {"id": "1653023a99114066b65ddb282681acbd", "answers": {"answer_start": [133], "text": ["BCR-ABL"]}}}, "e2579adb35664ac3b95116f73de7b51b": {"prediction": {"id": "e2579adb35664ac3b95116f73de7b51b", "prediction_text": "P210 BCR-ABL"}, "reference": {"id": "e2579adb35664ac3b95116f73de7b51b", "answers": {"answer_start": [361], "text": ["BCR-ABL"]}}}, "6156bb5fe1e44b5f9b339e0893af594f": {"prediction": {"id": "6156bb5fe1e44b5f9b339e0893af594f", "prediction_text": "imatinib"}, "reference": {"id": "6156bb5fe1e44b5f9b339e0893af594f", "answers": {"answer_start": [133], "text": ["BCR-ABL"]}}}, "3adffa605a904309849c2a3f50eb237a": {"prediction": {"id": "3adffa605a904309849c2a3f50eb237a", "prediction_text": "bcr-abl"}, "reference": {"id": "3adffa605a904309849c2a3f50eb237a", "answers": {"answer_start": [1284], "text": ["BCR-ABL"]}}}, "e19829974cee49fdabb464fbba01e824": {"prediction": {"id": "e19829974cee49fdabb464fbba01e824", "prediction_text": "inhibitors"}, "reference": {"id": "e19829974cee49fdabb464fbba01e824", "answers": {"answer_start": [1199], "text": ["BCR-ABL"]}}}, "70f3e56519f6465587a9002f5668af18": {"prediction": {"id": "70f3e56519f6465587a9002f5668af18", "prediction_text": "BCR-ABL"}, "reference": {"id": "70f3e56519f6465587a9002f5668af18", "answers": {"answer_start": [1409], "text": ["BCR-ABL"]}}}, "119f718041b24e06a2fbab711b828d29": {"prediction": {"id": "119f718041b24e06a2fbab711b828d29", "prediction_text": "BCR-ABL"}, "reference": {"id": "119f718041b24e06a2fbab711b828d29", "answers": {"answer_start": [281], "text": ["BCR-ABL"]}}}, "232a49a7f5e948f9bb4ca945967c75d8": {"prediction": {"id": "232a49a7f5e948f9bb4ca945967c75d8", "prediction_text": "BCR-ABL"}, "reference": {"id": "232a49a7f5e948f9bb4ca945967c75d8", "answers": {"answer_start": [169], "text": ["BCR-ABL"]}}}, "dbfaa69a8f754e1ea7d895e919403ef8": {"prediction": {"id": "dbfaa69a8f754e1ea7d895e919403ef8", "prediction_text": "Bcr-Abl"}, "reference": {"id": "dbfaa69a8f754e1ea7d895e919403ef8", "answers": {"answer_start": [1070], "text": ["BCR-ABL"]}}}, "4e91fcd5041e4529afdfd3424e0ed781": {"prediction": {"id": "4e91fcd5041e4529afdfd3424e0ed781", "prediction_text": "inhibitor"}, "reference": {"id": "4e91fcd5041e4529afdfd3424e0ed781", "answers": {"answer_start": [319], "text": ["BCR-ABL"]}}}, "351b1c6b494a4c13bf7ce4e83ead488e": {"prediction": {"id": "351b1c6b494a4c13bf7ce4e83ead488e", "prediction_text": "Abl"}, "reference": {"id": "351b1c6b494a4c13bf7ce4e83ead488e", "answers": {"answer_start": [203], "text": ["BCR-ABL"]}}}, "33e8a549e2814e9791932cef0938af36": {"prediction": {"id": "33e8a549e2814e9791932cef0938af36", "prediction_text": "CML) accounts for 15-20% of adult leukemias but is very rare in children (2%). Fewer than 10% of CML patients are younger than 20 years. CML is a myeloproliferative disorder characterized by the presence of the Philadelphia chromosome or the BCR-ABL"}, "reference": {"id": "33e8a549e2814e9791932cef0938af36", "answers": {"answer_start": [720], "text": ["BCR-ABL"]}}}, "4784746f3cfa4612888fb42cd3658c2a": {"prediction": {"id": "4784746f3cfa4612888fb42cd3658c2a", "prediction_text": "BCR-ABL"}, "reference": {"id": "4784746f3cfa4612888fb42cd3658c2a", "answers": {"answer_start": [30], "text": ["BCR-ABL"]}}}, "b338b784fb9943b796352226a89367f1": {"prediction": {"id": "b338b784fb9943b796352226a89367f1", "prediction_text": "CML"}, "reference": {"id": "b338b784fb9943b796352226a89367f1", "answers": {"answer_start": [394], "text": ["BCR-ABL"]}}}, "6452e35128684b0ea1d79b2cb20f6bbb": {"prediction": {"id": "6452e35128684b0ea1d79b2cb20f6bbb", "prediction_text": "Bcr and Abl"}, "reference": {"id": "6452e35128684b0ea1d79b2cb20f6bbb", "answers": {"answer_start": [243], "text": ["BCR-ABL"]}}}, "2393c37639004876ab27f019519a205e": {"prediction": {"id": "2393c37639004876ab27f019519a205e", "prediction_text": "BCR-ABL"}, "reference": {"id": "2393c37639004876ab27f019519a205e", "answers": {"answer_start": [866], "text": ["BCR-ABL"]}}}, "dff5a167837a43b68bf80815c1f7cd67": {"prediction": {"id": "dff5a167837a43b68bf80815c1f7cd67", "prediction_text": "BCR-ABL"}, "reference": {"id": "dff5a167837a43b68bf80815c1f7cd67", "answers": {"answer_start": [172], "text": ["BCR-ABL"]}}}, "9a98dda6ffa54a88be72e51b0fa09143": {"prediction": {"id": "9a98dda6ffa54a88be72e51b0fa09143", "prediction_text": "inhibitors (TKI) began in 1998 and today the use of the original TKI"}, "reference": {"id": "9a98dda6ffa54a88be72e51b0fa09143", "answers": {"answer_start": [735], "text": ["BCR-ABL"]}}}, "c73ea80f7fbe44b7a832d275a6adf121": {"prediction": {"id": "c73ea80f7fbe44b7a832d275a6adf121", "prediction_text": "BCR-ABL"}, "reference": {"id": "c73ea80f7fbe44b7a832d275a6adf121", "answers": {"answer_start": [465], "text": ["BCR-ABL"]}}}, "e46eeefd139c40d0beadc5759b2a28b8": {"prediction": {"id": "e46eeefd139c40d0beadc5759b2a28b8", "prediction_text": "BCR-ABL"}, "reference": {"id": "e46eeefd139c40d0beadc5759b2a28b8", "answers": {"answer_start": [317], "text": ["BCR-ABL"]}}}, "397d5afcb1914134b1eb15fc57f2d669": {"prediction": {"id": "397d5afcb1914134b1eb15fc57f2d669", "prediction_text": "Imatinib mesylate, a selective Bcr-Abl"}, "reference": {"id": "397d5afcb1914134b1eb15fc57f2d669", "answers": {"answer_start": [31], "text": ["BCR-ABL"]}}}, "ff9aa7daa876467c8abade014133438f": {"prediction": {"id": "ff9aa7daa876467c8abade014133438f", "prediction_text": "inhibitors"}, "reference": {"id": "ff9aa7daa876467c8abade014133438f", "answers": {"answer_start": [324], "text": ["BCR-ABL"]}}}, "ee509a3a62404d5c9639f64df3cbe456": {"prediction": {"id": "ee509a3a62404d5c9639f64df3cbe456", "prediction_text": "protein-tyrosine"}, "reference": {"id": "ee509a3a62404d5c9639f64df3cbe456", "answers": {"answer_start": [242], "text": ["BCR-ABL"]}}}, "5c2d1df5d89f4012b23e1d15dc0667f5": {"prediction": {"id": "5c2d1df5d89f4012b23e1d15dc0667f5", "prediction_text": "inhibitor"}, "reference": {"id": "5c2d1df5d89f4012b23e1d15dc0667f5", "answers": {"answer_start": [1195], "text": ["BCR-ABL"]}}}, "2c167cd911ba4b519c8f652b465f5b07": {"prediction": {"id": "2c167cd911ba4b519c8f652b465f5b07", "prediction_text": "CML"}, "reference": {"id": "2c167cd911ba4b519c8f652b465f5b07", "answers": {"answer_start": [797], "text": ["BCR-ABL"]}}}, "c39453d1ea1e4e29a6a90d26b015f814": {"prediction": {"id": "c39453d1ea1e4e29a6a90d26b015f814", "prediction_text": "BCR-ABL"}, "reference": {"id": "c39453d1ea1e4e29a6a90d26b015f814", "answers": {"answer_start": [655], "text": ["BCR-ABL"]}}}, "46d6e40a14a643d28b105852f10c99da": {"prediction": {"id": "46d6e40a14a643d28b105852f10c99da", "prediction_text": "constitutive"}, "reference": {"id": "46d6e40a14a643d28b105852f10c99da", "answers": {"answer_start": [183], "text": ["BCR-ABL"]}}}, "14f253a281f94594b314ad0d9b79a311": {"prediction": {"id": "14f253a281f94594b314ad0d9b79a311", "prediction_text": "Bcr-Abl"}, "reference": {"id": "14f253a281f94594b314ad0d9b79a311", "answers": {"answer_start": [506], "text": ["BCR-ABL"]}}}, "2f9d8ce54b754f33af316e9c54238181": {"prediction": {"id": "2f9d8ce54b754f33af316e9c54238181", "prediction_text": "Abl/Src"}, "reference": {"id": "2f9d8ce54b754f33af316e9c54238181", "answers": {"answer_start": [779], "text": ["BCR-ABL"]}}}, "9923a9fc49df40c79d8cb1e000870404": {"prediction": {"id": "9923a9fc49df40c79d8cb1e000870404", "prediction_text": "BCR-ABL"}, "reference": {"id": "9923a9fc49df40c79d8cb1e000870404", "answers": {"answer_start": [52], "text": ["BCR-ABL"]}}}, "226dbe62532a470fa2285603602bccbd": {"prediction": {"id": "226dbe62532a470fa2285603602bccbd", "prediction_text": "deregulated"}, "reference": {"id": "226dbe62532a470fa2285603602bccbd", "answers": {"answer_start": [476], "text": ["BCR-ABL"]}}}, "e3477da591774c6d9ea308a8b6260c3c": {"prediction": {"id": "e3477da591774c6d9ea308a8b6260c3c", "prediction_text": "Bcr-Abl"}, "reference": {"id": "e3477da591774c6d9ea308a8b6260c3c", "answers": {"answer_start": [376], "text": ["BCR-ABL"]}}}, "c167825d7d2a45ab802a100503a94a89": {"prediction": {"id": "c167825d7d2a45ab802a100503a94a89", "prediction_text": "BCR-ABL"}, "reference": {"id": "c167825d7d2a45ab802a100503a94a89", "answers": {"answer_start": [949], "text": ["BCR-ABL"]}}}, "1937524789d647cb8f8c9cfd997bee6c": {"prediction": {"id": "1937524789d647cb8f8c9cfd997bee6c", "prediction_text": "CML). Imatinib mesylate (STI571), a specific Bcr-Abl"}, "reference": {"id": "1937524789d647cb8f8c9cfd997bee6c", "answers": {"answer_start": [238], "text": ["BCR-ABL"]}}}, "e91ddf3db22647469e705def432b29fd": {"prediction": {"id": "e91ddf3db22647469e705def432b29fd", "prediction_text": "deregulated"}, "reference": {"id": "e91ddf3db22647469e705def432b29fd", "answers": {"answer_start": [73], "text": ["BCR-ABL"]}}}, "998ed8225b73494ca8239591e92d4f42": {"prediction": {"id": "998ed8225b73494ca8239591e92d4f42", "prediction_text": "Bcr-Abl"}, "reference": {"id": "998ed8225b73494ca8239591e92d4f42", "answers": {"answer_start": [445], "text": ["BCR-ABL"]}}}, "00f7a3a6932d479b961e6c4cef657286": {"prediction": {"id": "00f7a3a6932d479b961e6c4cef657286", "prediction_text": "BCR-ABL"}, "reference": {"id": "00f7a3a6932d479b961e6c4cef657286", "answers": {"answer_start": [283], "text": ["BCR-ABL"]}}}, "931ec46d26794bc7a9b8aacf346d4881": {"prediction": {"id": "931ec46d26794bc7a9b8aacf346d4881", "prediction_text": "BCR-ABL"}, "reference": {"id": "931ec46d26794bc7a9b8aacf346d4881", "answers": {"answer_start": [805], "text": ["BCR-ABL"]}}}, "c3af056fbabf4960a519668a011a813a": {"prediction": {"id": "c3af056fbabf4960a519668a011a813a", "prediction_text": "Imatinib"}, "reference": {"id": "c3af056fbabf4960a519668a011a813a", "answers": {"answer_start": [76], "text": ["BCR-ABL"]}}}, "fb77018014654535b02870202e5360de": {"prediction": {"id": "fb77018014654535b02870202e5360de", "prediction_text": "BCR-ABL"}, "reference": {"id": "fb77018014654535b02870202e5360de", "answers": {"answer_start": [23], "text": ["BCR-ABL"]}}}, "2349801994b34bf789b102d29157209c": {"prediction": {"id": "2349801994b34bf789b102d29157209c", "prediction_text": "CML"}, "reference": {"id": "2349801994b34bf789b102d29157209c", "answers": {"answer_start": [522], "text": ["BCR-ABL"]}}}, "c9b7d58fef7849d9ad2416123b7376e4": {"prediction": {"id": "c9b7d58fef7849d9ad2416123b7376e4", "prediction_text": "BCR-ABL TKIs"}, "reference": {"id": "c9b7d58fef7849d9ad2416123b7376e4", "answers": {"answer_start": [1287], "text": ["BCR-ABL"]}}}, "3e19f883e414483287de4f9e5954755e": {"prediction": {"id": "3e19f883e414483287de4f9e5954755e", "prediction_text": "Imatinib"}, "reference": {"id": "3e19f883e414483287de4f9e5954755e", "answers": {"answer_start": [134], "text": ["BCR-ABL"]}}}, "22a69a78fc994b80bb6025f4a2149e86": {"prediction": {"id": "22a69a78fc994b80bb6025f4a2149e86", "prediction_text": "BCR-ABL"}, "reference": {"id": "22a69a78fc994b80bb6025f4a2149e86", "answers": {"answer_start": [794], "text": ["BCR-ABL"]}}}, "a96475dda6ab408a8f7a5f1cdb44c1b7": {"prediction": {"id": "a96475dda6ab408a8f7a5f1cdb44c1b7", "prediction_text": "inhibitor"}, "reference": {"id": "a96475dda6ab408a8f7a5f1cdb44c1b7", "answers": {"answer_start": [853], "text": ["BCR-ABL"]}}}, "b8cf783d86674873a689abe6e1de1f73": {"prediction": {"id": "b8cf783d86674873a689abe6e1de1f73", "prediction_text": "Bcr-Abl"}, "reference": {"id": "b8cf783d86674873a689abe6e1de1f73", "answers": {"answer_start": [268], "text": ["BCR-ABL"]}}}, "43f02e81ceb84c49b3370167ba03945c": {"prediction": {"id": "43f02e81ceb84c49b3370167ba03945c", "prediction_text": "BCR-ABL"}, "reference": {"id": "43f02e81ceb84c49b3370167ba03945c", "answers": {"answer_start": [572], "text": ["BCR-ABL"]}}}, "534629e2188e41e2996ebb28de2b079a": {"prediction": {"id": "534629e2188e41e2996ebb28de2b079a", "prediction_text": "BCR-ABL on the 22q- (Ph chromosome) and the reciprocal ABL-BCR on 9q-. The BCR-ABL gene encodes for a 210-kD protein with deregulated"}, "reference": {"id": "534629e2188e41e2996ebb28de2b079a", "answers": {"answer_start": [332], "text": ["BCR-ABL"]}}}, "8cae6112866e4f69bb187e3217f23934": {"prediction": {"id": "8cae6112866e4f69bb187e3217f23934", "prediction_text": "BCR-ABL"}, "reference": {"id": "8cae6112866e4f69bb187e3217f23934", "answers": {"answer_start": [69], "text": ["BCR-ABL"]}}}, "226990634afb4104bd0fd9da6d9c7369": {"prediction": {"id": "226990634afb4104bd0fd9da6d9c7369", "prediction_text": "Bcr-Abl"}, "reference": {"id": "226990634afb4104bd0fd9da6d9c7369", "answers": {"answer_start": [606], "text": ["BCR-ABL"]}}}, "550299c2df244df895ef119f0a60c496": {"prediction": {"id": "550299c2df244df895ef119f0a60c496", "prediction_text": "Imatinib"}, "reference": {"id": "550299c2df244df895ef119f0a60c496", "answers": {"answer_start": [1058], "text": ["BCR-ABL"]}}}, "429ea654b2364794adb7a7b9285abbb9": {"prediction": {"id": "429ea654b2364794adb7a7b9285abbb9", "prediction_text": "BCR-ABL"}, "reference": {"id": "429ea654b2364794adb7a7b9285abbb9", "answers": {"answer_start": [488], "text": ["BCR-ABL"]}}}, "d02b324ddb9a4de6bd9b19b61cd64c6f": {"prediction": {"id": "d02b324ddb9a4de6bd9b19b61cd64c6f", "prediction_text": "BCR-ABL"}, "reference": {"id": "d02b324ddb9a4de6bd9b19b61cd64c6f", "answers": {"answer_start": [765], "text": ["BCR-ABL"]}}}, "20ec140826864395887cab69a4784fc8": {"prediction": {"id": "20ec140826864395887cab69a4784fc8", "prediction_text": "CML) was the first human malignancy to be associated with a single genetic abnormality, characterized by a reciprocal translocation involving chromosomes 9 and 22 (the Philadelphia chromosome). The fusion gene that results (BCR-ABL) produces a constitutively"}, "reference": {"id": "20ec140826864395887cab69a4784fc8", "answers": {"answer_start": [250], "text": ["BCR-ABL"]}}}, "ffa13314228144daa6935c6da8478a49": {"prediction": {"id": "ffa13314228144daa6935c6da8478a49", "prediction_text": "Bcr-Abl"}, "reference": {"id": "ffa13314228144daa6935c6da8478a49", "answers": {"answer_start": [260], "text": ["BCR-ABL"]}}}, "b6879ce054ae45e2950b250fcf0ec45e": {"prediction": {"id": "b6879ce054ae45e2950b250fcf0ec45e", "prediction_text": "inhibitors (TKIs) has considerably changed the management of Philadelphia chromosome positive leukemia. The BCR-ABL inhibitor imatinib is also known to inhibit the tyrosine kinase of the stem cell factor receptor, c-Kit"}, "reference": {"id": "b6879ce054ae45e2950b250fcf0ec45e", "answers": {"answer_start": [144], "text": ["BCR-ABL"]}}}, "6382242f16e3410295e6afeb01ddd6b8": {"prediction": {"id": "6382242f16e3410295e6afeb01ddd6b8", "prediction_text": "BCR/ABL"}, "reference": {"id": "6382242f16e3410295e6afeb01ddd6b8", "answers": {"answer_start": [1397], "text": ["BCR-ABL"]}}}, "47d3d41d02524742aba771a10b88b7f2": {"prediction": {"id": "47d3d41d02524742aba771a10b88b7f2", "prediction_text": "Abl TK"}, "reference": {"id": "47d3d41d02524742aba771a10b88b7f2", "answers": {"answer_start": [147], "text": ["BCR-ABL"]}}}, "731ded8cdd2c49b1b48f28b0ab2a10e1": {"prediction": {"id": "731ded8cdd2c49b1b48f28b0ab2a10e1", "prediction_text": "Bcr-Abl"}, "reference": {"id": "731ded8cdd2c49b1b48f28b0ab2a10e1", "answers": {"answer_start": [238], "text": ["BCR-ABL"]}}}, "22ba178c3c3344b48ad5b1aee2483cbc": {"prediction": {"id": "22ba178c3c3344b48ad5b1aee2483cbc", "prediction_text": "TKIs"}, "reference": {"id": "22ba178c3c3344b48ad5b1aee2483cbc", "answers": {"answer_start": [432], "text": ["BCR-ABL"]}}}, "61bd209a29254a16ab8f13f7999cf630": {"prediction": {"id": "61bd209a29254a16ab8f13f7999cf630", "prediction_text": "ABL"}, "reference": {"id": "61bd209a29254a16ab8f13f7999cf630", "answers": {"answer_start": [447], "text": ["BCR-ABL"]}}}, "6a3805c4679f405db30c552de11c6015": {"prediction": {"id": "6a3805c4679f405db30c552de11c6015", "prediction_text": "ABL"}, "reference": {"id": "6a3805c4679f405db30c552de11c6015", "answers": {"answer_start": [944], "text": ["BCR-ABL"]}}}, "5c7a424d70a04c6b9d8374b9377abdc1": {"prediction": {"id": "5c7a424d70a04c6b9d8374b9377abdc1", "prediction_text": "Imatinib mesylate, a selective BCR-ABL"}, "reference": {"id": "5c7a424d70a04c6b9d8374b9377abdc1", "answers": {"answer_start": [398], "text": ["BCR-ABL"]}}}, "8a6bfecdcb554bb4824cbc4c4e9b8478": {"prediction": {"id": "8a6bfecdcb554bb4824cbc4c4e9b8478", "prediction_text": "p210(Bcr-Abl"}, "reference": {"id": "8a6bfecdcb554bb4824cbc4c4e9b8478", "answers": {"answer_start": [374], "text": ["BCR-ABL"]}}}, "914727a1412645a99ba6bb20f071d7ec": {"prediction": {"id": "914727a1412645a99ba6bb20f071d7ec", "prediction_text": "BCr-ABL"}, "reference": {"id": "914727a1412645a99ba6bb20f071d7ec", "answers": {"answer_start": [1381], "text": ["BCR-ABL"]}}}, "016c386cd2824cf998c5440bc35e4afa": {"prediction": {"id": "016c386cd2824cf998c5440bc35e4afa", "prediction_text": "Imatinib mesylate, a selective Bcr-Abl"}, "reference": {"id": "016c386cd2824cf998c5440bc35e4afa", "answers": {"answer_start": [31], "text": ["BCR-ABL"]}}}, "f6a300304b7e4ff49ffd896aba86da40": {"prediction": {"id": "f6a300304b7e4ff49ffd896aba86da40", "prediction_text": "Bcr-Abl"}, "reference": {"id": "f6a300304b7e4ff49ffd896aba86da40", "answers": {"answer_start": [103], "text": ["BCR-ABL"]}}}, "e9377935852047c1a781cf47fd95e537": {"prediction": {"id": "e9377935852047c1a781cf47fd95e537", "prediction_text": "Staphylococcus aureus"}, "reference": {"id": "e9377935852047c1a781cf47fd95e537", "answers": {"answer_start": [86], "text": ["MRSA"]}}}, "21a094a657e64f43959c6acc105e1a96": {"prediction": {"id": "21a094a657e64f43959c6acc105e1a96", "prediction_text": "Staphylococcus aureus"}, "reference": {"id": "21a094a657e64f43959c6acc105e1a96", "answers": {"answer_start": [203], "text": ["MRSA"]}}}, "a89601ff6cb14156b59b4f66e1a7671e": {"prediction": {"id": "a89601ff6cb14156b59b4f66e1a7671e", "prediction_text": "CA-MRSA"}, "reference": {"id": "a89601ff6cb14156b59b4f66e1a7671e", "answers": {"answer_start": [307], "text": ["MRSA"]}}}, "d2aa4a47814f4460b3e370171ba60bca": {"prediction": {"id": "d2aa4a47814f4460b3e370171ba60bca", "prediction_text": "Staphylococcus aureus"}, "reference": {"id": "d2aa4a47814f4460b3e370171ba60bca", "answers": {"answer_start": [533], "text": ["MRSA"]}}}, "140e6d633680451c9240fdc75429198f": {"prediction": {"id": "140e6d633680451c9240fdc75429198f", "prediction_text": "Staphylococcus aureus"}, "reference": {"id": "140e6d633680451c9240fdc75429198f", "answers": {"answer_start": [1448], "text": ["MRSA"]}}}, "5e563632738645b2a822be265bf96255": {"prediction": {"id": "5e563632738645b2a822be265bf96255", "prediction_text": "HA-MRSA"}, "reference": {"id": "5e563632738645b2a822be265bf96255", "answers": {"answer_start": [1802], "text": ["MRSA"]}}}, "be0a03fc212a436690f59d4098da71dc": {"prediction": {"id": "be0a03fc212a436690f59d4098da71dc", "prediction_text": "livestock-associated"}, "reference": {"id": "be0a03fc212a436690f59d4098da71dc", "answers": {"answer_start": [1482], "text": ["MRSA"]}}}, "e2bb651c486d4efca27ba4df63b73870": {"prediction": {"id": "e2bb651c486d4efca27ba4df63b73870", "prediction_text": "Staphylococcus aureus"}, "reference": {"id": "e2bb651c486d4efca27ba4df63b73870", "answers": {"answer_start": [296], "text": ["MRSA"]}}}, "cfc1b78d8de4412ba55851f117093813": {"prediction": {"id": "cfc1b78d8de4412ba55851f117093813", "prediction_text": "Staphylococcus aureus"}, "reference": {"id": "cfc1b78d8de4412ba55851f117093813", "answers": {"answer_start": [863], "text": ["MRSA"]}}}, "8090879830f34ff48ad118780eff668d": {"prediction": {"id": "8090879830f34ff48ad118780eff668d", "prediction_text": "methicillin-resistant Staphylococcus aureus"}, "reference": {"id": "8090879830f34ff48ad118780eff668d", "answers": {"answer_start": [568], "text": ["MRSA"]}}}, "d9d347f352c345f39f8206c55719ee45": {"prediction": {"id": "d9d347f352c345f39f8206c55719ee45", "prediction_text": "Staphylococcus aureus"}, "reference": {"id": "d9d347f352c345f39f8206c55719ee45", "answers": {"answer_start": [641], "text": ["MRSA"]}}}, "b979954806824b408fc459b650463b76": {"prediction": {"id": "b979954806824b408fc459b650463b76", "prediction_text": "Staphylococcus aureus"}, "reference": {"id": "b979954806824b408fc459b650463b76", "answers": {"answer_start": [457], "text": ["MRSA"]}}}, "06817fc4e7ef4b0bbfb7c2b3b806a144": {"prediction": {"id": "06817fc4e7ef4b0bbfb7c2b3b806a144", "prediction_text": "Staphylococcus aureus"}, "reference": {"id": "06817fc4e7ef4b0bbfb7c2b3b806a144", "answers": {"answer_start": [191], "text": ["MRSA"]}}}, "a8f5e76905174f64b3e6bb396c3c15a1": {"prediction": {"id": "a8f5e76905174f64b3e6bb396c3c15a1", "prediction_text": "Methicillin-resistant Staphylococcus aureus"}, "reference": {"id": "a8f5e76905174f64b3e6bb396c3c15a1", "answers": {"answer_start": [2237], "text": ["MRSA"]}}}, "e6d999891ba04fa5b9f0f14be40c374f": {"prediction": {"id": "e6d999891ba04fa5b9f0f14be40c374f", "prediction_text": "strains"}, "reference": {"id": "e6d999891ba04fa5b9f0f14be40c374f", "answers": {"answer_start": [215], "text": ["MRSA"]}}}, "3c52b34eb9e34b23a892b9555e24ec51": {"prediction": {"id": "3c52b34eb9e34b23a892b9555e24ec51", "prediction_text": "methicillin-resistant"}, "reference": {"id": "3c52b34eb9e34b23a892b9555e24ec51", "answers": {"answer_start": [191], "text": ["MRSA"]}}}, "9b5c7ab6791a454eaad0f568e97e7254": {"prediction": {"id": "9b5c7ab6791a454eaad0f568e97e7254", "prediction_text": "Staphylococcus aureus"}, "reference": {"id": "9b5c7ab6791a454eaad0f568e97e7254", "answers": {"answer_start": [392], "text": ["MRSA"]}}}, "5965b1b456dd458eb506c8992e625dc1": {"prediction": {"id": "5965b1b456dd458eb506c8992e625dc1", "prediction_text": "BD GeneOhm Methicillin Resistant Staphylococcus aureus"}, "reference": {"id": "5965b1b456dd458eb506c8992e625dc1", "answers": {"answer_start": [584], "text": ["MRSA"]}}}, "a10f15bd41534735818c6d7a90630ba2": {"prediction": {"id": "a10f15bd41534735818c6d7a90630ba2", "prediction_text": "Postoperative methicillin-resistant Staphylococcus aureus"}, "reference": {"id": "a10f15bd41534735818c6d7a90630ba2", "answers": {"answer_start": [519], "text": ["MRSA"]}}}, "8f2040cc2d85431d91401aca92d1dc88": {"prediction": {"id": "8f2040cc2d85431d91401aca92d1dc88", "prediction_text": "Staphylococcus aureus"}, "reference": {"id": "8f2040cc2d85431d91401aca92d1dc88", "answers": {"answer_start": [106], "text": ["MRSA"]}}}, "802bc38711fa47988bfa5773c054234e": {"prediction": {"id": "802bc38711fa47988bfa5773c054234e", "prediction_text": "methicillin-resistant Staphylococcus aureus"}, "reference": {"id": "802bc38711fa47988bfa5773c054234e", "answers": {"answer_start": [839], "text": ["MRSA"]}}}, "6c5daa8451704fe196a2d598705403b0": {"prediction": {"id": "6c5daa8451704fe196a2d598705403b0", "prediction_text": "Staphylococcus aureus"}, "reference": {"id": "6c5daa8451704fe196a2d598705403b0", "answers": {"answer_start": [1036], "text": ["MRSA"]}}}, "2a0e58b47b98470891866c223be5d316": {"prediction": {"id": "2a0e58b47b98470891866c223be5d316", "prediction_text": "Staphylococcus aureus"}, "reference": {"id": "2a0e58b47b98470891866c223be5d316", "answers": {"answer_start": [129, 100], "text": ["methicillin-resistant S. aureus", "MRSA"]}}}, "c7a9ade7ada44baa92aa755882cd91fe": {"prediction": {"id": "c7a9ade7ada44baa92aa755882cd91fe", "prediction_text": "Staphylococcus aureus"}, "reference": {"id": "c7a9ade7ada44baa92aa755882cd91fe", "answers": {"answer_start": [2208], "text": ["MRSA"]}}}, "21482dbe9153468d9fea7b8131fe906d": {"prediction": {"id": "21482dbe9153468d9fea7b8131fe906d", "prediction_text": "Staphylococcus aureus"}, "reference": {"id": "21482dbe9153468d9fea7b8131fe906d", "answers": {"answer_start": [1094], "text": ["MRSA"]}}}, "827f2d317fd746acb5b64cc51ad58dfc": {"prediction": {"id": "827f2d317fd746acb5b64cc51ad58dfc", "prediction_text": "empirical methicillin resistance"}, "reference": {"id": "827f2d317fd746acb5b64cc51ad58dfc", "answers": {"answer_start": [144, 250], "text": ["methicillin-resistant S. aureus", "MRSA"]}}}, "4aa16f8c9a4140479ee75ee891848d51": {"prediction": {"id": "4aa16f8c9a4140479ee75ee891848d51", "prediction_text": "CO-MRSA"}, "reference": {"id": "4aa16f8c9a4140479ee75ee891848d51", "answers": {"answer_start": [1148], "text": ["MRSA"]}}}, "7ab243e06ab94dcdb5a760595d25efbf": {"prediction": {"id": "7ab243e06ab94dcdb5a760595d25efbf", "prediction_text": "Staphylococcus aureus"}, "reference": {"id": "7ab243e06ab94dcdb5a760595d25efbf", "answers": {"answer_start": [390], "text": ["MRSA"]}}}, "3fc497f90db14640b43f23322fff7b2c": {"prediction": {"id": "3fc497f90db14640b43f23322fff7b2c", "prediction_text": "Staphylococcus aureus"}, "reference": {"id": "3fc497f90db14640b43f23322fff7b2c", "answers": {"answer_start": [368], "text": ["MRSA"]}}}, "55b73713fe0449a999a9fb71bc0fc9c7": {"prediction": {"id": "55b73713fe0449a999a9fb71bc0fc9c7", "prediction_text": "attending family members"}, "reference": {"id": "55b73713fe0449a999a9fb71bc0fc9c7", "answers": {"answer_start": [181], "text": ["MRSA"]}}}, "01e5a01106cd4de381cb839f34dc407a": {"prediction": {"id": "01e5a01106cd4de381cb839f34dc407a", "prediction_text": "HA-MRSA"}, "reference": {"id": "01e5a01106cd4de381cb839f34dc407a", "answers": {"answer_start": [302, 479], "text": ["methicillin-resistant S. aureus", "MRSA"]}}}, "ca6db2981dec4d3dac9ce4525f9e60e7": {"prediction": {"id": "ca6db2981dec4d3dac9ce4525f9e60e7", "prediction_text": "Staphylococcus aureus"}, "reference": {"id": "ca6db2981dec4d3dac9ce4525f9e60e7", "answers": {"answer_start": [238], "text": ["MRSA"]}}}, "0efec2ad1cc342139fc4affbb948f5ae": {"prediction": {"id": "0efec2ad1cc342139fc4affbb948f5ae", "prediction_text": "CC398"}, "reference": {"id": "0efec2ad1cc342139fc4affbb948f5ae", "answers": {"answer_start": [1066], "text": ["MRSA"]}}}, "d15e5172720d4a04a0494bb1828b6e70": {"prediction": {"id": "d15e5172720d4a04a0494bb1828b6e70", "prediction_text": "nasal"}, "reference": {"id": "d15e5172720d4a04a0494bb1828b6e70", "answers": {"answer_start": [358], "text": ["MRSA"]}}}, "be6c21589b26415aa7d9c64949098801": {"prediction": {"id": "be6c21589b26415aa7d9c64949098801", "prediction_text": "methicillin-resistant Staphylococcus aureus"}, "reference": {"id": "be6c21589b26415aa7d9c64949098801", "answers": {"answer_start": [2726], "text": ["MRSA"]}}}, "ad789f13696d44aca4f65fb1da774335": {"prediction": {"id": "ad789f13696d44aca4f65fb1da774335", "prediction_text": "Staphylococcus aureus"}, "reference": {"id": "ad789f13696d44aca4f65fb1da774335", "answers": {"answer_start": [1110], "text": ["MRSA"]}}}, "3a01514d1558411fad17aa4a8ffe70cc": {"prediction": {"id": "3a01514d1558411fad17aa4a8ffe70cc", "prediction_text": "HCA-MRSA"}, "reference": {"id": "3a01514d1558411fad17aa4a8ffe70cc", "answers": {"answer_start": [434], "text": ["MRSA"]}}}, "5df78b58b4ac4c719cd843f8ce5297d0": {"prediction": {"id": "5df78b58b4ac4c719cd843f8ce5297d0", "prediction_text": "Staphylococcus aureus"}, "reference": {"id": "5df78b58b4ac4c719cd843f8ce5297d0", "answers": {"answer_start": [849], "text": ["MRSA"]}}}, "b4b3a6581cbc4c51a049e900d0bd9150": {"prediction": {"id": "b4b3a6581cbc4c51a049e900d0bd9150", "prediction_text": "Detection of methicillin"}, "reference": {"id": "b4b3a6581cbc4c51a049e900d0bd9150", "answers": {"answer_start": [172], "text": ["MRSA"]}}}, "8e525c6e49854b27a0f8bac40840ddf0": {"prediction": {"id": "8e525c6e49854b27a0f8bac40840ddf0", "prediction_text": "Methicillin-resistant Staphylococcus aureus"}, "reference": {"id": "8e525c6e49854b27a0f8bac40840ddf0", "answers": {"answer_start": [557], "text": ["MRSA"]}}}, "24068914d783428191f4edefbdffb9b6": {"prediction": {"id": "24068914d783428191f4edefbdffb9b6", "prediction_text": "Staphylococcus aureus"}, "reference": {"id": "24068914d783428191f4edefbdffb9b6", "answers": {"answer_start": [841], "text": ["MRSA"]}}}, "ff263153449d4f388fa7fe06fde80fd0": {"prediction": {"id": "ff263153449d4f388fa7fe06fde80fd0", "prediction_text": "a common multidrug-resistant (MDR) pathogen"}, "reference": {"id": "ff263153449d4f388fa7fe06fde80fd0", "answers": {"answer_start": [315], "text": ["MRSA"]}}}, "33d05b13c1cf42ad851105c32df538f3": {"prediction": {"id": "33d05b13c1cf42ad851105c32df538f3", "prediction_text": "Staphylococcus aureus"}, "reference": {"id": "33d05b13c1cf42ad851105c32df538f3", "answers": {"answer_start": [1902], "text": ["MRSA"]}}}, "3772cbce2705480884ae4594b22e849a": {"prediction": {"id": "3772cbce2705480884ae4594b22e849a", "prediction_text": "Staphylococcus aureus"}, "reference": {"id": "3772cbce2705480884ae4594b22e849a", "answers": {"answer_start": [274], "text": ["MRSA"]}}}, "fec166a2e7c94ac5985c7dbe25442d2a": {"prediction": {"id": "fec166a2e7c94ac5985c7dbe25442d2a", "prediction_text": "Staphylococcus aureus"}, "reference": {"id": "fec166a2e7c94ac5985c7dbe25442d2a", "answers": {"answer_start": [89], "text": ["MRSA"]}}}, "ff0b3520439e485e9ccd7699f6190939": {"prediction": {"id": "ff0b3520439e485e9ccd7699f6190939", "prediction_text": "methicillin-resistant Staphylococcus aureus"}, "reference": {"id": "ff0b3520439e485e9ccd7699f6190939", "answers": {"answer_start": [119], "text": ["MRSA"]}}}, "75ed8a21860b4ae7bd73373f188596ef": {"prediction": {"id": "75ed8a21860b4ae7bd73373f188596ef", "prediction_text": "methicillin-resistant Staphylococcus aureus"}, "reference": {"id": "75ed8a21860b4ae7bd73373f188596ef", "answers": {"answer_start": [1297], "text": ["MRSA"]}}}, "2eb9fbe882054cb1a51d382a9744f417": {"prediction": {"id": "2eb9fbe882054cb1a51d382a9744f417", "prediction_text": "methicillin (meticillin)-resistant Staphylococcus aureus"}, "reference": {"id": "2eb9fbe882054cb1a51d382a9744f417", "answers": {"answer_start": [409], "text": ["MRSA"]}}}, "d6533a04c8134d5ea70f4b48b9d3d4c2": {"prediction": {"id": "d6533a04c8134d5ea70f4b48b9d3d4c2", "prediction_text": "general anesthesia"}, "reference": {"id": "d6533a04c8134d5ea70f4b48b9d3d4c2", "answers": {"answer_start": [0], "text": ["flumazenil"]}}}, "c9bf2d4c5b69454ab95d5ab2c3850304": {"prediction": {"id": "c9bf2d4c5b69454ab95d5ab2c3850304", "prediction_text": "Anterograde amnesia, possibly accompanied by acute brain syndrome, is a potential side-effect of certain benzodiazepines, particularly triazolam. Flumazenil is a benzodiazepine"}, "reference": {"id": "c9bf2d4c5b69454ab95d5ab2c3850304", "answers": {"answer_start": [767], "text": ["flumazenil"]}}}, "5a3dc068f5bd438a85501ee1d4066250": {"prediction": {"id": "5a3dc068f5bd438a85501ee1d4066250", "prediction_text": "patients"}, "reference": {"id": "5a3dc068f5bd438a85501ee1d4066250", "answers": {"answer_start": [0], "text": ["flumazenil"]}}}, "16a5d9b04d92441c84c2ebf50502f6bf": {"prediction": {"id": "16a5d9b04d92441c84c2ebf50502f6bf", "prediction_text": "newborns"}, "reference": {"id": "16a5d9b04d92441c84c2ebf50502f6bf", "answers": {"answer_start": [696], "text": ["flumazenil"]}}}, "1b462c84659d465c82a88588785d9b7e": {"prediction": {"id": "1b462c84659d465c82a88588785d9b7e", "prediction_text": "opioid intoxication"}, "reference": {"id": "1b462c84659d465c82a88588785d9b7e", "answers": {"answer_start": [640], "text": ["flumazenil"]}}}, "f3e42e1ef6864c9ba055a9fba1505c68": {"prediction": {"id": "f3e42e1ef6864c9ba055a9fba1505c68", "prediction_text": "Flumazenil"}, "reference": {"id": "f3e42e1ef6864c9ba055a9fba1505c68", "answers": {"answer_start": [153], "text": ["flumazenil"]}}}, "de2174925ba54516823aacb48e26754a": {"prediction": {"id": "de2174925ba54516823aacb48e26754a", "prediction_text": "Flumazenil"}, "reference": {"id": "de2174925ba54516823aacb48e26754a", "answers": {"answer_start": [0], "text": ["flumazenil"]}}}, "e9c17054245a4446b7d989867a006f48": {"prediction": {"id": "e9c17054245a4446b7d989867a006f48", "prediction_text": "Flumazenil"}, "reference": {"id": "e9c17054245a4446b7d989867a006f48", "answers": {"answer_start": [976], "text": ["flumazenil"]}}}, "f282bb7492094f8aba574d8487a7d08b": {"prediction": {"id": "f282bb7492094f8aba574d8487a7d08b", "prediction_text": "Flumazenil"}, "reference": {"id": "f282bb7492094f8aba574d8487a7d08b", "answers": {"answer_start": [1327], "text": ["flumazenil"]}}}, "cd8de82a6ebc454d8b929fab367432a8": {"prediction": {"id": "cd8de82a6ebc454d8b929fab367432a8", "prediction_text": "encephalitis"}, "reference": {"id": "cd8de82a6ebc454d8b929fab367432a8", "answers": {"answer_start": [564], "text": ["flumazenil"]}}}, "a3c20477c00f4182988a1284157a8940": {"prediction": {"id": "a3c20477c00f4182988a1284157a8940", "prediction_text": "flumazenil"}, "reference": {"id": "a3c20477c00f4182988a1284157a8940", "answers": {"answer_start": [469], "text": ["flumazenil"]}}}, "867b49da71244658861ef74ac28aacda": {"prediction": {"id": "867b49da71244658861ef74ac28aacda", "prediction_text": "charcoal"}, "reference": {"id": "867b49da71244658861ef74ac28aacda", "answers": {"answer_start": [119], "text": ["flumazenil"]}}}, "3df621be848245eb958994232f91b4e4": {"prediction": {"id": "3df621be848245eb958994232f91b4e4", "prediction_text": "tricyclic antidepressants"}, "reference": {"id": "3df621be848245eb958994232f91b4e4", "answers": {"answer_start": [1324], "text": ["flumazenil"]}}}, "3124eff618214567a72c44ea0f681368": {"prediction": {"id": "3124eff618214567a72c44ea0f681368", "prediction_text": "lateralizing signs"}, "reference": {"id": "3124eff618214567a72c44ea0f681368", "answers": {"answer_start": [1112], "text": ["flumazenil"]}}}, "32d3ad7efaaa4ffcbdab033af6ee3afd": {"prediction": {"id": "32d3ad7efaaa4ffcbdab033af6ee3afd", "prediction_text": "Patients"}, "reference": {"id": "32d3ad7efaaa4ffcbdab033af6ee3afd", "answers": {"answer_start": [0], "text": ["flumazenil"]}}}, "915f12e882c64153aeafdfb846510d70": {"prediction": {"id": "915f12e882c64153aeafdfb846510d70", "prediction_text": "ethanol overdose. In a randomized double-blind study, 18 patients (group 1) and eight patients (group 2) with suspected benzodiazepine overdose received 5 mg (group 1) or 1 mg (group 2) flumazenil or placebo, respectively. The stage of coma, heart rate, blood pressure and respiratory rate were monitored within the following 15 min. If no change in the stage of coma was observed, 5 mg (group 1) or 1 mg (group 2) flumazenil were given, and the stage of coma, heart rate and blood pressure were again monitored. In a similar way, the effect of 5 and 1 mg flumazenil was investigated in 13 patients (group 3) and four patients (group 4) with ethanol intoxication. In an open trial, the clinical efficacy of flumazenil for the diagnosis of benzodiazepine or ethanol overdose was studied in 29 patients (group 5). In all patients, a toxicological screening confirmed benzodiazepine or ethanol overdose. None of the patients receiving placebo showed effects on stage of coma, heart rate, blood pressure or respiratory rate. Patients with benzodiazepine overdose who received 5 mg flumazenil regained consciousness about 1-2 min after the end of injection. The effect of 1 mg flumazenil (group 2) on benzodiazepine-induced coma was less pronounced. In patients with ethanol overdose (group 3), ethanol-induced coma was reversed after 5 mg flumazenil more slowly than in patients of group 1. No effect of flumazenil on ethanol-induced coma was observed in group 4. In group 5, flumazenil proved to be useful for diagnosing benzodiazepine or ethanol intoxication. In one patient with coma"}, "reference": {"id": "915f12e882c64153aeafdfb846510d70", "answers": {"answer_start": [1555], "text": ["flumazenil"]}}}, "f61efffa75c64181b75129019fcc85d0": {"prediction": {"id": "f61efffa75c64181b75129019fcc85d0", "prediction_text": "inhibitory GABAergic synapses. Animal studies and some human studies appear to demonstrate that flumazenil has weak intrinsic agonist activity; on the other hand, studies are inconclusive in demonstrating any inverse agonist effects of this agent. Evidence available suggests that flumazenil is well tolerated in human beings over a broad range of doses when given either orally or parenterally and does not produce serious adverse effects. In the setting of isolated benzodiazepine overdose, flumazenil is capable of completely reversing coma within one to two minutes, with this effect lasting between one and five hours. Repeat doses can be given safely to reverse recurrent effects of longer-acting benzodiazepines. Flumazenil is undergoing further evaluation by the Food and Drug Administration; should this drug receive approval, it is likely to be used in emergency departments as well as in a variety of other clinical settings. First, it could be used to effect rapid reversal of benzodiazepine-induced sedation that has been administered to facilitate medical, orthopedic, and surgical procedures, particularly in the event of inadvertent respiratory depression. Second, flumazenil might have a therapeutic role in the management of patients who have taken benzodiazepine overdoses. Although most of these patients can be managed successfully with supportive therapy alone, it is possible that the use of flumazenil may obviate the need for intubation and respiratory support in such patients and eliminate the possible adverse effects of even short-term endotracheal intubation. Finally, flumazenil could have both diagnostic and therapeutic value in patients with acute alterations of mental status of unknown etiology, particularly when possible drug overdose is a consideration. Because flumazenil appears to be specific in its antagonism of benzodiazepine-induced respiratory and CNS depression"}, "reference": {"id": "f61efffa75c64181b75129019fcc85d0", "answers": {"answer_start": [0], "text": ["flumazenil"]}}}, "44411a8af2204517b1fd7f24be0e93e8": {"prediction": {"id": "44411a8af2204517b1fd7f24be0e93e8", "prediction_text": "caution"}, "reference": {"id": "44411a8af2204517b1fd7f24be0e93e8", "answers": {"answer_start": [435], "text": ["flumazenil"]}}}, "ee75061e5f8e4e248087f64c0f8985d4": {"prediction": {"id": "ee75061e5f8e4e248087f64c0f8985d4", "prediction_text": "Glasgow Coma Scale (GSC), and Neurobehavioral Assessment Scale (NAS). The mean +/- SD CGIS score at ten minutes for BDZ-positive patients was 1.41 +/- 0.72 for patients who received flumazenil and 3.41 +/- 0.91 for the placebo group (P < .01). There was no difference in the mean CGIS score between the flumazenil (3.25 +/- 1.15) and placebo (3.75 +/- 0.69) groups in BDZ-negative patients. The GCS and NAS were also significantly better in patients who were BDZ-positive and received flumazenil. The mean +/- SD dose of flumazenil administered during the double-blind phase was 71.3 +/- 34.2 mL (7.13 mg) compared with 95.06 +/- 16.03 mL of placebo. Of the 39 patients who had BDZ-positive drug screens"}, "reference": {"id": "ee75061e5f8e4e248087f64c0f8985d4", "answers": {"answer_start": [865], "text": ["flumazenil"]}}}, "3eddac24dca748e4ac20fe1e873986a9": {"prediction": {"id": "3eddac24dca748e4ac20fe1e873986a9", "prediction_text": "hepatic encephalopathy"}, "reference": {"id": "3eddac24dca748e4ac20fe1e873986a9", "answers": {"answer_start": [176], "text": ["flumazenil"]}}}, "a45a31544ae1433685d6970a4f132ecc": {"prediction": {"id": "a45a31544ae1433685d6970a4f132ecc", "prediction_text": "EEG studies. In general, a total dose of 0.3-0.8 mg will be sufficient in clinical practice, avoiding side effects like nausea, tremor, sweating, or transient anxiety that could be observed when higher dosages were administered. Its therapeutic range is very high as could be demonstrated in experimental animal in which up to 8.000-fold the clinical dose was administered. The total volume of distribution (Vdes) amounts to nearly 1.000 ml/kg BW and the total clearance exceeds 1.200 ml/min, resulting in a biological half-life of less than 60 min. According to the benzodiazepine dosage and the rapid plasma concentration decline of flumazenil, in some cases a resedation could be observed. Hence, a careful observation of the antagonised patient on the ward is mandatory for 1.5-2 h, even if at first sight the antagonization seemed successful and the patient fully awake and cooperative. In anaesthesia, indications to administer flumazenil are adverse drug reactions and prolonged recovery after adequate benzodiazepine dosage. In intensive care medicine"}, "reference": {"id": "a45a31544ae1433685d6970a4f132ecc", "answers": {"answer_start": [0], "text": ["flumazenil"]}}}, "eae421d01c2d4dacb002bd4915a76cc8": {"prediction": {"id": "eae421d01c2d4dacb002bd4915a76cc8", "prediction_text": "Flumazenil"}, "reference": {"id": "eae421d01c2d4dacb002bd4915a76cc8", "answers": {"answer_start": [0], "text": ["flumazenil"]}}}, "7bb41a35cc96414ea9f500840c98e3b3": {"prediction": {"id": "7bb41a35cc96414ea9f500840c98e3b3", "prediction_text": "hepatic encephalopathy"}, "reference": {"id": "7bb41a35cc96414ea9f500840c98e3b3", "answers": {"answer_start": [161], "text": ["flumazenil"]}}}, "ba388b586aa14ea1adc37a9b56ba8532": {"prediction": {"id": "ba388b586aa14ea1adc37a9b56ba8532", "prediction_text": "benzodiazepine-induced coma"}, "reference": {"id": "ba388b586aa14ea1adc37a9b56ba8532", "answers": {"answer_start": [2297], "text": ["flumazenil"]}}}, "d50db294d76c42569b021af929c313fe": {"prediction": {"id": "d50db294d76c42569b021af929c313fe", "prediction_text": "Posterior"}, "reference": {"id": "d50db294d76c42569b021af929c313fe", "answers": {"answer_start": [0], "text": ["Posterior cruciate ligament"]}}}, "0347d62345cc4eaf9eab18a2457671e9": {"prediction": {"id": "0347d62345cc4eaf9eab18a2457671e9", "prediction_text": "Hyperflexion"}, "reference": {"id": "0347d62345cc4eaf9eab18a2457671e9", "answers": {"answer_start": [271], "text": ["Posterior cruciate ligament"]}}}, "7bd447f936bb4ff2a0ec166bdb9bea9c": {"prediction": {"id": "7bd447f936bb4ff2a0ec166bdb9bea9c", "prediction_text": "Yersinia pestis"}, "reference": {"id": "7bd447f936bb4ff2a0ec166bdb9bea9c", "answers": {"answer_start": [211], "text": ["Yersinia pestis"]}}}, "e5ab53744fa740f0b5f474632dbb298a": {"prediction": {"id": "e5ab53744fa740f0b5f474632dbb298a", "prediction_text": "MTBP)"}, "reference": {"id": "e5ab53744fa740f0b5f474632dbb298a", "answers": {"answer_start": [303], "text": ["MDM two binding protein (MTBP)"]}}}, "2a6052e1ca6944b38ae06b73d0c595bf": {"prediction": {"id": "2a6052e1ca6944b38ae06b73d0c595bf", "prediction_text": "Irish emergency department"}, "reference": {"id": "2a6052e1ca6944b38ae06b73d0c595bf", "answers": {"answer_start": [77], "text": ["stroke"]}}}, "732bed9eacfc4914bead9b23fc186a24": {"prediction": {"id": "732bed9eacfc4914bead9b23fc186a24", "prediction_text": "Face Arm Speech Test (FAST)"}, "reference": {"id": "732bed9eacfc4914bead9b23fc186a24", "answers": {"answer_start": [917], "text": ["stroke"]}}}, "3119cb496f0043b8b292507386b1d3b0": {"prediction": {"id": "3119cb496f0043b8b292507386b1d3b0", "prediction_text": "ambulance setting. We investigated whether ROSIER use by ambulance clinicians can improve stroke recognition. Ambulance clinicians used the ROSIER in place of the FAST to assess patients with suspected stroke. As the ROSIER includes all FAST elements, we calculated a FAST score from the ROSIER to enable comparisons between the two tools. Ambulance clinicians' provisional stroke diagnoses using the ROSIER and calculated FAST were compared with stroke consultants' diagnosis. We used stepwise logistic regression"}, "reference": {"id": "3119cb496f0043b8b292507386b1d3b0", "answers": {"answer_start": [662], "text": ["stroke"]}}}, "01074f825780487c81721ef57e164d1e": {"prediction": {"id": "01074f825780487c81721ef57e164d1e", "prediction_text": "ischaemic stroke"}, "reference": {"id": "01074f825780487c81721ef57e164d1e", "answers": {"answer_start": [95], "text": ["stroke"]}}}, "75dcb54ca0784c6984b5929aed529655": {"prediction": {"id": "75dcb54ca0784c6984b5929aed529655", "prediction_text": "Cincinnati Pre-Hospital Stroke Scale"}, "reference": {"id": "75dcb54ca0784c6984b5929aed529655", "answers": {"answer_start": [703], "text": ["stroke"]}}}, "72595d62299a410e946a037815c74a39": {"prediction": {"id": "72595d62299a410e946a037815c74a39", "prediction_text": "Recognition of Stroke in the Emergency Room"}, "reference": {"id": "72595d62299a410e946a037815c74a39", "answers": {"answer_start": [0], "text": ["stroke"]}}}, "5ed452b937084b7fa5b77e689da6c9e6": {"prediction": {"id": "5ed452b937084b7fa5b77e689da6c9e6", "prediction_text": "ER physicians"}, "reference": {"id": "5ed452b937084b7fa5b77e689da6c9e6", "answers": {"answer_start": [99], "text": ["stroke"]}}}, "7e2e2b79ae3d4355bb7175af161a8429": {"prediction": {"id": "7e2e2b79ae3d4355bb7175af161a8429", "prediction_text": "stroke"}, "reference": {"id": "7e2e2b79ae3d4355bb7175af161a8429", "answers": {"answer_start": [1681], "text": ["stroke"]}}}, "a4023a7904774d58babe7f32ad43bd61": {"prediction": {"id": "a4023a7904774d58babe7f32ad43bd61", "prediction_text": "ischaemic attacks (TIA), 45 intracerebral haemorrhages), and 344 (48%) had other illnesses i.e. stroke mimics. Common stroke mimics were spinal neuropathy, dementia, labyrinthitis and sepsis. The suggested cut-off score of>0 for the ROSIER scale for stroke"}, "reference": {"id": "a4023a7904774d58babe7f32ad43bd61", "answers": {"answer_start": [83], "text": ["stroke"]}}}, "9dea01384a784c16ac1ed5cd9a45e27b": {"prediction": {"id": "9dea01384a784c16ac1ed5cd9a45e27b", "prediction_text": "Drosophila melanogaster Trithorax"}, "reference": {"id": "9dea01384a784c16ac1ed5cd9a45e27b", "answers": {"answer_start": [1147], "text": ["H3K4"]}}}, "81ccdfdfc947422d9a94d26005983449": {"prediction": {"id": "81ccdfdfc947422d9a94d26005983449", "prediction_text": "trimethylated H3K4"}, "reference": {"id": "81ccdfdfc947422d9a94d26005983449", "answers": {"answer_start": [1493], "text": ["H3K4"]}}}, "47a485fe5a644a689e05a808d6918200": {"prediction": {"id": "47a485fe5a644a689e05a808d6918200", "prediction_text": "Heterozygosity for a truncated, lacZ knock-in allele of mixed-lineage leukemia 1 (Mll1"}, "reference": {"id": "47a485fe5a644a689e05a808d6918200", "answers": {"answer_start": [799], "text": ["H3K4"]}}}, "670e316ec01141a9b4695d1e62dd4c75": {"prediction": {"id": "670e316ec01141a9b4695d1e62dd4c75", "prediction_text": "Constitutive nuclear factor (NF)-kappaB activation in haematological malignancies is caused in several cases by loss of function mutations within the coding sequence of NF-kappaB inhibitory molecules such as IkappaBalpha or p100. Hut-78, a truncated form of p100, constitutively generates p52 and contributes to the development of T-cell lymphomas but the molecular mechanism underlying this oncogenic potential remains unclear. We show here that MMP9 gene expression is induced through the alternative NF-kappaB-activating pathway in fibroblasts and also on Hut-78 or p52 overexpression in fibroblasts as well as in lymphoma cells. p52 is critical for Hut-78-mediated MMP9 gene induction as a Hut-78 mutant as well as other truncated NF-kappaB2 proteins that are not processed into p52 failed to induce the expression of this metalloproteinase. Conversely, MMP9 gene expression is impaired in p52-depleted HUT-78 cells. Interestingly, MLL1 and MLL2 H3K4 methyltransferase complexes are tethered by p52 on the MMP9 but not on the IkappaBalpha promoter, and the H3K4 trimethyltransferase activity recruited on the MMP9 promoter is impaired in p52-depleted HUT-78 cells. Moreover, MLL1 and MLL2 are associated with Hut-78 in a native chromatin-enriched extract. Thus, we identified a molecular mechanism by which the recruitment of a H3K4"}, "reference": {"id": "670e316ec01141a9b4695d1e62dd4c75", "answers": {"answer_start": [950], "text": ["H3K4"]}}}, "11841d2e4e194f8589620cb7190c72f1": {"prediction": {"id": "11841d2e4e194f8589620cb7190c72f1", "prediction_text": "histone H3"}, "reference": {"id": "11841d2e4e194f8589620cb7190c72f1", "answers": {"answer_start": [528], "text": ["H3K4"]}}}, "0dd7f95ee49c47b093c462b962e414f9": {"prediction": {"id": "0dd7f95ee49c47b093c462b962e414f9", "prediction_text": "carboxyl-terminal SET domain"}, "reference": {"id": "0dd7f95ee49c47b093c462b962e414f9", "answers": {"answer_start": [193], "text": ["H3K4"]}}}, "28b8998138af40dc819e6807e5cf9aa5": {"prediction": {"id": "28b8998138af40dc819e6807e5cf9aa5", "prediction_text": "rhythmic"}, "reference": {"id": "28b8998138af40dc819e6807e5cf9aa5", "answers": {"answer_start": [944], "text": ["H3K4"]}}}, "92d8ebb129ad4dc794ff9739bebee097": {"prediction": {"id": "92d8ebb129ad4dc794ff9739bebee097", "prediction_text": "MT"}, "reference": {"id": "92d8ebb129ad4dc794ff9739bebee097", "answers": {"answer_start": [118], "text": ["H3K4"]}}}, "7b56d7defe6244faa4bc152c17edeecc": {"prediction": {"id": "7b56d7defe6244faa4bc152c17edeecc", "prediction_text": "Wdr82"}, "reference": {"id": "7b56d7defe6244faa4bc152c17edeecc", "answers": {"answer_start": [234], "text": ["H3K4"]}}}, "bf20e9da845a44a1878c2dea629bdf29": {"prediction": {"id": "bf20e9da845a44a1878c2dea629bdf29", "prediction_text": "H3K4"}, "reference": {"id": "bf20e9da845a44a1878c2dea629bdf29", "answers": {"answer_start": [1620], "text": ["H3K4"]}}}, "6d02a857048a45ab8db97655dd04fdaf": {"prediction": {"id": "6d02a857048a45ab8db97655dd04fdaf", "prediction_text": "P/CAF"}, "reference": {"id": "6d02a857048a45ab8db97655dd04fdaf", "answers": {"answer_start": [823], "text": ["H3K4"]}}}, "07d6b21f04614b80b6c9800365a4aab4": {"prediction": {"id": "07d6b21f04614b80b6c9800365a4aab4", "prediction_text": "in skin and connective tissue"}, "reference": {"id": "07d6b21f04614b80b6c9800365a4aab4", "answers": {"answer_start": [590], "text": ["plasma membrane"]}}}, "61b1ce8d0dc045a8bec352e64ac3aa85": {"prediction": {"id": "61b1ce8d0dc045a8bec352e64ac3aa85", "prediction_text": "c.20A>T mutation"}, "reference": {"id": "61b1ce8d0dc045a8bec352e64ac3aa85", "answers": {"answer_start": [73], "text": ["HBB"]}}}, "48becbb1278b440bbcbe52c60b3f4748": {"prediction": {"id": "48becbb1278b440bbcbe52c60b3f4748", "prediction_text": "CsA"}, "reference": {"id": "48becbb1278b440bbcbe52c60b3f4748", "answers": {"answer_start": [982], "text": ["cyclophilin"]}}}, "20803fc1b39b42049e5739874015179a": {"prediction": {"id": "20803fc1b39b42049e5739874015179a", "prediction_text": "cyclophilin"}, "reference": {"id": "20803fc1b39b42049e5739874015179a", "answers": {"answer_start": [568], "text": ["cyclophilin"]}}}, "7abc3f7176cc4c649016f528cf24c836": {"prediction": {"id": "7abc3f7176cc4c649016f528cf24c836", "prediction_text": "Mahalanobis distance"}, "reference": {"id": "7abc3f7176cc4c649016f528cf24c836", "answers": {"answer_start": [666], "text": ["delta-distance"]}}}, "414f819950c54012bf979a1ab982b8ba": {"prediction": {"id": "414f819950c54012bf979a1ab982b8ba", "prediction_text": "easy-to-use"}, "reference": {"id": "414f819950c54012bf979a1ab982b8ba", "answers": {"answer_start": [910], "text": ["traseR"]}}}, "964865cbc66745f78942037b52e0d5cd": {"prediction": {"id": "964865cbc66745f78942037b52e0d5cd", "prediction_text": "Cornelia de Lange syndrome"}, "reference": {"id": "964865cbc66745f78942037b52e0d5cd", "answers": {"answer_start": [0], "text": ["Cornelia de Lange syndrome."]}}}, "19a8383837044714a8bf0e2c88a113a2": {"prediction": {"id": "19a8383837044714a8bf0e2c88a113a2", "prediction_text": "Cornelia de Lange syndrome"}, "reference": {"id": "19a8383837044714a8bf0e2c88a113a2", "answers": {"answer_start": [210], "text": ["Cornelia de Lange syndrome."]}}}, "4266582d74c04ae596c70ea2d383d5af": {"prediction": {"id": "4266582d74c04ae596c70ea2d383d5af", "prediction_text": "https://ilir.warwick.ac.uk"}, "reference": {"id": "4266582d74c04ae596c70ea2d383d5af", "answers": {"answer_start": [1416], "text": ["The iLIR database"]}}}, "f3f0cba457ef4b57a2a0805a55967467": {"prediction": {"id": "f3f0cba457ef4b57a2a0805a55967467", "prediction_text": "FOXP2 gene"}, "reference": {"id": "f3f0cba457ef4b57a2a0805a55967467", "answers": {"answer_start": [232], "text": ["FOXP2"]}}}, "ac009bf0882744f6ac77d35f9daf046c": {"prediction": {"id": "ac009bf0882744f6ac77d35f9daf046c", "prediction_text": "FOXP2"}, "reference": {"id": "ac009bf0882744f6ac77d35f9daf046c", "answers": {"answer_start": [609], "text": ["FOXP2"]}}}, "74ec9ce1622a41658d808ade7b5ae8b6": {"prediction": {"id": "74ec9ce1622a41658d808ade7b5ae8b6", "prediction_text": "FOXP2"}, "reference": {"id": "74ec9ce1622a41658d808ade7b5ae8b6", "answers": {"answer_start": [1268], "text": ["FOXP2"]}}}, "2111192bddc74ed0b71cf82fe3cc11ca": {"prediction": {"id": "2111192bddc74ed0b71cf82fe3cc11ca", "prediction_text": "The FOXP2 protein"}, "reference": {"id": "2111192bddc74ed0b71cf82fe3cc11ca", "answers": {"answer_start": [736], "text": ["FOXP2"]}}}, "0da4631296fe4ce09a449fb85f0f0ae7": {"prediction": {"id": "0da4631296fe4ce09a449fb85f0f0ae7", "prediction_text": "Transcription factor forkhead box protein P2"}, "reference": {"id": "0da4631296fe4ce09a449fb85f0f0ae7", "answers": {"answer_start": [261], "text": ["FOXP2"]}}}, "6b0715238f8149a9bdb5b5fa30410269": {"prediction": {"id": "6b0715238f8149a9bdb5b5fa30410269", "prediction_text": "FOXP2"}, "reference": {"id": "6b0715238f8149a9bdb5b5fa30410269", "answers": {"answer_start": [727], "text": ["FOXP2"]}}}, "41761f46237244698562f27d40015b35": {"prediction": {"id": "41761f46237244698562f27d40015b35", "prediction_text": "FOXP2"}, "reference": {"id": "41761f46237244698562f27d40015b35", "answers": {"answer_start": [193], "text": ["FOXP2"]}}}, "bcc5bbb570c04956a2ff74cfb48b9a1f": {"prediction": {"id": "bcc5bbb570c04956a2ff74cfb48b9a1f", "prediction_text": "Forkhead box protein P2"}, "reference": {"id": "bcc5bbb570c04956a2ff74cfb48b9a1f", "answers": {"answer_start": [25], "text": ["FOXP2"]}}}, "e48f2125c80f4b88b8da44f80d9dbf90": {"prediction": {"id": "e48f2125c80f4b88b8da44f80d9dbf90", "prediction_text": "intravenous drug abuse"}, "reference": {"id": "e48f2125c80f4b88b8da44f80d9dbf90", "answers": {"answer_start": [55], "text": ["intravenous drug abuse"]}}}, "1bbf1c26802643ab85d700b32b4fe47a": {"prediction": {"id": "1bbf1c26802643ab85d700b32b4fe47a", "prediction_text": "intravenous drug abuse"}, "reference": {"id": "1bbf1c26802643ab85d700b32b4fe47a", "answers": {"answer_start": [41], "text": ["intravenous drug abuse"]}}}, "2bc2a165edf140249a0e291e7d9d9b12": {"prediction": {"id": "2bc2a165edf140249a0e291e7d9d9b12", "prediction_text": "IVDA complications in the upper extremity"}, "reference": {"id": "2bc2a165edf140249a0e291e7d9d9b12", "answers": {"answer_start": [30], "text": ["intravenous drug abuse"]}}}, "7a953ab97cb64506b2c62f7bd28bbd04": {"prediction": {"id": "7a953ab97cb64506b2c62f7bd28bbd04", "prediction_text": "Plasmodium spp"}, "reference": {"id": "7a953ab97cb64506b2c62f7bd28bbd04", "answers": {"answer_start": [145], "text": ["Plasmodium spp."]}}}, "6478cee2b91b4d49aa045e7066b74d78": {"prediction": {"id": "6478cee2b91b4d49aa045e7066b74d78", "prediction_text": "Apical membrane antigen 1"}, "reference": {"id": "6478cee2b91b4d49aa045e7066b74d78", "answers": {"answer_start": [971], "text": ["Plasmodium species"]}}}, "e347d67a40904c5eb253053ff5b9c1c2": {"prediction": {"id": "e347d67a40904c5eb253053ff5b9c1c2", "prediction_text": "Plasmodium spp"}, "reference": {"id": "e347d67a40904c5eb253053ff5b9c1c2", "answers": {"answer_start": [362], "text": ["Plasmodium spp."]}}}, "af183bc6e7bc49068b4a78a851575879": {"prediction": {"id": "af183bc6e7bc49068b4a78a851575879", "prediction_text": "P. vivax"}, "reference": {"id": "af183bc6e7bc49068b4a78a851575879", "answers": {"answer_start": [453], "text": ["Plasmodium spp."]}}}, "5159d8b1e7724ff6a0b212cda0deb1bd": {"prediction": {"id": "5159d8b1e7724ff6a0b212cda0deb1bd", "prediction_text": "Plasmodium falciparum"}, "reference": {"id": "5159d8b1e7724ff6a0b212cda0deb1bd", "answers": {"answer_start": [615], "text": ["Plasmodium species"]}}}, "392875a8fbf64b008b1815f5e07c9a0a": {"prediction": {"id": "392875a8fbf64b008b1815f5e07c9a0a", "prediction_text": "Plasmodium"}, "reference": {"id": "392875a8fbf64b008b1815f5e07c9a0a", "answers": {"answer_start": [429], "text": ["Plasmodium species"]}}}, "7418b2f08f744b3e97609fd0ff21246b": {"prediction": {"id": "7418b2f08f744b3e97609fd0ff21246b", "prediction_text": "Plasmodium"}, "reference": {"id": "7418b2f08f744b3e97609fd0ff21246b", "answers": {"answer_start": [491], "text": ["Plasmodium species"]}}}, "0ca5e255b7834656809175f1762f4fde": {"prediction": {"id": "0ca5e255b7834656809175f1762f4fde", "prediction_text": "Plasmodium"}, "reference": {"id": "0ca5e255b7834656809175f1762f4fde", "answers": {"answer_start": [364], "text": ["Plasmodium species"]}}}, "78bcb6ff2d684480977cacbe014889f2": {"prediction": {"id": "78bcb6ff2d684480977cacbe014889f2", "prediction_text": "P. vivax"}, "reference": {"id": "78bcb6ff2d684480977cacbe014889f2", "answers": {"answer_start": [401], "text": ["Plasmodium species"]}}}, "1f18d9d591ce413e8b4e2c387a2dcc55": {"prediction": {"id": "1f18d9d591ce413e8b4e2c387a2dcc55", "prediction_text": "vaginal lavages and vaginal/lower uterine tissues as compared to a drug suspension. Systemic drug exposure"}, "reference": {"id": "1f18d9d591ce413e8b4e2c387a2dcc55", "answers": {"answer_start": [149], "text": ["HIV"]}}}, "46fcc96af9574e36988f5cc678538230": {"prediction": {"id": "46fcc96af9574e36988f5cc678538230", "prediction_text": "vaginal microbicide"}, "reference": {"id": "46fcc96af9574e36988f5cc678538230", "answers": {"answer_start": [70], "text": ["HIV"]}}}, "db6fe65b37d546518d70fb83aae9bdac": {"prediction": {"id": "db6fe65b37d546518d70fb83aae9bdac", "prediction_text": "HIV"}, "reference": {"id": "db6fe65b37d546518d70fb83aae9bdac", "answers": {"answer_start": [479], "text": ["HIV"]}}}, "bea17e6cb40d4334985b8875d360d6ec": {"prediction": {"id": "bea17e6cb40d4334985b8875d360d6ec", "prediction_text": "cervicovaginal fluids"}, "reference": {"id": "bea17e6cb40d4334985b8875d360d6ec", "answers": {"answer_start": [218], "text": ["HIV"]}}}, "dbdc3ea1a9d04e05b8c6534e5d4e406c": {"prediction": {"id": "dbdc3ea1a9d04e05b8c6534e5d4e406c", "prediction_text": "HIV"}, "reference": {"id": "dbdc3ea1a9d04e05b8c6534e5d4e406c", "answers": {"answer_start": [76], "text": ["HIV"]}}}, "bddfa62f5924435caf7cd7192db8ce2f": {"prediction": {"id": "bddfa62f5924435caf7cd7192db8ce2f", "prediction_text": "HIV"}, "reference": {"id": "bddfa62f5924435caf7cd7192db8ce2f", "answers": {"answer_start": [132], "text": ["HIV"]}}}, "caa71ad8d5424b4085c0fea935c11a2d": {"prediction": {"id": "caa71ad8d5424b4085c0fea935c11a2d", "prediction_text": "rings"}, "reference": {"id": "caa71ad8d5424b4085c0fea935c11a2d", "answers": {"answer_start": [1255], "text": ["HIV"]}}}, "d73053008a824502b7c20f21f29c2de3": {"prediction": {"id": "d73053008a824502b7c20f21f29c2de3", "prediction_text": "HIV"}, "reference": {"id": "d73053008a824502b7c20f21f29c2de3", "answers": {"answer_start": [509], "text": ["HIV"]}}}, "a0e1ecc0b5954dcb9fff9cde0688476e": {"prediction": {"id": "a0e1ecc0b5954dcb9fff9cde0688476e", "prediction_text": "cervix"}, "reference": {"id": "a0e1ecc0b5954dcb9fff9cde0688476e", "answers": {"answer_start": [16], "text": ["HIV"]}}}, "96c1cd19c6b9422e93b5da63072ffcb8": {"prediction": {"id": "96c1cd19c6b9422e93b5da63072ffcb8", "prediction_text": "mucosal tissue"}, "reference": {"id": "96c1cd19c6b9422e93b5da63072ffcb8", "answers": {"answer_start": [732], "text": ["HIV"]}}}, "fd55d82a12b84a7e94de9504c977d9b5": {"prediction": {"id": "fd55d82a12b84a7e94de9504c977d9b5", "prediction_text": "syphilis"}, "reference": {"id": "fd55d82a12b84a7e94de9504c977d9b5", "answers": {"answer_start": [1622], "text": ["HIV"]}}}, "eead9180414f4866a86f00216a2f6649": {"prediction": {"id": "eead9180414f4866a86f00216a2f6649", "prediction_text": "HIV"}, "reference": {"id": "eead9180414f4866a86f00216a2f6649", "answers": {"answer_start": [936], "text": ["HIV"]}}}, "cf7850433a8a4df283350fea9d9302df": {"prediction": {"id": "cf7850433a8a4df283350fea9d9302df", "prediction_text": "serum concentrations"}, "reference": {"id": "cf7850433a8a4df283350fea9d9302df", "answers": {"answer_start": [136], "text": ["HIV"]}}}, "b84c6a795e574beba875026d18026d37": {"prediction": {"id": "b84c6a795e574beba875026d18026d37", "prediction_text": "HIV"}, "reference": {"id": "b84c6a795e574beba875026d18026d37", "answers": {"answer_start": [820], "text": ["HIV"]}}}, "def76fe07d6c4009a88638595db2b739": {"prediction": {"id": "def76fe07d6c4009a88638595db2b739", "prediction_text": "Vaginal microbicides"}, "reference": {"id": "def76fe07d6c4009a88638595db2b739", "answers": {"answer_start": [404], "text": ["HIV"]}}}, "f67a94d867b24a0ba21de82b3fd1642c": {"prediction": {"id": "f67a94d867b24a0ba21de82b3fd1642c", "prediction_text": "cervical"}, "reference": {"id": "f67a94d867b24a0ba21de82b3fd1642c", "answers": {"answer_start": [505], "text": ["HIV"]}}}, "c1b56cbce7764470a5f85858b0b3d42a": {"prediction": {"id": "c1b56cbce7764470a5f85858b0b3d42a", "prediction_text": "SILCS diaphragm"}, "reference": {"id": "c1b56cbce7764470a5f85858b0b3d42a", "answers": {"answer_start": [1078], "text": ["HIV"]}}}, "3f3abad86d8b48fd9c7170e954d66d52": {"prediction": {"id": "3f3abad86d8b48fd9c7170e954d66d52", "prediction_text": "HIV-1"}, "reference": {"id": "3f3abad86d8b48fd9c7170e954d66d52", "answers": {"answer_start": [309], "text": ["HIV"]}}}, "60b30d7af29f4411a290b39426fefb27": {"prediction": {"id": "60b30d7af29f4411a290b39426fefb27", "prediction_text": "examination"}, "reference": {"id": "60b30d7af29f4411a290b39426fefb27", "answers": {"answer_start": [1959], "text": ["HIV"]}}}, "e72743fe604a418f9b3b3908587f708d": {"prediction": {"id": "e72743fe604a418f9b3b3908587f708d", "prediction_text": "HIV-1"}, "reference": {"id": "e72743fe604a418f9b3b3908587f708d", "answers": {"answer_start": [417], "text": ["HIV"]}}}, "fb92ad7ecf4d4d69a5954c81c15c7c61": {"prediction": {"id": "fb92ad7ecf4d4d69a5954c81c15c7c61", "prediction_text": "vaginal ring"}, "reference": {"id": "fb92ad7ecf4d4d69a5954c81c15c7c61", "answers": {"answer_start": [171], "text": ["HIV"]}}}, "bc173d96342f4f31ad74fed0d4aabe75": {"prediction": {"id": "bc173d96342f4f31ad74fed0d4aabe75", "prediction_text": "HIV infection, the preclinical safety program must evaluate not only the active pharmaceutical ingredient but also the product itself. To that end, we applied several relatively standard toxicology study methodologies to female sheep, incorporating an assessment of the pharmacokinetics, safety, tolerability, and local toxicity of a dapivirine-containing human vaginal ring formulation (Dapivirine Vaginal Ring-004"}, "reference": {"id": "bc173d96342f4f31ad74fed0d4aabe75", "answers": {"answer_start": [65], "text": ["HIV"]}}}, "b3a55a6a206e4569bfa9c49a22b5496e": {"prediction": {"id": "b3a55a6a206e4569bfa9c49a22b5496e", "prediction_text": "monoclonal antibody (mAb) has been produced which reacts with human mitofilin, a mitochondrial inner membrane protein"}, "reference": {"id": "b3a55a6a206e4569bfa9c49a22b5496e", "answers": {"answer_start": [83], "text": ["mitochondrial inner membrane"]}}}, "966d193d8ddc49ceb6391ec40403f8c5": {"prediction": {"id": "966d193d8ddc49ceb6391ec40403f8c5", "prediction_text": "by decreasing food intake"}, "reference": {"id": "966d193d8ddc49ceb6391ec40403f8c5", "answers": {"answer_start": [375], "text": ["Reduces body weight"]}}}, "e62094123ff64d9181b14a5a44e7808c": {"prediction": {"id": "e62094123ff64d9181b14a5a44e7808c", "prediction_text": "RAMP module"}, "reference": {"id": "e62094123ff64d9181b14a5a44e7808c", "answers": {"answer_start": [39], "text": ["CRISPR-Cas"]}}}, "cb24e8b4c1bb401ca4bbce112b8c82c6": {"prediction": {"id": "cb24e8b4c1bb401ca4bbce112b8c82c6", "prediction_text": "spacer sequence"}, "reference": {"id": "cb24e8b4c1bb401ca4bbce112b8c82c6", "answers": {"answer_start": [4], "text": ["CRISPR-Cas"]}}}, "4084fabab22748d1b667f8e2224be141": {"prediction": {"id": "4084fabab22748d1b667f8e2224be141", "prediction_text": "self-non-self recognition mechanism"}, "reference": {"id": "4084fabab22748d1b667f8e2224be141", "answers": {"answer_start": [4], "text": ["CRISPR-Cas"]}}}, "c6e4b4b83c1547bcb39cd80208b7131d": {"prediction": {"id": "c6e4b4b83c1547bcb39cd80208b7131d", "prediction_text": "CRISPR-Cas system (CASS) is a mechanism of defense against invading phages and plasmids"}, "reference": {"id": "c6e4b4b83c1547bcb39cd80208b7131d", "answers": {"answer_start": [736], "text": ["CRISPR-Cas"]}}}, "7ac12bf10dab44adb82cb3fbd19afd60": {"prediction": {"id": "7ac12bf10dab44adb82cb3fbd19afd60", "prediction_text": "type-2 diabetes"}, "reference": {"id": "7ac12bf10dab44adb82cb3fbd19afd60", "answers": {"answer_start": [35], "text": ["SGLT2"]}}}, "6a606dc6e9124b8dbf508c27d21121cc": {"prediction": {"id": "6a606dc6e9124b8dbf508c27d21121cc", "prediction_text": "sodium glucose cotransporter 2 (SGLT2) inhibitor"}, "reference": {"id": "6a606dc6e9124b8dbf508c27d21121cc", "answers": {"answer_start": [63], "text": ["SGLT2"]}}}, "2655d44319464c999dc25a8e34ca8c7b": {"prediction": {"id": "2655d44319464c999dc25a8e34ca8c7b", "prediction_text": "glucose"}, "reference": {"id": "2655d44319464c999dc25a8e34ca8c7b", "answers": {"answer_start": [569], "text": ["SGLT2"]}}}, "3e27e1e0c69943bd86f6d731a7b3ed1f": {"prediction": {"id": "3e27e1e0c69943bd86f6d731a7b3ed1f", "prediction_text": "renal reabsorption of glucose, thereby promoting the increased urinary excretion of excess glucose"}, "reference": {"id": "3e27e1e0c69943bd86f6d731a7b3ed1f", "answers": {"answer_start": [549], "text": ["SGLT2"]}}}, "e319802533cb4b2d94535a17c1ab948f": {"prediction": {"id": "e319802533cb4b2d94535a17c1ab948f", "prediction_text": "insulin"}, "reference": {"id": "e319802533cb4b2d94535a17c1ab948f", "answers": {"answer_start": [621], "text": ["SGLT2"]}}}, "522e7176afb148c58462dadd4596a913": {"prediction": {"id": "522e7176afb148c58462dadd4596a913", "prediction_text": "Inhibitors"}, "reference": {"id": "522e7176afb148c58462dadd4596a913", "answers": {"answer_start": [927], "text": ["SGLT2"]}}}, "d472118631bf47868af5c74fbe9a3a9a": {"prediction": {"id": "d472118631bf47868af5c74fbe9a3a9a", "prediction_text": "macrophage chemoattractant protein-1 (MCP-1), transforming growth factor \u03b21 and fibronectin mRNA"}, "reference": {"id": "d472118631bf47868af5c74fbe9a3a9a", "answers": {"answer_start": [914], "text": ["SGLT2"]}}}, "99c30f8e9b5f429794c3e493bcde5cc6": {"prediction": {"id": "99c30f8e9b5f429794c3e493bcde5cc6", "prediction_text": "sodium glucose cotransporter 2"}, "reference": {"id": "99c30f8e9b5f429794c3e493bcde5cc6", "answers": {"answer_start": [115], "text": ["SGLT2"]}}}, "b025b776e79d4f4ca50637aa01d80ab7": {"prediction": {"id": "b025b776e79d4f4ca50637aa01d80ab7", "prediction_text": "Sodium glucose"}, "reference": {"id": "b025b776e79d4f4ca50637aa01d80ab7", "answers": {"answer_start": [673], "text": ["SGLT2"]}}}, "cb87d0563b5c46cab929dee75b944fe2": {"prediction": {"id": "cb87d0563b5c46cab929dee75b944fe2", "prediction_text": "SGLT2 co-transporters"}, "reference": {"id": "cb87d0563b5c46cab929dee75b944fe2", "answers": {"answer_start": [1723], "text": ["SGLT2"]}}}, "825489c118524320bd08a0537a691c96": {"prediction": {"id": "825489c118524320bd08a0537a691c96", "prediction_text": "blood glucose"}, "reference": {"id": "825489c118524320bd08a0537a691c96", "answers": {"answer_start": [156], "text": ["SGLT2"]}}}, "1475555188304ef2a04cb9c3fe5d9476": {"prediction": {"id": "1475555188304ef2a04cb9c3fe5d9476", "prediction_text": "glucose from the proximal tubules in the kidney via inhibition of SGLT2, empagliflozin provides a novel insulin-independent mechanism of lowering blood glucose"}, "reference": {"id": "1475555188304ef2a04cb9c3fe5d9476", "answers": {"answer_start": [270], "text": ["SGLT2"]}}}, "f242c4bb6bce4ed495585d29133fe45e": {"prediction": {"id": "f242c4bb6bce4ed495585d29133fe45e", "prediction_text": "SGLT2 inhibitor"}, "reference": {"id": "f242c4bb6bce4ed495585d29133fe45e", "answers": {"answer_start": [83], "text": ["SGLT2"]}}}, "f87dea1b77a242e7adc546f39b38a1ab": {"prediction": {"id": "f87dea1b77a242e7adc546f39b38a1ab", "prediction_text": "activator protein 1"}, "reference": {"id": "f87dea1b77a242e7adc546f39b38a1ab", "answers": {"answer_start": [1017], "text": ["SGLT2"]}}}, "0c062d3766834a65aa8b271bcb8c1b1f": {"prediction": {"id": "0c062d3766834a65aa8b271bcb8c1b1f", "prediction_text": "renal glucose reabsorption"}, "reference": {"id": "0c062d3766834a65aa8b271bcb8c1b1f", "answers": {"answer_start": [61], "text": ["SGLT2"]}}}, "1381ee81077a4de09e5a1e8948d19a41": {"prediction": {"id": "1381ee81077a4de09e5a1e8948d19a41", "prediction_text": "sodium glucose cotransporter 2"}, "reference": {"id": "1381ee81077a4de09e5a1e8948d19a41", "answers": {"answer_start": [278], "text": ["SGLT2"]}}}, "c10e66d784184e4c87cbc537a992f881": {"prediction": {"id": "c10e66d784184e4c87cbc537a992f881", "prediction_text": "urinary glucose excretion"}, "reference": {"id": "c10e66d784184e4c87cbc537a992f881", "answers": {"answer_start": [32], "text": ["SGLT2"]}}}, "b078126565634369b43e792fe5864c58": {"prediction": {"id": "b078126565634369b43e792fe5864c58", "prediction_text": "spinal AMs"}, "reference": {"id": "b078126565634369b43e792fe5864c58", "answers": {"answer_start": [437], "text": ["meningioma"]}}}, "fa9518f2644047f6a734d1cbc4346f83": {"prediction": {"id": "fa9518f2644047f6a734d1cbc4346f83", "prediction_text": "Grade I"}, "reference": {"id": "fa9518f2644047f6a734d1cbc4346f83", "answers": {"answer_start": [1761], "text": ["meningioma"]}}}, "c011fe35330a4c458dba894df47a2d59": {"prediction": {"id": "c011fe35330a4c458dba894df47a2d59", "prediction_text": "retreatment-free survival. The hazard ratios for retreatment after combined Simpson resection Grades II+III and IV+V were 4.9- and 13.2-times higher than after Simpson Grade I resection, respectively. Simpson Grade I"}, "reference": {"id": "c011fe35330a4c458dba894df47a2d59", "answers": {"answer_start": [364], "text": ["meningioma"]}}}, "7f9c7367ad4b49c185979948827e29e1": {"prediction": {"id": "7f9c7367ad4b49c185979948827e29e1", "prediction_text": "surgical"}, "reference": {"id": "7f9c7367ad4b49c185979948827e29e1", "answers": {"answer_start": [63], "text": ["meningioma"]}}}, "0a54cc863094463391b84815982df6b0": {"prediction": {"id": "0a54cc863094463391b84815982df6b0", "prediction_text": "Simpson Grade 1"}, "reference": {"id": "0a54cc863094463391b84815982df6b0", "answers": {"answer_start": [184], "text": ["meningioma"]}}}, "0988cbe6649b4161b17dca350e2e1b4d": {"prediction": {"id": "0988cbe6649b4161b17dca350e2e1b4d", "prediction_text": "stereotactic"}, "reference": {"id": "0988cbe6649b4161b17dca350e2e1b4d", "answers": {"answer_start": [62], "text": ["meningioma"]}}}, "98286e7deaa14096a1c83ec45c418b8b": {"prediction": {"id": "98286e7deaa14096a1c83ec45c418b8b", "prediction_text": "dura mater"}, "reference": {"id": "98286e7deaa14096a1c83ec45c418b8b", "answers": {"answer_start": [20], "text": ["meningioma"]}}}, "d614dda167a54ba4981ecda4c4e6420e": {"prediction": {"id": "d614dda167a54ba4981ecda4c4e6420e", "prediction_text": "seven"}, "reference": {"id": "d614dda167a54ba4981ecda4c4e6420e", "answers": {"answer_start": [980], "text": ["seven"]}}}, "5f6c6bbe679a491d8763cc3ded5ff40e": {"prediction": {"id": "5f6c6bbe679a491d8763cc3ded5ff40e", "prediction_text": "mRNAs"}, "reference": {"id": "5f6c6bbe679a491d8763cc3ded5ff40e", "answers": {"answer_start": [313], "text": ["seven"]}}}, "a7cc855af3f24c39a7ba2856c858571f": {"prediction": {"id": "a7cc855af3f24c39a7ba2856c858571f", "prediction_text": "LLPS"}, "reference": {"id": "a7cc855af3f24c39a7ba2856c858571f", "answers": {"answer_start": [17], "text": ["membrane-free microcompartments"]}}}, "d2efc99a04074c1ea271df1f5f68c0d3": {"prediction": {"id": "d2efc99a04074c1ea271df1f5f68c0d3", "prediction_text": "41 out of 48"}, "reference": {"id": "d2efc99a04074c1ea271df1f5f68c0d3", "answers": {"answer_start": [695], "text": ["48 genes"]}}}, "ae75f9e1a84d40b68842ff9c4648f14d": {"prediction": {"id": "ae75f9e1a84d40b68842ff9c4648f14d", "prediction_text": "48"}, "reference": {"id": "ae75f9e1a84d40b68842ff9c4648f14d", "answers": {"answer_start": [217], "text": ["48 genes"]}}}, "0d23826e74f24a71a3ad56676b5c7a23": {"prediction": {"id": "0d23826e74f24a71a3ad56676b5c7a23", "prediction_text": "48"}, "reference": {"id": "0d23826e74f24a71a3ad56676b5c7a23", "answers": {"answer_start": [213], "text": ["48 genes"]}}}, "66f666f053f84d70af98b5efd4f48b14": {"prediction": {"id": "66f666f053f84d70af98b5efd4f48b14", "prediction_text": "Nivolumab was developed as a monoclonal antibody against programmed death receptor-1, an immune checkpoint inhibitor"}, "reference": {"id": "66f666f053f84d70af98b5efd4f48b14", "answers": {"answer_start": [57], "text": ["programmed death receptor-1"]}}}, "8827e793825d471996880b8bdde84ddc": {"prediction": {"id": "8827e793825d471996880b8bdde84ddc", "prediction_text": "CTLA-4"}, "reference": {"id": "8827e793825d471996880b8bdde84ddc", "answers": {"answer_start": [47], "text": ["programmed death receptor-1"]}}}, "7a9aabf898be455dbd0baef15507b91f": {"prediction": {"id": "7a9aabf898be455dbd0baef15507b91f", "prediction_text": "RNA polymerase II"}, "reference": {"id": "7a9aabf898be455dbd0baef15507b91f", "answers": {"answer_start": [515], "text": ["RNA polymerase II"]}}}, "abd4f80706be4942ac52da968ef635f9": {"prediction": {"id": "abd4f80706be4942ac52da968ef635f9", "prediction_text": "RNA polymerase II"}, "reference": {"id": "abd4f80706be4942ac52da968ef635f9", "answers": {"answer_start": [113], "text": ["RNA polymerase II"]}}}, "aa82ea109202447b8c778bf8e9afe8f2": {"prediction": {"id": "aa82ea109202447b8c778bf8e9afe8f2", "prediction_text": "Polymerase II"}, "reference": {"id": "aa82ea109202447b8c778bf8e9afe8f2", "answers": {"answer_start": [717, 736], "text": ["RNA polymerase II", "RNAPII"]}}}, "4eb15852b450401991b53bd5b7f585b8": {"prediction": {"id": "4eb15852b450401991b53bd5b7f585b8", "prediction_text": "RNA polymerase II"}, "reference": {"id": "4eb15852b450401991b53bd5b7f585b8", "answers": {"answer_start": [198], "text": ["RNA polymerase II"]}}}, "229d3257dc4d4a5cb0c41ece792c6205": {"prediction": {"id": "229d3257dc4d4a5cb0c41ece792c6205", "prediction_text": "RNA polymerase II"}, "reference": {"id": "229d3257dc4d4a5cb0c41ece792c6205", "answers": {"answer_start": [69], "text": ["RNA polymerase II"]}}}, "eb5dbb4902a842d7b5c69645b7a6b232": {"prediction": {"id": "eb5dbb4902a842d7b5c69645b7a6b232", "prediction_text": "RNA polymerase II"}, "reference": {"id": "eb5dbb4902a842d7b5c69645b7a6b232", "answers": {"answer_start": [372], "text": ["RNA polymerase II"]}}}, "2462996e9d314566983d278d0354882f": {"prediction": {"id": "2462996e9d314566983d278d0354882f", "prediction_text": "RNA polymerase II"}, "reference": {"id": "2462996e9d314566983d278d0354882f", "answers": {"answer_start": [75], "text": ["RNA polymerase II"]}}}, "8a3b87b603064ff1bceb64184ecfd98c": {"prediction": {"id": "8a3b87b603064ff1bceb64184ecfd98c", "prediction_text": "RNA polymerase II"}, "reference": {"id": "8a3b87b603064ff1bceb64184ecfd98c", "answers": {"answer_start": [165], "text": ["RNA polymerase II"]}}}, "ec7ddf201225461dbfe886e2bf0aa364": {"prediction": {"id": "ec7ddf201225461dbfe886e2bf0aa364", "prediction_text": "polymerase II"}, "reference": {"id": "ec7ddf201225461dbfe886e2bf0aa364", "answers": {"answer_start": [405], "text": ["RNA polymerase II"]}}}, "828af37b67fb4fae8f3911a3a091ecdc": {"prediction": {"id": "828af37b67fb4fae8f3911a3a091ecdc", "prediction_text": "II inhibitor"}, "reference": {"id": "828af37b67fb4fae8f3911a3a091ecdc", "answers": {"answer_start": [576], "text": ["RNA polymerase II"]}}}, "52f2038291514a088bc3f75ecf7304be": {"prediction": {"id": "52f2038291514a088bc3f75ecf7304be", "prediction_text": "RNA polymerase II"}, "reference": {"id": "52f2038291514a088bc3f75ecf7304be", "answers": {"answer_start": [930], "text": ["RNA polymerase II"]}}}, "c9d4088a336f4b0388a247f8f8e36619": {"prediction": {"id": "c9d4088a336f4b0388a247f8f8e36619", "prediction_text": "RNA polymerase II"}, "reference": {"id": "c9d4088a336f4b0388a247f8f8e36619", "answers": {"answer_start": [192], "text": ["RNA polymerase II"]}}}, "47c7cd049c174d62ba344e994ae0e65c": {"prediction": {"id": "47c7cd049c174d62ba344e994ae0e65c", "prediction_text": "RNA polymerase II"}, "reference": {"id": "47c7cd049c174d62ba344e994ae0e65c", "answers": {"answer_start": [887], "text": ["RNA polymerase II"]}}}, "9c8550339b4a404fa7815d9dc2e04e73": {"prediction": {"id": "9c8550339b4a404fa7815d9dc2e04e73", "prediction_text": "RNA polymerase II"}, "reference": {"id": "9c8550339b4a404fa7815d9dc2e04e73", "answers": {"answer_start": [354], "text": ["RNA polymerase II"]}}}, "110c1056cc5f4e038b7a98ea69e7de4d": {"prediction": {"id": "110c1056cc5f4e038b7a98ea69e7de4d", "prediction_text": "we created a yeast strain by PCR-targeted disruption of the yeast gene"}, "reference": {"id": "110c1056cc5f4e038b7a98ea69e7de4d", "answers": {"answer_start": [95], "text": ["Batten disease"]}}}, "1236e9bdf75c435386205986bc622755": {"prediction": {"id": "1236e9bdf75c435386205986bc622755", "prediction_text": "Juvenile neuronal ceroid lipofuscinosis"}, "reference": {"id": "1236e9bdf75c435386205986bc622755", "answers": {"answer_start": [41], "text": ["Batten disease"]}}}, "861cf50954c3416d9679698343d8f3a3": {"prediction": {"id": "861cf50954c3416d9679698343d8f3a3", "prediction_text": "To elucidate the biosynthesis and localization of the CLN3 protein"}, "reference": {"id": "861cf50954c3416d9679698343d8f3a3", "answers": {"answer_start": [0, 16, 63], "text": ["Batten disease", "juvenile-onset neuronal ceroid lipofuscinosis", "JNCL"]}}}, "74cd27a3313c4183952ce2d661092447": {"prediction": {"id": "74cd27a3313c4183952ce2d661092447", "prediction_text": "encodes a lysosomal membrane protein, are responsible for the neurodegenerative disorder juvenile Batten disease. A previous study on the yeast homolog to CLN3, designated Btn1p, revealed a potential role for CLN3 in the transport of arginine into the yeast vacuole, the equivalent organelle to the mammalian lysosome. Lysosomes isolated from lymphoblast cell lines, established from individuals with juvenile Batten disease-bearing mutations in CLN3, but not age-matched controls, demonstrate defective transport of arginine. Furthermore, we show that there is a depletion of arginine in cells derived from individuals with juvenile Batten disease. We have, therefore, characterized lysosomal arginine transport in normal lysosomes and show that it is ATP-, v-ATPase- and cationic-dependent. This and previous studies have shown that both arginine and lysine are transported by the same transport system, designated system c. However, we report that lysosomes isolated from juvenile Batten disease lymphoblasts are only defective for arginine transport. These results suggest that the CLN3 defect in juvenile Batten disease may affect how intracellular levels of arginine are regulated or distributed throughout the cell. This assertion is supported by two other experimental approaches. First, an antibody to CLN3 can block lysosomal arginine transport and second, expression of CLN3 in JNCL cells using a lentiviral vector can restore lysosomal arginine transport. CLN3 may have a role in regulating intracellular levels of arginine possibly through control of the transport of this amino acid into lysosomes"}, "reference": {"id": "74cd27a3313c4183952ce2d661092447", "answers": {"answer_start": [132, 1423], "text": ["Batten disease", "JNCL"]}}}, "40f10daa641e466da0137888e0e61c47": {"prediction": {"id": "40f10daa641e466da0137888e0e61c47", "prediction_text": "increases survival of human NT2 neuronal precursor cells"}, "reference": {"id": "40f10daa641e466da0137888e0e61c47", "answers": {"answer_start": [138], "text": ["Batten disease"]}}}, "6e678bea997142479b209d0d3706a326": {"prediction": {"id": "6e678bea997142479b209d0d3706a326", "prediction_text": "anti-neuronal death function"}, "reference": {"id": "6e678bea997142479b209d0d3706a326", "answers": {"answer_start": [277, 197], "text": ["Batten disease", "JNCL"]}}}, "f5800be63a2e455b80ded361f19a1da3": {"prediction": {"id": "f5800be63a2e455b80ded361f19a1da3", "prediction_text": "unknown function"}, "reference": {"id": "f5800be63a2e455b80ded361f19a1da3", "answers": {"answer_start": [0, 16, 660], "text": ["Batten disease", "juvenile-onset neuronal ceroid lipofuscinosis", "JNCL"]}}}, "a94bfb10897948ae857956d7a7c4397a": {"prediction": {"id": "a94bfb10897948ae857956d7a7c4397a", "prediction_text": "Batten disease"}, "reference": {"id": "a94bfb10897948ae857956d7a7c4397a", "answers": {"answer_start": [338], "text": ["Batten disease"]}}}, "10179e8d18fc4458ad2a84d497eefce7": {"prediction": {"id": "10179e8d18fc4458ad2a84d497eefce7", "prediction_text": "increased expression of BTN2. BTN2 encodes Btn2p, a proposed homologue to a novel microtubule-binding protein Hook1, which regulates endocytosis in Drosophila. We analysed here the putative interconnection between CLN3 and Hook1 in the mammalian cells and discovered that overexpression of human CLN3 induces aggregation of Hook1 protein, potentially by mediating its dissociation from the microtubules. Using in vitro binding assay we were able to demonstrate a weak interaction between Hook1 and the cytoplasmic segments of CLN3. We also found receptor-mediated endocytosis"}, "reference": {"id": "10179e8d18fc4458ad2a84d497eefce7", "answers": {"answer_start": [69, 953], "text": ["Batten disease", "JNCL"]}}}, "3f6bbf35e50d4fdcb30e2197b707580c": {"prediction": {"id": "3f6bbf35e50d4fdcb30e2197b707580c", "prediction_text": "vitro"}, "reference": {"id": "3f6bbf35e50d4fdcb30e2197b707580c", "answers": {"answer_start": [325], "text": ["UCP1+ adipocytes"]}}}, "b5c30e4bff9543a59ef87c73e783bb29": {"prediction": {"id": "b5c30e4bff9543a59ef87c73e783bb29", "prediction_text": "UCP1+ adipocytes"}, "reference": {"id": "b5c30e4bff9543a59ef87c73e783bb29", "answers": {"answer_start": [608], "text": ["UCP1+ adipocytes"]}}}, "79c3e46c88d2498d9389548b4c5e0b2c": {"prediction": {"id": "79c3e46c88d2498d9389548b4c5e0b2c", "prediction_text": "CaM-kinase inhibitor KN-93"}, "reference": {"id": "79c3e46c88d2498d9389548b4c5e0b2c", "answers": {"answer_start": [367], "text": ["The calcium/calmodulin-dependent protein kinase-II"]}}}, "5b0ff704dc81476bb7eddb3b4c0b2b67": {"prediction": {"id": "5b0ff704dc81476bb7eddb3b4c0b2b67", "prediction_text": "CaM kinase II"}, "reference": {"id": "5b0ff704dc81476bb7eddb3b4c0b2b67", "answers": {"answer_start": [334], "text": ["CaM kinase II"]}}}, "e3f0bf4510cf49bcb17eb7ecadc1d6e9": {"prediction": {"id": "e3f0bf4510cf49bcb17eb7ecadc1d6e9", "prediction_text": "CaM Kinase II"}, "reference": {"id": "e3f0bf4510cf49bcb17eb7ecadc1d6e9", "answers": {"answer_start": [1141], "text": ["CaM kinase II"]}}}, "edcaab2d4da84816b7886e450a000a9c": {"prediction": {"id": "edcaab2d4da84816b7886e450a000a9c", "prediction_text": "CaM kinase activity was increased 5-fold in cells subjected to IH. KN 93 prevented IH-induced transactivation mediated by HIF-1alpha, and its coactivator p300, which was phosphorylated by CaM kinase II in vitro. Expression of the HIF-1-regulated gene encoding tyrosine hydroxylase was induced by IH and this effect was blocked by KN93. These observations suggest that IH induces HIF-1 transcriptional activity via a novel signaling pathway involving CaM kinase"}, "reference": {"id": "edcaab2d4da84816b7886e450a000a9c", "answers": {"answer_start": [1361], "text": ["CaM kinase II"]}}}, "8823fc06600441098f2beaeb40760694": {"prediction": {"id": "8823fc06600441098f2beaeb40760694", "prediction_text": "CaM kinase"}, "reference": {"id": "8823fc06600441098f2beaeb40760694", "answers": {"answer_start": [322, 1139], "text": ["The calcium/calmodulin-dependent protein kinase-II", "CaM kinase II"]}}}, "3784f88553de4c3d83c01239c33329ce": {"prediction": {"id": "3784f88553de4c3d83c01239c33329ce", "prediction_text": "MAP kinase antisense oligonucleotide reduced NE-induced activation of MAP kinase and cPLA2. NE-induced MAP kinase and cPLA2 activation was also inhibited in cells treated with a CaM kinase II inhibitor, KN-93, or with CaM kinase II antisense oligonucleotide. On the other hand, inhibition of MAP kinase kinase with PD-098059 or of MAP kinase with antisense oligonucleotides did not alter the NE-induced increase in CaM kinase II activity. Phosphorylation of MAP kinase and CaM kinase II"}, "reference": {"id": "3784f88553de4c3d83c01239c33329ce", "answers": {"answer_start": [1369], "text": ["CaM kinase II"]}}}, "e8dfe749bd9b4fe991378933dfae0be0": {"prediction": {"id": "e8dfe749bd9b4fe991378933dfae0be0", "prediction_text": "Mycobacterium tuberculosis"}, "reference": {"id": "e8dfe749bd9b4fe991378933dfae0be0", "answers": {"answer_start": [658], "text": ["tuberculosis"]}}}, "3117d303b23a4cb3b8a8208c03d880ba": {"prediction": {"id": "3117d303b23a4cb3b8a8208c03d880ba", "prediction_text": "bedaquiline"}, "reference": {"id": "3117d303b23a4cb3b8a8208c03d880ba", "answers": {"answer_start": [47], "text": ["tuberculosis"]}}}, "af722134f0c6432ca54f52731ebd07f2": {"prediction": {"id": "af722134f0c6432ca54f52731ebd07f2", "prediction_text": "Mycobacterium tuberculosis"}, "reference": {"id": "af722134f0c6432ca54f52731ebd07f2", "answers": {"answer_start": [405], "text": ["tuberculosis"]}}}, "9333b6965ebe4d6a8733d880d32e504c": {"prediction": {"id": "9333b6965ebe4d6a8733d880d32e504c", "prediction_text": "Tuberculosis"}, "reference": {"id": "9333b6965ebe4d6a8733d880d32e504c", "answers": {"answer_start": [0], "text": ["tuberculosis"]}}}, "9c68b72c44f64146b1e75805827f5797": {"prediction": {"id": "9c68b72c44f64146b1e75805827f5797", "prediction_text": "Mycobacterium tuberculosis. In this randomized, placebo-controlled, multinational clinical trial, we assigned 481 patients (nearly all of whom were negative for the human immunodeficiency virus) with pulmonary multidrug-resistant tuberculosis"}, "reference": {"id": "9c68b72c44f64146b1e75805827f5797", "answers": {"answer_start": [933], "text": ["tuberculosis"]}}}, "4c6f61cf627a4aacb56f72fdaca31c16": {"prediction": {"id": "4c6f61cf627a4aacb56f72fdaca31c16", "prediction_text": "pneumonic anthrax"}, "reference": {"id": "4c6f61cf627a4aacb56f72fdaca31c16", "answers": {"answer_start": [386], "text": ["Bacillus Anthracis"]}}}, "e22765feef4f4d1285354c69cb7d108d": {"prediction": {"id": "e22765feef4f4d1285354c69cb7d108d", "prediction_text": "anti-Vel"}, "reference": {"id": "e22765feef4f4d1285354c69cb7d108d", "answers": {"answer_start": [724], "text": ["a 17 nucleotide deletion"]}}}, "a922b21cfa464ccca4216af10e3b8184": {"prediction": {"id": "a922b21cfa464ccca4216af10e3b8184", "prediction_text": "McLeod"}, "reference": {"id": "a922b21cfa464ccca4216af10e3b8184", "answers": {"answer_start": [433], "text": ["XK"]}}}, "37c5bd39032b466ebbb8d93196a959ac": {"prediction": {"id": "37c5bd39032b466ebbb8d93196a959ac", "prediction_text": "XK"}, "reference": {"id": "37c5bd39032b466ebbb8d93196a959ac", "answers": {"answer_start": [334], "text": ["XK"]}}}, "6c7f26976f434cf79a92e296b95945c9": {"prediction": {"id": "6c7f26976f434cf79a92e296b95945c9", "prediction_text": "XK"}, "reference": {"id": "6c7f26976f434cf79a92e296b95945c9", "answers": {"answer_start": [282], "text": ["XK"]}}}, "78b66e8582044690b1ccf60206ab64f1": {"prediction": {"id": "78b66e8582044690b1ccf60206ab64f1", "prediction_text": "XK"}, "reference": {"id": "78b66e8582044690b1ccf60206ab64f1", "answers": {"answer_start": [1150], "text": ["XK"]}}}, "df429bf4496d4cb7937819df5cc59eff": {"prediction": {"id": "df429bf4496d4cb7937819df5cc59eff", "prediction_text": "hereditary neuroacanthocytosis"}, "reference": {"id": "df429bf4496d4cb7937819df5cc59eff", "answers": {"answer_start": [570], "text": ["XK"]}}}, "284c07dc26fe48148fa51764d6b729b2": {"prediction": {"id": "284c07dc26fe48148fa51764d6b729b2", "prediction_text": "gene XK"}, "reference": {"id": "284c07dc26fe48148fa51764d6b729b2", "answers": {"answer_start": [291], "text": ["XK"]}}}, "9fac184da23145cbaaaa6d9bfb3ac7b9": {"prediction": {"id": "9fac184da23145cbaaaa6d9bfb3ac7b9", "prediction_text": "XK"}, "reference": {"id": "9fac184da23145cbaaaa6d9bfb3ac7b9", "answers": {"answer_start": [424], "text": ["XK"]}}}, "e3802e9ef0164f4882ed517a151d595b": {"prediction": {"id": "e3802e9ef0164f4882ed517a151d595b", "prediction_text": "XK"}, "reference": {"id": "e3802e9ef0164f4882ed517a151d595b", "answers": {"answer_start": [490], "text": ["XK"]}}}, "003dd0aa2e7b442ca4f234a6f4c6e160": {"prediction": {"id": "003dd0aa2e7b442ca4f234a6f4c6e160", "prediction_text": "XK"}, "reference": {"id": "003dd0aa2e7b442ca4f234a6f4c6e160", "answers": {"answer_start": [715], "text": ["XK"]}}}, "7e4eba927487448fac99810aa9e45b38": {"prediction": {"id": "7e4eba927487448fac99810aa9e45b38", "prediction_text": "XK"}, "reference": {"id": "7e4eba927487448fac99810aa9e45b38", "answers": {"answer_start": [372], "text": ["XK"]}}}, "7c663311d02e4d1287891fdc489a2bed": {"prediction": {"id": "7c663311d02e4d1287891fdc489a2bed", "prediction_text": "XK"}, "reference": {"id": "7c663311d02e4d1287891fdc489a2bed", "answers": {"answer_start": [330], "text": ["XK"]}}}, "88867a37ea0842c886f48ae400d5f7bd": {"prediction": {"id": "88867a37ea0842c886f48ae400d5f7bd", "prediction_text": "XK gene"}, "reference": {"id": "88867a37ea0842c886f48ae400d5f7bd", "answers": {"answer_start": [372], "text": ["XK"]}}}, "2bc58c83fff54c9da9fff31dce5ed636": {"prediction": {"id": "2bc58c83fff54c9da9fff31dce5ed636", "prediction_text": "MLS"}, "reference": {"id": "2bc58c83fff54c9da9fff31dce5ed636", "answers": {"answer_start": [1112], "text": ["XK"]}}}, "30e783b3e88645f58bc06dab88f7789f": {"prediction": {"id": "30e783b3e88645f58bc06dab88f7789f", "prediction_text": "XK"}, "reference": {"id": "30e783b3e88645f58bc06dab88f7789f", "answers": {"answer_start": [443], "text": ["XK"]}}}, "cb855c2578e1481e8b124cef4982abb8": {"prediction": {"id": "cb855c2578e1481e8b124cef4982abb8", "prediction_text": "XK"}, "reference": {"id": "cb855c2578e1481e8b124cef4982abb8", "answers": {"answer_start": [355], "text": ["XK"]}}}, "275ac675a74a43eab92c9a337a1f56b2": {"prediction": {"id": "275ac675a74a43eab92c9a337a1f56b2", "prediction_text": "XK"}, "reference": {"id": "275ac675a74a43eab92c9a337a1f56b2", "answers": {"answer_start": [359], "text": ["XK"]}}}, "6322932e66cd463d8c67014a620a0f9b": {"prediction": {"id": "6322932e66cd463d8c67014a620a0f9b", "prediction_text": "XK gene"}, "reference": {"id": "6322932e66cd463d8c67014a620a0f9b", "answers": {"answer_start": [276], "text": ["XK"]}}}, "3fa2df7cb48d401c814d3dd83be03ca6": {"prediction": {"id": "3fa2df7cb48d401c814d3dd83be03ca6", "prediction_text": "XK"}, "reference": {"id": "3fa2df7cb48d401c814d3dd83be03ca6", "answers": {"answer_start": [169], "text": ["XK"]}}}, "5377d89ef7cd4c89bced8a7b69aab54e": {"prediction": {"id": "5377d89ef7cd4c89bced8a7b69aab54e", "prediction_text": "CYBB gene"}, "reference": {"id": "5377d89ef7cd4c89bced8a7b69aab54e", "answers": {"answer_start": [1155], "text": ["XK"]}}}, "ee9f55fb3aa0498e826d2ad473176973": {"prediction": {"id": "ee9f55fb3aa0498e826d2ad473176973", "prediction_text": "XK"}, "reference": {"id": "ee9f55fb3aa0498e826d2ad473176973", "answers": {"answer_start": [92], "text": ["XK"]}}}, "87962f491f454441aa68c13cd15f3483": {"prediction": {"id": "87962f491f454441aa68c13cd15f3483", "prediction_text": "XK gene"}, "reference": {"id": "87962f491f454441aa68c13cd15f3483", "answers": {"answer_start": [574], "text": ["XK"]}}}, "529c6101bbac43c7a1ef3a69cf270052": {"prediction": {"id": "529c6101bbac43c7a1ef3a69cf270052", "prediction_text": "K"}, "reference": {"id": "529c6101bbac43c7a1ef3a69cf270052", "answers": {"answer_start": [1160], "text": ["XK"]}}}, "9d1b1ca74f82489ebedd2759d6c60f61": {"prediction": {"id": "9d1b1ca74f82489ebedd2759d6c60f61", "prediction_text": "XK"}, "reference": {"id": "9d1b1ca74f82489ebedd2759d6c60f61", "answers": {"answer_start": [366], "text": ["XK"]}}}, "d5a0ba35421c46bb982a629dae6c5f81": {"prediction": {"id": "d5a0ba35421c46bb982a629dae6c5f81", "prediction_text": "XK"}, "reference": {"id": "d5a0ba35421c46bb982a629dae6c5f81", "answers": {"answer_start": [34], "text": ["XK"]}}}, "4a31247ac8454b6ca58762772e69ae41": {"prediction": {"id": "4a31247ac8454b6ca58762772e69ae41", "prediction_text": "XK gene"}, "reference": {"id": "4a31247ac8454b6ca58762772e69ae41", "answers": {"answer_start": [372], "text": ["XK"]}}}, "ea237b42dbd645bca499dbf78ac591d2": {"prediction": {"id": "ea237b42dbd645bca499dbf78ac591d2", "prediction_text": "XK"}, "reference": {"id": "ea237b42dbd645bca499dbf78ac591d2", "answers": {"answer_start": [1154], "text": ["XK"]}}}, "6f22d338cff046648157fda2b7184868": {"prediction": {"id": "6f22d338cff046648157fda2b7184868", "prediction_text": "XK"}, "reference": {"id": "6f22d338cff046648157fda2b7184868", "answers": {"answer_start": [1068], "text": ["XK"]}}}, "7ab0aff2f86d4b36b810a23e9a6a52d8": {"prediction": {"id": "7ab0aff2f86d4b36b810a23e9a6a52d8", "prediction_text": "Alzheimer"}, "reference": {"id": "7ab0aff2f86d4b36b810a23e9a6a52d8", "answers": {"answer_start": [94, 551], "text": ["Alzheimer's Disease", "AD"]}}}, "a2114ad9891a4e8ca8d2bf39b3be3fe9": {"prediction": {"id": "a2114ad9891a4e8ca8d2bf39b3be3fe9", "prediction_text": "Alzheimer's disease"}, "reference": {"id": "a2114ad9891a4e8ca8d2bf39b3be3fe9", "answers": {"answer_start": [140], "text": ["Alzheimer's Disease"]}}}, "73328e729cdb4022abf498e008e9f8b7": {"prediction": {"id": "73328e729cdb4022abf498e008e9f8b7", "prediction_text": "Alzheimer's disease (AD) is a complex neurodegenerative disorder characterized by extracellular plaques containing amyloid \u03b2 (A\u03b2)-protein and intracellular tangles containing hyperphosphorylated Tau protein. Here, we describe the generation of inducible pluripotent stem cell lines from patients harboring the London familial AD (fAD"}, "reference": {"id": "73328e729cdb4022abf498e008e9f8b7", "answers": {"answer_start": [0, 21], "text": ["Alzheimer's Disease", "AD"]}}}, "08a09942883a4962ba41129a74f8750a": {"prediction": {"id": "08a09942883a4962ba41129a74f8750a", "prediction_text": "Alzheimer"}, "reference": {"id": "08a09942883a4962ba41129a74f8750a", "answers": {"answer_start": [786, 428], "text": ["Alzheimer's Disease", "AD"]}}}, "e49abd2f67074e3ab4e71abaf76cd479": {"prediction": {"id": "e49abd2f67074e3ab4e71abaf76cd479", "prediction_text": "transgenic APP/V717I"}, "reference": {"id": "e49abd2f67074e3ab4e71abaf76cd479", "answers": {"answer_start": [1582], "text": ["Alzheimer's Disease"]}}}, "a39d59d2f1b94e81a356199dfc0ccca3": {"prediction": {"id": "a39d59d2f1b94e81a356199dfc0ccca3", "prediction_text": "Alzheimer"}, "reference": {"id": "a39d59d2f1b94e81a356199dfc0ccca3", "answers": {"answer_start": [0, 1472], "text": ["Alzheimer's Disease", "AD"]}}}, "e1aa829035394d3c9354206cb248fb10": {"prediction": {"id": "e1aa829035394d3c9354206cb248fb10", "prediction_text": "Alzheimer"}, "reference": {"id": "e1aa829035394d3c9354206cb248fb10", "answers": {"answer_start": [115, 1066], "text": ["Alzheimer's Disease", "AD"]}}}, "9962b65979334a32bcfa10dac19c9389": {"prediction": {"id": "9962b65979334a32bcfa10dac19c9389", "prediction_text": "human amyloid precursor protein"}, "reference": {"id": "9962b65979334a32bcfa10dac19c9389", "answers": {"answer_start": [1060], "text": ["Alzheimer's Disease"]}}}, "007814537bb04c5691caabc3ff9dd5f6": {"prediction": {"id": "007814537bb04c5691caabc3ff9dd5f6", "prediction_text": "Alzheimer"}, "reference": {"id": "007814537bb04c5691caabc3ff9dd5f6", "answers": {"answer_start": [40], "text": ["Alzheimer's Disease"]}}}, "0b63a2aaacb7427183624e2d2793923e": {"prediction": {"id": "0b63a2aaacb7427183624e2d2793923e", "prediction_text": "Alzheimer"}, "reference": {"id": "0b63a2aaacb7427183624e2d2793923e", "answers": {"answer_start": [454], "text": ["Alzheimer's Disease"]}}}, "dd2d930132674f94a0b3a4c5db09446f": {"prediction": {"id": "dd2d930132674f94a0b3a4c5db09446f", "prediction_text": "V717I"}, "reference": {"id": "dd2d930132674f94a0b3a4c5db09446f", "answers": {"answer_start": [186, 875], "text": ["Alzheimer's Disease", "AD"]}}}, "908ad27680be4dd2aefd40f338c2889a": {"prediction": {"id": "908ad27680be4dd2aefd40f338c2889a", "prediction_text": "murine PS1 gene"}, "reference": {"id": "908ad27680be4dd2aefd40f338c2889a", "answers": {"answer_start": [30, 51], "text": ["Alzheimer's Disease", "AD"]}}}, "ef8f224b7b8f4b14aecf9e7a6b4192ae": {"prediction": {"id": "ef8f224b7b8f4b14aecf9e7a6b4192ae", "prediction_text": "APP/Lo mice"}, "reference": {"id": "ef8f224b7b8f4b14aecf9e7a6b4192ae", "answers": {"answer_start": [22, 43], "text": ["Alzheimer's Disease", "AD"]}}}, "49dda71068324702a6d77b35a20a2720": {"prediction": {"id": "49dda71068324702a6d77b35a20a2720", "prediction_text": "Dutch mutation"}, "reference": {"id": "49dda71068324702a6d77b35a20a2720", "answers": {"answer_start": [110, 672], "text": ["Alzheimer's Disease", "AD"]}}}, "17602db909ff4596a5719c8cca4ebe30": {"prediction": {"id": "17602db909ff4596a5719c8cca4ebe30", "prediction_text": "pathogenesis of Alzheimer's disease"}, "reference": {"id": "17602db909ff4596a5719c8cca4ebe30", "answers": {"answer_start": [138, 1914], "text": ["Alzheimer's Disease", "AD"]}}}, "5ac9ac7ac7f746da9af4c7d55ed163fc": {"prediction": {"id": "5ac9ac7ac7f746da9af4c7d55ed163fc", "prediction_text": "codon 717"}, "reference": {"id": "5ac9ac7ac7f746da9af4c7d55ed163fc", "answers": {"answer_start": [43], "text": ["Alzheimer's Disease"]}}}, "ea1688073d914f2389adaf423b67306d": {"prediction": {"id": "ea1688073d914f2389adaf423b67306d", "prediction_text": "Alzheimer's disease"}, "reference": {"id": "ea1688073d914f2389adaf423b67306d", "answers": {"answer_start": [1763], "text": ["Alzheimer's Disease"]}}}, "684bc69d5c0848e3a9548250a8b08a7e": {"prediction": {"id": "684bc69d5c0848e3a9548250a8b08a7e", "prediction_text": "APP gene"}, "reference": {"id": "684bc69d5c0848e3a9548250a8b08a7e", "answers": {"answer_start": [68], "text": ["Alzheimer's Disease"]}}}, "7e8c3ff3e090425996dddb069fef44a5": {"prediction": {"id": "7e8c3ff3e090425996dddb069fef44a5", "prediction_text": "JAMM"}, "reference": {"id": "7e8c3ff3e090425996dddb069fef44a5", "answers": {"answer_start": [829], "text": ["JAMM"]}}}, "4b790f4d8ac347408b07f27b0e08f637": {"prediction": {"id": "4b790f4d8ac347408b07f27b0e08f637", "prediction_text": "Bacillus subtilis cells"}, "reference": {"id": "4b790f4d8ac347408b07f27b0e08f637", "answers": {"answer_start": [746], "text": ["stationary phase"]}}}, "7a614bd75381431fbf324ef38eb871e3": {"prediction": {"id": "7a614bd75381431fbf324ef38eb871e3", "prediction_text": "influence evolutionary processes"}, "reference": {"id": "7a614bd75381431fbf324ef38eb871e3", "answers": {"answer_start": [10], "text": ["stationary phase"]}}}, "468b63bb15894842a59db9dd5b716d57": {"prediction": {"id": "468b63bb15894842a59db9dd5b716d57", "prediction_text": "RNA polymerase (RNAP) processivity or transcriptional derepression contribute to the generation of stress-induced mutations. In Bacillus subtilis, transcription-associated mutagenesis has been shown to be independent of recombination-dependent repair and, in some cases, of the Y DNA polymerases. Central to stationary-phase mutagenesis in B. subtilis"}, "reference": {"id": "468b63bb15894842a59db9dd5b716d57", "answers": {"answer_start": [1044], "text": ["stationary phase"]}}}, "af44488c850649ad934a588c0ce6e880": {"prediction": {"id": "af44488c850649ad934a588c0ce6e880", "prediction_text": "nongrowing cells"}, "reference": {"id": "af44488c850649ad934a588c0ce6e880", "answers": {"answer_start": [200], "text": ["stationary phase"]}}}, "6174ee5625c646ac8be4de55010061b7": {"prediction": {"id": "6174ee5625c646ac8be4de55010061b7", "prediction_text": "nestin"}, "reference": {"id": "6174ee5625c646ac8be4de55010061b7", "answers": {"answer_start": [394], "text": ["Nestin"]}}}, "870e23c1391e4746bddc6d50c040c1f3": {"prediction": {"id": "870e23c1391e4746bddc6d50c040c1f3", "prediction_text": "olfactory bulb"}, "reference": {"id": "870e23c1391e4746bddc6d50c040c1f3", "answers": {"answer_start": [456], "text": ["Nestin"]}}}, "065baae313d8401bb0c60ceefeec9270": {"prediction": {"id": "065baae313d8401bb0c60ceefeec9270", "prediction_text": "glial"}, "reference": {"id": "065baae313d8401bb0c60ceefeec9270", "answers": {"answer_start": [618], "text": ["Nestin"]}}}, "bc058d832d8d4e80b603ad5ab1d66332": {"prediction": {"id": "bc058d832d8d4e80b603ad5ab1d66332", "prediction_text": "glial"}, "reference": {"id": "bc058d832d8d4e80b603ad5ab1d66332", "answers": {"answer_start": [992], "text": ["Nestin"]}}}, "07d72dfea7144161a20d3fda3c1159ba": {"prediction": {"id": "07d72dfea7144161a20d3fda3c1159ba", "prediction_text": "Nestin"}, "reference": {"id": "07d72dfea7144161a20d3fda3c1159ba", "answers": {"answer_start": [0], "text": ["Nestin"]}}}, "1cc69546b4df4a409355da95f34de264": {"prediction": {"id": "1cc69546b4df4a409355da95f34de264", "prediction_text": "glial fibrillary acidic protein (GFAP, 5%) immunoreactivities, respectively. In addition, bone marrow transplantation promoted proliferation of ependymal and subependymal cells, identified by nestin (a neuroepithelial stem cell marker), within the ventricular zone"}, "reference": {"id": "1cc69546b4df4a409355da95f34de264", "answers": {"answer_start": [596], "text": ["Nestin"]}}}, "fff06dac81ba4d23baec3f5e5626dd17": {"prediction": {"id": "fff06dac81ba4d23baec3f5e5626dd17", "prediction_text": "Nestin"}, "reference": {"id": "fff06dac81ba4d23baec3f5e5626dd17", "answers": {"answer_start": [0], "text": ["Nestin"]}}}, "71291768ba9e4b43b93a3b9cf266a55e": {"prediction": {"id": "71291768ba9e4b43b93a3b9cf266a55e", "prediction_text": "green"}, "reference": {"id": "71291768ba9e4b43b93a3b9cf266a55e", "answers": {"answer_start": [261], "text": ["Nestin"]}}}, "80800bf8db86465d872ce6c23f153886": {"prediction": {"id": "80800bf8db86465d872ce6c23f153886", "prediction_text": "piglet NSPs"}, "reference": {"id": "80800bf8db86465d872ce6c23f153886", "answers": {"answer_start": [640], "text": ["Nestin"]}}}, "6d3eae4ac14d4a3385103768227a2602": {"prediction": {"id": "6d3eae4ac14d4a3385103768227a2602", "prediction_text": "NeuN"}, "reference": {"id": "6d3eae4ac14d4a3385103768227a2602", "answers": {"answer_start": [647], "text": ["Nestin"]}}}, "e61251df8c8e4795a3ba1859f9b4e923": {"prediction": {"id": "e61251df8c8e4795a3ba1859f9b4e923", "prediction_text": "glial fibrillary"}, "reference": {"id": "e61251df8c8e4795a3ba1859f9b4e923", "answers": {"answer_start": [994], "text": ["Nestin"]}}}, "d0c791240bbe4052b872c0d1e07b56e0": {"prediction": {"id": "d0c791240bbe4052b872c0d1e07b56e0", "prediction_text": "multipotentiality"}, "reference": {"id": "d0c791240bbe4052b872c0d1e07b56e0", "answers": {"answer_start": [669], "text": ["Nestin"]}}}, "744c3c2c1a20418393ae7cf3f6af349e": {"prediction": {"id": "744c3c2c1a20418393ae7cf3f6af349e", "prediction_text": "olfactory bulb"}, "reference": {"id": "744c3c2c1a20418393ae7cf3f6af349e", "answers": {"answer_start": [1078], "text": ["Nestin"]}}}, "e6aed7f295584757a9c2de4e0ff76c31": {"prediction": {"id": "e6aed7f295584757a9c2de4e0ff76c31", "prediction_text": "mesenchymal"}, "reference": {"id": "e6aed7f295584757a9c2de4e0ff76c31", "answers": {"answer_start": [624], "text": ["Nestin"]}}}, "fb31b14065364ed5807a735c272d0d4d": {"prediction": {"id": "fb31b14065364ed5807a735c272d0d4d", "prediction_text": "hippocampal"}, "reference": {"id": "fb31b14065364ed5807a735c272d0d4d", "answers": {"answer_start": [818], "text": ["Nestin"]}}}, "a2db1553c2634e80a5b74226330c6fa1": {"prediction": {"id": "a2db1553c2634e80a5b74226330c6fa1", "prediction_text": "hematoma"}, "reference": {"id": "a2db1553c2634e80a5b74226330c6fa1", "answers": {"answer_start": [746], "text": ["dabigatran"]}}}, "42f3dbae1f0341ef8f8775e9e990cdf7": {"prediction": {"id": "42f3dbae1f0341ef8f8775e9e990cdf7", "prediction_text": "inhibitor"}, "reference": {"id": "42f3dbae1f0341ef8f8775e9e990cdf7", "answers": {"answer_start": [30], "text": ["dabigatran"]}}}, "7b4e5493e5d74072a3a319eb4f390502": {"prediction": {"id": "7b4e5493e5d74072a3a319eb4f390502", "prediction_text": "antibody fragment"}, "reference": {"id": "7b4e5493e5d74072a3a319eb4f390502", "answers": {"answer_start": [1870], "text": ["dabigatran"]}}}, "7454d0b7bfea4297858ab8bddcf6ba60": {"prediction": {"id": "7454d0b7bfea4297858ab8bddcf6ba60", "prediction_text": "Pharma GmbH"}, "reference": {"id": "7454d0b7bfea4297858ab8bddcf6ba60", "answers": {"answer_start": [1357], "text": ["dabigatran"]}}}, "12bf73e2e76f4065819f82c4432867b4": {"prediction": {"id": "12bf73e2e76f4065819f82c4432867b4", "prediction_text": "Pse-in-One"}, "reference": {"id": "12bf73e2e76f4065819f82c4432867b4", "answers": {"answer_start": [847], "text": ["Pse-in-One"]}}}, "1e20337955de45a1a8398a02a2edce8c": {"prediction": {"id": "1e20337955de45a1a8398a02a2edce8c", "prediction_text": "Wnt/\u03b2-catenin signaling"}, "reference": {"id": "1e20337955de45a1a8398a02a2edce8c", "answers": {"answer_start": [273], "text": ["bone metabolism"]}}}, "405f8a0b33914210a5bb6bbed746e6e8": {"prediction": {"id": "405f8a0b33914210a5bb6bbed746e6e8", "prediction_text": "bone metabolism"}, "reference": {"id": "405f8a0b33914210a5bb6bbed746e6e8", "answers": {"answer_start": [64], "text": ["bone metabolism"]}}}, "0c7787ec5ad046c3bbfaa2286c3740db": {"prediction": {"id": "0c7787ec5ad046c3bbfaa2286c3740db", "prediction_text": "Wnt signaling pathway"}, "reference": {"id": "0c7787ec5ad046c3bbfaa2286c3740db", "answers": {"answer_start": [17], "text": ["bone metabolism"]}}}, "664c9303dea4472e9f6f818834f7f0e7": {"prediction": {"id": "664c9303dea4472e9f6f818834f7f0e7", "prediction_text": "bone formation"}, "reference": {"id": "664c9303dea4472e9f6f818834f7f0e7", "answers": {"answer_start": [1238], "text": ["bone metabolism"]}}}, "e7dec002f0c446088090209d25fc26e8": {"prediction": {"id": "e7dec002f0c446088090209d25fc26e8", "prediction_text": "hypoxia-inducible factor-1\u03b1 (HIF-1\u03b1)"}, "reference": {"id": "e7dec002f0c446088090209d25fc26e8", "answers": {"answer_start": [1329], "text": ["mir-138"]}}}, "bfd081849bca43c79c2a6b610afd30c1": {"prediction": {"id": "bfd081849bca43c79c2a6b610afd30c1", "prediction_text": "miRNA"}, "reference": {"id": "bfd081849bca43c79c2a6b610afd30c1", "answers": {"answer_start": [1199], "text": ["mir-138"]}}}, "ef3358fe28a046beae6b13459afd48d7": {"prediction": {"id": "ef3358fe28a046beae6b13459afd48d7", "prediction_text": "CDR1as"}, "reference": {"id": "ef3358fe28a046beae6b13459afd48d7", "answers": {"answer_start": [284], "text": ["mir-138"]}}}, "9d4f94532d4547c5b026cc43a6b3b679": {"prediction": {"id": "9d4f94532d4547c5b026cc43a6b3b679", "prediction_text": "opioids"}, "reference": {"id": "9d4f94532d4547c5b026cc43a6b3b679", "answers": {"answer_start": [480], "text": ["naloxone"]}}}, "a708702228a74c058ed8d1c19a0a9243": {"prediction": {"id": "a708702228a74c058ed8d1c19a0a9243", "prediction_text": "bag-valve-mask ventilation"}, "reference": {"id": "a708702228a74c058ed8d1c19a0a9243", "answers": {"answer_start": [1204], "text": ["naloxone"]}}}, "f0568785563f4a45aa72b8d7f31ace06": {"prediction": {"id": "f0568785563f4a45aa72b8d7f31ace06", "prediction_text": "oxygen saturation"}, "reference": {"id": "f0568785563f4a45aa72b8d7f31ace06", "answers": {"answer_start": [125], "text": ["naloxone"]}}}, "174a5235db2a407abbf63b032ef76601": {"prediction": {"id": "174a5235db2a407abbf63b032ef76601", "prediction_text": "opioid therapy"}, "reference": {"id": "174a5235db2a407abbf63b032ef76601", "answers": {"answer_start": [332], "text": ["naloxone"]}}}, "1aca80d024d34f4daea5124e1d98b458": {"prediction": {"id": "1aca80d024d34f4daea5124e1d98b458", "prediction_text": "Activated charcoal"}, "reference": {"id": "1aca80d024d34f4daea5124e1d98b458", "answers": {"answer_start": [2918], "text": ["naloxone"]}}}, "3924b61bcc5442edbccfc005930aca92": {"prediction": {"id": "3924b61bcc5442edbccfc005930aca92", "prediction_text": "cascade method"}, "reference": {"id": "3924b61bcc5442edbccfc005930aca92", "answers": {"answer_start": [103], "text": ["naloxone"]}}}, "8c37203c3a424d65a25205de6d9b1aae": {"prediction": {"id": "8c37203c3a424d65a25205de6d9b1aae", "prediction_text": "3' UTR RNA (the SECIS element"}, "reference": {"id": "8c37203c3a424d65a25205de6d9b1aae", "answers": {"answer_start": [241], "text": ["SECIS"]}}}, "b20bb9bf10e54aabbda27bd16351f5a8": {"prediction": {"id": "b20bb9bf10e54aabbda27bd16351f5a8", "prediction_text": "Sec insertion sequence (SECIS) element"}, "reference": {"id": "b20bb9bf10e54aabbda27bd16351f5a8", "answers": {"answer_start": [771], "text": ["SECIS"]}}}, "f721e4a985bf42deacb4a96f15b8ee1e": {"prediction": {"id": "f721e4a985bf42deacb4a96f15b8ee1e", "prediction_text": "SECIS elements form stem-loop structures in the 3' untranslated regions (UTR"}, "reference": {"id": "f721e4a985bf42deacb4a96f15b8ee1e", "answers": {"answer_start": [0], "text": ["SECIS"]}}}, "a5978b695b034f74bebbaaba76b224de": {"prediction": {"id": "a5978b695b034f74bebbaaba76b224de", "prediction_text": "Sec insertion sequence"}, "reference": {"id": "a5978b695b034f74bebbaaba76b224de", "answers": {"answer_start": [1154], "text": ["SECIS"]}}}, "f58d903f61e147058a5d1ab6b18d70e3": {"prediction": {"id": "f58d903f61e147058a5d1ab6b18d70e3", "prediction_text": "selenocysteine insertion sequence (SECIS) element"}, "reference": {"id": "f58d903f61e147058a5d1ab6b18d70e3", "answers": {"answer_start": [960], "text": ["SECIS"]}}}, "cf4d141a6ab648d099035ca0cb912d00": {"prediction": {"id": "cf4d141a6ab648d099035ca0cb912d00", "prediction_text": "5'DI"}, "reference": {"id": "cf4d141a6ab648d099035ca0cb912d00", "answers": {"answer_start": [464], "text": ["SECIS"]}}}, "3a837a7964ee441eb80e525986c834c6": {"prediction": {"id": "3a837a7964ee441eb80e525986c834c6", "prediction_text": "selenocysteine insertion sequence (SECIS)"}, "reference": {"id": "3a837a7964ee441eb80e525986c834c6", "answers": {"answer_start": [950], "text": ["SECIS"]}}}, "8ee3f80e8e334efa9a4bd971b9f3f3a7": {"prediction": {"id": "8ee3f80e8e334efa9a4bd971b9f3f3a7", "prediction_text": "UGA"}, "reference": {"id": "8ee3f80e8e334efa9a4bd971b9f3f3a7", "answers": {"answer_start": [439], "text": ["SECIS"]}}}, "35de1db7853f4e699b9d9cbe2dae8297": {"prediction": {"id": "35de1db7853f4e699b9d9cbe2dae8297", "prediction_text": "Sec insertion sequence element (SECIS)"}, "reference": {"id": "35de1db7853f4e699b9d9cbe2dae8297", "answers": {"answer_start": [957], "text": ["SECIS"]}}}, "d58e9558b35e4900b0daeabe9b83b15e": {"prediction": {"id": "d58e9558b35e4900b0daeabe9b83b15e", "prediction_text": "six nucleotides"}, "reference": {"id": "d58e9558b35e4900b0daeabe9b83b15e", "answers": {"answer_start": [763], "text": ["SECIS"]}}}, "4079cef6a3e14d3d8fae0f418a8303ec": {"prediction": {"id": "4079cef6a3e14d3d8fae0f418a8303ec", "prediction_text": "non-Watson-Crick"}, "reference": {"id": "4079cef6a3e14d3d8fae0f418a8303ec", "answers": {"answer_start": [702], "text": ["SECIS"]}}}, "42e69ed1030d441aa28a689b00121b7d": {"prediction": {"id": "42e69ed1030d441aa28a689b00121b7d", "prediction_text": "selenocysteine"}, "reference": {"id": "42e69ed1030d441aa28a689b00121b7d", "answers": {"answer_start": [1184], "text": ["SECIS"]}}}, "6471075f428844e7b2c6698bac5ddc49": {"prediction": {"id": "6471075f428844e7b2c6698bac5ddc49", "prediction_text": "SElenoCysteine Insertion Sequence (SECIS)"}, "reference": {"id": "6471075f428844e7b2c6698bac5ddc49", "answers": {"answer_start": [997], "text": ["SECIS"]}}}, "902a30fa433e46cdafb253ea0f404ffc": {"prediction": {"id": "902a30fa433e46cdafb253ea0f404ffc", "prediction_text": "selenocysteine insertion sequence (SECIS) element"}, "reference": {"id": "902a30fa433e46cdafb253ea0f404ffc", "answers": {"answer_start": [754], "text": ["SECIS"]}}}, "9ee4738c7ff3448b816f2435f6e7c9fc": {"prediction": {"id": "9ee4738c7ff3448b816f2435f6e7c9fc", "prediction_text": "SECIS"}, "reference": {"id": "9ee4738c7ff3448b816f2435f6e7c9fc", "answers": {"answer_start": [749], "text": ["SECIS"]}}}, "e7b59c36c6e54ea282aaeb41b44f8b9a": {"prediction": {"id": "e7b59c36c6e54ea282aaeb41b44f8b9a", "prediction_text": "SECIS"}, "reference": {"id": "e7b59c36c6e54ea282aaeb41b44f8b9a", "answers": {"answer_start": [430], "text": ["SECIS"]}}}, "f4fa4c8bfc654b89a9b80bb933c913cf": {"prediction": {"id": "f4fa4c8bfc654b89a9b80bb933c913cf", "prediction_text": "a SEC incorporation sequence (SECIS)"}, "reference": {"id": "f4fa4c8bfc654b89a9b80bb933c913cf", "answers": {"answer_start": [862], "text": ["SECIS"]}}}, "be7a524e61a34e478e3aa8f29bd0dec5": {"prediction": {"id": "be7a524e61a34e478e3aa8f29bd0dec5", "prediction_text": "SECIS"}, "reference": {"id": "be7a524e61a34e478e3aa8f29bd0dec5", "answers": {"answer_start": [353], "text": ["SECIS"]}}}, "fd731852e62b4642a89dd46fa8652318": {"prediction": {"id": "fd731852e62b4642a89dd46fa8652318", "prediction_text": "UTRs"}, "reference": {"id": "fd731852e62b4642a89dd46fa8652318", "answers": {"answer_start": [0], "text": ["SECIS"]}}}, "88f165d69ff44fa0ac198f1aeeadc64d": {"prediction": {"id": "88f165d69ff44fa0ac198f1aeeadc64d", "prediction_text": "proximal"}, "reference": {"id": "88f165d69ff44fa0ac198f1aeeadc64d", "answers": {"answer_start": [741], "text": ["SECIS"]}}}, "b0f63aee962d48e69f53d71d6706e261": {"prediction": {"id": "b0f63aee962d48e69f53d71d6706e261", "prediction_text": "SECIS"}, "reference": {"id": "b0f63aee962d48e69f53d71d6706e261", "answers": {"answer_start": [762], "text": ["SECIS"]}}}, "9fed7f47597f490db2562eb987efad65": {"prediction": {"id": "9fed7f47597f490db2562eb987efad65", "prediction_text": "selenocysteine insertion sequence (SECIS"}, "reference": {"id": "9fed7f47597f490db2562eb987efad65", "answers": {"answer_start": [311], "text": ["SECIS"]}}}, "db7d00df6242408791dcef65efe87192": {"prediction": {"id": "db7d00df6242408791dcef65efe87192", "prediction_text": "apical loop surmounting helix II"}, "reference": {"id": "db7d00df6242408791dcef65efe87192", "answers": {"answer_start": [712], "text": ["SECIS"]}}}, "665a0e49c10a4259b48a30a57f45a188": {"prediction": {"id": "665a0e49c10a4259b48a30a57f45a188", "prediction_text": "BCR-ABL"}, "reference": {"id": "665a0e49c10a4259b48a30a57f45a188", "answers": {"answer_start": [93], "text": ["The BCR/ABL gene fusion"]}}}, "f1b78bcf77fd4cb1b2242a8f8e079a03": {"prediction": {"id": "f1b78bcf77fd4cb1b2242a8f8e079a03", "prediction_text": "BCR/ABL"}, "reference": {"id": "f1b78bcf77fd4cb1b2242a8f8e079a03", "answers": {"answer_start": [4], "text": ["The BCR/ABL gene fusion"]}}}, "7b26cfed3abe464f9624963b17798086": {"prediction": {"id": "7b26cfed3abe464f9624963b17798086", "prediction_text": "BCR/ABL"}, "reference": {"id": "7b26cfed3abe464f9624963b17798086", "answers": {"answer_start": [1444], "text": ["The BCR/ABL gene fusion"]}}}, "94525b8b7de6487283ea38e34f4de8bd": {"prediction": {"id": "94525b8b7de6487283ea38e34f4de8bd", "prediction_text": "BCR-ABL"}, "reference": {"id": "94525b8b7de6487283ea38e34f4de8bd", "answers": {"answer_start": [1388], "text": ["ABL/BCR fusion"]}}}, "74521b2166164e9e94dc7548caddb31e": {"prediction": {"id": "74521b2166164e9e94dc7548caddb31e", "prediction_text": "BCR-ABL"}, "reference": {"id": "74521b2166164e9e94dc7548caddb31e", "answers": {"answer_start": [1426], "text": ["The BCR/ABL gene fusion"]}}}, "c8fb87382eb9435c833b57c7e1a3fae8": {"prediction": {"id": "c8fb87382eb9435c833b57c7e1a3fae8", "prediction_text": "BCR-ABL"}, "reference": {"id": "c8fb87382eb9435c833b57c7e1a3fae8", "answers": {"answer_start": [92], "text": ["The BCR/ABL gene fusion"]}}}, "c1a0363a05ed4b13abcb588d19b36441": {"prediction": {"id": "c1a0363a05ed4b13abcb588d19b36441", "prediction_text": "AML1-EVI1"}, "reference": {"id": "c1a0363a05ed4b13abcb588d19b36441", "answers": {"answer_start": [1469], "text": ["ABL/BCR fusion"]}}}, "af6c53df1d5644e3b77f6e7d3cb1024a": {"prediction": {"id": "af6c53df1d5644e3b77f6e7d3cb1024a", "prediction_text": "BCR/ABL"}, "reference": {"id": "af6c53df1d5644e3b77f6e7d3cb1024a", "answers": {"answer_start": [141], "text": ["The BCR/ABL gene fusion"]}}}, "9f3d76a23f394150ad93cdf5b7f1acf8": {"prediction": {"id": "9f3d76a23f394150ad93cdf5b7f1acf8", "prediction_text": "disorders"}, "reference": {"id": "9f3d76a23f394150ad93cdf5b7f1acf8", "answers": {"answer_start": [144], "text": ["Craniosynostosis"]}}}, "8d8ccd5320ef4137bcf37079744165ba": {"prediction": {"id": "8d8ccd5320ef4137bcf37079744165ba", "prediction_text": "clover-leaf skull"}, "reference": {"id": "8d8ccd5320ef4137bcf37079744165ba", "answers": {"answer_start": [25], "text": ["Craniosynostosis"]}}}, "4b483637ba014f7891fec501f16b8e63": {"prediction": {"id": "4b483637ba014f7891fec501f16b8e63", "prediction_text": "frontometaphyseal dysplasia"}, "reference": {"id": "4b483637ba014f7891fec501f16b8e63", "answers": {"answer_start": [389], "text": ["Craniosynostosis"]}}}, "5a3f08b460054c22b60a8f278c2cf23d": {"prediction": {"id": "5a3f08b460054c22b60a8f278c2cf23d", "prediction_text": "Cardiac abnormalities"}, "reference": {"id": "5a3f08b460054c22b60a8f278c2cf23d", "answers": {"answer_start": [117], "text": ["Craniosynostosis"]}}}, "3b141965106147779863f175a9dd4f9b": {"prediction": {"id": "3b141965106147779863f175a9dd4f9b", "prediction_text": "cervical vertebrae"}, "reference": {"id": "3b141965106147779863f175a9dd4f9b", "answers": {"answer_start": [1356], "text": ["Craniosynostosis"]}}}, "078c6c9f8a14445f822bce30fa0750c8": {"prediction": {"id": "078c6c9f8a14445f822bce30fa0750c8", "prediction_text": "obstructive apnea, foot deformity, and congenital weakness of the abdominal wall"}, "reference": {"id": "078c6c9f8a14445f822bce30fa0750c8", "answers": {"answer_start": [778], "text": ["Craniosynostosis"]}}}, "1db89e651c1741189c9218342bccfa18": {"prediction": {"id": "1db89e651c1741189c9218342bccfa18", "prediction_text": "perioperative and postoperative complications"}, "reference": {"id": "1db89e651c1741189c9218342bccfa18", "answers": {"answer_start": [55], "text": ["Craniosynostosis"]}}}, "1783bef6f7a84719bddb8b30122fb7a1": {"prediction": {"id": "1783bef6f7a84719bddb8b30122fb7a1", "prediction_text": "SGS"}, "reference": {"id": "1783bef6f7a84719bddb8b30122fb7a1", "answers": {"answer_start": [81], "text": ["Craniosynostosis"]}}}, "8531da492a514c5093b6c9e40379c6a6": {"prediction": {"id": "8531da492a514c5093b6c9e40379c6a6", "prediction_text": "prion"}, "reference": {"id": "8531da492a514c5093b6c9e40379c6a6", "answers": {"answer_start": [291], "text": ["The glutamine-rich prion-related domain (PRD)"]}}}, "59eb134437564569b0026aedc4b64fcd": {"prediction": {"id": "59eb134437564569b0026aedc4b64fcd", "prediction_text": "four"}, "reference": {"id": "59eb134437564569b0026aedc4b64fcd", "answers": {"answer_start": [435], "text": ["Hepcidin contains eight cysteine residues that form four disulfide bridges"]}}}, "206d145aaf004430a0bf77f7c547349f": {"prediction": {"id": "206d145aaf004430a0bf77f7c547349f", "prediction_text": "alpha-synuclein"}, "reference": {"id": "206d145aaf004430a0bf77f7c547349f", "answers": {"answer_start": [118], "text": ["alpha-Synuclein"]}}}, "40c490165326439699862479df068df1": {"prediction": {"id": "40c490165326439699862479df068df1", "prediction_text": "alpha-syn"}, "reference": {"id": "40c490165326439699862479df068df1", "answers": {"answer_start": [9], "text": ["alpha-Synuclein"]}}}, "217979bee3d948ba88adf9ca4e1c73fa": {"prediction": {"id": "217979bee3d948ba88adf9ca4e1c73fa", "prediction_text": "LB formation"}, "reference": {"id": "217979bee3d948ba88adf9ca4e1c73fa", "answers": {"answer_start": [619], "text": ["alpha-Synuclein"]}}}, "05db34385b244af88c90cc5bdf13e308": {"prediction": {"id": "05db34385b244af88c90cc5bdf13e308", "prediction_text": "soma"}, "reference": {"id": "05db34385b244af88c90cc5bdf13e308", "answers": {"answer_start": [742], "text": ["alpha-Synuclein"]}}}, "d524e5d96a214a98916a9527ed8caeb2": {"prediction": {"id": "d524e5d96a214a98916a9527ed8caeb2", "prediction_text": "LBs to tau pathology"}, "reference": {"id": "d524e5d96a214a98916a9527ed8caeb2", "answers": {"answer_start": [1376], "text": ["alpha-Synuclein"]}}}, "e25f1fd764ed456196871e66c2989ffe": {"prediction": {"id": "e25f1fd764ed456196871e66c2989ffe", "prediction_text": "SLA"}, "reference": {"id": "e25f1fd764ed456196871e66c2989ffe", "answers": {"answer_start": [177], "text": ["alpha-Synuclein"]}}}, "4e84581c149744ce985dbfcacb7a4fd7": {"prediction": {"id": "4e84581c149744ce985dbfcacb7a4fd7", "prediction_text": "alpha-Synuclein"}, "reference": {"id": "4e84581c149744ce985dbfcacb7a4fd7", "answers": {"answer_start": [195], "text": ["alpha-Synuclein"]}}}, "740bf9b1be33473ba914c3dca5d372bc": {"prediction": {"id": "740bf9b1be33473ba914c3dca5d372bc", "prediction_text": "immunohistochemically"}, "reference": {"id": "740bf9b1be33473ba914c3dca5d372bc", "answers": {"answer_start": [785], "text": ["alpha-Synuclein"]}}}, "c58b26e2dd66425aa0e30dfe32e21c08": {"prediction": {"id": "c58b26e2dd66425aa0e30dfe32e21c08", "prediction_text": "unaltered"}, "reference": {"id": "c58b26e2dd66425aa0e30dfe32e21c08", "answers": {"answer_start": [508], "text": ["alpha-Synuclein"]}}}, "705f31ad8c254b86ac1a951cd04d3684": {"prediction": {"id": "705f31ad8c254b86ac1a951cd04d3684", "prediction_text": "alphaSYN"}, "reference": {"id": "705f31ad8c254b86ac1a951cd04d3684", "answers": {"answer_start": [124], "text": ["alpha-Synuclein"]}}}, "f43ff4e2f93d46578d5ca490356e829f": {"prediction": {"id": "f43ff4e2f93d46578d5ca490356e829f", "prediction_text": "C-terminal"}, "reference": {"id": "f43ff4e2f93d46578d5ca490356e829f", "answers": {"answer_start": [1302], "text": ["alpha-Synuclein"]}}}, "560a73fbe944457bb731294bd06f3a82": {"prediction": {"id": "560a73fbe944457bb731294bd06f3a82", "prediction_text": "protein tau"}, "reference": {"id": "560a73fbe944457bb731294bd06f3a82", "answers": {"answer_start": [1661], "text": ["alpha-Synuclein"]}}}, "bac0666af1e14f2abef83d9eaab64731": {"prediction": {"id": "bac0666af1e14f2abef83d9eaab64731", "prediction_text": "alpha-synuclein"}, "reference": {"id": "bac0666af1e14f2abef83d9eaab64731", "answers": {"answer_start": [1220], "text": ["alpha-Synuclein"]}}}, "cd4046bc164d497b96a2f3632d74dbd2": {"prediction": {"id": "cd4046bc164d497b96a2f3632d74dbd2", "prediction_text": "hypermobile urethra"}, "reference": {"id": "cd4046bc164d497b96a2f3632d74dbd2", "answers": {"answer_start": [252], "text": ["stress urinary incontinence"]}}}, "0759e7200d2c4c4ab60c811def790da2": {"prediction": {"id": "0759e7200d2c4c4ab60c811def790da2", "prediction_text": "1-h pad test, 4-day bladder diary"}, "reference": {"id": "0759e7200d2c4c4ab60c811def790da2", "answers": {"answer_start": [246], "text": ["stress urinary incontinence"]}}}, "8ca92bc0af884290b1479c1a0cb7f6ec": {"prediction": {"id": "8ca92bc0af884290b1479c1a0cb7f6ec", "prediction_text": "SUI"}, "reference": {"id": "8ca92bc0af884290b1479c1a0cb7f6ec", "answers": {"answer_start": [325], "text": ["stress urinary incontinence"]}}}, "8f616e76a8e9467db52897f641a18738": {"prediction": {"id": "8f616e76a8e9467db52897f641a18738", "prediction_text": "stress"}, "reference": {"id": "8f616e76a8e9467db52897f641a18738", "answers": {"answer_start": [58], "text": ["stress urinary incontinence"]}}}, "e77d90d88d5d4e54a341ce09f9754645": {"prediction": {"id": "e77d90d88d5d4e54a341ce09f9754645", "prediction_text": "Preoperatively"}, "reference": {"id": "e77d90d88d5d4e54a341ce09f9754645", "answers": {"answer_start": [216], "text": ["stress urinary incontinence"]}}}, "03a4aff1f6a24b369fe3c64a1abb7f22": {"prediction": {"id": "03a4aff1f6a24b369fe3c64a1abb7f22", "prediction_text": "SUI"}, "reference": {"id": "03a4aff1f6a24b369fe3c64a1abb7f22", "answers": {"answer_start": [61], "text": ["stress urinary incontinence"]}}}, "c3508ca179894bb3a9b38935d40a37b5": {"prediction": {"id": "c3508ca179894bb3a9b38935d40a37b5", "prediction_text": "SUI"}, "reference": {"id": "c3508ca179894bb3a9b38935d40a37b5", "answers": {"answer_start": [90], "text": ["stress urinary incontinence"]}}}, "d4ce178bfff042fdbec3581d40aac2f3": {"prediction": {"id": "d4ce178bfff042fdbec3581d40aac2f3", "prediction_text": "stress"}, "reference": {"id": "d4ce178bfff042fdbec3581d40aac2f3", "answers": {"answer_start": [1490], "text": ["stress urinary incontinence"]}}}, "0ff3ac1ba56b4abd86f79266ddf9d6d8": {"prediction": {"id": "0ff3ac1ba56b4abd86f79266ddf9d6d8", "prediction_text": "mpMoRFsDB"}, "reference": {"id": "0ff3ac1ba56b4abd86f79266ddf9d6d8", "answers": {"answer_start": [941], "text": ["mpMoRFsDB"]}}}, "b65a7adcbbb142579958f2d61e88ce8b": {"prediction": {"id": "b65a7adcbbb142579958f2d61e88ce8b", "prediction_text": "catalyzed by the spliceosome, a highly complex and dynamic macromolecular machine composed of RNA and protein. Because of its complexity, biochemical analysis of the spliceosome has been previously limited to bulk assays in largely unfractionated cell extracts. We now report development of methodologies for studying the splicing of isolated single pre-mRNA molecules in real time. In this system, a fluorescently tagged pre-mRNA is tethered to a glass surface via its 3'-end. Splicing can be observed in Saccharomyces cerevisiae whole cell extract by monitoring loss of intron-specific fluorescence with a multi-wavelength total internal reflection fluorescence (TIRF) microscope. To prolong fluorophore lifetime, two enzyme-based O2 scavenging systems compatible with splicing were also developed. This work provides a powerful new approach for elucidating the mechanisms"}, "reference": {"id": "b65a7adcbbb142579958f2d61e88ce8b", "answers": {"answer_start": [4], "text": ["The excision of introns from nascent eukaryotic transcripts is catalyzed by the spliceosome."]}}}, "02e235bc15974bc5b99b7b5d2e7a49fa": {"prediction": {"id": "02e235bc15974bc5b99b7b5d2e7a49fa", "prediction_text": "P\u22640.013"}, "reference": {"id": "02e235bc15974bc5b99b7b5d2e7a49fa", "answers": {"answer_start": [10], "text": ["nerve growth factor"]}}}, "ba97264fd46e471ca142a1869eadbe6e": {"prediction": {"id": "ba97264fd46e471ca142a1869eadbe6e", "prediction_text": "pregnant cynomolgus monkeys"}, "reference": {"id": "ba97264fd46e471ca142a1869eadbe6e", "answers": {"answer_start": [26], "text": ["nerve growth factor"]}}}, "7df7ce88791a4aca8ce2abe56e7c49f3": {"prediction": {"id": "7df7ce88791a4aca8ce2abe56e7c49f3", "prediction_text": "500mg twice daily"}, "reference": {"id": "7df7ce88791a4aca8ce2abe56e7c49f3", "answers": {"answer_start": [72], "text": ["nerve growth factor"]}}}, "ba820764e12041c1b50aae2abe415868": {"prediction": {"id": "ba820764e12041c1b50aae2abe415868", "prediction_text": "potency"}, "reference": {"id": "ba820764e12041c1b50aae2abe415868", "answers": {"answer_start": [150, 171], "text": ["nerve growth factor", "NGF"]}}}, "cd756c972c014cccbd63d23c12400b3e": {"prediction": {"id": "cd756c972c014cccbd63d23c12400b3e", "prediction_text": "OA"}, "reference": {"id": "cd756c972c014cccbd63d23c12400b3e", "answers": {"answer_start": [325, 346], "text": ["nerve growth factor", "NGF"]}}}, "0b48bd9a691e4e48b813ec6ae4239853": {"prediction": {"id": "0b48bd9a691e4e48b813ec6ae4239853", "prediction_text": "optimization"}, "reference": {"id": "0b48bd9a691e4e48b813ec6ae4239853", "answers": {"answer_start": [0, 381], "text": ["nerve growth factor", "NGF"]}}}, "ccb782a35dd94ec0882dbfe98cd8229b": {"prediction": {"id": "ccb782a35dd94ec0882dbfe98cd8229b", "prediction_text": "novel analgesic therapeutics"}, "reference": {"id": "ccb782a35dd94ec0882dbfe98cd8229b", "answers": {"answer_start": [0, 21], "text": ["nerve growth factor", "NGF"]}}}, "9d13f61085f442608a5430825e5b0355": {"prediction": {"id": "9d13f61085f442608a5430825e5b0355", "prediction_text": "peptide hormones"}, "reference": {"id": "9d13f61085f442608a5430825e5b0355", "answers": {"answer_start": [145], "text": ["nerve growth factor"]}}}, "220dbdc374634c24827d751c41838b49": {"prediction": {"id": "220dbdc374634c24827d751c41838b49", "prediction_text": "C"}, "reference": {"id": "220dbdc374634c24827d751c41838b49", "answers": {"answer_start": [0, 934], "text": ["nerve growth factor", "NGF"]}}}, "4ea1fe1717eb45679fb25c610e27807c": {"prediction": {"id": "4ea1fe1717eb45679fb25c610e27807c", "prediction_text": "nerve growth factor, for the treatment of moderate to severe osteoarthritis in Japanese patients. Patients received tanezumab 10, 25, 50, 100, 200\u00a0\u03bcg/kg, or placebo and were followed for 92 or 120 days. Endpoints included the incidence of adverse events (AEs) and the change from baseline to week 8 in pain intensity and the Western Ontario and McMaster Universities Osteoarthritis (WOMAC) subscales. Patients (n\u00a0=\u00a083) were 69% female, age 44-73 years, with a Kellgren-Lawrence X-ray grade of 2-4. At week 8, compared with placebo, tanezumab 25, 100, and 200\u00a0\u03bcg/kg improved index knee pain during walking (-18.5,\u00a0-14.3, and\u00a0-27.6, respectively), index knee pain in the past 24\u00a0h (-19.1,\u00a0-14.6, and\u00a0-24.2, respectively), current index knee pain (-16.5,\u00a0-10.9, and\u00a0-22.8, respectively), and the WOMAC pain (-11.5,\u00a0-9.6, and\u00a0-18.8, respectively), physical function (-8.7,\u00a0-9.5, and\u00a0-17.6, respectively), and stiffness (-20.4,\u00a0-11.2, and\u00a0-10.2, respectively) subscales. Overall, seven patients reported AEs of abnormal peripheral sensation: allodynia (two in the tanezumab 200\u00a0\u03bcg/kg group); paresthesia (two in the tanezumab 200\u00a0\u03bcg/kg group"}, "reference": {"id": "4ea1fe1717eb45679fb25c610e27807c", "answers": {"answer_start": [83], "text": ["nerve growth factor"]}}}, "e55d8b558db24693b8a0fece7ea6a204": {"prediction": {"id": "e55d8b558db24693b8a0fece7ea6a204", "prediction_text": "17.6%, placebo 3.3%"}, "reference": {"id": "e55d8b558db24693b8a0fece7ea6a204", "answers": {"answer_start": [153], "text": ["nerve growth factor"]}}}, "e0ef6c94d1d14bfe980f631e9ca58e69": {"prediction": {"id": "e0ef6c94d1d14bfe980f631e9ca58e69", "prediction_text": "rats"}, "reference": {"id": "e0ef6c94d1d14bfe980f631e9ca58e69", "answers": {"answer_start": [38, 1214], "text": ["nerve growth factor", "NGF"]}}}, "89b89086074147cd9f0e8c353f67acef": {"prediction": {"id": "89b89086074147cd9f0e8c353f67acef", "prediction_text": "\u03b2-nerve growth factor"}, "reference": {"id": "89b89086074147cd9f0e8c353f67acef", "answers": {"answer_start": [727], "text": ["nerve growth factor"]}}}, "a0f14708673848daa64de49e24067470": {"prediction": {"id": "a0f14708673848daa64de49e24067470", "prediction_text": "opioids"}, "reference": {"id": "a0f14708673848daa64de49e24067470", "answers": {"answer_start": [44], "text": ["NGF"]}}}, "7f0222f55df04bda8a6e739408479df8": {"prediction": {"id": "7f0222f55df04bda8a6e739408479df8", "prediction_text": "pain therapy. Tanezumab (RN-624), a first-in-class recombinant humanized mAb targeting NGF"}, "reference": {"id": "7f0222f55df04bda8a6e739408479df8", "answers": {"answer_start": [273, 590], "text": ["nerve growth factor", "NGF"]}}}, "8c5d976b4f35459a89c4c98658f46ed8": {"prediction": {"id": "8c5d976b4f35459a89c4c98658f46ed8", "prediction_text": "NGF"}, "reference": {"id": "8c5d976b4f35459a89c4c98658f46ed8", "answers": {"answer_start": [390, 925], "text": ["nerve growth factor", "NGF"]}}}, "28b345ae87c5456a83bbf0f997919054": {"prediction": {"id": "28b345ae87c5456a83bbf0f997919054", "prediction_text": "NGF for pain"}, "reference": {"id": "28b345ae87c5456a83bbf0f997919054", "answers": {"answer_start": [271, 422], "text": ["nerve growth factor", "NGF"]}}}, "9cba28dd3364423a996e730eef346184": {"prediction": {"id": "9cba28dd3364423a996e730eef346184", "prediction_text": "nerve growth factor"}, "reference": {"id": "9cba28dd3364423a996e730eef346184", "answers": {"answer_start": [130], "text": ["nerve growth factor"]}}}, "2bc5f9da0133432a908ff41c5af08dfe": {"prediction": {"id": "2bc5f9da0133432a908ff41c5af08dfe", "prediction_text": "nerve growth factor and reduces chronic pain"}, "reference": {"id": "2bc5f9da0133432a908ff41c5af08dfe", "answers": {"answer_start": [43], "text": ["nerve growth factor"]}}}, "94aab590ff484625af512432f4a680b5": {"prediction": {"id": "94aab590ff484625af512432f4a680b5", "prediction_text": "nerve growth factor (NGF) and the pathophysiology of persistent pain. Anti-NGF could be an alternative drug treatment for low back pain. Systematically review the efficacy and safety of anti-NGF in the treatment of low back pain. A systematic review of the literature with no language, date or publication status restriction, using Medline, EMBASE, Cochrane Library, and the clinicaltrials.gov database. Additional literature was retrieved by conferring with experts in the field or reviewing bibliographies and annals of meetings and congresses. Search terms included \"monoclonal antibodies,\" \"nerve growth factor,\" \"anti-ngf"}, "reference": {"id": "94aab590ff484625af512432f4a680b5", "answers": {"answer_start": [817, 845], "text": ["nerve growth factor", "NGF"]}}}, "86b0c744a8cd40c8a9befb92dc43456b": {"prediction": {"id": "86b0c744a8cd40c8a9befb92dc43456b", "prediction_text": "7%"}, "reference": {"id": "86b0c744a8cd40c8a9befb92dc43456b", "answers": {"answer_start": [269], "text": ["nerve growth factor"]}}}, "5efda0846d194cd0b840649fca9369d7": {"prediction": {"id": "5efda0846d194cd0b840649fca9369d7", "prediction_text": "NGF"}, "reference": {"id": "5efda0846d194cd0b840649fca9369d7", "answers": {"answer_start": [786, 807], "text": ["nerve growth factor", "NGF"]}}}, "b0fb65d7550b44099b1f66856c6accf4": {"prediction": {"id": "b0fb65d7550b44099b1f66856c6accf4", "prediction_text": "PHN"}, "reference": {"id": "b0fb65d7550b44099b1f66856c6accf4", "answers": {"answer_start": [83], "text": ["nerve growth factor"]}}}}